1
|
Ghilardi G, Fraietta JA, Gerson JN, Van Deerlin VM, Morrissette JJD, Caponetti GC, Paruzzo L, Harris JC, Chong EA, Susanibar Adaniya SP, Svoboda J, Nasta SD, Ugwuanyi OH, Landsburg DJ, Fardella E, Waxman AJ, Chong ER, Patel V, Pajarillo R, Kulikovskaya I, Lieberman DB, Cohen AD, Levine BL, Stadtmauer EA, Frey NV, Vogl DT, Hexner EO, Barta SK, Porter DL, Garfall AL, Schuster SJ, June CH, Ruella M. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy. Nat Med 2024; 30:984-989. [PMID: 38266761 DOI: 10.1038/s41591-024-02826-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Accepted: 01/22/2024] [Indexed: 01/26/2024]
Abstract
We report a T cell lymphoma (TCL) occurring 3 months after anti-CD19 chimeric antigen receptor (CAR) T cell immunotherapy for non-Hodgkin B cell lymphoma. The TCL was diagnosed from a thoracic lymph node upon surgery for lung cancer. The TCL exhibited CD8+ cytotoxic phenotype and a JAK3 variant, while the CAR transgene was very low. The T cell clone was identified at low levels in the blood before CAR T infusion and in lung cancer. To assess the overall risk of secondary primary malignancy after commercial CAR T (CD19, BCMA), we analyzed 449 patients treated at the University of Pennsylvania. At a median follow-up of 10.3 months, 16 patients (3.6%) had a secondary primary malignancy. The median onset time was 26.4 and 9.7 months for solid and hematological malignancies, respectively. The projected 5-year cumulative incidence is 15.2% for solid and 2.3% for hematological malignancies. Overall, one case of TCL was observed, suggesting a low risk of TCL after CAR T.
Collapse
Affiliation(s)
- Guido Ghilardi
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Joseph A Fraietta
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - James N Gerson
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Vivianna M Van Deerlin
- Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Personalized Diagnostics, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Jennifer J D Morrissette
- Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Personalized Diagnostics, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Gabriel C Caponetti
- Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Luca Paruzzo
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Jaryse C Harris
- Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Elise A Chong
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Sandra P Susanibar Adaniya
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Jakub Svoboda
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Sunita D Nasta
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Ositadimma H Ugwuanyi
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Daniel J Landsburg
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Eugenio Fardella
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Adam J Waxman
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Emeline R Chong
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Vrutti Patel
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Raymone Pajarillo
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Irina Kulikovskaya
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
| | - David B Lieberman
- Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Personalized Diagnostics, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Adam D Cohen
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Bruce L Levine
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
| | - Edward A Stadtmauer
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Noelle V Frey
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Dan T Vogl
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Elizabeth O Hexner
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Stefan K Barta
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - David L Porter
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Alfred L Garfall
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA
| | - Stephen J Schuster
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
| | - Carl H June
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA
| | - Marco Ruella
- Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
- Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
- Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
| |
Collapse
|
2
|
Hasanali ZS, Garfall AL, Burzenski L, Shultz LD, Tang Y, Kadu S, Sheppard NC, Dopkin D, Vogl DT, Cohen AD, Waxman AJ, Susanibar-Adaniya SP, Carroll M, Stadtmauer EA, Allman D. Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice. bioRxiv 2024:2024.01.21.576547. [PMID: 38328086 PMCID: PMC10849475 DOI: 10.1101/2024.01.21.576547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/09/2024]
Abstract
Multiple myeloma is a largely incurable and life-threatening malignancy of antibody-secreting plasma cells. An effective and widely available animal model that recapitulates human myeloma and related plasma cell disorders is lacking. We show that busulfan-conditioned hIL-6 transgenic NSG mice (NSG+hIL6) reliably support the engraftment of malignant and pre-malignant human plasma cells including from patients diagnosed with monoclonal gammopathy of undetermined significance, pre- and post-relapse myeloma, plasma cell leukemia, and AL amyloidosis. Consistent with human disease, NSG+hIL6 mice engrafted with patient-derived myeloma cells, developed serum M spikes, and a majority developed anemia, hypercalcemia, and/or bone lesions. Single cell RNA sequencing showed non-malignant and malignant cell engraftment, the latter expressing a wide array of mRNAs associated with myeloma cell survival and proliferation. Myeloma engrafted mice given CAR T-cells targeting plasma cells or bortezomib experienced reduced tumor burden. Our results establish NSG+hIL6 mice as an effective patient derived xenograft model for study and preclinical drug development of multiple myeloma and related plasma cell disorders.
Collapse
|
3
|
Tang Y, Liu W, Kadu S, Johnson O, Hasanali ZS, Kelly A, Shestov A, Pajarillo R, Greenblatt E, Holmes M, Wang LP, Shih N, O’Connor RS, Ruella M, Garfall AL, Allman D, Vogl DT, Cohen A, June CH, Sheppard NC. Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy. Blood 2024; 143:139-151. [PMID: 37616575 PMCID: PMC10862366 DOI: 10.1182/blood.2022018658] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Revised: 06/22/2023] [Accepted: 07/15/2023] [Indexed: 08/26/2023] Open
Abstract
ABSTRACT Patients with multiple myeloma (MM) treated with B-cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T cells usually relapse with BCMA+ disease, indicative of CAR T-cell suppression. CD200 is an immune checkpoint that is overexpressed on aberrant plasma cells (aPCs) in MM and is an independent negative prognostic factor for survival. However, CD200 is not present on MM cell lines, a potential limitation of current preclinical models. We engineered MM cell lines to express CD200 at levels equivalent to those found on aPCs in MM and show that these are sufficient to suppress clinical-stage CAR T-cells targeting BCMA or the Tn glycoform of mucin 1 (TnMUC1), costimulated by 4-1BB and CD2, respectively. To prevent CD200-mediated suppression of CAR T cells, we compared CRISPR-Cas9-mediated knockout of the CD200 receptor (CD200RKO), to coexpression of versions of the CD200 receptor that were nonsignaling, that is, dominant negative (CD200RDN), or that leveraged the CD200 signal to provide CD28 costimulation (CD200R-CD28 switch). We found that the CD200R-CD28 switch potently enhanced the polyfunctionality of CAR T cells, and improved cytotoxicity, proliferative capacity, CAR T-cell metabolism, and performance in a chronic antigen exposure assay. CD200RDN provided modest benefits, but surprisingly, the CD200RKO was detrimental to CAR T-cell activity, adversely affecting CAR T-cell metabolism. These patterns held up in murine xenograft models of plasmacytoma, and disseminated bone marrow predominant disease. Our findings underscore the importance of CD200-mediated immune suppression in CAR T-cell therapy of MM, and highlight a promising approach to enhance such therapies by leveraging CD200 expression on aPCs to provide costimulation via a CD200R-CD28 switch.
Collapse
Affiliation(s)
- Yan Tang
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
| | - Wei Liu
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
| | - Siddhant Kadu
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
| | - Omar Johnson
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
| | - Zainul S. Hasanali
- Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Andre Kelly
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
| | - Alexander Shestov
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
| | - Raymone Pajarillo
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
- Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | | | | | - Li-Ping Wang
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Natalie Shih
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Roddy S. O’Connor
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Marco Ruella
- Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Alfred L. Garfall
- Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - David Allman
- Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Dan T. Vogl
- Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Adam Cohen
- Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Carl H. June
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Neil C. Sheppard
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
| |
Collapse
|
4
|
Garfall AL, Cohen AD, Susanibar-Adaniya SP, Hwang WT, Vogl DT, Waxman AJ, Lacey SF, Gonzalez VE, Fraietta JA, Gupta M, Kulikovskaya I, Tian L, Chen F, Koterba N, Bartoszek RL, Patchin M, Xu R, Plesa G, Siegel DL, Brennan A, Nelson AM, Ferthio R, Cosey A, Shea KM, Leskowitz R, Four M, Wilson WV, Miao F, Lancaster E, Carreno BM, Linette GP, Hexner EO, Young RM, Bu D, Mansfield KG, Brogdon JL, June CH, Milone MC, Stadtmauer EA. Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy. Blood Cancer Discov 2023; 4:118-133. [PMID: 36413381 PMCID: PMC9975770 DOI: 10.1158/2643-3230.bcd-22-0074] [Citation(s) in RCA: 18] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2022] [Revised: 09/16/2022] [Accepted: 11/16/2022] [Indexed: 11/23/2022] Open
Abstract
We conducted a phase I clinical trial of anti-BCMA chimeric antigen receptor T cells (CART-BCMA) with or without anti-CD19 CAR T cells (huCART19) in multiple myeloma (MM) patients responding to third- or later-line therapy (phase A, N = 10) or high-risk patients responding to first-line therapy (phase B, N = 20), followed by early lenalidomide or pomalidomide maintenance. We observed no high-grade cytokine release syndrome (CRS) and only one instance of low-grade neurologic toxicity. Among 15 subjects with measurable disease, 10 exhibited partial response (PR) or better; among 26 subjects responding to prior therapy, 9 improved their response category and 4 converted to minimal residual disease (MRD)-negative complete response/stringent complete response. Early maintenance therapy was safe, feasible, and coincided in some patients with CAR T-cell reexpansion and late-onset, durable clinical response. Outcomes with CART-BCMA + huCART19 were similar to CART-BCMA alone. Collectively, our results demonstrate favorable safety, pharmacokinetics, and antimyeloma activity of dual-target CAR T-cell therapy in early lines of MM treatment. SIGNIFICANCE CAR T cells in early lines of MM therapy could be safer and more effective than in the advanced setting, where prior studies have focused. We evaluated the safety, pharmacokinetics, and efficacy of CAR T cells in patients with low disease burden, responding to current therapy, combined with standard maintenance therapy. This article is highlighted in the In This Issue feature, p. 101.
Collapse
Affiliation(s)
- Alfred L. Garfall
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Adam D. Cohen
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Sandra P. Susanibar-Adaniya
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Wei-Ting Hwang
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
- Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Dan T. Vogl
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Adam J. Waxman
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Simon F. Lacey
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Vanessa E. Gonzalez
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Joseph A. Fraietta
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Minnal Gupta
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Irina Kulikovskaya
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Lifeng Tian
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Fang Chen
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Natalka Koterba
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Robert L. Bartoszek
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Margaret Patchin
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Rong Xu
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Gabriela Plesa
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Don L. Siegel
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Andrea Brennan
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Anne Marie Nelson
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Regina Ferthio
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Angela Cosey
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Kim-Marie Shea
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Rachel Leskowitz
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Megan Four
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Wesley V. Wilson
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Fei Miao
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Eric Lancaster
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Beatriz M. Carreno
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Gerald P. Linette
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Elizabeth O. Hexner
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Regina M. Young
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Dexiu Bu
- Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
| | | | | | - Carl H. June
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Michael C. Milone
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Edward A. Stadtmauer
- Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| |
Collapse
|
5
|
Lin C, Garcia-Gerique L, Bonner EE, Mastio J, Rosenwasser M, Cruz Z, Lawler M, Bernabei L, Muthumani K, Liu Q, Poncz M, Vogl T, Törngren M, Eriksson H, Vogl DT, Gabrilovich DI, Nefedova Y. S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes. Cancer Res Commun 2023; 3:420-430. [PMID: 36923707 PMCID: PMC10010194 DOI: 10.1158/2767-9764.crc-22-0368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 12/30/2022] [Accepted: 02/14/2023] [Indexed: 02/22/2023]
Abstract
Multiple myeloma is characterized by clonal proliferation of plasma cells that accumulate preferentially in the bone marrow (BM). The tumor microenvironment is one of the leading factors that promote tumor progression. Neutrophils and monocytes are a major part of the BM tumor microenvironment, but the mechanism of their contribution to multiple myeloma progression remains unclear. Here, we describe a novel mechanism by which S100A8/S100A9 proteins produced by BM neutrophils and monocytes promote the expansion of megakaryocytes supporting multiple myeloma progression. S100A8/S100A9 alone was not sufficient to drive megakaryopoiesis but markedly enhanced the effect of thrombopoietin, an effect that was mediated by Toll-like receptor 4 and activation of the STAT5 transcription factor. Targeting S100A9 with tasquinimod as a single agent and in combination with lenalidomide and with proteasome inhibitors has potent antimyeloma effect that is at least partly independent of the adaptive immune system. This newly identified axis of signaling involving myeloid cells and megakaryocytes may provide a new avenue for therapeutic targeting in multiple myeloma. Significance We identified a novel mechanism by which myeloid cells promote myeloma progression independently of the adaptive immune system. Specifically, we discovered a novel role of S100A8/S100A9, the most abundant proteins produced by neutrophils and monocytes, in regulation of myeloma progression via promotion of the megakaryocyte expansion and angiogenesis. Tasquinimod, an inhibitor of S100A9, has potent antimyeloma effects as a single agent and in combination with lenalidomide and with proteasome inhibitors.
Collapse
Affiliation(s)
- Cindy Lin
- The Wistar Institute, Philadelphia, Pennsylvania
| | | | | | - Jerome Mastio
- The Wistar Institute, Philadelphia, Pennsylvania
- ICC, Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom
| | | | - Zachary Cruz
- The Wistar Institute, Philadelphia, Pennsylvania
| | | | - Luca Bernabei
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Kar Muthumani
- The Wistar Institute, Philadelphia, Pennsylvania
- GeneOne Life Science, Inc, Fort Washington, Pennsylvania
| | - Qin Liu
- The Wistar Institute, Philadelphia, Pennsylvania
| | - Mortimer Poncz
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | | | | | | | - Dan T. Vogl
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Dmitry I. Gabrilovich
- The Wistar Institute, Philadelphia, Pennsylvania
- ICC, Early Oncology R&D, AstraZeneca, Gaithersburg, Maryland
| | | |
Collapse
|
6
|
Hoeynck BW, Cohen AD, Stadtmauer EA, Susanibar-Adaniya SP, Vogl DT, Waxman AJ, Bardsley M, Le S, LaMaestra L, Garfall AL. Progressive multifocal leukoencephalopathy in multiple myeloma. Eur J Haematol Suppl 2023; 110:322-329. [PMID: 36465014 DOI: 10.1111/ejh.13909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Revised: 11/28/2022] [Accepted: 11/30/2022] [Indexed: 12/12/2022]
Abstract
Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal demyelinating disease of the central nervous system caused by reactivation of the JC virus in the context of immune suppression such as HIV, malignancy, and certain immunomodulatory medications. PML has been reported only rarely in multiple myeloma patients, and its presenting features and natural history in this population are not well known. We describe six cases of PML among multiple myeloma patients treated at our institution between 2013 and 2022, including two that developed on or shortly after treatment with recently developed BCMA-directed immunotherapies.
Collapse
Affiliation(s)
- Brian W Hoeynck
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Adam D Cohen
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Edward A Stadtmauer
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Sandra P Susanibar-Adaniya
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Dan T Vogl
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Adam J Waxman
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Mark Bardsley
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Samantha Le
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Lexis LaMaestra
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Alfred L Garfall
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
7
|
Dawson MA, Borthakur G, Huntly BJ, Karadimitris A, Alegre A, Chaidos A, Vogl DT, Pollyea DA, Davies FE, Morgan GJ, Glass JL, Kamdar M, Mateos MV, Tovar N, Yeh P, Delgado RG, Basheer F, Marando L, Gallipoli P, Wyce A, Krishnatry AS, Barbash O, Bakirtzi E, Ferron-Brady G, Karpinich NO, McCabe MT, Foley SW, Horner T, Dhar A, Kremer BE, Dickinson M. A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies. Clin Cancer Res 2023; 29:711-722. [PMID: 36350312 PMCID: PMC9932578 DOI: 10.1158/1078-0432.ccr-22-1284] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Revised: 08/02/2022] [Accepted: 11/07/2022] [Indexed: 11/10/2022]
Abstract
PURPOSE Molibresib is a selective, small molecule inhibitor of the bromodomain and extra-terminal (BET) protein family. This was an open-label, two-part, Phase I/II study investigating molibresib monotherapy for the treatment of hematological malignancies (NCT01943851). PATIENTS AND METHODS Part 1 (dose escalation) determined the recommended Phase 2 dose (RP2D) of molibresib in patients with acute myeloid leukemia (AML), Non-Hodgkin lymphoma (NHL), or multiple myeloma. Part 2 (dose expansion) investigated the safety and efficacy of molibresib at the RP2D in patients with relapsed/refractory myelodysplastic syndrome (MDS; as well as AML evolved from antecedent MDS) or cutaneous T-cell lymphoma (CTCL). The primary endpoint in Part 1 was safety and the primary endpoint in Part 2 was objective response rate (ORR). RESULTS There were 111 patients enrolled (87 in Part 1, 24 in Part 2). Molibresib RP2Ds of 75 mg daily (for MDS) and 60 mg daily (for CTCL) were selected. Most common Grade 3+ adverse events included thrombocytopenia (37%), anemia (15%), and febrile neutropenia (15%). Six patients achieved complete responses [3 in Part 1 (2 AML, 1 NHL), 3 in Part 2 (MDS)], and 7 patients achieved partial responses [6 in Part 1 (4 AML, 2 NHL), 1 in Part 2 (MDS)]. The ORRs for Part 1, Part 2, and the total study population were 10% [95% confidence interval (CI), 4.8-18.7], 25% (95% CI, 7.3-52.4), and 13% (95% CI, 6.9-20.6), respectively. CONCLUSIONS While antitumor activity was observed with molibresib, use was limited by gastrointestinal and thrombocytopenia toxicities. Investigations of molibresib as part of combination regimens may be warranted.
Collapse
Affiliation(s)
- Mark A. Dawson
- Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia
| | - Gautam Borthakur
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | | | - Anastasios Karadimitris
- Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
| | - Adrian Alegre
- Hospital Universitario de La Princesa and Quironsalud, Madrid, Spain
| | - Aristeidis Chaidos
- Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
| | - Dan T. Vogl
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | | | - Faith E. Davies
- Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York
| | - Gareth J. Morgan
- Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York
| | - Jacob L. Glass
- Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Manali Kamdar
- University of Colorado School of Medicine, Aurora, Colorado
| | | | - Natalia Tovar
- Hospital Clínic, University of Barcelona, Barcelona, Spain
| | - Paul Yeh
- Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Michael Dickinson
- Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia
| |
Collapse
|
8
|
Deng H, Lin C, Garcia-Gerique L, Fu S, Cruz Z, Bonner EE, Rosenwasser M, Rajagopal S, Sadhu MN, Gajendran C, Zainuddin M, Gosu R, Sivanandhan D, Shelef MA, Nam B, Vogl DT, Gabrilovich DI, Nefedova Y. A novel selective inhibitor JBI-589 targets PAD4-mediated neutrophil migration to suppress tumor progression. Cancer Res 2022; 82:3561-3572. [PMID: 36069973 PMCID: PMC9532374 DOI: 10.1158/0008-5472.can-21-4045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2021] [Revised: 06/02/2022] [Accepted: 08/16/2022] [Indexed: 11/16/2022]
Abstract
Neutrophils are closely involved in the regulation of tumor progression and formation of pre-metastatic niches. However, the mechanisms of their involvement and therapeutic regulation of these processes remain elusive. Here, we report a critical role of neutrophil peptidylarginine deiminase 4 (PAD4) in neutrophil migration in cancer. In several transplantable and genetically engineered mouse models, tumor growth was accompanied by significantly elevated enzymatic activity of neutrophil PAD4. Targeted deletion of PAD4 in neutrophils markedly decreased the intratumoral abundance of neutrophils and led to delayed growth of primary tumors and dramatically reduced lung metastases. PAD4 mediated neutrophil accumulation by regulating the expression of the major chemokine receptor CXCR2. PAD4 expression and activity as well as CXCR2 expression were significantly upregulated in neutrophils from patients with lung and colon cancers compared to healthy donors, and PAD4 and CXCR2 expression were positively correlated in neutrophils from cancer patients. In tumor-bearing mice, pharmacological inhibition of PAD4 with the novel PAD4 isoform-selective small molecule inhibitor JBI-589 resulted in reduced CXCR2 expression and blocked neutrophil chemotaxis. In mouse tumor models, targeted deletion of PAD4 in neutrophils or pharmacological inhibition of PAD4 with JBI-589 reduced both primary tumor growth and lung metastases and substantially enhanced the effect of immune checkpoint inhibitors. Taken together, these results suggest a therapeutic potential of targeting PAD4 in cancer.
Collapse
Affiliation(s)
- Hui Deng
- The Wistar Institute, Philadelphia, PA, United States
| | - Cindy Lin
- The Wistar Institute, Philadelphia, Pennsylvania, United States
| | | | - Shuyu Fu
- The Wistar Institute, Philadelphia, PA, United States
| | | | - Erin E Bonner
- The Wistar Institute, Philadelphia, PA, United States
| | | | | | - M Naveen Sadhu
- Jubilant Therapeutics Inc, Bedminster, New Jersey, United States
| | | | - Mohd Zainuddin
- Jubilant Therapeutics Inc, Bedminster, New Jersey, United States
| | | | | | | | - Brian Nam
- The Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE, United States
| | - Dan T Vogl
- University of Pennsylvania, Philadelphia, PA, United States
| | | | - Yulia Nefedova
- The Wistar Institute, Philadelphia, Pennsylvania, United States
| |
Collapse
|
9
|
Cornell RF, Baz R, Richter JR, Rossi A, Vogl DT, Chen C, Shustik C, Alvarez MJ, Shen Y, Unger TJ, Ben-Shahar O, Wang H, Baloglu E, Senapedis W, Ma X, Landesman Y, Bai X, Bader J, Xu H, Marshall T, Chang H, Walker CJ, Shah J, Shacham S, Kauffman MG, Hofmeister CC. A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. Am J Hematol 2022; 97:E54-E58. [PMID: 34817872 DOI: 10.1002/ajh.26420] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2021] [Revised: 10/29/2021] [Accepted: 11/16/2021] [Indexed: 11/11/2022]
Affiliation(s)
| | - Rachid Baz
- Moffitt Cancer Center, Tampa, Florida, USA
| | - Joshua R Richter
- Hackensack University John Theurer Cancer Center, Hackensack, New Jersey, USA
| | - Adriana Rossi
- Weill Cornell Medical College Myeloma Center, New York, New York, USA
| | - Dan T Vogl
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Christine Chen
- UHN Princess Margaret Cancer Centre, Toronto, Ontario, Canada
| | - Chaim Shustik
- McGill University Health Centre, Montreal, Quebec, Canada
| | | | - Yao Shen
- DarwinHealth Inc., New York, New York, USA
| | - T J Unger
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | | | - Hongwei Wang
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | - Erkan Baloglu
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | | | - Xiwen Ma
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | | | - Xiang Bai
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | - Justin Bader
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | - Hongmei Xu
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | | | - Hua Chang
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | | | - Jatin Shah
- Karyopharm Therapeutics Inc, Newton, Massachusetts, USA
| | | | | | | |
Collapse
|
10
|
Chen H, Li Z, Feng S, Richard-Greenblatt M, Hutson E, Andrianus S, Glaser LJ, Rodino KG, Qian J, Jayaraman D, Collman RG, Glascock A, Bushman FD, Lee JS, Cherry S, Fausto A, Weiss SR, Koo H, Corby PM, Oceguera A, O’Doherty U, Garfall AL, Vogl DT, Stadtmauer EA, Wang P. Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking. Clin Chem 2021; 68:230-239. [PMID: 34383886 PMCID: PMC8436368 DOI: 10.1093/clinchem/hvab158] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Accepted: 08/02/2021] [Indexed: 11/12/2022]
Abstract
BACKGROUND High-sensitivity severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen assays are desirable to mitigate false negative results. Limited data are available to quantify and track SARS-CoV-2 antigen burden in respiratory samples from different populations. METHODS We developed the Microbubbling SARS-CoV-2 Antigen Assay (MSAA) with smartphone readout, with a limit of detection of 0.5 pg/mL (10.6 fmol/L) nucleocapsid antigen or 4000 copies/mL inactivated SARS-CoV-2 virus in nasopharyngeal (NP) swabs. We developed a computer vision and machine learning-based automatic microbubble image classifier to accurately identify positives and negatives and quantified and tracked antigen dynamics in intensive care unit coronavirus disease 2019 (COVID-19) inpatients and immunocompromised COVID-19 patients. RESULTS Compared to qualitative reverse transcription-polymerase chain reaction methods, the MSAA demonstrated a positive percentage agreement of 97% (95% CI 92%-99%) and a negative percentage agreement of 97% (95% CI 94%-100%) in a clinical validation study with 372 residual clinical NP swabs. In immunocompetent individuals, the antigen positivity rate in swabs decreased as days-after-symptom-onset increased, despite persistent nucleic acid positivity. Antigen was detected for longer and variable periods of time in immunocompromised patients with hematologic malignancies. Total microbubble volume, a quantitative marker of antigen burden, correlated inversely with cycle threshold values and days-after-symptom-onset. Viral sequence variations were detected in patients with long duration of high antigen burden. CONCLUSIONS The MSAA enables sensitive and specific detection of acute infections and quantification and tracking of antigen burden and may serve as a screening method in longitudinal studies to identify patients who are likely experiencing active rounds of ongoing replication and warrant close viral sequence monitoring.
Collapse
Affiliation(s)
- Hui Chen
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Zhao Li
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Sheng Feng
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | | | - Emily Hutson
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Stefen Andrianus
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Laurel J Glaser
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Kyle G Rodino
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Jianing Qian
- Department of Computer and Information Science and GRASP Lab, University of Pennsylvania, Philadelphia, PA, USA
| | - Dinesh Jayaraman
- Department of Computer and Information Science and GRASP Lab, University of Pennsylvania, Philadelphia, PA, USA
| | - Ronald G Collman
- Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Abigail Glascock
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA, USA
| | - Frederic D Bushman
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA, USA
| | - Jae Seung Lee
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Sara Cherry
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Alejandra Fausto
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA, USA
| | - Susan R Weiss
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA, USA
| | - Hyun Koo
- Department of Orthodontics, Divisions of Pediatric Dentistry and Community of Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Center for Innovation & Precision Dentistry, School of Dental Medicine and School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA
| | - Patricia M Corby
- Department of Orthodontics, Divisions of Pediatric Dentistry and Community of Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Center for Innovation & Precision Dentistry, School of Dental Medicine and School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA
- Department of Oral Medicine, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA, Center for Clinical and Translational Research, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Alfonso Oceguera
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Una O’Doherty
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Alfred L Garfall
- Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Dan T Vogl
- Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | | | - Ping Wang
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
11
|
Dispenzieri A, Krishnan AY, Arendt B, Dasari S, Efebera YA, Geller N, Giralt S, Hahn T, Kohlhagen MC, Landau HJ, Hari P, Pasquini MC, Qazilbash MH, McCarthy PL, Shah N, Vesole DH, Vogl DT, Wallace PK, Stadtmauer EA, Murray DL. MASS-FIX versus standard methods to predict for PFS and OS among multiple myeloma patients participating on the STAMINA trial. J Clin Oncol 2021. [DOI: 10.1200/jco.2021.39.15_suppl.8009] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8009 Background: Measuring response among patients with multiple myeloma is essential for the care of patients. Deeper responses have been associated with better progression free survival (PFS) and overall survival (OS). Serum (SIFE) and urine immunofixation are the currently used markers for biochemical documentation of CR after which marrow is tested for plasma cell clearance. Next generation flow cytometry and sequencing are used to document the presence of minimal residual disease (MRD). Mass spectrometry of blood by MALDI (Mass-Fix) is a new simple, inexpensive, sensitive, and specific means of detecting monoclonal immunoglobulins. To better test the hypothesis that Mass-Fix is superior to existing methodologies to predict for survival outcomes—especially SIFE-- samples from the STAMINA trial (NCT01109004), a trial comparing 3 transplant approaches among patients who have already received induction, were employed. Methods: Five-hundred and seventy-five patients were included. Samples from enrollment post-induction (post-I) and 1-year post enrollment (1YR) were tested when available. Four response parameters were assessed univariately: Mass-Fix, SIFE, complete response, and MRD by next generation flow cytometry. Mass spectrometry spectra were evaluated in a blinded fashion. Complete response was according to the 2006 International Myeloma Working Group criteria. Multivariate Cox proportional hazard models using stepwise regression were developed to explore the independent effect of the different response parameters on PFS and OS and interactions with other risk factors. Results: Of the 4 response measures, only MRD and Mass-Fix predicted for PFS and OS at multiple testing points on multivariate analyses (Table). Of the 4 post-I measurements, only MRD predicted for PFS; however, Mass-Fix was the only post-I measurement to predict for OS. Of all the 1-year measures, both 1YR Mass-Fix and 1YR MRD positivity predicted for inferior PFS and OS. In models including MRD and Mass-Fix, SIFE and CR were not prognostic for PFS or OS. Conclusions: Mass-Fix is a powerful means to track monoclonal proteins. The full utility of Mass-Fix was not exploited given the absence of a diagnostic sample and the fact that only serum (and not urine) was tested. Despite these limitations, it performed well at pre-induction and at 1 year. Mass-Fix provides a convenient and non-invasive means of predicting for myeloma outcomes. Clinical trial information: NCT01109004. [Table: see text]
Collapse
Affiliation(s)
| | | | | | - Surendra Dasari
- Department of Health Sciences Research, Mayo Clinic, Rochester, MN
| | | | - Nancy Geller
- NIH - NHLBI Government Agency Partners, Bethesda, MD
| | - Sergio Giralt
- Memorial Sloan Kettering Cancer Center, New York, NY
| | - Theresa Hahn
- Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | | | | | | | | | - Muzaffar H. Qazilbash
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
| | | | - Nina Shah
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - David H. Vesole
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
| | - Dan T. Vogl
- University of Pennsylvania, Philadelphia, PA
| | | | | | | |
Collapse
|
12
|
Vogl DT, Sallée V, Hendricks MC, Redlinger Tabery C, Blair ML, Dahlmeier E, Meagher EA, Cohen RB, Vonderheide RH. A unique window of opportunity for practical reform of cancer clinical trials. Cancer 2021; 127:2855-2860. [PMID: 33849079 DOI: 10.1002/cncr.33585] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2021] [Revised: 03/15/2021] [Accepted: 03/22/2021] [Indexed: 11/11/2022]
Abstract
With rapid modifications in cancer clinical trial operations necessitated by the global pandemic over the last year, there is now an unprecedented opportunity to reform clinical research permanently and solidify innovative practices that have clearly been effective. On the basis of the authors' experience and recommendations from other institutions, a set of specific proposals for clinical trial reform are identified that can be implemented immediately by sponsors, regulators, and study sites. Improvements in clinical trial processes should include increased leverage of technology to facilitate remote trial activity and electronic documents, more efficient and effective communication of adverse event information, and better study design to optimize inclusion criteria, required research procedures, and data collection. The authors suggest that such reform will preserve patient safety and study integrity, address unnecessary and inefficient pre-pandemic constraints, improve access to clinical trials for patients, and speed improvements in cancer care.
Collapse
Affiliation(s)
- Dan T Vogl
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Vicki Sallée
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Maria C Hendricks
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Colleen Redlinger Tabery
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Meghan L Blair
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Erica Dahlmeier
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Emma A Meagher
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Roger B Cohen
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Robert H Vonderheide
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.,Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| |
Collapse
|
13
|
Chen H, Li Z, Feng S, Wang A, Richard-Greenblatt M, Hutson E, Andrianus S, Glaser LJ, Rodino KG, Qian J, Jayaraman D, Collman RG, Glascock A, Bushman FD, Lee JS, Cherry S, Fausto A, Weiss SR, Koo H, Corby PM, O’Doherty U, Garfall AL, Vogl DT, Stadtmauer EA, Wang P. Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Dynamics Tracking. medRxiv 2021:2021.03.17.21253847. [PMID: 33791710 PMCID: PMC8010739 DOI: 10.1101/2021.03.17.21253847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Background Little is known about the dynamics of SARS-CoV-2 antigen burden in respiratory samples in different patient populations at different stages of infection. Current rapid antigen tests cannot quantitate and track antigen dynamics with high sensitivity and specificity in respiratory samples. Methods We developed and validated an ultra-sensitive SARS-CoV-2 antigen assay with smartphone readout using the Microbubbling Digital Assay previously developed by our group, which is a platform that enables highly sensitive detection and quantitation of protein biomarkers. A computer vision-based algorithm was developed for microbubble smartphone image recognition and quantitation. A machine learning-based classifier was developed to classify the smartphone images based on detected microbubbles. Using this assay, we tracked antigen dynamics in serial swab samples from COVID patients hospitalized in ICU and immunocompromised COVID patients. Results The limit of detection (LOD) of the Microbubbling SARS-CoV-2 Antigen Assay was 0.5 pg/mL (10.6 fM) recombinant nucleocapsid (N) antigen or 4000 copies/mL inactivated SARS-CoV-2 virus in nasopharyngeal (NP) swabs, comparable to many rRT-PCR methods. The assay had high analytical specificity towards SARS-CoV-2. Compared to EUA-approved rRT-PCR methods, the Microbubbling Antigen Assay demonstrated a positive percent agreement (PPA) of 97% (95% confidence interval (CI), 92-99%) in symptomatic individuals within 7 days of symptom onset and positive SARS-CoV-2 nucleic acid results, and a negative percent agreement (NPA) of 97% (95% CI, 94-100%) in symptomatic and asymptomatic individuals with negative nucleic acid results. Antigen positivity rate in NP swabs gradually decreased as days-after-symptom-onset increased, despite persistent nucleic acid positivity of the same samples. The computer vision and machine learning-based automatic microbubble image classifier could accurately identify positives and negatives, based on microbubble counts and sizes. Total microbubble volume, a potential marker of antigen burden, correlated inversely with Ct values and days-after-symptom-onset. Antigen was detected for longer periods of time in immunocompromised patients with hematologic malignancies, compared to immunocompetent individuals. Simultaneous detectable antigens and nucleic acids may indicate the presence of replicating viruses in patients with persistent infections. Conclusions The Microbubbling SARS-CoV-2 Antigen Assay enables sensitive and specific detection of acute infections, and quantitation and tracking of antigen dynamics in different patient populations at various stages of infection. With smartphone compatibility and automated image processing, the assay is well-positioned to be adapted for point-of-care diagnosis and to explore the clinical implications of antigen dynamics in future studies.
Collapse
Affiliation(s)
- Hui Chen
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Zhao Li
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Sheng Feng
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Anni Wang
- Bioengineering Graduate Program, University of Pennsylvania, Philadelphia, PA
| | | | - Emily Hutson
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Stefen Andrianus
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Laurel J. Glaser
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Kyle G. Rodino
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Jianing Qian
- Department of Computer and Information Science and GRASP Lab, University of Pennsylvania, Philadelphia, PA
| | - Dinesh Jayaraman
- Department of Computer and Information Science and GRASP Lab, University of Pennsylvania, Philadelphia, PA
| | - Ronald G. Collman
- Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Abigail Glascock
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA
| | - Frederic D. Bushman
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA
| | - Jae Seung Lee
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Sara Cherry
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Alejandra Fausto
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA
| | - Susan R. Weiss
- Department of Microbiology and Penn Center for Research on Coronavirus and Other Emerging Pathogens, University of Pennsylvania, Philadelphia, PA
| | - Hyun Koo
- Department of Orthodontics, Divisions of Pediatric Dentistry and Community of Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA
- Center for Innovation & Precision Dentistry, School of Dental Medicine and School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA
| | - Patricia M. Corby
- Center for Innovation & Precision Dentistry, School of Dental Medicine and School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA
- Department of Oral Medicine, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA
- Center for Clinical and Translational Research, University of Pennsylvania, Philadelphia, PA
| | - Una O’Doherty
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
| | - Alfred L. Garfall
- Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | - Dan T. Vogl
- Department of Medicine, University of Pennsylvania, Philadelphia, PA
| | | | - Ping Wang
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
- Bioengineering Graduate Program, University of Pennsylvania, Philadelphia, PA
| |
Collapse
|
14
|
Bernabei L, Tian L, Garfall AL, Melenhorst JJ, Lacey SF, Stadtmauer EA, Vogl DT, Gonzalez VE, Plesa G, Young RM, Waxman A, Levine BL, June CH, Milone MC, Cohen AD. B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy. Br J Haematol 2021; 193:851-855. [PMID: 33713436 DOI: 10.1111/bjh.17397] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Luca Bernabei
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Lifeng Tian
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Alfred L Garfall
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - J Joseph Melenhorst
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Simon F Lacey
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Edward A Stadtmauer
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Dan T Vogl
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Vanessa E Gonzalez
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Gabriela Plesa
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Regina M Young
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Adam Waxman
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Bruce L Levine
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Carl H June
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Michael C Milone
- Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Adam D Cohen
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
15
|
Hogan JJ, Vogl DT. Untangling immunotactoid glomerulopathy in the MGRS era. Kidney Int 2021; 99:303-305. [PMID: 33509349 DOI: 10.1016/j.kint.2020.09.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Revised: 08/31/2020] [Accepted: 09/01/2020] [Indexed: 12/31/2022]
Abstract
Immunotactoid glomerulopathy (ITG) is a rare disease diagnosed by kidney biopsy showing characteristic microtubules, often in parallel arrays, in glomeruli on electron microscopy. Most cases are caused by lymphoproliferative disorders that produce monoclonal immunoglobulins that cause kidney damage, but these disorders do not meet criteria for overt malignancy. The published literature on ITG is limited. In this issue of Kidney International, 2 manuscripts provide significant insight into the clinical presentation, pathology, and treatment of ITG.
Collapse
Affiliation(s)
- Jonathan J Hogan
- Division of Nephrology Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
| | - Dan T Vogl
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
16
|
Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, Hensley SE, Gill S, Vogl DT, Maillard I, Babushok DV, Huang AC, Nasta SD, Walsh JC, Wiletyo EP, Gimotty PA, Milone MC, Amaravadi RK. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA Intern Med 2021; 181:195-202. [PMID: 33001138 PMCID: PMC7527945 DOI: 10.1001/jamainternmed.2020.6319] [Citation(s) in RCA: 122] [Impact Index Per Article: 40.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
IMPORTANCE Health care workers (HCWs) caring for patients with coronavirus disease 2019 (COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, to our knowledge, there is no effective pharmacologic prophylaxis for individuals at risk. OBJECTIVE To evaluate the efficacy of hydroxychloroquine to prevent transmission of SARS-CoV-2 in hospital-based HCWs with exposure to patients with COVID-19 using a pre-exposure prophylaxis strategy. DESIGN, SETTING, AND PARTICIPANTS This randomized, double-blind, placebo-controlled clinical trial (the Prevention and Treatment of COVID-19 With Hydroxychloroquine Study) was conducted at 2 tertiary urban hospitals, with enrollment from April 9, 2020, to July 14, 2020; follow-up ended August 4, 2020. The trial randomized 132 full-time, hospital-based HCWs (physicians, nurses, certified nursing assistants, emergency technicians, and respiratory therapists), of whom 125 were initially asymptomatic and had negative results for SARS-CoV-2 by nasopharyngeal swab. The trial was terminated early for futility before reaching a planned enrollment of 200 participants. INTERVENTIONS Hydroxychloroquine, 600 mg, daily, or size-matched placebo taken orally for 8 weeks. MAIN OUTCOMES AND MEASURES The primary outcome was the incidence of SARS-CoV-2 infection as determined by a nasopharyngeal swab during the 8 weeks of treatment. Secondary outcomes included adverse effects, treatment discontinuation, presence of SARS-CoV-2 antibodies, frequency of QTc prolongation, and clinical outcomes for SARS-CoV-2-positive participants. RESULTS Of the 132 randomized participants (median age, 33 years [range, 20-66 years]; 91 women [69%]), 125 (94.7%) were evaluable for the primary outcome. There was no significant difference in infection rates in participants randomized to receive hydroxychloroquine compared with placebo (4 of 64 [6.3%] vs 4 of 61 [6.6%]; P > .99). Mild adverse events were more common in participants taking hydroxychloroquine compared with placebo (45% vs 26%; P = .04); rates of treatment discontinuation were similar in both arms (19% vs 16%; P = .81). The median change in QTc (baseline to 4-week evaluation) did not differ between arms (hydroxychloroquine: 4 milliseconds; 95% CI, -9 to 17; vs placebo: 3 milliseconds; 95% CI, -5 to 11; P = .98). Of the 8 participants with positive results for SARS-CoV-2 (6.4%), 6 developed viral symptoms; none required hospitalization, and all clinically recovered. CONCLUSIONS AND RELEVANCE In this randomized clinical trial, although limited by early termination, there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT04329923.
Collapse
Affiliation(s)
- Benjamin S Abella
- Department of Emergency Medicine, University of Pennsylvania, Philadelphia
| | - Eliana L Jolkovsky
- Department of Emergency Medicine, University of Pennsylvania, Philadelphia
| | - Barbara T Biney
- Department of Emergency Medicine, University of Pennsylvania, Philadelphia
| | - Julie E Uspal
- Department of Emergency Medicine, University of Pennsylvania, Philadelphia
| | - Matthew C Hyman
- Division of Cardiology, Department of Medicine University of Pennsylvania, Philadelphia
| | - Ian Frank
- Division of Infectious Disease, Department of Medicine University of Pennsylvania, Philadelphia
| | - Scott E Hensley
- Department of Microbiology, University of Pennsylvania, Philadelphia
| | - Saar Gill
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | - Dan T Vogl
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | - Ivan Maillard
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | - Daria V Babushok
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | - Alexander C Huang
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | - Sunita D Nasta
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | - Jennifer C Walsh
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | - E Paul Wiletyo
- Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia
| | - Phyllis A Gimotty
- Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia
| | - Michael C Milone
- Department of Pathology, University of Pennsylvania, Philadelphia
| | - Ravi K Amaravadi
- Abramson Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia
| | | |
Collapse
|
17
|
Richardson PG, Jagannath S, Chari A, Vogl DT, Dimopoulos MA, Moreau P, Dingli D, Wei L, Richter J, Biran N, Siegel D, Reichmann W, Li L, Tang S, Saint‐Martin J, Joshi A, Kauffman M, Shah J, Shacham S, Lonial S. Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma. eJHaem 2021; 2:48-55. [PMID: 35846096 PMCID: PMC9175889 DOI: 10.1002/jha2.120] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 10/06/2020] [Accepted: 10/09/2020] [Indexed: 11/09/2022]
Affiliation(s)
- Paul G. Richardson
- Jerome Lipper Multiple Myeloma Center Department of Medical Oncology Dana‐Farber Cancer Institute Harvard Medical School Boston Massachusetts
| | | | - Ajai Chari
- Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York
| | - Dan T. Vogl
- Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania
| | | | | | | | - Lee‐Jen Wei
- Harvard T.H. Chan School of Public Health Boston Massachusetts
| | - Joshua Richter
- Myeloma Division John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey
| | - Noa Biran
- Myeloma Division John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey
| | - David Siegel
- Myeloma Division John Theurer Cancer Center Hackensack University Medical Center Hackensack New Jersey
| | | | - Lingling Li
- Karyopharm Therapeutics Inc. Newton Massachusetts USA
| | - Shijie Tang
- Karyopharm Therapeutics Inc. Newton Massachusetts USA
| | | | - Anita Joshi
- Karyopharm Therapeutics Inc. Newton Massachusetts USA
| | | | - Jatin Shah
- Karyopharm Therapeutics Inc. Newton Massachusetts USA
| | | | - Sagar Lonial
- Winship Cancer Institute of Emory University Atlanta Georgia USA
| |
Collapse
|
18
|
Gavriatopoulou M, Chari A, Chen C, Bahlis N, Vogl DT, Jakubowiak A, Dingli D, Cornell RF, Hofmeister CC, Siegel D, Berdeja JG, Reece D, White D, Lentzsch S, Gasparetto C, Huff CA, Jagannath S, Baz R, Nooka AK, Richter J, Abonour R, Parker TL, Yee AJ, Moreau P, Lonial S, Tuchman S, Weisel KC, Mohty M, Choquet S, Unger TJ, Li K, Chai Y, Li L, Shah J, Shacham S, Kauffman MG, Dimopoulos MA. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia 2020; 34:2430-2440. [PMID: 32094461 PMCID: PMC7449872 DOI: 10.1038/s41375-020-0756-6] [Citation(s) in RCA: 42] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 02/07/2020] [Accepted: 02/10/2020] [Indexed: 12/23/2022]
Abstract
Selinexor is an oral, small molecule inhibitor of the nuclear export protein exportin 1 with demonstrated activity in hematologic and solid malignancies. Side effects associated with selinexor include nausea, vomiting, fatigue, diarrhea, decreased appetite, weight loss, thrombocytopenia, neutropenia, and hyponatremia. We reviewed 437 patients with multiple myeloma treated with selinexor and assessed the kinetics of adverse events and impact of supportive care measures. Selinexor reduced both platelets and neutrophils over the first cycle of treatment and reached a nadir between 28 and 42 days. Platelet transfusions and thrombopoietin receptor agonists were effective at treating thrombocytopenia, and granulocyte colony stimulating factors were effective at resolving neutropenia. The onset of gastrointestinal side effects (nausea, vomiting, and diarrhea) was most common during the first 1-2 weeks of treatment. Nausea could be mitigated with 5-HT3 antagonists and either neurokinin 1 receptor antagonists, olanzapine, or cannbainoids. Loperamide and bismuth subsalicylate ameliorated diarrhea. The primary constitutional side effects of fatigue and decreased appetite could be managed with methylphenidate, megestrol, cannabinoids or olanzapine, respectively. Hyponatremia was highly responsive to sodium replacement. Selinexor has well-established adverse effects that mainly occur within the first 8 weeks of treatment, are reversible, and respond to supportive care.
Collapse
Affiliation(s)
- Maria Gavriatopoulou
- Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
| | - Ajai Chari
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Christine Chen
- Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Nizar Bahlis
- Charbonneau Cancer Research Institute, Calgary, AB, Canada
| | - Dan T Vogl
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | | | | | | | - Craig C Hofmeister
- Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH, USA
| | - David Siegel
- Department of Hematology, John Theurer Cancer Center, Hackensack, NJ, USA
| | | | - Donna Reece
- Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Darrell White
- QEII Health Sciences Center, Dalhousie University, Halifax, NS, Canada
| | - Suzanne Lentzsch
- Department of Medicine, Division of Hematology/Oncology, Columbia University, New York, NY, USA
| | | | | | - Sundar Jagannath
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Rachid Baz
- Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - Ajay K Nooka
- Winship Cancer Institute, Emory University, Atlanta, GA, USA
| | - Joshua Richter
- Department of Hematology, John Theurer Cancer Center, Hackensack, NJ, USA
| | - Rafat Abonour
- Indiana University Cancer Center, Indianapolis, IN, USA
| | | | - Andrew J Yee
- Massachusetts General Hospital Cancer Center, Boston, MA, USA
| | | | - Sagar Lonial
- Winship Cancer Institute, Emory University, Atlanta, GA, USA
| | - Sascha Tuchman
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA
| | - Katja C Weisel
- University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
| | | | | | - T J Unger
- Karyopharm Therapeutics, Newton, MA, USA
| | - Kai Li
- Karyopharm Therapeutics, Newton, MA, USA
| | - Yi Chai
- Karyopharm Therapeutics, Newton, MA, USA
| | | | - Jatin Shah
- Karyopharm Therapeutics, Newton, MA, USA
| | | | | | | |
Collapse
|
19
|
Hari P, Pasquini MC, Stadtmauer EA, Fraser R, Fei M, Devine SM, Efebera YA, Geller N, Horowitz MM, Koreth J, Landau HJ, McCarthy PL, Qazilbash MH, Shah N, Vesole DH, Vogl DT, Somlo G, Krishnan AY, Giralt S. Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM). J Clin Oncol 2020. [DOI: 10.1200/jco.2020.38.15_suppl.8506] [Citation(s) in RCA: 42] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8506 Background: STaMINA was a phase III trial comparing progression-free survival (PFS) among 758 pts randomized to: 1. second autoHCT then lenalidomide (Len) maintenance (Auto/Auto, n = 247); 2. consolidation with Len/bortezomib/ dexamethasone (RVD) followed by Len maintenance (Auto/RVD, 254); 3. Len maintenance (Auto/Len, 257). All three arms were similar (Stadtmauer JCO 2018). Len maintenance was designed to continue for 3 years and amended to allow continuation until disease progression through a follow up protocol (07LT, NCT#02322320). We report 6 yr follow up for STaMINA and the results of Len discontinuation beyond 3 years. Methods: 07LT was offered to pts who were progression-free at 38 mo; completed planned Len maintenance and were within 4 years of BMT CTN 0702 follow up. Among 431 07LT eligible patients, 273 enrolled and 179 opted to continue maintenance until disease progression. All patients enrolled in STaMINA were reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) and long-term outcomes for patients not enrolled on 07LT (N = 166) were available through this mechanism. Before combining 07LT data and CIBMTR data for LTFU analysis, outcomes in both databases were analyzed separately and confirmed to be comparable. Results: Using intent-to-treat (ITT), 6yr PFS and overall survival (OS) was the same among Auto/Auto (43.9%; 73.1%), Auto/RVD (39.7%, 74.9%) and Auto/Len (40.9%, 76.4%)(p = 0.6; p = 0.8). Protocol defined high risk disease, (HR = 1.53, p < 0.0001) and age (p = 0.03) were adverse risks for PFS. In as treated analysis, 6yr PFS were 49.4%, 39.7% and 38.6% for Auto/auto (170), Auto/RVD (222) and Auto/Len (361), respectively (p = 0.01). 6yr PFS in high risk pts as treated analysis were 43.6% and 26% for Auto/auto and Auto/Len, respectively (p = 0.03). Landmark analysis at 38 mo included 215 pts who continued Len maintenance (either on 07LT study or commercial Len) vs. 207 who stopped. Baseline demographics; study arm on 0702, induction pre-autoHCT were similar. Len discontinuation after 38 mo was associated with inferior PFS (79.5% vs. 61% at 5yr; HR = 1.91, p = 0.0004) but similar OS. Incidence of all second primary malignancies (SPM)(81 cases with 43 heme-malignancies) was associated with age. Conclusions: Long term outcomes are similar using ITT, but as treated analysis suggested a PFS benefit for tandem autoHCT, driven mainly by pts with high risk MM. Len discontinuation even at 38 mo was associated with inferior PFS. Clinical trial information: NCT02322320 .
Collapse
Affiliation(s)
- Parameswaran Hari
- CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
| | - Marcelo C. Pasquini
- CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
| | | | - Raphael Fraser
- CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
| | - Mingwei Fei
- CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
| | - Steven Michael Devine
- CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
| | | | - Nancy Geller
- NIH - NHLBI Government Agency Partners, Bethesda, MD
| | - Mary M. Horowitz
- CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
| | | | | | | | - Muzaffar H. Qazilbash
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Nina Shah
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - David H. Vesole
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
| | - Dan T. Vogl
- University of Pennsylvania, Philadelphia, PA
| | | | | | - Sergio Giralt
- Memorial Sloan Kettering Cancer Center, New York, NY
| |
Collapse
|
20
|
Li M, Lin C, Deng H, Strnad J, Bernabei L, Vogl DT, Burke JJ, Nefedova Y. A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Mol Cancer Ther 2020; 19:1530-1538. [PMID: 32371579 DOI: 10.1158/1535-7163.mct-19-1020] [Citation(s) in RCA: 71] [Impact Index Per Article: 17.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2019] [Revised: 03/25/2020] [Accepted: 05/01/2020] [Indexed: 12/27/2022]
Abstract
Multiple myeloma is a plasma cell malignancy, which grows in the bone marrow (BM). The major population of cells in the BM is represented by neutrophils and they can form neutrophil extracellular traps (NET). Here, we investigated whether multiple myeloma cells induce NET formation and whether targeting this process would delay multiple myeloma progression. We demonstrated that murine and human multiple myeloma cells stimulate citrullination of histone H3 and NET formation by neutrophils and that this process is abrogated by pharmacological targeting of peptidylarginine deiminase 4 (PAD4) with a novel-specific small molecule inhibitor BMS-P5. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression. Taken together, our data demonstrate that targeting PAD4 may be beneficial for treatment of multiple myeloma.
Collapse
Affiliation(s)
- Marina Li
- Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania
| | - Cindy Lin
- Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania
| | - Hui Deng
- Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania
| | | | - Luca Bernabei
- Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Dan T Vogl
- Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
| | | | - Yulia Nefedova
- Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, Pennsylvania.
| |
Collapse
|
21
|
Chari A, Vogl DT, Jagannath S, Jasielec J, Unger TJ, DeCastro A, Shah J, Kauffman M, Shacham S, Jakubowiak A. Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy. Br J Haematol 2020; 189:e126-e130. [DOI: 10.1111/bjh.16550] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Ajai Chari
- Icahn School of Medicine at Mount Sanai New York NY USA
| | - Dan T. Vogl
- Abramson Cancer Center Perelman School of Medicine University of Pennsylvania Philadelphia PA USA
| | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Affiliation(s)
| | - Dan T Vogl
- University of Pennsylvania, Philadelphia, PA
| | | |
Collapse
|
23
|
Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. N Engl J Med 2019; 381:727-738. [PMID: 31433920 DOI: 10.1056/nejmoa1903455] [Citation(s) in RCA: 396] [Impact Index Per Article: 79.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Selinexor, a selective inhibitor of nuclear export compound that blocks exportin 1 (XPO1) and forces nuclear accumulation and activation of tumor suppressor proteins, inhibits nuclear factor κB, and reduces oncoprotein messenger RNA translation, is a potential novel treatment for myeloma that is refractory to current therapeutic options. METHODS We administered oral selinexor (80 mg) plus dexamethasone (20 mg) twice weekly to patients with myeloma who had previous exposure to bortezomib, carfilzomib, lenalidomide, pomalidomide, daratumumab, and an alkylating agent and had disease refractory to at least one proteasome inhibitor, one immunomodulatory agent, and daratumumab (triple-class refractory). The primary end point was overall response, defined as a partial response or better, with response assessed by an independent review committee. Clinical benefit, defined as a minimal response or better, was a secondary end point. RESULTS A total of 122 patients in the United States and Europe were included in the modified intention-to-treat population (primary analysis), and 123 were included in the safety population. The median age was 65 years, and the median number of previous regimens was 7; a total of 53% of the patients had high-risk cytogenetic abnormalities. A partial response or better was observed in 26% of patients (95% confidence interval, 19 to 35), including two stringent complete responses; 39% of patients had a minimal response or better. The median duration of response was 4.4 months, median progression-free survival was 3.7 months, and median overall survival was 8.6 months. Fatigue, nausea, and decreased appetite were common and were typically grade 1 or 2 (grade 3 events were noted in up to 25% of patients, and no grade 4 events were reported). Thrombocytopenia occurred in 73% of the patients (grade 3 in 25% and grade 4 in 33%). Thrombocytopenia led to bleeding events of grade 3 or higher in 6 patients. CONCLUSIONS Selinexor-dexamethasone resulted in objective treatment responses in patients with myeloma refractory to currently available therapies. (Funded by Karyopharm Therapeutics; STORM ClinicalTrials.gov number, NCT02336815.).
Collapse
Affiliation(s)
- Ajai Chari
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Dan T Vogl
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Maria Gavriatopoulou
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Ajay K Nooka
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Andrew J Yee
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Carol A Huff
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Philippe Moreau
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - David Dingli
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Craig Cole
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Sagar Lonial
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Meletios Dimopoulos
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - A Keith Stewart
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Joshua Richter
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Ravi Vij
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Sascha Tuchman
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Marc S Raab
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Katja C Weisel
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Michel Delforge
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Robert F Cornell
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - David Kaminetzky
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - James E Hoffman
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Luciano J Costa
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Terri L Parker
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Moshe Levy
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Martin Schreder
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Nathalie Meuleman
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Laurent Frenzel
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Mohamad Mohty
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Sylvain Choquet
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Gary Schiller
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Raymond L Comenzo
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Monika Engelhardt
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Thomas Illmer
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Philip Vlummens
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Chantal Doyen
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Thierry Facon
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Lionel Karlin
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Aurore Perrot
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Klaus Podar
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Michael G Kauffman
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Sharon Shacham
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Lingling Li
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Shijie Tang
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Carla Picklesimer
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Jean-Richard Saint-Martin
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Marsha Crochiere
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Hua Chang
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Samir Parekh
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Yosef Landesman
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Jatin Shah
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Paul G Richardson
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| | - Sundar Jagannath
- From the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (A.C., S.P., S.J.), and New York University Langone Medical Center (D.K.) - both in New York; the Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.T.V.); the School of Medicine, National and Kapodistrian University of Athens, Athens (M.G., M. Dimopoulos); the Winship Cancer Institute, Emory University, Atlanta (A.K.N., S.L.); Massachusetts General Hospital Cancer Center (A.J.Y.), Tufts Medical Center (R.L.C.), and the Dana-Farber Cancer Institute (P.G.R.), Boston, and Karyopharm Therapeutics, Newton (M.G.K., S.S., L.L., S. Tang, C.P., J.-R.S.-M., M.C., H.C., Y.L., J.S.) - all in Massachusetts; Johns Hopkins University, Baltimore (C.A.H.); the University of Nantes, Nantes (P.M.), Hôpital Necker (L.F.), Hôpital Saint-Antoine (M.M.), and La Pitié-Salpêtrière Hospital (S.C.), Paris, University Hospital, Lille (T.F.), Centre Hospitalier Lyon Sud, Pierre-Benite (L.K.), and Centre Hospitalo-Universitaire Vandoeuvre-lès-Nancy, Nancy (A.P.) - all in France; the Mayo Clinic, Rochester, MN (D.D.); the University of Michigan, Ann Arbor (C.C.); the Mayo Clinic of Arizona, Phoenix (A.K.S.); Hackensack University Medical Center, Hackensack, NJ (J.R.); Washington University School of Medicine, St. Louis (R.V.); Lineberger Comprehensive Cancer Center at University of North Carolina-Chapel Hill, Chapel Hill (S. Tuchman); the University of Heidelberg, Heidelberg (M.S.R.), University Medical Center Hamburg-Eppendorf, Hamburg (K.C.W.), the University of Tübingen, Tübingen (K.C.W.), University Hospital Würzburg, Würzburg (M.S.), the University of Freiburg, Freiburg (M.E.), and Gemeinschaftspraxis Hämatologie-Onkologie, Dresden (T.I.) - all in Germany; the University of Leuven, Leuven (M. Delforge), Institut Jules Bordet, Université Libre de Bruxelles, Brussels (N.M.), University Hospital Ghent, Ghent (P.V.), and Centre Hospitalier Universitaire Université Catholique de Louvain Namur, Yvoir (C.D.) - all in Belgium; Vanderbilt University Medical Center, Nashville (R.F.C.); Sylvester Cancer Center, University of Miami, Miami (J.E.H.); the University of Alabama at Birmingham, Birmingham (L.J.C.); Yale School of Medicine, New Haven, CT (T.L.P.); Baylor University Medical Center, Dallas (M.L.); the David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles (G.S.); and University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (K.P.)
| |
Collapse
|
24
|
Cornell RF, Ky B, Weiss BM, Dahm CN, Gupta DK, Du L, Carver JR, Cohen AD, Engelhardt BG, Garfall AL, Goodman SA, Harrell SL, Kassim AA, Jadhav T, Jagasia M, Moslehi J, O’Quinn R, Savona MR, Slosky D, Smith A, Stadtmauer EA, Vogl DT, Waxman A, Lenihan D. Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma. J Clin Oncol 2019; 37:1946-1955. [PMID: 31188726 PMCID: PMC9798911 DOI: 10.1200/jco.19.00231] [Citation(s) in RCA: 105] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
PURPOSE Cardiovascular adverse events (CVAEs) can occur during proteasome inhibitor (PI) therapy. We conducted a prospective, observational, multi-institutional study to define risk factors and outcomes in patients with multiple myeloma (MM) receiving PIs. PATIENTS AND METHODS Patients with relapsed MM initiating carfilzomib- or bortezomib-based therapy underwent baseline assessments and repeated assessments at regular intervals over 6 months, including cardiac biomarkers (troponin I or T, brain natriuretic peptide [BNP], and N-terminal proBNP), ECG, and echocardiography. Monitoring occurred over 18 months for development of CVAEs. RESULTS Of 95 patients enrolled, 65 received carfilzomib and 30 received bortezomib, with median 25 months of follow-up. Sixty-four CVAEs occurred, with 55% grade 3 or greater in severity. CVAEs occurred in 51% of patients treated with carfilzomib and 17% of those treated with bortezomib (P = .002). Median time to first CVAE from treatment start was 31 days, and 86% occurred within the first 3 months. Patients receiving carfilzomib-based therapy with a baseline elevated BNP level higher than 100 pg/mL or N-terminal proBNP level higher than 125 pg/mL had increased risk for CVAE (odds ratio, 10.8; P < .001). Elevated natriuretic peptides occurring mid-first cycle of treatment with carfilzomib were associated with a substantially higher risk of CVAEs (odds ratio, 36.0; P < .001). Patients who experienced a CVAE had inferior progression-free survival (log-rank P = .01) and overall survival (log-rank P < .001). PI therapy was safely resumed in 89% of patients, although 41% required chemotherapy modifications. CONCLUSION CVAEs are common during PI therapy for relapsed MM, especially with carfilzomib, particularly within the first 3 months of therapy. CVAEs were associated with worse overall outcomes, but usually, discontinuation of therapy was not required. Natriuretic peptides were highly predictive of CVAEs; however, validation of this finding is necessary before uniform incorporation into the routine management of patients receiving carfilzomib.
Collapse
Affiliation(s)
- Robert F. Cornell
- Vanderbilt University Medical Center, Nashville, TN,Robert F. Cornell, MS, MD, Division of Hematology and Oncology, Vanderbilt University Medical Center, 777 Preston Research Building, Nashville, TN 37232; Twitter: @myeloma_doc_com; e-mail:
| | - Bonnie Ky
- University of Pennsylvania, Philadelphia, PA
| | | | | | | | - Liping Du
- Vanderbilt University Medical Center, Nashville, TN
| | - Joseph R. Carver
- University of Pennsylvania, Philadelphia, PA,Abramson Cancer Center, Penn Medicine, Philadelphia, PA
| | - Adam D. Cohen
- Abramson Cancer Center, Penn Medicine, Philadelphia, PA
| | | | | | | | | | | | | | | | | | | | | | - David Slosky
- Vanderbilt University Medical Center, Nashville, TN
| | | | | | - Dan T. Vogl
- Abramson Cancer Center, Penn Medicine, Philadelphia, PA
| | - Adam Waxman
- Abramson Cancer Center, Penn Medicine, Philadelphia, PA
| | | |
Collapse
|
25
|
Lin C, Herlihy SE, Li M, Deng H, Bernabei L, Gabrilovich DI, Vogl DT, Nefedova Y. Abstract 2103: NETs promote tumor resistance to anthracyclines. Cancer Res 2019. [DOI: 10.1158/1538-7445.am2019-2103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Multiple Myeloma (MM) is an incurable blood cancer characterized by the clonal proliferation of plasma cells that accumulate in the bone marrow (BM). Resistance to chemotherapy represents one of the main challenges in the treatment of this disease. We have previously shown that neutrophils, one of the major cellular populations in the BM, protect MM cells from chemotherapies including anthracyclines; however, the mechanisms of this effect remain unknown. Thus, we set out to investigate the mechanisms by which neutrophils reduce sensitivity of tumor cells to anthracyclines. Neutrophil extracellular traps (NETs) are structures composed of chromatin and protein formed by neutrophils that are a part of an innate immune mechanism of binding and killing pathogens. Recently, NETs have been shown to form in cancer patients as well as tumor-bearing animals and have been implicated in solid tumor progression; however, their role in hematological malignancies remain poorly understood. Utilizing an in vitro culture system, we demonstrated that MM cells were able to induce NET formation by BM neutrophils. Interestingly, neutrophils isolated from the BM of patients with MM have a significantly higher ability to produce NETs in response to tumor cells as compared to BM neutrophils from donors. NET formation was accompanied by an increase in the level of extracellular DNA. Using imaging flow cytometry and confocal microscopy we demonstrated that extracellular DNA is internalized by tumor cells and localizes to the cytoplasm. This internalized DNA was able to bind to doxorubicin and other anthracyclines thereby reducing their cytotoxic effects. Significantly increased cell-free DNA levels were detected in BM aspirates from MM patients as well as in tumor-bearing mice. Targeting the extracellular DNA in vivo using the clinically available DNase, Pulmozyme, restored the sensitivity of tumor cells to doxorubicin resulting in prolonged survival of tumor-bearing animals. Here, we have identified a novel mechanism of resistance to anthracyclines that is mediated by neutrophils in the tumor microenvironment and provided evidence to support the premise that targeting this mechanism would be of significant benefit in the treatment of MM.
Citation Format: Cindy Lin, Sarah E. Herlihy, Marina Li, Hui Deng, Luca Bernabei, Dmitry I. Gabrilovich, Dan T. Vogl, Yulia Nefedova. NETs promote tumor resistance to anthracyclines [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2103.
Collapse
Affiliation(s)
- Cindy Lin
- 1The Wistar Institute, Philadelphia, PA
| | - Sarah E. Herlihy
- 2Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
| | - Marina Li
- 1The Wistar Institute, Philadelphia, PA
| | - Hui Deng
- 1The Wistar Institute, Philadelphia, PA
| | - Luca Bernabei
- 3Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
| | | | - Dan T. Vogl
- 3Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
| | | |
Collapse
|
26
|
Waxman AJ, Clasen S, Garfall AL, Carver JR, Vogl DT, O'quinn R, Cohen AD, Stadtmauer EA, Hennessy S, Ky B. Proteasome inhibitor associated cardiovascular adverse events: A real-world claims based study. J Clin Oncol 2019. [DOI: 10.1200/jco.2019.37.15_suppl.e19534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e19534 Background: Cardiovascular adverse events (CVAE) are common in patients with multiple myeloma (MM). Recent evidence suggests higher rates of CVAE occur among patients receiving carfilzomib (CFZ) compared to other MM therapies. We sought to determine the real-world relative incidence of CVAE in patients receiving CFZ and bortezomib (BTZ). Methods: We conducted a retrospective cohort study using the Optum Clinformatics Datamart. Patients with MM were included if they received BTZ or CFZ from 2012 to 2016. Exposure periods were defined as 90 days following infusion of either drug. Cardiac hospitalizations were identified using validated ICD-9 or ICD-10 code algorithms for heart failure, arrhythmia, myocardial infarction, and hypertensive urgency. Incidence rate ratios (IRR) were calculated using Poisson regression. Results: We identified 922 patients receiving CFZ and 4092 patients receiving BTZ (median age 70 and 72; median treatment duration 99 and 107 days; concurrent immunomodulatory drugs received in 28% and 25%, respectively). Unadjusted CVAE rates are summarized below. A multivariable regression model showed age (IRR 1.43, 95% CI 1.33-1.55) and male gender (IRR 1.22, 95% CI 1.07-1.40) were independent risk factors for CVAE while concurrent IMiD prescription was associated with lower risk (IRR 0.70, 95% CI 0.58-0.85). Adjusted CVAE rates were similar for patients treated with CFZ and BTZ (IRR 1.06, 95% CI 0.89-1.27). Conclusions: We found higher rates of CVAE hospitalizations than described in clinical trials. This may reflect differences in real-world treatment, patient selection patterns, or later identification of CVAE. Further study is need to identify patients at high-risk of CVAE and to develop risk reduction strategies. [Table: see text]
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Bonnie Ky
- Hospital of the University of Pennsylvania, Philadelphia, PA
| |
Collapse
|
27
|
Richardson PG, Jagannath S, Chari A, Vogl DT, Dimopoulos MA, Moreau P, Dingli D, Wei LJ, Li L, Tang S, Reichman W, Kauffman MG, Shah JJ, Shacham S, Lonial S. Overall survival (OS) with oral selinexor plus low dose dexamethasone (Sd) in patients with triple class refractory-multiple myeloma (TCR-MM). J Clin Oncol 2019. [DOI: 10.1200/jco.2019.37.15_suppl.8014] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8014 Background: TCR-MM is defined as being refractory to immunomodulatory agents, proteasome inhibitors, and anti-CD38 mAbs, representing an urgent unmet medical need with a median OS of 3-5 months( Pick M et al, Eur J Haem 2018; Gandhi U et al, ASH 2018). Sd has shown a 26.2% overall response rate (ORR) in 122 patients (pts) with TCR-MM in the Phase 2b STORM study ( Chari A et al, ASH 2018). Here, we evaluate the OS of pts in the STORM study with Sd and in pts with bortezomib, carfilzomib, lenalidomide, pomalidomide, and daratumumab (“penta”)-exposed, TCR-MM from an observational cohort not receiving Sd. Methods: Data were drawn from STORM and a retrospective cohort from the nationally representative Flatiron Health Analytic Database (FHAD). All pts from both sources had penta-exposed TCR-MM. In order to align study populations, OS was evaluated in pts in STORM whose first therapy after their MM reached TCR status was Sd and in pts in the FHAD who received ≥1 therapy after their MM reached TCR status. The index date for this evaluation was the start date of treatment after their MM reached TCR status. A Cox proportional hazards regression model was performed to assess the survival impact of Sd. In STORM, ORR was assessed by an Independent Review Committee based on IMWG criteria. Results: In the FHAD, 69 pts with TCR-MM were identified. Characteristics of the two groups of pts were similar, except that pts in STORM were more heavily pretreated, had a higher frequency of high-risk MM, a longer time since initial diagnosis of MM, and higher baseline hemoglobin and platelet values. Among the 122 pts in STORM, 64 received Sd as their first therapy after their MM became TCR, and ORR was 32.8%. Among the 69 pts from FHAD, 37 received ≥1 therapy after their MM became TCR. Median OS (N = 64) was 10.4 months for pts receiving Sd in STORM and 5.2 months (N = 37) for pts not receiving Sd in FHAD (HR = 0.49, p = 0.0241). Conclusions: The prognosis of TCR-MM in the real-world population appears very poor. Within the limits of this analysis, median OS of pts receiving Sd as their first therapy after their MM becomes TCR is significantly better than those not receiving Sd, suggesting that Sd may be associated with an OS benefit in pts with TCR-MM. Clinical trial information: NCT02336815.
Collapse
Affiliation(s)
- Paul G. Richardson
- Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
| | | | - Ajai Chari
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
| | | | | | | | | | - L J Wei
- Harvard School of Public Health, Boston, MA
| | | | | | | | | | | | | | - Sagar Lonial
- Winship Cancer Institute of Emory University, Atlanta, GA
| |
Collapse
|
28
|
Cohen AD, Garfall AL, Stadtmauer EA, Melenhorst JJ, Lacey SF, Lancaster E, Vogl DT, Weiss BM, Dengel K, Nelson A, Plesa G, Chen F, Davis MM, Hwang WT, Young RM, Brogdon JL, Isaacs R, Pruteanu-Malinici I, Siegel DL, Levine BL, June CH, Milone MC. B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. J Clin Invest 2019; 129:2210-2221. [PMID: 30896447 DOI: 10.1172/jci126397] [Citation(s) in RCA: 457] [Impact Index Per Article: 91.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Chimeric antigen receptor (CAR) T cells are a promising therapy for hematologic malignancies. B-cell maturation antigen (BCMA) is a rational target in multiple myeloma (MM). METHODS We conducted a phase I study of autologous T cells lentivirally-transduced with a fully-human, BCMA-specific CAR containing CD3ζ and 4-1BB signaling domains (CART-BCMA), in subjects with relapsed/refractory MM. Twenty-five subjects were treated in 3 cohorts: 1) 1-5 x 108 CART-BCMA cells alone; 2) Cyclophosphamide (Cy) 1.5 g/m2 + 1-5 x 107 CART-BCMA cells; and 3) Cy 1.5 g/m2 + 1-5 x 108 CART-BCMA cells. No pre-specified BCMA expression level was required. RESULTS CART-BCMA cells were manufactured and expanded in all subjects. Toxicities included cytokine release syndrome and neurotoxicity, which were grade 3-4 in 8 (32%) and 3 (12%) subjects, respectively, and reversible. One subject died at day 24 from candidemia and progressive myeloma, following treatment for severe CRS and encephalopathy. Responses (based on treated subjects) were seen in 4/9 (44%) in cohort 1, 1/5 (20%) in cohort 2, and 7/11 (64%) in cohort 3, including 5 partial, 5 very good partial, and 2 complete responses, 3 of which were ongoing at 11, 14, and 32 months. Decreased BCMA expression on residual MM cells was noted in responders; expression increased at progression in most. Responses and CART-BCMA expansion were associated with CD4:CD8 T cell ratio and frequency of CD45RO-CD27+CD8+ T cells in the pre-manufacturing leukapheresis product. CONCLUSION CART-BCMA infusions with or without lymphodepleting chemotherapy are clinically active in heavily-pretreated MM patients. TRIAL REGISTRATION NCT02546167. FUNDING University of Pennsylvania-Novartis Alliance and NIH.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | - Wei-Ting Hwang
- Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | | | - Jennifer L Brogdon
- Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA
| | - Randi Isaacs
- Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA
| | | | - Don L Siegel
- Center for Cellular Immunotherapies.,Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Bruce L Levine
- Center for Cellular Immunotherapies.,Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Carl H June
- Center for Cellular Immunotherapies.,Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Michael C Milone
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
29
|
Garfall AL, Stadtmauer EA, Hwang WT, Lacey SF, Melenhorst JJ, Krevvata M, Carroll MP, Matsui WH, Wang Q, Dhodapkar MV, Dhodapkar K, Das R, Vogl DT, Weiss BM, Cohen AD, Mangan PA, Ayers EC, Nunez-Cruz S, Kulikovskaya I, Davis MM, Lamontagne A, Dengel K, Kerr ND, Young RM, Siegel DL, Levine BL, Milone MC, Maus MV, June CH. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI Insight 2019; 4:127684. [PMID: 30830874 DOI: 10.1172/jci.insight.127684] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
30
|
Zhou N, Gutierrez-Uzquiza A, Zheng XY, Chang R, Vogl DT, Garfall AL, Bernabei L, Saraf A, Florens L, Washburn MP, Illendula A, Bushweller JH, Busino L. RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. Leukemia 2019; 33:2006-2021. [PMID: 30760870 PMCID: PMC6687534 DOI: 10.1038/s41375-019-0403-2] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2018] [Revised: 12/14/2018] [Accepted: 01/21/2019] [Indexed: 12/20/2022]
Abstract
Ikaros family zinc finger protein 1 and 3 (IKZF1 and IKZF3) are transcription factors that promote multiple myeloma (MM) proliferation. The immunomodulatory imide drug (IMiD) lenalidomide promotes myeloma cell death via Cereblon (CRBN)-dependent ubiquitylation and proteasome-dependent degradation of IKZF1 and IKZF3. Although IMiDs have been used as first-line drugs for MM, the overall survival of refractory MM patients remains poor and demands the identification of novel agents to potentiate the therapeutic effect of IMiDs. Using an unbiased screen based on mass spectrometry, we identified the Runt-related transcription factor 1 and 3 (RUNX1 and RUNX3) as interactors of IKZF1 and IKZF3. Interaction with RUNX1 and RUNX3 inhibits CRBN-dependent binding, ubiquitylation, and degradation of IKZF1 and IKZF3 upon lenalidomide treatment. Inhibition of RUNXs, via genetic ablation or a small molecule (AI-10-104), results in sensitization of myeloma cell lines and primary tumors to lenalidomide. Thus, RUNX inhibition represents a valuable therapeutic opportunity to potentiate IMiDs therapy for the treatment of multiple myeloma.
Collapse
Affiliation(s)
- Nan Zhou
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Alvaro Gutierrez-Uzquiza
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Xiang Yu Zheng
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Renxu Chang
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Dan T Vogl
- Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Alfred L Garfall
- Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Luca Bernabei
- Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Anita Saraf
- The Stowers Institute for Medical Research, Kansas City, MO, USA
| | - Laurence Florens
- The Stowers Institute for Medical Research, Kansas City, MO, USA
| | - Michael P Washburn
- The Stowers Institute for Medical Research, Kansas City, MO, USA.,Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, USA
| | - Anuradha Illendula
- Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA
| | - John H Bushweller
- Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA
| | - Luca Busino
- Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
| |
Collapse
|
31
|
Stadtmauer EA, Pasquini MC, Blackwell B, Hari P, Bashey A, Devine S, Efebera Y, Ganguly S, Gasparetto C, Geller N, Horowitz MM, Koreth J, Knust K, Landau H, Brunstein C, McCarthy P, Nelson C, Qazilbash MH, Shah N, Vesole DH, Vij R, Vogl DT, Giralt S, Somlo G, Krishnan A. Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. J Clin Oncol 2019; 37:589-597. [PMID: 30653422 PMCID: PMC6553842 DOI: 10.1200/jco.18.00685] [Citation(s) in RCA: 167] [Impact Index Per Article: 33.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
PURPOSE Single-cycle melphalan 200 mg/m2 and autologous hematopoietic cell transplantation (AHCT) followed by lenalidomide (len) maintenance have improved progression-free survival (PFS) and overall survival (OS) for transplantation-eligible patients with multiple myeloma (MM). We designed a prospective, randomized, phase III study to test additional interventions to improve PFS by comparing AHCT, tandem AHCT (AHCT/AHCT), and AHCT and four subsequent cycles of len, bortezomib, and dexamethasone (RVD; AHCT + RVD), all followed by len until disease progression. PATIENTS AND METHODS Patients with symptomatic MM within 12 months from starting therapy and without progression who were age 70 years or younger were randomly assigned to AHCT/AHCT + len (n = 247), AHCT + RVD + len (n = 254), or AHCT + len (n = 257). The primary end point was 38-month PFS. RESULTS The study population had a median age of 56 years (range, 20 to 70 years); 24% of patients had high-risk MM, 73% had a triple-drug regimen as initial therapy, and 18% were in complete response at enrollment. The 38-month PFS rate was 58.5% (95% CI, 51.7% to 64.6%) for AHCT/AHCT + len, 57.8% (95% CI, 51.4% to 63.7%) for AHCT + RVD + len, and 53.9% (95% CI, 47.4% to 60%) for AHCT + len. For AHCT/AHCT + len, AHCT + RVD + len, and AHCT + len, the OS rates were 81.8% (95% CI, 76.2% to 86.2%), 85.4% (95% CI, 80.4% to 89.3%), and 83.7% (95% CI, 78.4% to 87.8%), respectively, and the complete response rates at 1 year were 50.5% (n = 192), 58.4% (n = 209), and 47.1% (n = 208), respectively. Toxicity profiles and development of second primary malignancies were similar across treatment arms. CONCLUSION Second AHCT or RVD consolidation as post-AHCT interventions for the up-front treatment of transplantation-eligible patients with MM did not improve PFS or OS. Single AHCT and len should remain as the standard approach for this population.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Nancy Geller
- 8 National Heart, Lung, and Blood Institute, Rockville, MD
| | | | | | | | | | | | | | | | | | - Nina Shah
- 14 University of California, San Francisco, San Francisco, CA
| | | | - Ravi Vij
- 16 Washington University, St Louis, MO
| | - Dan T Vogl
- 1 University of Pennsylvania, Philadelphia, PA
| | - Sergio Giralt
- 10 Memorial Sloan Kettering Cancer Center, New York, NY
| | | | | |
Collapse
|
32
|
Jagannath S, Vogl DT, Dimopoulos MA, Nooka A, Huff C, Moreau P, Cole C, Richter J, Dingli D, Vij R, Tuchman S, Raab MS, Weisel K, Delforge M, Kaminetzky D, Cornell RF, Stewart AK, Hoffman J, Godby KN, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Yee A, Gavriatopoulou M, Costa L, Shah J, Picklesimer C, Saint-Martin JR, Li L, Kauffman M, Shacham S, Richardson P, Chari A. Phase 2b Results of the STORM Study: Oral Selinexor plus Low Dose Dexamethasone (Sd) in Patients with Penta-Refractory Myeloma (penta-MM). Clinical Lymphoma Myeloma and Leukemia 2018. [DOI: 10.1016/j.clml.2018.07.149] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
33
|
Gumber R, Cohen JB, Palmer MB, Kobrin SM, Vogl DT, Wasserstein AG, Nasta SD, Bleicher MB, Bloom RD, Dember L, Cohen A, Weiss BM, Hogan JJ. A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney Int 2018; 94:199-205. [DOI: 10.1016/j.kint.2018.02.020] [Citation(s) in RCA: 65] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2017] [Revised: 01/24/2018] [Accepted: 02/08/2018] [Indexed: 11/16/2022]
|
34
|
Garfall AL, Stadtmauer EA, Hwang WT, Lacey SF, Melenhorst JJ, Krevvata M, Carroll MP, Matsui WH, Wang Q, Dhodapkar MV, Dhodapkar K, Das R, Vogl DT, Weiss BM, Cohen AD, Mangan PA, Ayers EC, Nunez-Cruz S, Kulikovskaya I, Davis MM, Lamontagne A, Dengel K, Kerr ND, Young RM, Siegel DL, Levine BL, Milone MC, Maus MV, June CH. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI Insight 2018; 3:120505. [PMID: 29669947 DOI: 10.1172/jci.insight.120505] [Citation(s) in RCA: 108] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Accepted: 03/20/2018] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Multiple myeloma is usually fatal due to serial relapses that become progressively refractory to therapy. CD19 is typically absent on the dominant multiple myeloma cell population but may be present on minor subsets with unique myeloma-propagating properties. To target myeloma-propagating cells, we clinically evaluated autologous T cells transduced with a chimeric antigen receptor (CAR) against CD19 (CTL019). METHODS Subjects received CTL019 following salvage high-dose melphalan and autologous stem cell transplantation (ASCT). All subjects had relapsed/refractory multiple myeloma and had previously undergone ASCT with less than 1 year progression-free survival (PFS). RESULTS ASCT + CTL019 was safe and feasible, with most toxicity attributable to ASCT and no severe cytokine release syndrome. Two of 10 subjects exhibited significantly longer PFS after ASCT + CTL019 compared with prior ASCT (479 vs. 181 days; 249 vs. 127 days). Correlates of favorable clinical outcome included peak CTL019 frequency in bone marrow and emergence of humoral and cellular immune responses against the stem-cell antigen Sox2. Ex vivo treatment of primary myeloma samples with a combination of CTL019 and CAR T cells against the plasma cell antigen BCMA reliably inhibited myeloma colony formation in vitro, whereas treatment with either CAR alone inhibited colony formation inconsistently. CONCLUSION CTL019 may improve duration of response to standard multiple myeloma therapies by targeting and precipitating secondary immune responses against myeloma-propagating cells. TRIAL REGISTRATION Clinicaltrials.gov identifier NCT02135406. FUNDING Novartis, NIH, Conquer Cancer Foundation.
Collapse
Affiliation(s)
- Alfred L Garfall
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Edward A Stadtmauer
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Wei-Ting Hwang
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Simon F Lacey
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Jan Joseph Melenhorst
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Maria Krevvata
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Martin P Carroll
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - William H Matsui
- Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Qiuju Wang
- Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | | | | | - Rituparna Das
- Yale University School of Medicine, New Haven, Connecticut, USA
| | - Dan T Vogl
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Brendan M Weiss
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Adam D Cohen
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Patricia A Mangan
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Emily C Ayers
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Selene Nunez-Cruz
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Irina Kulikovskaya
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Megan M Davis
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Anne Lamontagne
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Karen Dengel
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Naseem Ds Kerr
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Regina M Young
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Donald L Siegel
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Bruce L Levine
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Michael C Milone
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Marcela V Maus
- Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Carl H June
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
35
|
Vogl DT, Dingli D, Cornell RF, Huff CA, Jagannath S, Bhutani D, Zonder J, Baz R, Nooka A, Richter J, Cole C, Vij R, Jakubowiak A, Abonour R, Schiller G, Parker TL, Costa LJ, Kaminetzky D, Hoffman JE, Yee AJ, Chari A, Siegel D, Fonseca R, Van Wier S, Ahmann G, Lopez I, Kauffman M, Shacham S, Saint-Martin JR, Picklesimer CD, Choe-Juliak C, Stewart AK. Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma. J Clin Oncol 2018; 36:859-866. [PMID: 29381435 PMCID: PMC6905485 DOI: 10.1200/jco.2017.75.5207] [Citation(s) in RCA: 119] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Purpose Selinexor, a first-in-class, oral, selective exportin 1 (XPO1) inhibitor, induces apoptosis in cancer cells through nuclear retention of tumor suppressor proteins and the glucocorticoid receptor, along with inhibition of translation of oncoprotein mRNAs. We studied selinexor in combination with low-dose dexamethasone in patients with multiple myeloma refractory to the most active available agents. Patients and Methods This phase II trial evaluated selinexor 80 mg and dexamethasone 20 mg, both orally and twice weekly, in patients with myeloma refractory to bortezomib, carfilzomib, lenalidomide, and pomalidomide (quad-refractory disease), with a subset also refractory to an anti-CD38 antibody (penta-refractory disease). The primary end point was overall response rate (ORR). Results Of 79 patients, 48 had quad-refractory and 31 had penta-refractory myeloma. Patients had received a median of seven prior regimens. The ORR was 21% and was similar for patients with quad-refractory (21%) and penta-refractory (20%) disease. Among patients with high-risk cytogenetics, including t(4;14), t(14;16), and del(17p), the ORR was 35% (six of 17 patients). The median duration of response was 5 months, and 65% of responding patients were alive at 12 months. The most common grade ≥ 3 adverse events were thrombocytopenia (59%), anemia (28%), neutropenia (23%), hyponatremia (22%), leukopenia (15%), and fatigue (15%). Dose interruptions for adverse events occurred in 41 patients (52%), dose reductions occurred in 29 patients (37%), and treatment discontinuation occurred in 14 patients (18%). Conclusion The combination of selinexor and dexamethasone has an ORR of 21% in patients with heavily pretreated, refractory myeloma with limited therapeutic options.
Collapse
Affiliation(s)
- Dan T. Vogl
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - David Dingli
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Robert Frank Cornell
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Carol Ann Huff
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Sundar Jagannath
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Divaya Bhutani
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Jeffrey Zonder
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Rachid Baz
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Ajay Nooka
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Joshua Richter
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Craig Cole
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Ravi Vij
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Andrzej Jakubowiak
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Rafat Abonour
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Gary Schiller
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Terri L. Parker
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Luciano J. Costa
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - David Kaminetzky
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - James E. Hoffman
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Andrew J. Yee
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Ajai Chari
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - David Siegel
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Rafael Fonseca
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Scott Van Wier
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Gregory Ahmann
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Ilsel Lopez
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Michael Kauffman
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Sharon Shacham
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Jean-Richard Saint-Martin
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Carla D. Picklesimer
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - Cassandra Choe-Juliak
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| | - A. Keith Stewart
- Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ
| |
Collapse
|
36
|
Waxman AJ, Clasen S, Hwang WT, Garfall A, Vogl DT, Carver J, O'Quinn R, Cohen AD, Stadtmauer EA, Ky B, Weiss BM. Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol 2018; 4:e174519. [PMID: 29285538 DOI: 10.1001/jamaoncol.2017.4519] [Citation(s) in RCA: 167] [Impact Index Per Article: 27.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Importance Cardiovascular adverse events (CVAE) with carfilzomib in patients with multiple myeloma can be potentially life-threatening and remain incompletely characterized. We performed the first systematic review and meta-analysis of carfilzomib-associated CVAE. Objective To determine the incidence of carfilzomib-associated CVAE and to compare the rates of carfilzomib CVAE among different doses and companion therapies. Data Sources PubMed, EMBASE, Web of Science, and clinicaltrials.gov were queried for the keywords "carfilzomib," "Kyprolis," and "PX-171" through January 1, 2017. Study Selection Phase 1 to 3 prospective clinical trials of carfilzomib in patients with multiple myeloma with evaluable toxic effects data were eligible for meta-analysis. Data Extraction and Synthesis Data were independently extracted by 2 reviewers following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Pooled incidence rates and relative risks (for randomized trials) and 95% confidence intervals were calculated using a random effects model. Subgroup analyses were performed to assess study-level characteristics associated with CVAE. Main Outcomes and Measures Cardiovascular adverse events were defined as heart failure, hypertension, ischemia, and arrhythmia. All-grade and grades 3 or higher AEs and study characteristics were recorded. Results A total of 514 studies were assessed for eligibility. Of those, 24 studies were eligible, including a total of 2594 patients with multiple myeloma. All-grade and grades 3 and higher CVAE were seen in 617 (18.1%) and 274 (8.2%), respectively. Phase 2 or 3 studies and carfilzomib doses of 45 mg/m2 or higher were associated with high-grade CVAE. Median age older than 65 years, prior myeloma therapies, and concurrent myeloma therapies were not associated with CVAE. For the 3 randomized clinical trials, the summary relative risk of all-grade and grade 3 or higher CVAE for patients receiving carfilzomib compared with noncarfilzomib-receiving control patients were 1.8 and 2.2, respectively. Conclusions and Relevance Carfilzomib was associated with a significant incidence of CVAE, with higher rates seen with higher doses of carfilzomib. Phase 1 studies may be underdetecting CVAE. Future studies are needed to identify patients at high risk for CVAE, develop optimal monitoring strategies, and explore strategies to mitigate these risks.
Collapse
Affiliation(s)
- Adam J Waxman
- Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Suparna Clasen
- Cardio-Oncology Program, Division of Cardiovascular Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Wei-Ting Hwang
- Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia
| | - Alfred Garfall
- Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Dan T Vogl
- Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Joseph Carver
- Cardio-Oncology Program, Division of Cardiovascular Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Rupal O'Quinn
- Cardio-Oncology Program, Division of Cardiovascular Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Adam D Cohen
- Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Edward A Stadtmauer
- Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Bonnie Ky
- Cardio-Oncology Program, Division of Cardiovascular Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| | - Brendan M Weiss
- Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia
| |
Collapse
|
37
|
Vogl DT, Delforge M, Song K, Guo S, Gibson CJ, Ervin-Haynes A, Facon T. Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone. Leuk Lymphoma 2017. [PMID: 28641472 DOI: 10.1080/10428194.2017.1334125] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The FIRST trial demonstrated that continuous therapy with lenalidomide and dexamethasone (Rd) prolongs overall survival (OS) and improves health-related quality of life (HRQoL) during the first 18 months of therapy in newly diagnosed multiple myeloma (NDMM) patients. However, patient-reported HRQoL data were not collected after 18 months. We therefore estimated HRQoL scores based on time-varying data collected during progression-free follow-up after 18 months. During the initial 18 months of Rd, observed changes from baseline were within the 95% confidence interval of the predictive models at 33 of 35 time points across 7 HRQoL scores. Predicted scores after 18 months of therapy showed that observed HRQoL improvements during therapy were maintained or improved. Therefore, the survival gain observed with Rd does not come at a cost of declining HRQoL during continuous therapy beyond 18 months, supporting long-term Rd as a standard of care for initial myeloma therapy.
Collapse
Affiliation(s)
- Dan T Vogl
- a Abramson Cancer Center, University of Pennsylvania , Philadelphia , PA , USA
| | - Michel Delforge
- b Campus Gasthuisberg, Universitair Ziekenhuis Leuven , Leuven , Belgium
| | - Kevin Song
- c Vancouver General Hospital , Vancouver , BC , Canada
| | | | | | | | | |
Collapse
|
38
|
Somlo G, Pasquini MC, Blackwell B, Devine SM, Ganguly S, Efebera Y, Giralt S, Hari P, Koreth J, Landau HJ, McClune BL, Quazilbash M, McCarthy PL, Shah N, Vesole DH, Vij R, Vogl DT, Krishnan AY, Stadtmauer EA, Geller N. Response status as predictor of survival after autologous hematopoietic cell transplant (AHCT), without or with consolidation (with bortezomib, lenalidomide (Len) and dexamethasone) and len maintenance (AM vs. ACM) versus tandem AHCT and len maintenance (TAM) for up-front treatment of patients (pts) with multiple myeloma (MM): BMT CTN0702-stamina (NCT01109004). J Clin Oncol 2017. [DOI: 10.1200/jco.2017.35.15_suppl.8010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8010 Background: The Stamina trial primarily aimed to identify the best strategy among AM, ACM, and TAM, leading to longer PFS (LBA-1, ASH, 2016). Here we report on interim, exploratory results of the association between PFS and overall survival (OS) and baseline MM response, risk category, and treatments (Rx). Methods: Pts with MM, < 71 years, < 12 mos from diagnosis were randomized to melphalan 200mg/m2(mel) and AHCT (AM), tandem mel AHCT (TAM), or mel AHCT and 4 cycles of RVD ((ACM). Pts received Len till progression. Pts were stratified by high risk vs. standard ( del13q, del17q, t(4;14), t(14;16), t(14;20) and hypodyploid; high β2 microglobulin). Kaplan Meier estimates of PFS and OS were performed as a function of Rx and ≥ very good partial response (VPGR including CRs) vs. < VGPR. Cox proportional hazard models explored associations between PFS or OS and risk category, Rx, and ≥ VPGR vs. < VGPR. Results: Between 6/2010-11/2013, 758 pts (AM, N = 257; ACM, N = 254; TAM, N = 247) aged 20-70 years (median 57y) were enrolled (24% high-risk). Baseline ≥VGPR responses were 45.5- 49.8%. PFS at 38 months was similar. For < VGPR, 38-mos PFS with TAM:55.8% (95%CI: 45.8%, 64.7%); ACM: 54.0% (44.7%, 62.5%); AM: 50.1% (40.6%, 58.9%); For ≥VGPR, 38-mos PFS with TAM: 57.1% (46.8%, 66.1%); ACM: 60.1% (50.1%, 68.7%); AM: 55.1% (45.1%, 64.0%). Analyzing response, risk category, and Rx revealed no association between baseline response and PFS (Baseline response < VGPR, hazard ratio (HR): 1.21,95% CI: 0.97-1.52) or OS (baseline response < VGPR, HR 1.02, 95%CI:0.70-1.48). High risk category had an adverse association for PFS (HR 1.62, 95% CI: 1.27-2.07) and OS (HR 1.51 (95% CI:1.01-2.26). Conclusions: In this analysis < VGPR at baseline was not associated with PFS or OS. High-risk had an adverse association. Whether accomplishment of CR/minimal residual disease after AM, ACM,or TAM predicts for longer PFS and OS is the subject of ongoing analysis. Clinical trial information: NCT01109004.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Sergio Giralt
- Memorial Sloan-Kettering Cancer Center, New York, NY
| | | | | | | | | | | | | | - Nina Shah
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - David H. Vesole
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
| | - Ravi Vij
- Washington University School of Medicine in St. Louis, St. Louis, MO
| | | | | | | | - Nancy Geller
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
| |
Collapse
|
39
|
Waxman AJ, Chandra Clasen S, Garfall AL, Carver JR, Vogl DT, O'Quinn R, Cohen AD, Stadtmauer EA, Ky B, Weiss BM. Carfilzomib-associated cardiovascular adverse events: A systematic review and meta-analysis. J Clin Oncol 2017. [DOI: 10.1200/jco.2017.35.15_suppl.8018] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
8018 Background: The incidence and nature of cardiovascular adverse events (CVAEs) with carfilzomib (CFZ) in multiple myeloma (MM) remain incompletely defined. We performed the first systematic review and meta-analysis of CFZ CVAEs. Methods: PubMed was queried for the keywords “carfilzomib,” “Kyprolis,” and “PX-171.” Phase 1-3 clinical trials of carfilzomib in MM with evaluable toxicity data were included. CVAEs were defined as heart failure, hypertension, ischemia, and arrhythmia. All-grade and grade ≥3 CVAEs and study characteristics were recorded. Summary incidence rates and relative risks (for randomized trials) with 95% confidence intervals were calculated using the logistic-normal random-effects model. Subgroup analyses were performed using study level covariates. Results: 514 studies were reviewed. 2623 MM patients from 25 eligible studies were included. Incidence rates are summarized in the table. All grade and grade ≥3 CVAEs were seen in 16.8% and 7.6 %, respectively. Phase 2 or 3 studies, carfilzomib doses ≥45mg/m2, and longer infusion length were study characteristics associated with high-grade cardiac AEs (p<0.05). Median age >65, prior MM therapies, and concurrent MM therapies were not associated with CVAEs (p>.05). For the three randomized trials, the relative risk of all-grade and grade ≥3 CVAEs were 1.75 and 2.25, respectively (p<0.001). Conclusions: CFZ is associated with a significant incidence of CVAEs, including heart failure, hypertension, ischemia, and arrhythmia. Phase I studies may be underdetecting CVAEs. Future studies are needed to: identify patients at high-risk for CVAEs, develop optimal monitoring strategies, and explore therapies to mitigate these risks. [Table: see text]
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Bonnie Ky
- Hospital of the University of Pennsylvania, Philadelphia, PA
| | | |
Collapse
|
40
|
Scott EC, Maziarz RT, Spurgeon SE, Medvedova E, Gajewski J, Reasor-Heard S, Park B, Kratz A, Thomas GV, Loriaux M, Cascio M, Podolak J, Gordon M, Botelho J, Stadtmauer E, Amaravadi R, Vogl DT. Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma. Haematologica 2017; 102:e261-e265. [PMID: 28385778 DOI: 10.3324/haematol.2016.162321] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Affiliation(s)
- Emma C Scott
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Richard T Maziarz
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Stephen E Spurgeon
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Eva Medvedova
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - James Gajewski
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Shara Reasor-Heard
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Byung Park
- Public Health and Preventative Medicine, Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Anne Kratz
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - George V Thomas
- The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Marc Loriaux
- The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Michael Cascio
- The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Jennifer Podolak
- The Department of Pathology and Laboratory Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Miranda Gordon
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Jennifer Botelho
- The Department of Medicine and the Knight Cancer Institute at Oregon Health & Science University, the University of Pennsylvania, PN, USA
| | - Edward Stadtmauer
- Department of Medicine and the Abramson Cancer Center, the University of Pennsylvania, PN, USA
| | - Ravi Amaravadi
- Department of Medicine and the Abramson Cancer Center, the University of Pennsylvania, PN, USA
| | - Dan T Vogl
- Department of Medicine and the Abramson Cancer Center, the University of Pennsylvania, PN, USA
| |
Collapse
|
41
|
Ayers EC, Vogl DT, Cohen AD, Weiss BM, Cunningham K, Mangan P, Erb C, Shelly B, Sanchez M, Kraus K, Stadtmauer EA, Garfall AL. Outcomes of Salvage Second Autologous Stem Cell Transplantation for Relapsed/Refractory Multiple Myeloma in the Era of Modern Therapy. Biol Blood Marrow Transplant 2017. [DOI: 10.1016/j.bbmt.2016.12.425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
42
|
Vogl DT, Martin TG, Vij R, Hari P, Mikhael JR, Siegel D, Wu KL, Delforge M, Gasparetto C. Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma. Leuk Lymphoma 2017; 58:1872-1879. [DOI: 10.1080/10428194.2016.1263842] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Dan T. Vogl
- Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
| | - Thomas G. Martin
- Adult Leukemia and Bone Marrow Transplantation Program, University of California San Francisco, San Francisco, CA, USA
| | - Ravi Vij
- Bone Marrow Transplantation and Leukemia Section, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA
| | - Parameswaran Hari
- Adult Blood and Marrow Transplant Program, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Joseph R. Mikhael
- Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA
| | - David Siegel
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA
| | - Ka Lung Wu
- Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium
| | - Michel Delforge
- Department of Hematology, University Hospital Leuven, Leuven, Belgium
| | - Cristina Gasparetto
- Division of Medicine–Cell Therapy and Hematologica, Duke University Medical Center, Durham, NC, USA
| |
Collapse
|
43
|
Vogl DT, Raje N, Jagannath S, Richardson P, Hari P, Orlowski R, Supko JG, Tamang D, Yang M, Jones SS, Wheeler C, Markelewicz RJ, Lonial S. Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma. Clin Cancer Res 2017; 23:3307-3315. [PMID: 28053023 DOI: 10.1158/1078-0432.ccr-16-2526] [Citation(s) in RCA: 171] [Impact Index Per Article: 24.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2016] [Revised: 12/06/2016] [Accepted: 12/14/2016] [Indexed: 11/16/2022]
Abstract
Purpose: Histone deacetylase (HDAC) inhibition improves the efficacy of proteasome inhibition for multiple myeloma but adds substantial toxicity. Preclinical models suggest that the observed synergy is due to the role of HDAC6 in mediating resistance to proteasome inhibition via the aggresome/autophagy pathway of protein degradation.Experimental Design: We conducted a phase I/II trial of the HDAC6-selective inhibitor ricolinostat to define the safety, preliminary efficacy, and recommended phase II dose in combination with standard proteasome inhibitor therapy. Patients with relapsed or refractory multiple myeloma received oral ricolinostat on days 1-5 and 8-12 of each 21-day cycle.Results: Single-agent ricolinostat therapy resulted in neither significant toxicity nor clinical responses. Combination therapy with bortezomib and dexamethasone was well-tolerated during dose escalation but led to dose-limiting diarrhea in an expansion cohort at a ricolinostat dose of 160 mg twice daily. Combination therapy at a ricolinostat dose of 160 mg daily in a second expansion cohort was well tolerated, with less severe hematologic, gastrointestinal, and constitutional toxicities compared with published data on nonselective HDAC inhibitors. The overall response rate in combination with daily ricolinostat at ≥160 mg was 37%. The response rate to combination therapy among bortezomib-refractory patients was 14%. Samples taken during therapy showed dose-dependent increases of acetylated tubulin in peripheral blood lymphocytes.Conclusions: At the recommended phase II dose of ricolinostat of 160 mg daily, the combination with bortezomib and dexamethasone is safe, well-tolerated, and active, suggesting that selective inhibition of HDAC6 is a promising approach to multiple myeloma therapy. Clin Cancer Res; 23(13); 3307-15. ©2017 AACR.
Collapse
Affiliation(s)
- Dan T Vogl
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
| | - Noopur Raje
- Massachusetts General Hospital, Boston, Massachusetts
| | | | | | | | | | | | - David Tamang
- Acetylon Pharmaceuticals Inc., Boston, Massachusetts
| | - Min Yang
- Acetylon Pharmaceuticals Inc., Boston, Massachusetts
| | - Simon S Jones
- Acetylon Pharmaceuticals Inc., Boston, Massachusetts
| | | | | | | |
Collapse
|
44
|
Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, Malietzis G, Lee GH, Eruslanov E, Albelda SM, Wang X, Mehta JL, Bewtra M, Rustgi A, Hockstein N, Witt R, Masters G, Nam B, Smirnov D, Sepulveda MA, Gabrilovich DI. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci Immunol 2016; 1. [PMID: 28417112 DOI: 10.1126/sciimmunol.aaf8943] [Citation(s) in RCA: 522] [Impact Index Per Article: 65.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are important regulators of immune responses in cancer and have been directly implicated in promotion of tumor progression. However, the heterogeneity of these cells and lack of distinct markers hampers the progress in understanding of the biology and clinical importance of these cells. Using partial enrichment of PMN-MDSC with gradient centrifugation we determined that low density PMN-MDSC and high density neutrophils from the same cancer patients had a distinct gene profile. Most prominent changes were observed in the expression of genes associated with endoplasmic reticulum (ER) stress. Surprisingly, low-density lipoprotein (LDL) was one of the most increased regulators and its receptor oxidized LDL receptor 1 OLR1 was one of the most overexpressed genes in PMN-MDSC. Lectin-type oxidized LDL receptor 1 (LOX-1) encoded by OLR1 was practically undetectable in neutrophils in peripheral blood of healthy donors, whereas 5-15% of total neutrophils in cancer patients and 15-50% of neutrophils in tumor tissues were LOX-1+. In contrast to their LOX-1- counterparts, LOX-1+ neutrophils had gene signature, potent immune suppressive activity, up-regulation of ER stress, and other biochemical characteristics of PMN-MDSC. Moreover, induction of ER stress in neutrophils from healthy donors up-regulated LOX-1 expression and converted these cells to suppressive PMN-MDSC. Thus, we identified a specific marker of human PMN-MDSC associated with ER stress and lipid metabolism, which provides new insight to the biology and potential therapeutic targeting of these cells.
Collapse
Affiliation(s)
| | | | - Je-In Youn
- The Wistar Institute, Philadelphia, PA, 19104, USA
| | | | - Sridevi Mony
- The Wistar Institute, Philadelphia, PA, 19104, USA
| | | | | | | | | | - Cindy Lin
- The Wistar Institute, Philadelphia, PA, 19104, USA
| | | | - Alfred Garfall
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104, USA.,Division of Gastroenterology, Departments of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Dan T Vogl
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104, USA.,Division of Gastroenterology, Departments of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Xiaowei Xu
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104, USA.,Division of Gastroenterology, Departments of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Stella C Knight
- Antigen Presentation Research Group, Imperial College London, London, UK HA1 3UJ
| | - George Malietzis
- Antigen Presentation Research Group, Imperial College London, London, UK HA1 3UJ.,St. Mark's Hospital, Harrow, UK, HA1 3UJ
| | - Gui Han Lee
- Antigen Presentation Research Group, Imperial College London, London, UK HA1 3UJ.,St. Mark's Hospital, Harrow, UK, HA1 3UJ
| | - Evgeniy Eruslanov
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Steven M Albelda
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104, USA.,Division of Gastroenterology, Departments of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Xianwei Wang
- Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - Jawahar L Mehta
- Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - Meenakshi Bewtra
- Division of Gastroenterology, Departments of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Anil Rustgi
- Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, 19104, USA.,Division of Gastroenterology, Departments of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
| | - Neil Hockstein
- Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE 19713, USA
| | - Robert Witt
- Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE 19713, USA
| | - Gregory Masters
- Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE 19713, USA
| | - Brian Nam
- Helen F. Graham Cancer Center & Research Institute, Christiana Care Health System, Newark, DE 19713, USA
| | - Denis Smirnov
- Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, PA, 19477, USA
| | - Manuel A Sepulveda
- Janssen Oncology Therapeutic Area, Janssen Research and Development, LLC, Pharmaceutical Companies of Johnson & Johnson, Spring House, PA, 19477, USA
| | | |
Collapse
|
45
|
Vogl DT, Delforge M, Song KW, Guo S, Gibson CJ, Ervin-Haynes AL, Facon T. Health-related quality of life over time in transplant-ineligible patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone until progression. J Clin Oncol 2016. [DOI: 10.1200/jco.2016.34.15_suppl.8047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Dan T. Vogl
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
| | | | | | | | | | | | - Thierry Facon
- Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France
| |
Collapse
|
46
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, Albani D, Albert ML, Aldudo J, Algül H, Alirezaei M, Alloza I, Almasan A, Almonte-Beceril M, Alnemri ES, Alonso C, Altan-Bonnet N, Altieri DC, Alvarez S, Alvarez-Erviti L, Alves S, Amadoro G, Amano A, Amantini C, Ambrosio S, Amelio I, Amer AO, Amessou M, Amon A, An Z, Anania FA, Andersen SU, Andley UP, Andreadi CK, Andrieu-Abadie N, Anel A, Ann DK, Anoopkumar-Dukie S, Antonioli M, Aoki H, Apostolova N, Aquila S, Aquilano K, Araki K, Arama E, Aranda A, Araya J, Arcaro A, Arias E, Arimoto H, Ariosa AR, Armstrong JL, Arnould T, Arsov I, Asanuma K, Askanas V, Asselin E, Atarashi R, Atherton SS, Atkin JD, Attardi LD, Auberger P, Auburger G, Aurelian L, Autelli R, Avagliano L, Avantaggiati ML, Avrahami L, Awale S, Azad N, Bachetti T, Backer JM, Bae DH, Bae JS, Bae ON, Bae SH, Baehrecke EH, Baek SH, Baghdiguian S, Bagniewska-Zadworna A, Bai H, Bai J, Bai XY, Bailly Y, Balaji KN, Balduini W, Ballabio A, Balzan R, Banerjee R, Bánhegyi G, Bao H, Barbeau B, Barrachina MD, Barreiro E, Bartel B, Bartolomé A, Bassham DC, Bassi MT, Bast RC, Basu A, Batista MT, Batoko H, Battino M, Bauckman K, Baumgarner BL, Bayer KU, Beale R, Beaulieu JF, Beck GR, Becker C, Beckham JD, Bédard PA, Bednarski PJ, Begley TJ, Behl C, Behrends C, Behrens GMN, Behrns KE, Bejarano E, Belaid A, Belleudi F, Bénard G, Berchem G, Bergamaschi D, Bergami M, Berkhout B, Berliocchi L, Bernard A, Bernard M, Bernassola F, Bertolotti A, Bess AS, Besteiro S, Bettuzzi S, Bhalla S, Bhattacharyya S, Bhutia SK, Biagosch C, Bianchi MW, Biard-Piechaczyk M, Billes V, Bincoletto C, Bingol B, Bird SW, Bitoun M, Bjedov I, Blackstone C, Blanc L, Blanco GA, Blomhoff HK, Boada-Romero E, Böckler S, Boes M, Boesze-Battaglia K, Boise LH, Bolino A, Boman A, Bonaldo P, Bordi M, Bosch J, Botana LM, Botti J, Bou G, Bouché M, Bouchecareilh M, Boucher MJ, Boulton ME, Bouret SG, Boya P, Boyer-Guittaut M, Bozhkov PV, Brady N, Braga VMM, Brancolini C, Braus GH, Bravo-San Pedro JM, Brennan LA, Bresnick EH, Brest P, Bridges D, Bringer MA, Brini M, Brito GC, Brodin B, Brookes PS, Brown EJ, Brown K, Broxmeyer HE, Bruhat A, Brum PC, Brumell JH, Brunetti-Pierri N, Bryson-Richardson RJ, Buch S, Buchan AM, Budak H, Bulavin DV, Bultman SJ, Bultynck G, Bumbasirevic V, Burelle Y, Burke RE, Burmeister M, Bütikofer P, Caberlotto L, Cadwell K, Cahova M, Cai D, Cai J, Cai Q, Calatayud S, Camougrand N, Campanella M, Campbell GR, Campbell M, Campello S, Candau R, Caniggia I, Cantoni L, Cao L, Caplan AB, Caraglia M, Cardinali C, Cardoso SM, Carew JS, Carleton LA, Carlin CR, Carloni S, Carlsson SR, Carmona-Gutierrez D, Carneiro LAM, Carnevali O, Carra S, Carrier A, Carroll B, Casas C, Casas J, Cassinelli G, Castets P, Castro-Obregon S, Cavallini G, Ceccherini I, Cecconi F, Cederbaum AI, Ceña V, Cenci S, Cerella C, Cervia D, Cetrullo S, Chaachouay H, Chae HJ, Chagin AS, Chai CY, Chakrabarti G, Chamilos G, Chan EYW, Chan MTV, Chandra D, Chandra P, Chang CP, Chang RCC, Chang TY, Chatham JC, Chatterjee S, Chauhan S, Che Y, Cheetham ME, Cheluvappa R, Chen CJ, Chen G, Chen GC, Chen G, Chen H, Chen JW, Chen JK, Chen M, Chen M, Chen P, Chen Q, Chen Q, Chen SD, Chen S, Chen SSL, Chen W, Chen WJ, Chen WQ, Chen W, Chen X, Chen YH, Chen YG, Chen Y, Chen Y, Chen Y, Chen YJ, Chen YQ, Chen Y, Chen Z, Chen Z, Cheng A, Cheng CHK, Cheng H, Cheong H, Cherry S, Chesney J, Cheung CHA, Chevet E, Chi HC, Chi SG, Chiacchiera F, Chiang HL, Chiarelli R, Chiariello M, Chieppa M, Chin LS, Chiong M, Chiu GNC, Cho DH, Cho SG, Cho WC, Cho YY, Cho YS, Choi AMK, Choi EJ, Choi EK, Choi J, Choi ME, Choi SI, Chou TF, Chouaib S, Choubey D, Choubey V, Chow KC, Chowdhury K, Chu CT, Chuang TH, Chun T, Chung H, Chung T, Chung YL, Chwae YJ, Cianfanelli V, Ciarcia R, Ciechomska IA, Ciriolo MR, Cirone M, Claerhout S, Clague MJ, Clària J, Clarke PGH, Clarke R, Clementi E, Cleyrat C, Cnop M, Coccia EM, Cocco T, Codogno P, Coers J, Cohen EEW, Colecchia D, Coletto L, Coll NS, Colucci-Guyon E, Comincini S, Condello M, Cook KL, Coombs GH, Cooper CD, Cooper JM, Coppens I, Corasaniti MT, Corazzari M, Corbalan R, Corcelle-Termeau E, Cordero MD, Corral-Ramos C, Corti O, Cossarizza A, Costelli P, Costes S, Cotman SL, Coto-Montes A, Cottet S, Couve E, Covey LR, Cowart LA, Cox JS, Coxon FP, Coyne CB, Cragg MS, Craven RJ, Crepaldi T, Crespo JL, Criollo A, Crippa V, Cruz MT, Cuervo AM, Cuezva JM, Cui T, Cutillas PR, Czaja MJ, Czyzyk-Krzeska MF, Dagda RK, Dahmen U, Dai C, Dai W, Dai Y, Dalby KN, Dalla Valle L, Dalmasso G, D'Amelio M, Damme M, Darfeuille-Michaud A, Dargemont C, Darley-Usmar VM, Dasarathy S, Dasgupta B, Dash S, Dass CR, Davey HM, Davids LM, Dávila D, Davis RJ, Dawson TM, Dawson VL, Daza P, de Belleroche J, de Figueiredo P, de Figueiredo RCBQ, de la Fuente J, De Martino L, De Matteis A, De Meyer GRY, De Milito A, De Santi M, de Souza W, De Tata V, De Zio D, Debnath J, Dechant R, Decuypere JP, Deegan S, Dehay B, Del Bello B, Del Re DP, Delage-Mourroux R, Delbridge LMD, Deldicque L, Delorme-Axford E, Deng Y, Dengjel J, Denizot M, Dent P, Der CJ, Deretic V, Derrien B, Deutsch E, Devarenne TP, Devenish RJ, Di Bartolomeo S, Di Daniele N, Di Domenico F, Di Nardo A, Di Paola S, Di Pietro A, Di Renzo L, DiAntonio A, Díaz-Araya G, Díaz-Laviada I, Diaz-Meco MT, Diaz-Nido J, Dickey CA, Dickson RC, Diederich M, Digard P, Dikic I, Dinesh-Kumar SP, Ding C, Ding WX, Ding Z, Dini L, Distler JHW, Diwan A, Djavaheri-Mergny M, Dmytruk K, Dobson RCJ, Doetsch V, Dokladny K, Dokudovskaya S, Donadelli M, Dong XC, Dong X, Dong Z, Donohue TM, Doran KS, D'Orazi G, Dorn GW, Dosenko V, Dridi S, Drucker L, Du J, Du LL, Du L, du Toit A, Dua P, Duan L, Duann P, Dubey VK, Duchen MR, Duchosal MA, Duez H, Dugail I, Dumit VI, Duncan MC, Dunlop EA, Dunn WA, Dupont N, Dupuis L, Durán RV, Durcan TM, Duvezin-Caubet S, Duvvuri U, Eapen V, Ebrahimi-Fakhari D, Echard A, Eckhart L, Edelstein CL, Edinger AL, Eichinger L, Eisenberg T, Eisenberg-Lerner A, Eissa NT, El-Deiry WS, El-Khoury V, Elazar Z, Eldar-Finkelman H, Elliott CJH, Emanuele E, Emmenegger U, Engedal N, Engelbrecht AM, Engelender S, Enserink JM, Erdmann R, Erenpreisa J, Eri R, Eriksen JL, Erman A, Escalante R, Eskelinen EL, Espert L, Esteban-Martínez L, Evans TJ, Fabri M, Fabrias G, Fabrizi C, Facchiano A, Færgeman NJ, Faggioni A, Fairlie WD, Fan C, Fan D, Fan J, Fang S, Fanto M, Fanzani A, Farkas T, Faure M, Favier FB, Fearnhead H, Federici M, Fei E, Felizardo TC, Feng H, Feng Y, Feng Y, Ferguson TA, Fernández ÁF, Fernandez-Barrena MG, Fernandez-Checa JC, Fernández-López A, Fernandez-Zapico ME, Feron O, Ferraro E, Ferreira-Halder CV, Fesus L, Feuer R, Fiesel FC, Filippi-Chiela EC, Filomeni G, Fimia GM, Fingert JH, Finkbeiner S, Finkel T, Fiorito F, Fisher PB, Flajolet M, Flamigni F, Florey O, Florio S, Floto RA, Folini M, Follo C, Fon EA, Fornai F, Fortunato F, Fraldi A, Franco R, Francois A, François A, Frankel LB, Fraser IDC, Frey N, Freyssenet DG, Frezza C, Friedman SL, Frigo DE, Fu D, Fuentes JM, Fueyo J, Fujitani Y, Fujiwara Y, Fujiya M, Fukuda M, Fulda S, Fusco C, Gabryel B, Gaestel M, Gailly P, Gajewska M, Galadari S, Galili G, Galindo I, Galindo MF, Galliciotti G, Galluzzi L, Galluzzi L, Galy V, Gammoh N, Gandy S, Ganesan AK, Ganesan S, Ganley IG, Gannagé M, Gao FB, Gao F, Gao JX, García Nannig L, García Véscovi E, Garcia-Macía M, Garcia-Ruiz C, Garg AD, Garg PK, Gargini R, Gassen NC, Gatica D, Gatti E, Gavard J, Gavathiotis E, Ge L, Ge P, Ge S, Gean PW, Gelmetti V, Genazzani AA, Geng J, Genschik P, Gerner L, Gestwicki JE, Gewirtz DA, Ghavami S, Ghigo E, Ghosh D, Giammarioli AM, Giampieri F, Giampietri C, Giatromanolaki A, Gibbings DJ, Gibellini L, Gibson SB, Ginet V, Giordano A, Giorgini F, Giovannetti E, Girardin SE, Gispert S, Giuliano S, Gladson CL, Glavic A, Gleave M, Godefroy N, Gogal RM, Gokulan K, Goldman GH, Goletti D, Goligorsky MS, Gomes AV, Gomes LC, Gomez H, Gomez-Manzano C, Gómez-Sánchez R, Gonçalves DAP, Goncu E, Gong Q, Gongora C, Gonzalez CB, Gonzalez-Alegre P, Gonzalez-Cabo P, González-Polo RA, Goping IS, Gorbea C, Gorbunov NV, Goring DR, Gorman AM, Gorski SM, Goruppi S, Goto-Yamada S, Gotor C, Gottlieb RA, Gozes I, Gozuacik D, Graba Y, Graef M, Granato GE, Grant GD, Grant S, Gravina GL, Green DR, Greenhough A, Greenwood MT, Grimaldi B, Gros F, Grose C, Groulx JF, Gruber F, Grumati P, Grune T, Guan JL, Guan KL, Guerra B, Guillen C, Gulshan K, Gunst J, Guo C, Guo L, Guo M, Guo W, Guo XG, Gust AA, Gustafsson ÅB, Gutierrez E, Gutierrez MG, Gwak HS, Haas A, Haber JE, Hadano S, Hagedorn M, Hahn DR, Halayko AJ, Hamacher-Brady A, Hamada K, Hamai A, Hamann A, Hamasaki M, Hamer I, Hamid Q, Hammond EM, Han F, Han W, Handa JT, Hanover JA, Hansen M, Harada M, Harhaji-Trajkovic L, Harper JW, Harrath AH, Harris AL, Harris J, Hasler U, Hasselblatt P, Hasui K, Hawley RG, Hawley TS, He C, He CY, He F, He G, He RR, He XH, He YW, He YY, Heath JK, Hébert MJ, Heinzen RA, Helgason GV, Hensel M, Henske EP, Her C, Herman PK, Hernández A, Hernandez C, Hernández-Tiedra S, Hetz C, Hiesinger PR, Higaki K, Hilfiker S, Hill BG, Hill JA, Hill WD, Hino K, Hofius D, Hofman P, Höglinger GU, Höhfeld J, Holz MK, Hong Y, Hood DA, Hoozemans JJM, Hoppe T, Hsu C, Hsu CY, Hsu LC, Hu D, Hu G, Hu HM, Hu H, Hu MC, Hu YC, Hu ZW, Hua F, Hua Y, Huang C, Huang HL, Huang KH, Huang KY, Huang S, Huang S, Huang WP, Huang YR, Huang Y, Huang Y, Huber TB, Huebbe P, Huh WK, Hulmi JJ, Hur GM, Hurley JH, Husak Z, Hussain SNA, Hussain S, Hwang JJ, Hwang S, Hwang TIS, Ichihara A, Imai Y, Imbriano C, Inomata M, Into T, Iovane V, Iovanna JL, Iozzo RV, Ip NY, Irazoqui JE, Iribarren P, Isaka Y, Isakovic AJ, Ischiropoulos H, Isenberg JS, Ishaq M, Ishida H, Ishii I, Ishmael JE, Isidoro C, Isobe KI, Isono E, Issazadeh-Navikas S, Itahana K, Itakura E, Ivanov AI, Iyer AKV, Izquierdo JM, Izumi Y, Izzo V, Jäättelä M, Jaber N, Jackson DJ, Jackson WT, Jacob TG, Jacques TS, Jagannath C, Jain A, Jana NR, Jang BK, Jani A, Janji B, Jannig PR, Jansson PJ, Jean S, Jendrach M, Jeon JH, Jessen N, Jeung EB, Jia K, Jia L, Jiang H, Jiang H, Jiang L, Jiang T, Jiang X, Jiang X, Jiang X, Jiang Y, Jiang Y, Jiménez A, Jin C, Jin H, Jin L, Jin M, Jin S, Jinwal UK, Jo EK, Johansen T, Johnson DE, Johnson GVW, Johnson JD, Jonasch E, Jones C, Joosten LAB, Jordan J, Joseph AM, Joseph B, Joubert AM, Ju D, Ju J, Juan HF, Juenemann K, Juhász G, Jung HS, Jung JU, Jung YK, Jungbluth H, Justice MJ, Jutten B, Kaakoush NO, Kaarniranta K, Kaasik A, Kabuta T, Kaeffer B, Kågedal K, Kahana A, Kajimura S, Kakhlon O, Kalia M, Kalvakolanu DV, Kamada Y, Kambas K, Kaminskyy VO, Kampinga HH, Kandouz M, Kang C, Kang R, Kang TC, Kanki T, Kanneganti TD, Kanno H, Kanthasamy AG, Kantorow M, Kaparakis-Liaskos M, Kapuy O, Karantza V, Karim MR, Karmakar P, Kaser A, Kaushik S, Kawula T, Kaynar AM, Ke PY, Ke ZJ, Kehrl JH, Keller KE, Kemper JK, Kenworthy AK, Kepp O, Kern A, Kesari S, Kessel D, Ketteler R, Kettelhut IDC, Khambu B, Khan MM, Khandelwal VKM, Khare S, Kiang JG, Kiger AA, Kihara A, Kim AL, Kim CH, Kim DR, Kim DH, Kim EK, Kim HY, Kim HR, Kim JS, Kim JH, Kim JC, Kim JH, Kim KW, Kim MD, Kim MM, Kim PK, Kim SW, Kim SY, Kim YS, Kim Y, Kimchi A, Kimmelman AC, Kimura T, King JS, Kirkegaard K, Kirkin V, Kirshenbaum LA, Kishi S, Kitajima Y, Kitamoto K, Kitaoka Y, Kitazato K, Kley RA, Klimecki WT, Klinkenberg M, Klucken J, Knævelsrud H, Knecht E, Knuppertz L, Ko JL, Kobayashi S, Koch JC, Koechlin-Ramonatxo C, Koenig U, Koh YH, Köhler K, Kohlwein SD, Koike M, Komatsu M, Kominami E, Kong D, Kong HJ, Konstantakou EG, Kopp BT, Korcsmaros T, Korhonen L, Korolchuk VI, Koshkina NV, Kou Y, Koukourakis MI, Koumenis C, Kovács AL, Kovács T, Kovacs WJ, Koya D, Kraft C, Krainc D, Kramer H, Kravic-Stevovic T, Krek W, Kretz-Remy C, Krick R, Krishnamurthy M, Kriston-Vizi J, Kroemer G, Kruer MC, Kruger R, Ktistakis NT, Kuchitsu K, Kuhn C, Kumar AP, Kumar A, Kumar A, Kumar D, Kumar D, Kumar R, Kumar S, Kundu M, Kung HJ, Kuno A, Kuo SH, Kuret J, Kurz T, Kwok T, Kwon TK, Kwon YT, Kyrmizi I, La Spada AR, Lafont F, Lahm T, Lakkaraju A, Lam T, Lamark T, Lancel S, Landowski TH, Lane DJR, Lane JD, Lanzi C, Lapaquette P, Lapierre LR, Laporte J, Laukkarinen J, Laurie GW, Lavandero S, Lavie L, LaVoie MJ, Law BYK, Law HKW, Law KB, Layfield R, Lazo PA, Le Cam L, Le Roch KG, Le Stunff H, Leardkamolkarn V, Lecuit M, Lee BH, Lee CH, Lee EF, Lee GM, Lee HJ, Lee H, Lee JK, Lee J, Lee JH, Lee JH, Lee M, Lee MS, Lee PJ, Lee SW, Lee SJ, Lee SJ, Lee SY, Lee SH, Lee SS, Lee SJ, Lee S, Lee YR, Lee YJ, Lee YH, Leeuwenburgh C, Lefort S, Legouis R, Lei J, Lei QY, Leib DA, Leibowitz G, Lekli I, Lemaire SD, Lemasters JJ, Lemberg MK, Lemoine A, Leng S, Lenz G, Lenzi P, Lerman LO, Lettieri Barbato D, Leu JIJ, Leung HY, Levine B, Lewis PA, Lezoualc'h F, Li C, Li F, Li FJ, Li J, Li K, Li L, Li M, Li M, Li Q, Li R, Li S, Li W, Li W, Li X, Li Y, Lian J, Liang C, Liang Q, Liao Y, Liberal J, Liberski PP, Lie P, Lieberman AP, Lim HJ, Lim KL, Lim K, Lima RT, Lin CS, Lin CF, Lin F, Lin F, Lin FC, Lin K, Lin KH, Lin PH, Lin T, Lin WW, Lin YS, Lin Y, Linden R, Lindholm D, Lindqvist LM, Lingor P, Linkermann A, Liotta LA, Lipinski MM, Lira VA, Lisanti MP, Liton PB, Liu B, Liu C, Liu CF, Liu F, Liu HJ, Liu J, Liu JJ, Liu JL, Liu K, Liu L, Liu L, Liu Q, Liu RY, Liu S, Liu S, Liu W, Liu XD, Liu X, Liu XH, Liu X, Liu X, Liu X, Liu Y, Liu Y, Liu Z, Liu Z, Liuzzi JP, Lizard G, Ljujic M, Lodhi IJ, Logue SE, Lokeshwar BL, Long YC, Lonial S, Loos B, López-Otín C, López-Vicario C, Lorente M, Lorenzi PL, Lõrincz P, Los M, Lotze MT, Lovat PE, Lu B, Lu B, Lu J, Lu Q, Lu SM, Lu S, Lu Y, Luciano F, Luckhart S, Lucocq JM, Ludovico P, Lugea A, Lukacs NW, Lum JJ, Lund AH, Luo H, Luo J, Luo S, Luparello C, Lyons T, Ma J, Ma Y, Ma Y, Ma Z, Machado J, Machado-Santelli GM, Macian F, MacIntosh GC, MacKeigan JP, Macleod KF, MacMicking JD, MacMillan-Crow LA, Madeo F, Madesh M, Madrigal-Matute J, Maeda A, Maeda T, Maegawa G, Maellaro E, Maes H, Magariños M, Maiese K, Maiti TK, Maiuri L, Maiuri MC, Maki CG, Malli R, Malorni W, Maloyan A, Mami-Chouaib F, Man N, Mancias JD, Mandelkow EM, Mandell MA, Manfredi AA, Manié SN, Manzoni C, Mao K, Mao Z, Mao ZW, Marambaud P, Marconi AM, Marelja Z, Marfe G, Margeta M, Margittai E, Mari M, Mariani FV, Marin C, Marinelli S, Mariño G, Markovic I, Marquez R, Martelli AM, Martens S, Martin KR, Martin SJ, Martin S, Martin-Acebes MA, Martín-Sanz P, Martinand-Mari C, Martinet W, Martinez J, Martinez-Lopez N, Martinez-Outschoorn U, Martínez-Velázquez M, Martinez-Vicente M, Martins WK, Mashima H, Mastrianni JA, Matarese G, Matarrese P, Mateo R, Matoba S, Matsumoto N, Matsushita T, Matsuura A, Matsuzawa T, Mattson MP, Matus S, Maugeri N, Mauvezin C, Mayer A, Maysinger D, Mazzolini GD, McBrayer MK, McCall K, McCormick C, McInerney GM, McIver SC, McKenna S, McMahon JJ, McNeish IA, Mechta-Grigoriou F, Medema JP, Medina DL, Megyeri K, Mehrpour M, Mehta JL, Mei Y, Meier UC, Meijer AJ, Meléndez A, Melino G, Melino S, de Melo EJT, Mena MA, Meneghini MD, Menendez JA, Menezes R, Meng L, Meng LH, Meng S, Menghini R, Menko AS, Menna-Barreto RFS, Menon MB, Meraz-Ríos MA, Merla G, Merlini L, Merlot AM, Meryk A, Meschini S, Meyer JN, Mi MT, Miao CY, Micale L, Michaeli S, Michiels C, Migliaccio AR, Mihailidou AS, Mijaljica D, Mikoshiba K, Milan E, Miller-Fleming L, Mills GB, Mills IG, Minakaki G, Minassian BA, Ming XF, Minibayeva F, Minina EA, Mintern JD, Minucci S, Miranda-Vizuete A, Mitchell CH, Miyamoto S, Miyazawa K, Mizushima N, Mnich K, Mograbi B, Mohseni S, Moita LF, Molinari M, Molinari M, Møller AB, Mollereau B, Mollinedo F, Mongillo M, Monick MM, Montagnaro S, Montell C, Moore DJ, Moore MN, Mora-Rodriguez R, Moreira PI, Morel E, Morelli MB, Moreno S, Morgan MJ, Moris A, Moriyasu Y, Morrison JL, Morrison LA, Morselli E, Moscat J, Moseley PL, Mostowy S, Motori E, Mottet D, Mottram JC, Moussa CEH, Mpakou VE, Mukhtar H, Mulcahy Levy JM, Muller S, Muñoz-Moreno R, Muñoz-Pinedo C, Münz C, Murphy ME, Murray JT, Murthy A, Mysorekar IU, Nabi IR, Nabissi M, Nader GA, Nagahara Y, Nagai Y, Nagata K, Nagelkerke A, Nagy P, Naidu SR, Nair S, Nakano H, Nakatogawa H, Nanjundan M, Napolitano G, Naqvi NI, Nardacci R, Narendra DP, Narita M, Nascimbeni AC, Natarajan R, Navegantes LC, Nawrocki ST, Nazarko TY, Nazarko VY, Neill T, Neri LM, Netea MG, Netea-Maier RT, Neves BM, Ney PA, Nezis IP, Nguyen HTT, Nguyen HP, Nicot AS, Nilsen H, Nilsson P, Nishimura M, Nishino I, Niso-Santano M, Niu H, Nixon RA, Njar VCO, Noda T, Noegel AA, Nolte EM, Norberg E, Norga KK, Noureini SK, Notomi S, Notterpek L, Nowikovsky K, Nukina N, Nürnberger T, O'Donnell VB, O'Donovan T, O'Dwyer PJ, Oehme I, Oeste CL, Ogawa M, Ogretmen B, Ogura Y, Oh YJ, Ohmuraya M, Ohshima T, Ojha R, Okamoto K, Okazaki T, Oliver FJ, Ollinger K, Olsson S, Orban DP, Ordonez P, Orhon I, Orosz L, O'Rourke EJ, Orozco H, Ortega AL, Ortona E, Osellame LD, Oshima J, Oshima S, Osiewacz HD, Otomo T, Otsu K, Ou JHJ, Outeiro TF, Ouyang DY, Ouyang H, Overholtzer M, Ozbun MA, Ozdinler PH, Ozpolat B, Pacelli C, Paganetti P, Page G, Pages G, Pagnini U, Pajak B, Pak SC, Pakos-Zebrucka K, Pakpour N, Palková Z, Palladino F, Pallauf K, Pallet N, Palmieri M, Paludan SR, Palumbo C, Palumbo S, Pampliega O, Pan H, Pan W, Panaretakis T, Pandey A, Pantazopoulou A, Papackova Z, Papademetrio DL, Papassideri I, Papini A, Parajuli N, Pardo J, Parekh VV, Parenti G, Park JI, Park J, Park OK, Parker R, Parlato R, Parys JB, Parzych KR, Pasquet JM, Pasquier B, Pasumarthi KBS, Patschan D, Patterson C, Pattingre S, Pattison S, Pause A, Pavenstädt H, Pavone F, Pedrozo Z, Peña FJ, Peñalva MA, Pende M, Peng J, Penna F, Penninger JM, Pensalfini A, Pepe S, Pereira GJS, Pereira PC, Pérez-de la Cruz V, Pérez-Pérez ME, Pérez-Rodríguez D, Pérez-Sala D, Perier C, Perl A, Perlmutter DH, Perrotta I, Pervaiz S, Pesonen M, Pessin JE, Peters GJ, Petersen M, Petrache I, Petrof BJ, Petrovski G, Phang JM, Piacentini M, Pierdominici M, Pierre P, Pierrefite-Carle V, Pietrocola F, Pimentel-Muiños FX, Pinar M, Pineda B, Pinkas-Kramarski R, Pinti M, Pinton P, Piperdi B, Piret JM, Platanias LC, Platta HW, Plowey ED, Pöggeler S, Poirot M, Polčic P, Poletti A, Poon AH, Popelka H, Popova B, Poprawa I, Poulose SM, Poulton J, Powers SK, Powers T, Pozuelo-Rubio M, Prak K, Prange R, Prescott M, Priault M, Prince S, Proia RL, Proikas-Cezanne T, Prokisch H, Promponas VJ, Przyklenk K, Puertollano R, Pugazhenthi S, Puglielli L, Pujol A, Puyal J, Pyeon D, Qi X, Qian WB, Qin ZH, Qiu Y, Qu Z, Quadrilatero J, Quinn F, Raben N, Rabinowich H, Radogna F, Ragusa MJ, Rahmani M, Raina K, Ramanadham S, Ramesh R, Rami A, Randall-Demllo S, Randow F, Rao H, Rao VA, Rasmussen BB, Rasse TM, Ratovitski EA, Rautou PE, Ray SK, Razani B, Reed BH, Reggiori F, Rehm M, Reichert AS, Rein T, Reiner DJ, Reits E, Ren J, Ren X, Renna M, Reusch JEB, Revuelta JL, Reyes L, Rezaie AR, Richards RI, Richardson DR, Richetta C, Riehle MA, Rihn BH, Rikihisa Y, Riley BE, Rimbach G, Rippo MR, Ritis K, Rizzi F, Rizzo E, Roach PJ, Robbins J, Roberge M, Roca G, Roccheri MC, Rocha S, Rodrigues CMP, Rodríguez CI, de Cordoba SR, Rodriguez-Muela N, Roelofs J, Rogov VV, Rohn TT, Rohrer B, Romanelli D, Romani L, Romano PS, Roncero MIG, Rosa JL, Rosello A, Rosen KV, Rosenstiel P, Rost-Roszkowska M, Roth KA, Roué G, Rouis M, Rouschop KM, Ruan DT, Ruano D, Rubinsztein DC, Rucker EB, Rudich A, Rudolf E, Rudolf R, Ruegg MA, Ruiz-Roldan C, Ruparelia AA, Rusmini P, Russ DW, Russo GL, Russo G, Russo R, Rusten TE, Ryabovol V, Ryan KM, Ryter SW, Sabatini DM, Sacher M, Sachse C, Sack MN, Sadoshima J, Saftig P, Sagi-Eisenberg R, Sahni S, Saikumar P, Saito T, Saitoh T, Sakakura K, Sakoh-Nakatogawa M, Sakuraba Y, Salazar-Roa M, Salomoni P, Saluja AK, Salvaterra PM, Salvioli R, Samali A, Sanchez AMJ, Sánchez-Alcázar JA, Sanchez-Prieto R, Sandri M, Sanjuan MA, Santaguida S, Santambrogio L, Santoni G, dos Santos CN, Saran S, Sardiello M, Sargent G, Sarkar P, Sarkar S, Sarrias MR, Sarwal MM, Sasakawa C, Sasaki M, Sass M, Sato K, Sato M, Satriano J, Savaraj N, Saveljeva S, Schaefer L, Schaible UE, Scharl M, Schatzl HM, Schekman R, Scheper W, Schiavi A, Schipper HM, Schmeisser H, Schmidt J, Schmitz I, Schneider BE, Schneider EM, Schneider JL, Schon EA, Schönenberger MJ, Schönthal AH, Schorderet DF, Schröder B, Schuck S, Schulze RJ, Schwarten M, Schwarz TL, Sciarretta S, Scotto K, Scovassi AI, Screaton RA, Screen M, Seca H, Sedej S, Segatori L, Segev N, Seglen PO, Seguí-Simarro JM, Segura-Aguilar J, Seki E, Seiliez I, Sell C, Semenkovich CF, Semenza GL, Sen U, Serra AL, Serrano-Puebla A, Sesaki H, Setoguchi T, Settembre C, Shacka JJ, Shajahan-Haq AN, Shapiro IM, Sharma S, She H, Shen CKJ, Shen CC, Shen HM, Shen S, Shen W, Sheng R, Sheng X, Sheng ZH, Shepherd TG, Shi J, Shi Q, Shi Q, Shi Y, Shibutani S, Shibuya K, Shidoji Y, Shieh JJ, Shih CM, Shimada Y, Shimizu S, Shin DW, Shinohara ML, Shintani M, Shintani T, Shioi T, Shirabe K, Shiri-Sverdlov R, Shirihai O, Shore GC, Shu CW, Shukla D, Sibirny AA, Sica V, Sigurdson CJ, Sigurdsson EM, Sijwali PS, Sikorska B, Silveira WA, Silvente-Poirot S, Silverman GA, Simak J, Simmet T, Simon AK, Simon HU, Simone C, Simons M, Simonsen A, Singh R, Singh SV, Singh SK, Sinha D, Sinha S, Sinicrope FA, Sirko A, Sirohi K, Sishi BJN, Sittler A, Siu PM, Sivridis E, Skwarska A, Slack R, Slaninová I, Slavov N, Smaili SS, Smalley KSM, Smith DR, Soenen SJ, Soleimanpour SA, Solhaug A, Somasundaram K, Son JH, Sonawane A, Song C, Song F, Song HK, Song JX, Song W, Soo KY, Sood AK, Soong TW, Soontornniyomkij V, Sorice M, Sotgia F, Soto-Pantoja DR, Sotthibundhu A, Sousa MJ, Spaink HP, Span PN, Spang A, Sparks JD, Speck PG, Spector SA, Spies CD, Springer W, Clair DS, Stacchiotti A, Staels B, Stang MT, Starczynowski DT, Starokadomskyy P, Steegborn C, Steele JW, Stefanis L, Steffan J, Stellrecht CM, Stenmark H, Stepkowski TM, Stern ST, Stevens C, Stockwell BR, Stoka V, Storchova Z, Stork B, Stratoulias V, Stravopodis DJ, Strnad P, Strohecker AM, Ström AL, Stromhaug P, Stulik J, Su YX, Su Z, Subauste CS, Subramaniam S, Sue CM, Suh SW, Sui X, Sukseree S, Sulzer D, Sun FL, Sun J, Sun J, Sun SY, Sun Y, Sun Y, Sun Y, Sundaramoorthy V, Sung J, Suzuki H, Suzuki K, Suzuki N, Suzuki T, Suzuki YJ, Swanson MS, Swanton C, Swärd K, Swarup G, Sweeney ST, Sylvester PW, Szatmari Z, Szegezdi E, Szlosarek PW, Taegtmeyer H, Tafani M, Taillebourg E, Tait SWG, Takacs-Vellai K, Takahashi Y, Takáts S, Takemura G, Takigawa N, Talbot NJ, Tamagno E, Tamburini J, Tan CP, Tan L, Tan ML, Tan M, Tan YJ, Tanaka K, Tanaka M, Tang D, Tang D, Tang G, Tanida I, Tanji K, Tannous BA, Tapia JA, Tasset-Cuevas I, Tatar M, Tavassoly I, Tavernarakis N, Taylor A, Taylor GS, Taylor GA, Taylor JP, Taylor MJ, Tchetina EV, Tee AR, Teixeira-Clerc F, Telang S, Tencomnao T, Teng BB, Teng RJ, Terro F, Tettamanti G, Theiss AL, Theron AE, Thomas KJ, Thomé MP, Thomes PG, Thorburn A, Thorner J, Thum T, Thumm M, Thurston TLM, Tian L, Till A, Ting JPY, Titorenko VI, Toker L, Toldo S, Tooze SA, Topisirovic I, Torgersen ML, Torosantucci L, Torriglia A, Torrisi MR, Tournier C, Towns R, Trajkovic V, Travassos LH, Triola G, Tripathi DN, Trisciuoglio D, Troncoso R, Trougakos IP, Truttmann AC, Tsai KJ, Tschan MP, Tseng YH, Tsukuba T, Tsung A, Tsvetkov AS, Tu S, Tuan HY, Tucci M, Tumbarello DA, Turk B, Turk V, Turner RFB, Tveita AA, Tyagi SC, Ubukata M, Uchiyama Y, Udelnow A, Ueno T, Umekawa M, Umemiya-Shirafuji R, Underwood BR, Ungermann C, Ureshino RP, Ushioda R, Uversky VN, Uzcátegui NL, Vaccari T, Vaccaro MI, Váchová L, Vakifahmetoglu-Norberg H, Valdor R, Valente EM, Vallette F, Valverde AM, Van den Berghe G, Van Den Bosch L, van den Brink GR, van der Goot FG, van der Klei IJ, van der Laan LJW, van Doorn WG, van Egmond M, van Golen KL, Van Kaer L, van Lookeren Campagne M, Vandenabeele P, Vandenberghe W, Vanhorebeek I, Varela-Nieto I, Vasconcelos MH, Vasko R, Vavvas DG, Vega-Naredo I, Velasco G, Velentzas AD, Velentzas PD, Vellai T, Vellenga E, Vendelbo MH, Venkatachalam K, Ventura N, Ventura S, Veras PST, Verdier M, Vertessy BG, Viale A, Vidal M, Vieira HLA, Vierstra RD, Vigneswaran N, Vij N, Vila M, Villar M, Villar VH, Villarroya J, Vindis C, Viola G, Viscomi MT, Vitale G, Vogl DT, Voitsekhovskaja OV, von Haefen C, von Schwarzenberg K, Voth DE, Vouret-Craviari V, Vuori K, Vyas JM, Waeber C, Walker CL, Walker MJ, Walter J, Wan L, Wan X, Wang B, Wang C, Wang CY, Wang C, Wang C, Wang C, Wang D, Wang F, Wang F, Wang G, Wang HJ, Wang H, Wang HG, Wang H, Wang HD, Wang J, Wang J, Wang M, Wang MQ, Wang PY, Wang P, Wang RC, Wang S, Wang TF, Wang X, Wang XJ, Wang XW, Wang X, Wang X, Wang Y, Wang Y, Wang Y, Wang YJ, Wang Y, Wang Y, Wang YT, Wang Y, Wang ZN, Wappner P, Ward C, Ward DM, Warnes G, Watada H, Watanabe Y, Watase K, Weaver TE, Weekes CD, Wei J, Weide T, Weihl CC, Weindl G, Weis SN, Wen L, Wen X, Wen Y, Westermann B, Weyand CM, White AR, White E, Whitton JL, Whitworth AJ, Wiels J, Wild F, Wildenberg ME, Wileman T, Wilkinson DS, Wilkinson S, Willbold D, Williams C, Williams K, Williamson PR, Winklhofer KF, Witkin SS, Wohlgemuth SE, Wollert T, Wolvetang EJ, Wong E, Wong GW, Wong RW, Wong VKW, Woodcock EA, Wright KL, Wu C, Wu D, Wu GS, Wu J, Wu J, Wu M, Wu M, Wu S, Wu WKK, Wu Y, Wu Z, Xavier CPR, Xavier RJ, Xia GX, Xia T, Xia W, Xia Y, Xiao H, Xiao J, Xiao S, Xiao W, Xie CM, Xie Z, Xie Z, Xilouri M, Xiong Y, Xu C, Xu C, Xu F, Xu H, Xu H, Xu J, Xu J, Xu J, Xu L, Xu X, Xu Y, Xu Y, Xu ZX, Xu Z, Xue Y, Yamada T, Yamamoto A, Yamanaka K, Yamashina S, Yamashiro S, Yan B, Yan B, Yan X, Yan Z, Yanagi Y, Yang DS, Yang JM, Yang L, Yang M, Yang PM, Yang P, Yang Q, Yang W, Yang WY, Yang X, Yang Y, Yang Y, Yang Z, Yang Z, Yao MC, Yao PJ, Yao X, Yao Z, Yao Z, Yasui LS, Ye M, Yedvobnick B, Yeganeh B, Yeh ES, Yeyati PL, Yi F, Yi L, Yin XM, Yip CK, Yoo YM, Yoo YH, Yoon SY, Yoshida KI, Yoshimori T, Young KH, Yu H, Yu JJ, Yu JT, Yu J, Yu L, Yu WH, Yu XF, Yu Z, Yuan J, Yuan ZM, Yue BYJT, Yue J, Yue Z, Zacks DN, Zacksenhaus E, Zaffaroni N, Zaglia T, Zakeri Z, Zecchini V, Zeng J, Zeng M, Zeng Q, Zervos AS, Zhang DD, Zhang F, Zhang G, Zhang GC, Zhang H, Zhang H, Zhang H, Zhang H, Zhang J, Zhang J, Zhang J, Zhang J, Zhang JP, Zhang L, Zhang L, Zhang L, Zhang L, Zhang MY, Zhang X, Zhang XD, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhang Y, Zhao M, Zhao WL, Zhao X, Zhao YG, Zhao Y, Zhao Y, Zhao YX, Zhao Z, Zhao ZJ, Zheng D, Zheng XL, Zheng X, Zhivotovsky B, Zhong Q, Zhou GZ, Zhou G, Zhou H, Zhou SF, Zhou XJ, Zhu H, Zhu H, Zhu WG, Zhu W, Zhu XF, Zhu Y, Zhuang SM, Zhuang X, Ziparo E, Zois CE, Zoladek T, Zong WX, Zorzano A, Zughaier SM. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016; 12:1-222. [PMID: 26799652 PMCID: PMC4835977 DOI: 10.1080/15548627.2015.1100356] [Citation(s) in RCA: 4041] [Impact Index Per Article: 505.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2015] [Accepted: 09/22/2015] [Indexed: 12/09/2022] Open
Affiliation(s)
- Daniel J Klionsky
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Kotb Abdelmohsen
- National Institute on Aging, National Institutes of Health, Biomedical Research Center, RNA Regulation Section, Laboratory of Genetics, Baltimore, MD, USA
| | - Akihisa Abe
- Tokyo Medical University, Department of Biochemistry, Tokyo, Japan
| | - Md Joynal Abedin
- University of Minnesota, Department of Lab Medicine and Pathology, Minneapolis, MN, USA
| | - Hagai Abeliovich
- Hebrew University of Jerusalem, Faculty of Agriculture, Food, and Environment, Biochemistry and Food Science, Rehovot, Israel
| | | | - Hiroaki Adachi
- University of Occupational and Environmental Health School of Medicine, Department of Neurology, Fukuoka, Japan
| | | | - Peter D Adams
- Beatson Institute for Cancer Research, University of Glasgow, Glasgow, UK
| | - Khosrow Adeli
- University of Toronto, Molecular Structure and Function, Research Institute, Hospital for Sick Children, Toronto, ON, Canada
| | - Peter J Adhihetty
- University of Florida, Department of Applied Physiology and Kinesiology, Gainesville, FL, USA
| | - Sharon G Adler
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
| | - Galila Agam
- Ben-Gurion University of the Negev and Mental Health Center, Department of Clinical Biochemistry and Pharmacology and Psychiatry Research Unit, Beer-Sheva, Israel
| | - Rajesh Agarwal
- University of Colorado Denver, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Aurora, CO, USA
| | - Manish K Aghi
- University of California San Francisco, Department of Neurological Surgery, San Francisco, CA, USA
| | - Maria Agnello
- University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Palermo, Italy
| | - Patrizia Agostinis
- KU Leuven, Laboratory for Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, Campus Gasthuisberg, Leuven, Belgium
| | - Patricia V Aguilar
- University of Texas, Medical Branch, Department of Pathology, Galveston, TX, USA
| | - Julio Aguirre-Ghiso
- Icahn School of Medicine at Mount Sinai, Department of Otolaryngology, Tisch Cancer Institute at Mount Sinai, New York, NY, USA
- Icahn School of Medicine at Mount Sinai, Division of Hematology and Oncology, Department of Medicine, New York, NY, USA
| | - Edoardo M Airoldi
- Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Harvard University, Department of Statistics, Cambridge, MA, USA
| | - Slimane Ait-Si-Ali
- Université Paris Diderot, Sorbonne Paris Cité, Centre Epigénétique et Destin Cellulaire, UMR 7216, Centre National de la Recherche Scientifique CNRS, Paris, France
| | - Takahiko Akematsu
- University of Vienna, Department of Chromosome Biology, Max F. Perutz Laboratories, Vienna, Austria
| | | | - Mohamed Al-Rubeai
- University College Dublin, School of Chemical and Bioprocess Engineering, Dublin, Ireland
| | | | - Chris Albanese
- Georgetown University, Lombardi Comprehensive Cancer Center, Departments of Oncology and Pathology, Washington, DC, USA
| | - Diego Albani
- IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Department of Neuroscience, Milan, Italy
| | | | - Jesus Aldudo
- Centro de Biologia Molecular “Severo Ochoa” (UAM/CSIC), Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
| | - Hana Algül
- Technische Universität München, II. Medizinische Klinik, Klinikum rechts der Isar, Munich, Germany
| | - Mehrdad Alirezaei
- The Scripps Research Institute, Department of Immunology and Microbial Science, La Jolla, CA, USA
| | - Iraide Alloza
- KERBASQUE, Basque Foundation for Sciences, Bilbao, Spain
- Neurogenomiks, Neurosciences Department, Faculty of Medicine and Odontology, University of Basque, Leioa, Spain
| | | | - Maylin Almonte-Beceril
- Institute of Biomedical Investigation (INIBIC), Aging, Inflamation and Regenerative Medicine, Coruña, Spain
| | - Emad S Alnemri
- Thomas Jefferson University, Department of Biochemistry and Molecular Biology, Philadelphia, PA, USA
| | - Covadonga Alonso
- Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Departamento de Biotecnología, Madrid, Spain
| | - Nihal Altan-Bonnet
- National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | | | - Silvia Alvarez
- University of Buenos Aires, Institute of Biochemistry and Biophysics, School of Pharmacy and Biochemistry, Buenos Aires, Argentina
| | | | - Sandro Alves
- CEA/DSV/12;BM, INSERM U1169, Gene Therapy for Neurodegenerative Diseases, Fontenay-aux-Roses Cedex, France
| | - Giuseppina Amadoro
- National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy
| | - Atsuo Amano
- Osaka University Graduate School of Dentistry, Department of Preventive Dentistry, Osaka, Japan
| | - Consuelo Amantini
- University of Camerino, School of Biosciences and Veterinary Medicine, Camerino, Italy
| | - Santiago Ambrosio
- University of Barcelona, School of Medicine, Campus Bellvitge, Hospitalet del Llobregat, Spain
| | - Ivano Amelio
- Medical Research Council (MRC), Toxicology Unit, Leicester, UK
| | - Amal O Amer
- Ohio State University, Department of Microbial Infection and Immunity, Columbus, OH, USA
| | - Mohamed Amessou
- Wayne State University, School of Medicine, Department of Pathology, Karmanos Cancer Institute, Detroit, MI, USA
| | - Angelika Amon
- Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
| | - Zhenyi An
- University of California San Francisco, Department of Neurology, San Francisco, CA, USA
| | - Frank A Anania
- Emory University, School of Medicine, Division of Digestive Diseases, Atlanta, GA, USA
| | - Stig U Andersen
- Aarhus University, Department of Molecular Biology and Genetics, Aarhus, Denmark
| | - Usha P Andley
- Washington University in St. Louis, School of Medicine, Department of Ophthalmology and Visual Sciences, St. Louis, MO, USA
| | | | | | - Alberto Anel
- University of Zaragoza, Department of Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Zaragoza, Spain
| | - David K Ann
- Beckman Research Institute, City of Hope, Department of Molecular Pharmacology, Duarte, CA, USA
| | | | - Manuela Antonioli
- National Institute for Infectious Diseases “L. Spallanzani” IRCCS, Rome, Italy
- Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Germany
| | - Hiroshi Aoki
- University of Niigata, Department of Neurosurgery, Brain Research Institute, Niigata, Japan
| | | | - Saveria Aquila
- University of Calabria, Department of Pharmacy, Health and Nutritional Sciences, Arcavacata di Rende (Cosenza), Italy
| | - Katia Aquilano
- University of Rome “Tor Vergata”, Department of Biology, Rome, Italy
| | - Koichi Araki
- Emory University, School of Medicine, Emory Vaccine Center and Department of Microbiology and Immunology, Atlanta, GA, USA
| | - Eli Arama
- Weizmann Institute of Science, Department of Molecular Genetics, Rehovot, Israel
| | - Agustin Aranda
- IATA-CSIC, Institute of Agrochemistry and Food Technology, Paterna (Valencia), Spain
| | - Jun Araya
- Jikei University School of Medicine, Divison of Respiratory Disease, Department of Internal Medicine, Tokyo, Japan
| | - Alexandre Arcaro
- University of Bern, Division of Pediatric Hematology/Oncology, Department of Clinical Research, Bern, Switzerland
| | - Esperanza Arias
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
| | - Hirokazu Arimoto
- Tohoku University, Graduate School of Life Sciences, Sendai, Miyagi, Japan
| | - Aileen R Ariosa
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Jane L Armstrong
- University of Sunderland, Department of Pharmacy, Health and Wellbeing, Faculty of Applied Sciences, Sunderland, UK
| | - Thierry Arnould
- University of Namur, Laboratory of Biochemistry and Cell Biology (URBC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium
| | - Ivica Arsov
- York College/The City University of New York, Department of Biology, Jamaica, NY, USA
| | - Katsuhiko Asanuma
- Kyoto University, Graduate School of Medicine, Medical Innocation Center (TMK project), Kyoto, Japan
| | - Valerie Askanas
- University of Southern California, Keck School of Medicine, Neurology and Pathology, Los Angeles, CA, USA
| | - Eric Asselin
- University of Quebec at Trois-Rivieres, Department of Biology and Medicine, Trois-Rivieres, Quebec, Canada
| | - Ryuichiro Atarashi
- Nagasaki University Graduate School of Biomedical Sciences, Department of Molecular Microbiology and Immunology, Nagasaki, Japan
| | - Sally S Atherton
- Georgia Regents University, Medical College of Georgia, Augusta, GA, USA
| | - Julie D Atkin
- Macquarie University, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Sydney, NSW, Australia
| | - Laura D Attardi
- Stanford University, School of Medicine, Departments of Radiation Oncology and Genetics, Stanford, CA, USA
| | | | - Georg Auburger
- Goethe University Medical School, Experimental Neurology, Frankfurt am Main, Germany
| | - Laure Aurelian
- University of Maryland, School of Medicine, Department of Pharmacology, Baltimore, MD, USA
| | - Riccardo Autelli
- University of Turin, Department of Clinical and Biological Sciences, Turin, TO, Italy
| | - Laura Avagliano
- San Paolo Hospital Medical School, Unit of Obstetrics and Gynecology, Milano, Italy
- University of Milan, Department of Health Sciences, Milan, Italy
| | | | - Limor Avrahami
- Tel Aviv University, Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv, Israel
| | - Suresh Awale
- University of Toyama, Division of Natural Drug Discovery, Institute of Natural Medicine, Toyama, Japan
| | - Neelam Azad
- Hampton University, Department of Pharmaceutical Sciences, School of Pharmacy, Hampton, VA, USA
| | | | - Jonathan M Backer
- Albert Einstein College of Medicine, Department of Molecular Pharmacology, Bronx, NY, USA
| | - Dong-Hun Bae
- University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
| | - Jae-sung Bae
- Kyungpook National University, Department of Physiology, School of Medicine, Jung-gu, Daegu, Korea
| | - Ok-Nam Bae
- Hanyang University, College of Pharmacy, Ansan, Korea
| | - Soo Han Bae
- Yonsei University, College of Medicine, Severance Biomedical Science Institute, Seoul, Korea
| | - Eric H Baehrecke
- University of Massachusetts, Medical School, Department of Molecular, Cell and Cancer Biology, Worcester, MA, USA
| | | | - Stephen Baghdiguian
- Université Montpellier 2, Institut des Sciences de l'Evolution - UMR CNRS 5554, Montpellier, Languedoc-Roussillon, France
| | - Agnieszka Bagniewska-Zadworna
- A. Mickiewicz University, Department of General Botany, Institute of Experimental Biology, Faculty of Biology, Poznań, Poland
| | - Hua Bai
- Brown University, Department of Ecology and Evolutionary Biology, Providence, RI, USA
| | - Jie Bai
- Kunming University of Science and Technology, Medical School, Kunmimg, Yunnan, China
| | - Xue-Yuan Bai
- State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, Beijing, China
| | - Yannick Bailly
- INCI, CNRS UPR3212, Institut des Neurosciences Cellulaires and Intégratives, Strasbourg, France
| | | | - Walter Balduini
- University of Urbino “Carlo Bo”, Department of Biomolecular Sciences, Urbino, Italy
| | - Andrea Ballabio
- Federico II University, Telethon Institute of Genetics and Medicine (TIGEM), Department of Medical and Translational Sciences, Naples, Italy
| | - Rena Balzan
- University of Malta, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, Msida, Malta
| | - Rajkumar Banerjee
- CSIR, Indian Institute of Chemical Technology, Biomaterials Group, Hyderabad, India
| | - Gábor Bánhegyi
- Semmelweis University, Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Budapest, Hungary
| | - Haijun Bao
- Xuzhou Medical College, Department of Pathology, Xuzhou, Jiangsu, China
| | - Benoit Barbeau
- Université du Québec à Montréal, Département des Sciences Biologiques and Centre de Recherche BioMed, Montréal, Québec, Canada
| | | | - Esther Barreiro
- IMIM-Hospital del Mar CIBERES, Pompeu Fabra University, Barcelona Biomedical Research Park, Respiratory Medicine Department, Lung Cancer and Muscle Research Group, Barcelona, Spain
| | - Bonnie Bartel
- Rice University, Department of BioSciences, Houston, TX, USA
| | | | - Diane C Bassham
- Iowa State University, Department of Genetics, Development and Cell Biology, Ames, IA, USA
| | - Maria Teresa Bassi
- Scientific Institute IRCCS Eugenio Medea, Laboratory of Molecular Biology, Bosisio Parini, Lecco, Italy
| | - Robert C Bast
- University of Texas, MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA
| | - Alakananda Basu
- University of North Texas Health Science Center, Department of Molecular and Medical Genetics, Fort Worth, TX, USA
| | | | - Henri Batoko
- Université Catholique de Louvain (UCL), Institut des Sciences de la Vie, Louvain-la-Neuve, Belgium
| | - Maurizio Battino
- Polytechnic University of Marche, Department of Clinical Science, Faculty of Medicine, Ancona, Italy
| | - Kyle Bauckman
- Washington University, School of Medicine, Departments of Obstetrics and Gynecology, and Pathology and Immunology, St. Louis, MO, USA
| | - Bradley L Baumgarner
- University of South Carolina Upstate, Department of Biology, Division of Natural Sciences and Engineering, Spartanburg, SC
| | - K Ulrich Bayer
- University of Colorado, School of Medicine, Department of Pharmacology, Aurora, CO, USA
| | - Rupert Beale
- University of Cambridge, Division of Virology, Department of Pathology, Cambridge, UK
| | - Jean-François Beaulieu
- Université de Sherbrooke, Department of Anatomy and Cell Biology, Faculty of Medicine and Health Sciences, Sherbrooke, QC, Canada
| | - George R. Beck
- Atlanta Department of Veterans Affairs Medical Center, Decatur, GA
- Emory University, Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Atlanta, GA, USA
| | - Christoph Becker
- Friedrich-Alexander-University Erlangen-Nürnberg, Department of Medicine 1, Erlangen, Germany
| | - J David Beckham
- University of Colorado, School of Medicine, Division of Infectious Diseases, Aurora, CO, USA
| | | | | | - Thomas J Begley
- State University of New York, College of Nanoscale Science and Engineering, Albany, NY, USA
| | - Christian Behl
- University Medical Center of the Johannes Gutenberg-University, Institute for Pathobiochemistry, Mainz, Germany
| | - Christian Behrends
- Medical School Goethe University, Institute of Biochemistry II, Frankfurt, Germany
| | - Georg MN Behrens
- Hannover Medical School, Department for Clinical Immunology and Rheumotology, Hannover, Germany
| | - Kevin E Behrns
- University of Florida, Department of Surgery, Gainesville, FL, USA
| | - Eloy Bejarano
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
| | - Amine Belaid
- INSERM U1081, CNRS UMR7284, Institute of Research on Cancer and Ageing of Nice (IRCAN), Nice, France
| | - Francesca Belleudi
- Sapienza University of Rome, Department of Clinical and Molecular Medicine, Rome, Italy
| | | | - Guy Berchem
- Luxembourg Institute of Health and Centre Hospitalier de Luxembourg, Luxembourg
| | - Daniele Bergamaschi
- Queen Mary University of London, Blizard Institute, Centre for Cell Biology and Cutaneous Research, London, UK
| | - Matteo Bergami
- University Hospital Cologne, CECAD Research Center, Cologne, Germany
| | - Ben Berkhout
- University of Amsterdam, Laboratory of Experimental Virology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center (AMC), Amsterdam, The Netherlands
| | - Laura Berliocchi
- Magna Graecia University, Department of Health Sciences, Catanzaro, Italy
| | - Amélie Bernard
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Monique Bernard
- Université de Montréal, Department of Medicine, Montréal, Quebec, Canada
| | - Francesca Bernassola
- University of Rome “Tor Vergata”, Department of Experimental Medicine and Surgery, Rome, Italy
| | | | - Amanda S Bess
- Duke University, Nicholas School of the Environment, Durham, NC, USA
| | | | - Saverio Bettuzzi
- University of Parma, Department of Biomedicine, Biotechnology and Translational Research, Parma, Italy
| | - Savita Bhalla
- Northwestern University, Division of Hematology/Oncology, Chicago, IL, USA
| | - Shalmoli Bhattacharyya
- Post Graduate Institute of Medical Education and Research (PGIMER), Department of Biophysics, Chandigarh, India
| | - Sujit K Bhutia
- National Institute of Technology Rourkela, Department of Life Science, Rourkela, Odisha, India
| | - Caroline Biagosch
- Technical University Munich, Institute of Human Genetics, Munich, Bavaria, Germany
| | - Michele Wolfe Bianchi
- Institute for Integrative Biology of the Cell, Université Paris-Saclay, Gif-sur-Yvette, France
- Université Paris-Est Créteil, Créteil, France
- Université Paris-Sud, CEA, CNRS, Paris, France
| | - Martine Biard-Piechaczyk
- CNRS UM, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé, Montpellier, France
| | - Viktor Billes
- Eötvös Loránd University, Department of Genetics, Budapest, Hungary
| | - Claudia Bincoletto
- Universidade Federal de São Paulo (UNIFESP), Departamento de Farmacologia, Escola Paulista de Medicina, São Paulo, SP, Brazil
| | - Baris Bingol
- Genentech Inc., Department of Neuroscience, South San Francisco, CA, USA
| | - Sara W Bird
- Stanford University, Department of Microbiology and Immunology, Stanford, CA, USA
| | - Marc Bitoun
- Sorbonne Universités, UPMC Univ Paris 06, INSERM UMRS974, CNRS FRE 3617, Center for Research in Myology, Paris, France
| | | | - Craig Blackstone
- National Institutes of Health, Cell Biology Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
| | - Lionel Blanc
- The Feinstein Institute for Medical Research, Laboratory of Developmental Erythropoiesis, Manhasset, NY
| | - Guillermo A Blanco
- University of Buenos Aires, IDEHU-CONICET, Faculty of Pharmacy and Biochemistry, Buenos Aires, Argentina
| | | | - Emilio Boada-Romero
- Universidad de Salamanca, Campus Unamuno, Instituto de Biologia Molecular y Celular del Cancer (IBMCC), Centro de Investigacion del Cancer, Salamanca, Spain
| | | | - Marianne Boes
- University Medical Centre Utrecht, Laboratory of Translational Immunology and Department of Pediatric Immunology, Utrecht, The Netherlands
| | | | - Lawrence H Boise
- Emory University, Department of Cell Biology, Atlanta, GA, USA
- Emory University, Department of Hematology and Medical Oncology, Atlanta, GA, USA
| | - Alessandra Bolino
- INSPE, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy
| | - Andrea Boman
- Linköping University, Experimental Pathology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping, Sweden
| | - Paolo Bonaldo
- University of Padova, Department of Molecular Medicine, Padova, Italy
| | - Matteo Bordi
- New York University, Department of Psychiatry, New York NY; and Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
| | - Jürgen Bosch
- Johns Hopkins, Bloomberg School of Public Health, Department of Biochemistry and Molecular Biology and Johns Hopkins Malaria Research Institute, Baltimore, MD, USA
| | - Luis M Botana
- Universidade de Santiago de Compostela, Departamento Farmacoloxía, Facultade de Veterinaria, Lugo, Spain
| | - Joelle Botti
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | - German Bou
- University Hospital La Coruña, Microbiology Department, La Coruña, Spain
| | - Marina Bouché
- Sapienza University of Rome, DAHFMO-Section of Histology, Rome, Italy
| | - Marion Bouchecareilh
- Université Bordeaux Segalen, Institut de Biochimie et Génétique Cellulaires, CNRS UMR 5095, Bordeaux, France
| | - Marie-Josée Boucher
- University of Sherbrooke, Faculté de Médecine et des Sciences de la Santé, Department of Medicine/Gastroenterology Division, Sherbrooke, Québec, Canada
| | - Michael E Boulton
- Indiana University School of Medicine, Department of Ophthalmology, Indianapolis, IN, USA
| | - Sebastien G Bouret
- University of Southern California, The Saban Research Institute, Developmental Neuroscience Program, Children's Hospital Los Angeles, Los Angeles, CA, USA
| | - Patricia Boya
- Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
| | - Michaël Boyer-Guittaut
- Université de Franche-Comté, UFR Sciences et Techniques, Laboratoire de Biochimie, Besançon, France
| | - Peter V Bozhkov
- Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, Department of Chemistry and Biotechnology, Uppsala BioCenter, Uppsala, Sweden
| | - Nathan Brady
- German Cancer Research Center (DKFZ), Systems Biology of Cell Death Mechanisms, Heidelberg, Germany
| | - Vania MM Braga
- Imperial College London, National Heart and Lung Institute, London, UK
| | - Claudio Brancolini
- University of Udine, Dipartimento di Scienze Mediche e Biologiche, Udine, Italy
| | - Gerhard H Braus
- Georg-August-Universität Göttingen, Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Göttingen, Germany
| | - José M Bravo-San Pedro
- Centre de Recherche des Cordeliers, Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Gustave Roussy Cancer Campus, Villejuif, France
- INSERM, U1138, Paris, France
- Université Paris Descartes/Paris V, Paris, France
| | - Lisa A Brennan
- Florida Atlantic University, Schmidt College of Medicine, Department of Biomedical Sciences, Boca Raton, FL, USA
| | - Emery H Bresnick
- University of Wisconsin, School of Medicine and Public Health, Department of Cell and Regenerative Biology, Carbone Cancer Center, Madison, WI, USA
| | - Patrick Brest
- INSERM U1081, CNRS UMR7284, Institute of Research on Cancer and Ageing of Nice (IRCAN), Nice, France
| | - Dave Bridges
- University of Tennessee Health Science Center, Department of Physiology, Memphis, TN, USA
| | - Marie-Agnès Bringer
- UMR 1324 INRA, 6265 CNRS, Université de Bourgogne Franche-Comté, Centre des Sciences du Goût et de l'Alimentation, Dijon, France
| | - Marisa Brini
- University of Padova, Department of Biology, Padova, Italy
| | - Glauber C Brito
- Universidade de São Paulo, Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina, São Paulo, SP, Brazil
| | - Bertha Brodin
- Karolinska Institute, Cancer Center Karolinska, Department of Oncology-Pathology, Stockholm, Sweden
| | - Paul S Brookes
- University of Rochester Medical Center, Department of Anesthesiology, Rochester, NY, USA
| | - Eric J Brown
- Genentech Inc., Immunology and Infectious Diseases, South San Francisco, CA, USA
| | - Karen Brown
- University of Leicester, Department of Cancer Studies, Leicester, UK
| | - Hal E Broxmeyer
- Indiana University School of Medicine, Department of Microbiology and Immunology, Indianapolis, IN, USA
| | - Alain Bruhat
- INRA, UMR 1019 Nutrition Humaine, Centre de Clermont Theix, Saint Genès Champanelle, France
- Université Clermont 1, UFR Médecine, UMR1019 Nutrition Humaine, Clermont-Ferrand, France
| | - Patricia Chakur Brum
- University of São Paulo, School of Physical Education and Sport, Cellular and Molecular Exercise Physiology Laboratory, São Paulo, Brazil
| | | | - Nicola Brunetti-Pierri
- Federico II University, Department of Translational Medicine, Naples, Italy
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy
| | | | - Shilpa Buch
- University of Nebraska Medical Center, Omaha, NE, USA
| | - Alastair M Buchan
- University of Oxford, Acute Stroke Programme, Radcliffe Department of Medicine, Oxford, UK
| | - Hikmet Budak
- Sabanci University, Molecular Biology, Genetics and Bioengineering Program, Istanbul, Turkey
| | - Dmitry V Bulavin
- Centre Antoine Lacassagne, Nice, France
- INSERM, U1081-UMR CNRS 7284, Nice, France
- University of Nice-Sophia Antipolis, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France
| | - Scott J Bultman
- University of North Carolina, Department of Genetics, Chapel Hill, NC, USA
| | - Geert Bultynck
- KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, Leuven, Belgium
| | - Vladimir Bumbasirevic
- University of Belgrade, School of Medicine, Institute of Histology and Embryology, Belgrade, Serbia
| | - Yan Burelle
- Université de Montréal, Faculty of Pharmacy, Montréal, Québec, Canada
| | - Robert E Burke
- Columbia University Medical Center, Department of Neurology, New York, NY, USA
- Columbia University Medical Center, Department of Pathology and Cell Biology, New York, NY, USA
| | - Margit Burmeister
- University of Michigan, Molecular and Behavioral Neuroscience Institute, Departments of Computational Medicine and Bioinformatics, Psychiatry, and Human Genetics, Ann Arbor, MI, USA
| | - Peter Bütikofer
- University of Bern, Institute of Biochemistry and Molecular Medicine, Bern, Switzerland
| | - Laura Caberlotto
- University of Trento, The Microsoft Research, Centre for Computational and Systems Biology (COSBI), Rovereto, TN, Italy
| | - Ken Cadwell
- New York University School of Medicine, Skirball Institute, Department of Microbiology, New York, NY, USA
| | - Monika Cahova
- Center of Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
| | | | - Jingjing Cai
- Wenzhou Medical University, School of Optometry and Ophthalmology and Eye Hospital, Wenzhou, Zhejiang, China
| | - Qian Cai
- Rutgers University, The State University of New Jersey, Department of Cell Biology and Neuroscience, Piscataway, NJ, USA
| | - Sara Calatayud
- University of Valencia, Department of Pharmacology, Valencia, Spain
| | - Nadine Camougrand
- Université de Bordeaux, UMR 5095, CNRS, Institut de Biochimie et génétique Cellulaires, Bordeaux, France
| | - Michelangelo Campanella
- University of London, RVC Department of Comparative Biomedical Sciences, UCL Consortium for Mitochondrial Research, London, UK
| | - Grant R Campbell
- University of California San Diego, Department of Pediatrics, La Jolla, CA, USA
| | - Matthew Campbell
- Trinity College Dublin, Smurfit Institute of Genetics, Dublin, Ireland
| | - Silvia Campello
- IRCCS Santa Lucia Foundation, Department of Experimental Neurosciences, Rome, Italy
- University of Rome “Tor Vergata”, Department of Biology, Rome, Italy
| | - Robin Candau
- University of Montpellier, UMR 866, Dynamique Musculaire et Métabolisme, Montpellier, France
| | - Isabella Caniggia
- University of Toronto/Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Department of Obstetrics and Gynecology, Toronto, Ontario, Canada
| | - Lavinia Cantoni
- IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Department of Molecular Biochemistry and Pharmacology, Milan, Italy
| | - Lizhi Cao
- Central South University, Department of Pediatrics, Xiangya Hospital, Changsha, Hunan, China
| | - Allan B Caplan
- University of Idaho, Plant, Soil, and Entomological Sciences, Moscow, ID, USA
| | - Michele Caraglia
- Second University of Naples, Department of Biochemistry, Biophysics and General Pathology, Naples, Italy
| | - Claudio Cardinali
- Sapienza University of Rome, Department of Molecular Medicine, Rome, Italy
| | - Sandra Morais Cardoso
- University of Coimbra, Faculty of Medicine, Center for Neuroscience and Cell Biology, Coimbra, Portugal
| | | | - Laura A Carleton
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Cathleen R Carlin
- Case Western Reserve University, Molecular Biology and Microbiology, Cleveland, OH, USA
| | - Silvia Carloni
- University of Urbino “Carlo Bo”, Department of Biomolecular Sciences, Urbino, Italy
| | - Sven R Carlsson
- Umeå University, Department of Medical Biochemistry and Biophysics, Umeå, Sweden
| | | | - Leticia AM Carneiro
- Federal University of Rio de Janeiro, Insititute of Microbiology, Department of Immunology, Rio de Janeiro, Brazil
| | - Oliana Carnevali
- Polytechnic University of Marche, Department of Life and Environmental Sciences, Ancona, Italy
| | - Serena Carra
- Universita' degli Studi di Modena e Reggio Emilia, Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze, Modena, Italy
| | - Alice Carrier
- Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université, Institut Paoli-Calmette, Parc Scientifique et Technologique de Luminy, Marseille, France
| | - Bernadette Carroll
- Newcastle University, Campus for Ageing and Vitality, Institute for Cell and Molecular Biosciences and Institute for Ageing, Newcastle upon Tyne, UK
| | - Caty Casas
- Universitat Autònoma de Barcelona, Department of Cell Biology, Physiology and Immunology, Institut de Neurociències, Barcelona, Spain
| | - Josefina Casas
- Spanish Council for Scientific Research, Institute for Advanced Chemistry of Catalonia, Department of Biomedicinal Chemistry, Barcelona, Spain
| | - Giuliana Cassinelli
- Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Experimental Oncology and Molecular Medicine, Milan, Italy
| | | | - Susana Castro-Obregon
- Colonia Ciudad Universitaria, Neurodevelopment and Physiology Department, Neuroscience Division, Instituto de Fisiologia Celular, UNAM, Mexico, DF, Mexico
| | - Gabriella Cavallini
- University of Pisa, Interdepartmental Research Centre on Biology and Pathology of Aging, Pisa, Italy
| | | | - Francesco Cecconi
- Danish Cancer Society Research Center, Unit of Cell Stress and Survival (CSS), Copenhagen, Denmark
- IRCCS Santa Lucia Foundation, Rome, Italy
- University of Rome “Tor Vergata”, Department of Biology, Rome, Italy
| | - Arthur I Cederbaum
- Icahn School of Medicine at Mount Sinai, Department of Pharmacology and Systems Therapeutics, New York, NY, USA
| | - Valentín Ceña
- CIBERNED, ISCIII, Unidad Asociada Neurodeath, Madrid, Spain
- Universidad de Castilla-La Mancha, Albacete, Spain
| | - Simone Cenci
- Università Vita-Salute San Raffaele, Milan, Italy
- San Raffaele Scientific Institute, Milan, Italy
| | - Claudia Cerella
- Hôpital Kirchberg, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
| | - Davide Cervia
- University of Tuscia, Department for Innovation in Biological, Agro-food and Forest Systems (DIBAF), Viterbo, Italy
| | - Silvia Cetrullo
- University of Bologna, Dipartimento di Scienze Biomediche e Neuromotorie, Bologna, Italy
| | - Hassan Chaachouay
- University of Zürich, Department of Radiation Oncology, Zurich, Switzerland
| | - Han-Jung Chae
- Chonbuk National University, Department of Pharmacology, Medical School, Chonbuk, Korea
| | - Andrei S Chagin
- Karolinska Institute, Department of Physiology and Pharmacology, Stockholm, Sweden
| | - Chee-Yin Chai
- Kaohsiung Medical University Hospital, Department of Pathology, Kaohsiung City, Taiwan
- Kaohsiung Medical University, Faculty of Medicine, Department of Pathology, Kaohsiung City, Taiwan
| | - Gopal Chakrabarti
- University of Calcutta, Department of Biotechnology, Dr.B.C. Guha Centre for Genetic Engineering and Biotechnology, Kolkata, WB, India
| | - Georgios Chamilos
- University of Crete, School of Medicine, Department of Infectious Diseases, Heraklion, Crete, Greece
| | - Edmond YW Chan
- Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK
| | - Matthew TV Chan
- Chinese University of Hong Kong, Department of Anaesthesia and Intensive Care, Shatin, NT, Hong Kong
| | - Dhyan Chandra
- Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics, Buffalo, NY, USA
| | - Pallavi Chandra
- International Center for Genetic Engineering and Biotechnology, Immunology Group, New Delhi, India
| | - Chih-Peng Chang
- National Cheng Kung University, Department of Microbiology and Immunology, College of Medicine, Tainan, Taiwan
| | - Raymond Chuen-Chung Chang
- University of Hong Kong, Laboratory of Neurodegenerative Diseases, School of Biomedical Sciences, LKS Faculty of Medicine, Hong Kong, China
| | - Ta Yuan Chang
- Geisel School of Medicine at Dartmouth, Department of Biochemistry, Hanover, NH, USA
| | - John C Chatham
- University of Alabama at Birmingham, Division of Molecular and Cellular Pathology, Department of Pathology, Birmingham, AL, USA
| | - Saurabh Chatterjee
- University of South Carolina, Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Columbia, SC, USA
| | | | - Yongsheng Che
- Beijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
| | | | - Rajkumar Cheluvappa
- University of New South Wales, Inflammation and Infection Research Centre, School of Medical Sciences, Sydney, NSW, Australia
| | - Chun-Jung Chen
- Taichung Veterans General Hospital, Department of Medical Research, Taichung City, Taiwan
| | - Gang Chen
- Jinshan Hospital of Fudan University, Department of Urology, Shanghai, China
- University of Kentucky, College of Medicine, Department of Pharmacology and Nutritional Sciences, Lexington, KY, USA
| | - Guang-Chao Chen
- Academia Sinica, Institute of Biological Chemistry, Taipei, Taiwan
| | - Guoqiang Chen
- Shanghai Jiao Tong University, School of Medicine, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai, China
| | - Hongzhuan Chen
- Shanghai Jiao Tong University, School of Medicine, Department of Pharmacology and Chemical Biology, Shanghai, China
| | - Jeff W Chen
- University of California Irvine, Department of Neurosurgery, Irvine, CA, USA
| | - Jian-Kang Chen
- Georgia Regents University, Medical College of Georgia, Department of Cellular Biology and Anatomy, Augusta, GA, USA
- Georgia Regents University, Medical College of Georgia, Department of Medicine, Augusta, GA, USA
| | - Min Chen
- Dalian Medical University, Department of Food Nutrition and Safety, Dalian, China
| | - Mingzhou Chen
- Wuhan University, College of Life Science, State Key Laboratory of Virology, Wuhan, Hubei, China
| | - Peiwen Chen
- University of Padova, Department of Molecular Medicine, Padova, Italy
| | - Qi Chen
- University of Kansas Medical Center, Department of Pharmacology, Toxicology and Therapeutics, Kansas City, KS, USA
| | - Quan Chen
- Chinese Academy of Sciences, Institute of Zoology, Beijing, China
| | - Shang-Der Chen
- Chang Gung University, College of Medicine, Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
| | - Si Chen
- Food and Drug Administration (FDA), Division of Biochemical Toxicology, National Center for Toxicological Research (NCTR), Jefferson, AR, USA
| | - Steve S-L Chen
- Academia Sinica, Institute of Biomedical Sciences, Taipei, Taiwan
| | - Wei Chen
- Zhejiang University, Department of Food Science and Nutrition, Hangzhou, China
| | - Wei-Jung Chen
- National Ilan University, Department of Biotechnology and Animal Science, Yilan City, Taiwan
| | - Wen Qiang Chen
- Qilu Hospital of Shandong University, Cardiology, Jinan, Shandong, China
| | - Wenli Chen
- South China Normal University, College of Biophotonics, Guangdong, China
| | - Xiangmei Chen
- State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, Beijing, China
| | - Yau-Hung Chen
- Tamkang University, Department of Chemistry, Tamsui, New Taipei City, Taiwan
| | - Ye-Guang Chen
- Tsinghua University, School of Life Sciences, Beijing, China
| | - Yin Chen
- University of Arizona, Department of Pharmacology and Toxicology, College of Pharmacy, Tucson, AZ, USA
| | - Yingyu Chen
- Peking University, Department of Immunology, Beijing, China
- Peking University, Health Science Center, Center for Human Disease Genomics, Beijing, China
| | - Yongshun Chen
- Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, China
| | - Yu-Jen Chen
- Mackay Memorial Hospital, Department of Radiation Oncology, Taipei, Taiwan
| | - Yue-Qin Chen
- Sun Yat-Sen University, Key Laboratory of Gene Engineering of the Ministry of Education, School of Life Science, Guangzhou, China
| | - Yujie Chen
- Third Military Medical University, Department of Neurosurgery, Southwest Hospital, Shapingba District, Chongqing, China
| | - Zhen Chen
- Fudan University, Cancer Center, Department of Integrative Oncology, Shanghai, China
| | - Zhong Chen
- Zhejiang University, Deparment of Pharmacology, College of Pharmaceutical Sciences, Hangzhou, Zhejiang, China
| | - Alan Cheng
- University of Louisville, Department of Biochemistry and Molecular Genetics, Louisville, KY, USA
| | - Christopher HK Cheng
- Chinese University of Hong Kong, School of Biomedical Sciences, Faculty of Medicine, Shatin, NT, Hong Kong
| | - Hua Cheng
- University of Maryland, School of Medicine, Institute of Human Virology, Baltimore, MD, USA
| | - Heesun Cheong
- National Cancer Center, Division of Cancer Biology, Research Institute, Gyeonggi, Korea
| | - Sara Cherry
- University of Pennsylvania, Department of Microbiology, Philadelphia, PA, USA
| | - Jason Chesney
- University of Louisville, Department of Medicine (Hem-Onc), Louisville, KY, USA
| | - Chun Hei Antonio Cheung
- National Cheng Kung University, College of Medicine, Department of Pharmacology and Institute of Basic Medical Sciences, Tainan, Taiwan
| | - Eric Chevet
- Université de Rennes-1, Oncogenesis, stress, Signaling” (OSS), ERL 440 INSERM, Centre de Lutte Contre le Cancer Eugene Marquis, Rennes, France
| | - Hsiang Cheng Chi
- Chang Gung University, Department of Biochemistry, College of Medicine, Taoyuan, Taiwan
| | - Sung-Gil Chi
- Korea University, Department of Life Science and Biotechnology, Seoul, Korea
| | - Fulvio Chiacchiera
- European Institute of Oncology (IEO), Department of Experimental Oncology, Milan, Italy
| | - Hui-Ling Chiang
- Pennsylvania State University, College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA
| | - Roberto Chiarelli
- University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Palermo, Italy
| | - Mario Chiariello
- Consiglio Nazionale delle Ricerche, Core Research Laboratory, Siena, Italy
- Istituto di Fisiologia Clinica, Siena, Italy
- Istituto Toscano Tumori, Siena, Italy
| | - Marcello Chieppa
- National Institute of Gastoenterology, Laboratory of Experimental Immunopathology, Castellana Grotte (BA), Italy
| | - Lih-Shen Chin
- Emory University, School of Medicine, Department of Pharmacology, Atlanta, GA, USA
| | - Mario Chiong
- Universidad de Chile, Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile
| | - Gigi NC Chiu
- National University of Singapore, Department of Pharmacy, Singapore
| | - Dong-Hyung Cho
- Kyung Hee University, Graduate School of East-West Medical Science, Seoul, Korea
| | - Ssang-Goo Cho
- Konkuk University, Department of Animal Biotechnology, Seoul, Korea
| | - William C Cho
- Queen Elizabeth Hospital, Department of Clinical Oncology, Kowloon, Hong Kong
| | - Yong-Yeon Cho
- Catholic University of Korea, College of Pharmacy, Bucheon, Korea
| | - Young-Seok Cho
- Seoul St. Mary's Hospital, Department of Internal Medicine, Seoul, Korea
| | | | - Eui-Ju Choi
- Korea University, Department of Life Science and Biotechnology, Seoul, Korea
| | - Eun-Kyoung Choi
- Graduate School of Hallym University, Chuncheon, Kangwon-do, Korea
- Hallym University, Department of Biomedical Gerontology, Chuncheon, Kangwon-do, Korea; and Anyang, Gyeonggi-do, Korea
- Laboratory of Cellular Aging and Neurodegeneration, Ilsong Institute of Life Science, Anyang, Gyeonggi-do, Korea
| | - Jayoung Choi
- University of Chicago, Department of Pathology, Chicago, IL, USA
| | - Mary E Choi
- Weill Cornell Medical College, Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, New York, NY, USA
| | - Seung-Il Choi
- Yonsei University, College of Medicine, Corneal Dystrophy Research Institute; and Department of Ophthalmology, Seoul, Korea
| | - Tsui-Fen Chou
- Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Division of Medical Genetics, Department of Pediatrics, Torrance, CA, USA
| | | | | | - Vinay Choubey
- University of Tartu, Department of Pharmacology, Tartu, Estonia
| | - Kuan-Chih Chow
- National Chung Hsing University, Graduate Institute of Biomedical Sciences, Taichung, Taiwan
| | - Kamal Chowdhury
- Max Planck Institute of Biophysical Chemistry, Department of Molecular Cell Biology, Göttingen, Germany
| | - Charleen T Chu
- University of Pittsburgh, School of Medicine, Department of Pathology and Center for Neuroscience, Pittsburgh, PA, USA
| | - Tsung-Hsien Chuang
- National Health Research Institutes, Immunology Research Center, Miaoli, Taiwan
| | - Taehoon Chun
- Korea University, Department of Biotechnology, College of Life Sciences and Biotechnology, Seoul, Korea
| | - Hyewon Chung
- Konkuk University School of Medicine, Department of Ophthalmology, Seoul, Korea
| | - Taijoon Chung
- Pusan National University, Department of Biological Sciences, Busan, Korea
| | - Yuen-Li Chung
- The Institute of Cancer Research, Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, Sutton, Surrey, UK
| | - Yong-Joon Chwae
- Ajou University, School of Medicine, Department of Microbiology, Gyeonggi-do, Korea
| | - Valentina Cianfanelli
- Danish Cancer Society Research Center, Unit of Cell Stress and Survival, Copenhagen, Denmark
| | - Roberto Ciarcia
- University of Naples Federico II, Department of Veterinary Medicine and Animal Production, Naples, Italy
| | - Iwona A Ciechomska
- Nencki Institute of Experimental Biology, Neurobiology Center, Laboratory of Molecular Neurobiology, Warsaw, Poland
| | | | - Mara Cirone
- Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy
| | - Sofie Claerhout
- KU Leuven–University of Leuven, Center for Human Genetics; VIB Center for the Biology of Disease, Leuven, Belgium
| | - Michael J Clague
- University of Liverpool, Cellular and Molecular Physiology, Institute of Translational Medicine, Liverpool, UK
| | - Joan Clària
- University of Barcelona, Department of Biochemistry and Molecular Genetics, Hospital Clínic, IDIBAPS-CIBERehd, Barcelona, Spain
| | - Peter GH Clarke
- University of Lausanne, Department of Fundamental Neurosciences, Faculty of Biology and Medicine, Lausanne, Switzerland
| | - Robert Clarke
- Georgetown University Medical Center, Department of Oncology, Washington, DC, USA
| | - Emilio Clementi
- Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy
- University Hospital “Luigi Sacco”, Università di Milano, Unit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences “Luigi Sacco”, Milano, Italy
| | - Cédric Cleyrat
- University of New Mexico, Department of Pathology and Cancer Research and Treatment Center, Albuquerque, NM, USA
| | - Miriam Cnop
- Universite Libre de Bruxelles, ULB Center for Diabetes Research, Brussels, Belgium
| | - Eliana M Coccia
- Istituto Superiore di Sanità, Department of Infectious, Parasitic and Immunomediated Diseases, Rome, Italy
| | - Tiziana Cocco
- University of Bari ‘Aldo Moro', Department of Basic Medical Sciences, Neurosciences and Organs of Senses, Bari, Italy
| | - Patrice Codogno
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | - Jörn Coers
- Duke University, Medical Center, Department of Molecular Genetics and Microbiology, Durham, NC, USA
| | - Ezra EW Cohen
- University of California San Diego, Moores Cancer Center, La Jolla, CA, USA
| | - David Colecchia
- Consiglio Nazionale delle Ricerche, Core Research Laboratory, Siena, Italy
- Istituto di Fisiologia Clinica, Siena, Italy
- Istituto Toscano Tumori, Siena, Italy
| | - Luisa Coletto
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Bronx, NY, USA
| | - Núria S Coll
- Centre for Research in Agricultural Genomics (CSIC-IRTA-UAB-UB), Bellaterra, Catalonia, Spain
| | - Emma Colucci-Guyon
- Institut Pasteur, CNRS, URA2578, Unité Macrophages et Développement de l'Immunité, Département de Biologie du Développement et des Cellules Souches, Paris, France
| | - Sergio Comincini
- University of Pavia, Department of Biology and Biotechnology, Pavia, Italy
| | - Maria Condello
- Italian National Institute of Health, Department of Technology and Health, Rome, Italy
| | - Katherine L Cook
- Wake Forest University, Department of Surgery, Hypertension and Vascular Research Center, Wake Forest Comprehensive Cancer Center, Winston-Salem, NC, USA
| | - Graham H Coombs
- University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK
| | - Cynthia D Cooper
- Washington State University Vancouver, School of Molecular Biosciences, Vancouver, WA, USA
| | - J Mark Cooper
- University College London, Department of Clinical Neurosciences, London, UK
| | - Isabelle Coppens
- Johns Hopkins University, Bloomberg School of Public Health, Malaria Research Institute, Department of Molecular Microbiology and Immunology, Baltimore, MD, USA
| | | | - Marco Corazzari
- INMI-IRCCS “L. Spallanzani”, Rome, Italy
- University of Rome “Tor Vergata”, Department of Biology, Rome, Italy
| | - Ramon Corbalan
- University of Chile, Advanced Center for Chronic Diseases (ACCDiS), Division of Cardiovascular Diseases, Faculty of Medicine, Santiago, Chile
| | - Elisabeth Corcelle-Termeau
- Danish Cancer Society Research Center, Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Copenhagen, Denmark
| | - Mario D Cordero
- University of Sevilla, Instituto de Biomedicina de Sevilla (IBIS), Oral Medicine Department, Sevilla, Spain
| | - Cristina Corral-Ramos
- Universidad de Córdoba, Campus de Excelencia Agroalimentario (ceiA3), Departamento de Genética, Córdoba, Spain
| | - Olga Corti
- INSERM, U1127, CNRS, UMR 7225, Paris, France
- Sorbonne Universités, UMR S1127, Paris, France
| | - Andrea Cossarizza
- University of Modena and Reggio Emilia, School of Medicine, Department of Surgery, Medicine, Dentistry and Morphological Sciences, Modena, Italy
| | - Paola Costelli
- University of Turin, Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, Turin, Italy
| | - Safia Costes
- University of California Los Angeles, Larry Hillblom Islet Research Center, David Geffen School of Medicine, Los Angeles, CA, USA
| | - Susan L Cotman
- Massachusetts General Hospital and Harvard Medical School, Center for Human Genetic Research and Department of Neurology, Boston, MA, USA
| | - Ana Coto-Montes
- Oviedo University, Morphology and Cellular Biology Department, Oviedo, Spain
| | - Sandra Cottet
- IRO, Institute for Research in Ophthalmology, Sion, Switzerland
- University of Lausanne, Department of Ophthalmology, Lausanne, Switzerland
| | - Eduardo Couve
- Universidad de Valparaíso, Instituto de Biología, Facultad de Ciencias, Valparaíso, Chile
| | - Lori R Covey
- Rutgers University, Department of Cell Biology and Neuroscience, Piscataway, NJ, USA
| | - L Ashley Cowart
- Medical University of South Carolina, Biochemistry and Molecular Biology, Charleston, SC, USA
| | - Jeffery S Cox
- University of California San Francisco, Department of Microbiology and Immunology, San Francisco, CA, USA
| | - Fraser P Coxon
- University of Aberdeen, Division of Applied Medicine, Aberdeen, UK
| | - Carolyn B Coyne
- University of Pittsburgh, Department of Microbiology and Molecular Genetics, Pittsburgh, PA, USA
| | - Mark S Cragg
- University of Southampton, Cancer Sciences, Southampton, UK
| | - Rolf J Craven
- University of Kentucky, Department of Pharmacology and Nutritional Sciences, Lexington, KY, USA
| | | | - Jose L Crespo
- Universidad de Sevilla, Instituto de Bioquímica Vegetal y Fotosíntesis, CSIC, Sevilla, Spain
| | - Alfredo Criollo
- Universidad de Chile, Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile
| | - Valeria Crippa
- IRCCS, “C. Mondino” National Neurological Institute, Experimental Neurobiology Lab, Pavia, Italy
| | - Maria Teresa Cruz
- University of Coimbra, Center for Neuroscience and Cell Biology and Faculty of Pharmacy, Coimbra, Portugal
| | - Ana Maria Cuervo
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
| | - Jose M Cuezva
- Universidad Autonoma de Madrid, Departamento de Biologia Molecular, Madrid, Spain
| | - Taixing Cui
- University of South Carolina School of Medicine, Department of Cell Biology and Anatomy, Columbia, SC, USA
| | - Pedro R Cutillas
- Queen Mary University of London, Centre for Haemato-Oncology, Barts Cancer Institute, London, UK
| | - Mark J Czaja
- Albert Einstein College of Medicine, Department of Medicine, Bronx, NY, USA
| | - Maria F Czyzyk-Krzeska
- University of Cincinnati College of Medicine, Department of Cancer Biology, Cincinnati, OH, USA
| | - Ruben K Dagda
- University of Nevada School of Medicine, Department of Pharmacology, Reno, NV, USA
| | - Uta Dahmen
- University Hospital Jena, Department of General, Visceral and Vascular Surgery, Experimental Transplantation Surgery, Jena, Germany
| | - Chunsun Dai
- Nanjing Medical University, Center for Kidney Disease, 2nd Affiliated Hospital, Jiangsu, China
| | - Wenjie Dai
- The First Affiliated Hospital of Harbin Medical University, Key Laboratory of Hepatosplenic Surgery, Department of General Surgery, Harbin, China
| | - Yun Dai
- Virginia Commonwealth University, Massey Cancer Center, Department of Medicine, Richmond, VA, USA
| | - Kevin N Dalby
- University of Texas at Austin, College of Pharmacy, Division of Medicinal Chemistry, Austin, TX, USA
| | | | - Guillaume Dalmasso
- Université d'Auvergne, M2iSH “Microbes, Intestine, Inflammation, Susceptibility of the Host”, UMR 1071 INSERM, Centre Biomédical de Recherche et Valorisation, Faculté de Médecine, Clermont-Ferrand, France
| | | | - Markus Damme
- Christian Albrechts University, Institut für Biochemie, Kiel, Germany
| | - Arlette Darfeuille-Michaud
- Université d'Auvergne, M2iSH “Microbes, Intestine, Inflammation, Susceptibility of the Host”, UMR 1071 INSERM, Centre Biomédical de Recherche et Valorisation, Faculté de Médecine, Clermont-Ferrand, France
| | | | - Victor M Darley-Usmar
- University of Alabama at Birmingham, Department of Pathology, Center for Free Radical Biology, Birmingham, AL, USA
| | | | - Biplab Dasgupta
- Cincinnati Children's Hospital Medical Center, Division of Oncology, Cincinnati, OH, USA
| | - Srikanta Dash
- Tulane University Health Sciences Center, Department of Pathology and Laboratory Medicine, New Orleans, LA, USA
| | - Crispin R Dass
- Curtin University, School of Pharmacy, Bentley, Australia
| | - Hazel Marie Davey
- Alberystwyth University, Institute of Biological, Environmental and Rural Sciences, Penglais, Aberystwyth, Wales, UK
| | - Lester M Davids
- University of Cape Town, Redox Laboratory, Department of Human Biology, Cape Town, South Africa
| | - David Dávila
- Complutense University, Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Department of Biochemistry and Molecular Biology I, School of Biology, Madrid, Spain
| | - Roger J Davis
- University of Massachusetts, Medical School, Howard Hughes Medical Institute, Worcester, MA, USA
| | - Ted M Dawson
- Johns Hopkins University, School of Medicine, Departments of Neurology, Neuroscience and Pharmacology and Molecular Sciences; Neuroregeneration Program, Institute for Cell Engineering, Baltimore, MD, USA
| | - Valina L Dawson
- Johns Hopkins University, School of Medicine, Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Department of Neurology, Department of Physiology, Baltimore, MD, USA
| | - Paula Daza
- University of Sevilla, Department of Cell Biology, Sevilla, Spain
| | - Jackie de Belleroche
- Imperial College London, Neurogenetics Group, Division of Brain Sciences, London, UK
| | - Paul de Figueiredo
- Texas A&M University, Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, TX, USA
- Texas A&M University, The Norman Borlaug Center, College Station, TX, USA
| | | | - José de la Fuente
- SaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ciudad Real, Spain
| | - Luisa De Martino
- University of Naples Federico II, Department of Veterinary Medicine and Animal Production, Naples, Italy
| | | | - Guido RY De Meyer
- University of Antwerp, Laboratory of Physiopharmacology, Wilrijk, Antwerp, Belgium
| | - Angelo De Milito
- Karolinska Institute, Cancer Center Karolinska, Department of Oncology-Pathology, Stockholm, Sweden
| | - Mauro De Santi
- University of Urbino “Carlo Bo”, Department of Biomolecular Sciences, Urbino, Italy
| | - Wanderley de Souza
- Rio de Janeiro Federal University, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, Brazil
| | - Vincenzo De Tata
- University of Pisa, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy
| | - Daniela De Zio
- Danish Cancer Society Research Center, Cell Stress and Survival Unit, Copenhagen, Denmark
| | - Jayanta Debnath
- University of California San Francisco, School of Medicine, Department of Pathology, San Francisco, CA, USA
| | | | - Jean-Paul Decuypere
- KU Leuven, Department of Abdominal Transplant Surgery, Leuven, Belgium
- University Hospitals Leuven, Department of Microbiology and Immunology, Laboratory of Abdominal Transplantation, Leuven, Belgium
| | - Shane Deegan
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Benjamin Dehay
- Université de Bordeaux, Institut des Maladies Neurodégénératives, CNRS UMR 5293, Bordeaux, France
| | - Barbara Del Bello
- University of Siena, Department of Molecular and Developmental Medicine, Siena, Italy
| | - Dominic P Del Re
- Rutgers University, New Jersey Medical School, Department of Cell Biology and Molecular Medicine, Newark, NJ, USA
| | - Régis Delage-Mourroux
- Université de Franche-Comté, UFR Sciences et Techniques EA3922/SFR IBCT FED 4234, Estrogènes, Expression Génique et Pathologies du Système Nerveux Central, Besançon, France
| | - Lea MD Delbridge
- University of Melbourne, Department of Physiology, Parkville, Australia
| | - Louise Deldicque
- Université Catholique de Louvain (UCL), Institute of Neuroscience, Louvain-la-Neuve, Belgium
| | | | | | - Joern Dengjel
- University of Freiburg, Department of Dermatology, Medical Center, Center for Biological Systems Analysis (ZBSA), Freiburg, Germany
| | - Melanie Denizot
- University of La Réunion, CYROI, IRG Immunopathology and Infection Research Grouping, Reunion, France
| | - Paul Dent
- Virginia Commonwealth University, Department of Biochemistry and Molecular Biology, Richmond, VA, USA
| | - Channing J Der
- University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
| | - Vojo Deretic
- University of New Mexico, Health Sciences Center, Department of Molecular Genetics and Microbiology, Albuquerque, NM, USA
| | | | - Eric Deutsch
- Université Paris-Sud, INSERM 1030, Gustave Roussy Cancer Campus, Paris, France
| | - Timothy P Devarenne
- Texas A&M University, Department of Biochemistry and Biophysics, College Station, TX, USA
| | - Rodney J Devenish
- Monash University, Clayton Campus, Department of Biochemistry and Molecular Biology, Melbourne, Victoria, Australia
| | | | - Nicola Di Daniele
- University of Rome “Tor Vergata”, Department of System Medicine, Rome, Italy
| | - Fabio Di Domenico
- Sapienza University of Rome, Department of Biochemical Sciences “A. Rossi Fanelli”, Rome, Italy
| | | | - Simone Di Paola
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy
| | - Antonio Di Pietro
- Universidad de Córdoba, Campus de Excelencia Agroalimentario (ceiA3), Departamento de Genética, Córdoba, Spain
| | - Livia Di Renzo
- Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy
| | - Aaron DiAntonio
- Washington University, School of Medicine, Department of Developmental Biology, St. Louis, MO, USA
| | - Guillermo Díaz-Araya
- Universidad de Chile, Facultad de Ciencias Químicas y Farmacéuticas, Santos Dumont, Santiago de Chile
| | - Ines Díaz-Laviada
- University of Alcala, Department of System Biology, Biochemistry and Molecular Biology Unit, School of Medicine, Madrid, Spain
| | - Maria T Diaz-Meco
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
| | - Javier Diaz-Nido
- Universidad Autónoma de Madrid, Centro de Biología Molecular Severo Ochoa, CIBERER, Madrid, Spain
| | - Chad A Dickey
- University of South Florida, Byrd Alzheimer's Institute, Tampa, FL, USA
| | - Robert C Dickson
- University of Kentucky, Department of Molecular and Cellular Biochemistry, Lexington, KY, USA
| | - Marc Diederich
- Seoul National University, College of Pharmacy, Seoul, Korea
| | - Paul Digard
- University of Edinburgh, Easter Bush, The Roslin Insitute, Midlothian, UK
| | - Ivan Dikic
- Goethe University School of Medicine, Institute of Biochemistry II and Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany
| | - Savithrama P Dinesh-Kumar
- University of California Davis, Department of Plant Biology and the Genome Center, College of Biological Sciences, Davis, CA, USA
| | - Chan Ding
- Shanghai Veterinary Research Institute, Shanghai, China
| | - Wen-Xing Ding
- University of Kansas Medical Center, Department of Pharmacology, Toxicology and Therapeutics, Kansas City, KS, USA
| | - Zufeng Ding
- University of Arkansas for Medical Sciences, Department of Cardiology, Little Rock, AR, USA
| | - Luciana Dini
- University of Salento, Department of Biological and Environmental Science and Technology, Lecce, Italy
| | - Jörg HW Distler
- University of Erlangen-Nuremberg, Department of Internal Medicine 3, Erlangen, Germany
| | - Abhinav Diwan
- Washington University, School of Medicine, John Cochran VA Medical Center, Center for Cardiovascular Research, St. Louis, MO, USA
| | | | - Kostyantyn Dmytruk
- NAS of Ukraine, Department of Molecular Genetics and Biotechnology, Institute of Cell Biology, Lviv, Ukraine
| | - Renwick CJ Dobson
- University of Canterbury, Biomolecular Interaction Centre, School of Biological Sciences, Christchurch, New Zealand
| | - Volker Doetsch
- Goethe University of Frankfurt, Institute of Biophysical Chemistry, Frankfurt am Main, Germany
| | - Karol Dokladny
- University of New Mexico, Department of Internal Medicine, Albuquerque, NM, USA
| | | | - Massimo Donadelli
- University of Verona, Department of Neurological, Biomedical and Movement Sciences, Verona, Italy
| | - X Charlie Dong
- Indiana University School of Medicine, Department of Biochemistry and Molecular Biology, Indianapolis, IN, USA
| | - Xiaonan Dong
- University of Texas, Southwestern Medical Center, Department of Internal Medicine, Center for Autophagy Research, Dallas, TX, USA
| | - Zheng Dong
- Georgia Regents University, Medical College of Georgia, Department of Cellular Biology and Anatomy, Augusta, GA, USA
| | - Terrence M Donohue
- University of Nebraska Medical Center, Department of Internal Medicine, Omaha, NE, USA
- VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA
| | - Kelly S Doran
- San Diego State University, Department of Biology and Center for Microbial Sciences, San Diego, CA, USA
| | - Gabriella D'Orazi
- University “G. dAnnunzio”, Department of Medical, Oral and Biotechnological Sciences, Chieti, Italy
| | - Gerald W Dorn
- Washington University in St. Louis, School of Medicine, Department of Internal Medicine, St. Louis, MO, USA
| | - Victor Dosenko
- Bogomoletz Institute of Physiology, National Academy of Sciences Ukraine, General and Molecular Pathophysiology Department, Kiev, Ukraine
| | - Sami Dridi
- University of Arkansas, Center of Excellence for Poultry Science, Fayetteville, AR, USA
| | - Liat Drucker
- Tel Aviv University, Oncogenetic Laboratory, Meir Medical Center, Kfar Saba and Sackler Faculty of Medicine, Tel Aviv, Israel
| | - Jie Du
- Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China
| | - Li-Lin Du
- National Institute of Biological Sciences, Beijing, China
| | - Lihuan Du
- Fujian Provincial Hospital, Department of Urology, Fuzhou, China
| | - André du Toit
- Stellenbosch University, Department of Physiological Sciences, Stellenbosch, South Africa
| | - Priyamvada Dua
- Queen Mary University of London, Blizard Institute, Department of Neuroscience and Trauma, London, UK
| | - Lei Duan
- Rush University Medical Center, Department of Anatomy and Cell Biology, Chicago, IL, USA
| | - Pu Duann
- Ohio State University, DHLRI, Department of Medicine, Columbus, OH, USA
| | - Vikash Kumar Dubey
- Indian Institute of Technology Guwahati, Department of Biosciences and Bioengineering, Guwahati, Assam, India
| | - Michael R Duchen
- University College London, UCL Consortium for Mitochondrial Research and Department of Cell and Developmental Biology, London, UK
| | - Michel A Duchosal
- University Hospital of Lausanne, Service and Central Laboratory of Hematology, Lausanne, Switzerland
| | - Helene Duez
- University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Lille, France
| | - Isabelle Dugail
- INSERM UMRS 1166, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition, Paris, France
| | - Verónica I Dumit
- Freiburg University, Center for Biological Systems Analysis (ZBSA), Core Facility Proteomics, Freiburg, Germany
| | - Mara C Duncan
- University of Michigan, Department of Cell and Developmental Biology, Ann Arbor, MI, USA
| | - Elaine A Dunlop
- Cardiff University, Institute of Cancer and Genetics, Cardiff, Wales, UK
| | - William A Dunn
- University of Florida, College of Medicine, Department of Anatomy and Cell Biology, Gainesville, FL, USA
| | - Nicolas Dupont
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | - Luc Dupuis
- INSERM U1118, Mécanismes Centraux et Périphétiques de la Neurodégénérescence, Strasbourg, France
- Université de Strasbourg, Faculté de Médecine, UMRS 1118, Strasbourg, France
| | - Raúl V Durán
- INSERM U916, Université de Bordeaux, Institut Européen de Chimie et Biologie, Pessac, France
| | - Thomas M Durcan
- McGill University, Montreal Neurological Institute, Montreal, QC, Canada
| | - Stéphane Duvezin-Caubet
- Université Bordeaux, CNRS, Institut de Biochimie et Génétique Cellulaires, UMR 5095, Bordeaux, France
| | - Umamaheswar Duvvuri
- VA Pittsburgh Health System, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - Vinay Eapen
- Brandeis University, Department of Biology, Waltham, MA, USA
| | - Darius Ebrahimi-Fakhari
- Ruprecht-Karls-University Heidelberg, Division of Pediatric Neurology, Department of Pediatrics, Heidelberg University Hospital, Heidelberg, Germany
| | - Arnaud Echard
- Institut Pasteur, CNRS URA2582, Cell Biology and Infection Department, Membrane Traffic and Cell Division Lab, Paris, France
| | - Leopold Eckhart
- Medical University of Vienna, Department of Dermatology, Vienna, Austria
| | | | - Aimee L Edinger
- University of California Irvine, Department of Developmental and Cell Biology, Irvine, CA, USA
| | - Ludwig Eichinger
- University of Cologne, Medical Faculty, Center for Biochemistry, Cologne, Germany
| | - Tobias Eisenberg
- University of Graz, Institute of Molecular Biosciences, BioTechMed Graz, Graz, Austria
| | | | - N Tony Eissa
- Baylor College of Medicine, Department of Medicine, Houston, TX, USA
| | - Wafik S El-Deiry
- Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Hematology/Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA
| | - Victoria El-Khoury
- Luxembourg Institute of Health, Department of Oncology, Luxembourg City, Luxembourg
| | - Zvulun Elazar
- Weizmann Institute of Science, Department of Biological Chemistry, Rehovot, Israel
| | - Hagit Eldar-Finkelman
- Tel Aviv University, Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv, Israel
| | | | - Enzo Emanuele
- University of Pavia, Department of Health Sciences, Pavia, Italy
| | - Urban Emmenegger
- University of Toronto, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
| | - Nikolai Engedal
- University of Oslo, Oslo University Hospital, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, Oslo, Norway
| | - Anna-Mart Engelbrecht
- Stellenbosch University, Department of Physiological Sciences, Stellenbosch, South Africa
| | - Simone Engelender
- Technion-Israel Institute of Technology, The Rappaport Faculty of Medicine and Research Institute, Department of Biochemistry, Haifa, Israel
| | | | - Ralf Erdmann
- Ruhr University Bochum, Medical Faculty, System Biochemistry, Bochum, Germany
| | | | - Rajaraman Eri
- University of Tasmania, School of Health Sciences, Launceston, Tasmania
| | - Jason L Eriksen
- University of Houston, College of Pharmacy, Pharmacological and Pharmaceutical Sciences, Houston, TX, USA
| | - Andreja Erman
- University of Ljubljana, Institute of Cell Biology, Faculty of Medicine, Ljubljana, Slovenia
| | - Ricardo Escalante
- C.S.I.C./U.A.M., Instituto de Investigaciones Biomédicas Alberto Sols, Madrid, Spain
| | | | - Lucile Espert
- CNRS UM, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé, Montpellier, France
| | - Lorena Esteban-Martínez
- Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
| | - Thomas J Evans
- University of Glasgow, Institute of Infection, Immunity and Inflammation, Glasgow, UK
| | - Mario Fabri
- University of Cologne, Department of Dermatology, Cologne, Germany
| | - Gemma Fabrias
- Spanish Council for Scientific Research, Institute for Advanced Chemistry of Catalonia, Department of Biomedicinal Chemistry, Barcelona, Spain
| | - Cinzia Fabrizi
- Sapienza University of Rome, DAHFMO-Section of Anatomy, Rome, Italy
| | | | - Nils J Færgeman
- University of Southern Denmark, Villum Center for Bioanalytical Sciences, Department of Biochemistry and Molecular Biology, Odense, Denmark
| | - Alberto Faggioni
- Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy
| | - W Douglas Fairlie
- Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia
- La Trobe University, Department of Chemistry and Physics, Melbourne, Victoria, Australia
- La Trobe University, School of Cancer Medicine, Melbourne, Victoria, Australia
| | - Chunhai Fan
- Chinese Academy of Sciences, Division of Physical Biology and Bioimaging Center, Shanghai Synchrotron Radiation Facility, Shanghai Institute of Applied Physics, Shanghai, China
| | - Daping Fan
- University of South Carolina School of Medicine, Department of Cell Biology and Anatomy, Columbia, SC, USA
| | - Jie Fan
- University of Pittsburgh, Department of Surgery, Pittsburgh, PA, USA
| | - Shengyun Fang
- University of Maryland, School of Medicine, Center for Biomedical Engineering and Technology, Department of Physiology, Baltimore, MD, USA
| | - Manolis Fanto
- King's College London, Department of Basic and Clinical Neuroscience, IoPPN, London, UK
| | - Alessandro Fanzani
- University of Brescia, Department of Molecular and Translational Medicine, Brescia, Italy
| | - Thomas Farkas
- Danish Cancer Society Research Center, Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Copenhagen, Denmark
| | - Mathias Faure
- Université de Lyon, INSERM, U 1111, Centre International de Recherche en Infectiologie (CIRI), Ecole Normale Supérieure de Lyon, CNRS, UMR 5308, Lyon, France
| | - Francois B Favier
- INRA, UMR866 Dynamique Musculaire et Métabolisme, Montpellier, France
- Université de Montpellier, Montpellier, France
| | - Howard Fearnhead
- National University of Ireland, Pharmacology and Therapeutics, Galway, Ireland
| | - Massimo Federici
- University of Rome “Tor Vergata”, Department of Systems Medicine, Rome, Italy
| | - Erkang Fei
- Nanchang University, Institute of Life Science, Nanchang, China
| | - Tania C Felizardo
- National Institutes of Health, Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD, USA
| | - Hua Feng
- Third Military Medical University, Department of Neurosurgery, Southwest Hospital, Shapingba District, Chongqing, China
| | - Yibin Feng
- University of Hong Kong, Hong Kong, China
| | - Yuchen Feng
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Thomas A Ferguson
- Washington University in St. Louis, School of Medicine, Department of Ophthalmology and Visual Sciences, St. Louis, MO, USA
| | - Álvaro F Fernández
- Universidad de Oviedo, Instituto Universitario de Oncología, Departamento de Bioquímica y Biología Molecular, Oviedo, Spain
| | | | - Jose C Fernandez-Checa
- Instituto de Investigaciones Biomedicas de Barcelona, CSIC-IDIBAPS and Centro de Investigacion en Red en enfermedades hepáticas y digestivas, CIBEREHD, ISCIII, Barcelona, Spain
- University of Southern California, Research ALPD and Cirrhosis Center, Keck School of Medicine, Los Angeles, CA, USA
| | | | - Martin E Fernandez-Zapico
- Mayo Clinic, Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Rochester, MN, USA
| | - Olivier Feron
- Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium
| | - Elisabetta Ferraro
- IRCCS San Raffaele Pisana, Laboratory of Skeletal Muscle Development and Metabolism, Rome, Italy
| | | | | | - Ralph Feuer
- San Diego State University, Department of Biology, San Diego, CA, USA
| | | | - Eduardo C Filippi-Chiela
- Universidad Federal do Rio Grande do Sul (UFRGS), Department of Biophysics and Center of Biotechnology, Porto Alegre, Brazil
| | - Giuseppe Filomeni
- Danish Cancer Society Research Center, Cell Stress and Survival Unit, Copenhagen, Denmark
- University of Rome “Tor Vergata”, Department of Biology, Rome, Italy
| | - Gian Maria Fimia
- National Institute for Infectious Diseases “L. Spallanzani” IRCCS, Rome, Italy
- University of Salento, Department of Biological and Environmental Sciences and Technologies (DiSTeBA), Lecce, Italy
| | - John H Fingert
- Stephen A. Wynn Institute for Vision Research, Iowa City, IA, USA
- University of Iowa, Department of Ophthalmology and Visual Sciences, Iowa City, IA, USA
| | - Steven Finkbeiner
- University of California San Francisco, Departments of Neurology and Physiology; Gladstone Institute of Neurological Disease, San Francisco, CA, USA
| | - Toren Finkel
- National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | - Filomena Fiorito
- Istituto Zooprofilattico Sperimentale del Mezzogiorno, Department of Chemistry, Portici (Naples), Italy
- University of Naples Federico II, Department of Veterinary Medicine and Animal Production, Naples, Italy
| | - Paul B Fisher
- Virginia Commonwealth University, Institute of Molecular Medicine, Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Department of Human and Molecular Genetics, Richmond, VA, USA
| | | | - Flavio Flamigni
- University of Bologna, Dipartimento di Scienze Biomediche e Neuromotorie, Bologna, Italy
| | - Oliver Florey
- Babraham Institute, Signalling Program, Cambridge, UK
| | - Salvatore Florio
- University of Naples Federico II, Department of Veterinary Medicine and Animal Production, Naples, Italy
| | - R Andres Floto
- University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK
| | - Marco Folini
- Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Experimental Oncology and Molecular Medicine, Milan, Italy
| | - Carlo Follo
- Università del Piemonte Orientale “A. Avogadro”, Dipartimento di Scienze della Salute, Novara, Italy
| | - Edward A Fon
- McGill University, McGill Parkinson Program, Department of Neurology and Neurosurgery, Montreal, QC, Canada
| | - Francesco Fornai
- IRCCS Neuromed, Pozzilli, IS, Italy
- University of Pisa, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy
| | - Franco Fortunato
- University Clinic Heidelberg, Department of Experimental Surgery, Heidelberg, Germany
| | - Alessandro Fraldi
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy
| | - Rodrigo Franco
- University of Nebraska-Lincoln, Redox Biology Center and School of Veterinary Medicine and Biomedical Sciences, Lincoln, NE, USA
| | - Arnaud Francois
- Centre de Recherche du CHU de Québec, Faculty of Pharmacy, Québec, Canada
- Université Laval, Neurosciences Axis, Québec, Canada
| | - Aurélie François
- Institut de Cancérologie de Lorraine, Vandoeuvre-Lès-Nancy Cedex, France
| | - Lisa B Frankel
- University of Copenhagen, Biotech Research and Innovative Center (BRIC), Copenhagen, Denmark
| | - Iain DC Fraser
- National Institutes of Health, NIAID, Laboratory of Systems Biology, Bethesda, MD, USA
| | - Norbert Frey
- University of Kiel, Department of Cardiology, Kiel, Germany
| | | | - Christian Frezza
- MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK
| | - Scott L Friedman
- Icahn School of Medicine at Mount Sinai, Division of Liver Diseases, New York, NY, USA
| | - Daniel E Frigo
- Houston Methodist Research Institute, Genomic Medicine Program, Houston, TX, USA
- University of Houston, Department of Biology and Biochemistry, Center for Nuclear Receptors and Cell Signaling, Houston, TX, USA
| | - Dongxu Fu
- Queen's University of Belfast, Centre for Experimental Medicine, Belfast, UK
| | - José M Fuentes
- Universidad de Extremadura, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Cáceres, Spain
| | - Juan Fueyo
- University of Texas, MD Anderson Cancer Center, Department of Neuro-Oncology, Houston, TX, USA
| | - Yoshio Fujitani
- Juntendo University, Graduate School of Medicine, Department of Metabolism and Endocrinology, Tokyo, Japan
| | - Yuuki Fujiwara
- National Institute of Neuroscience, National Center of Neurology and Psychiatry, Department of Degenerative Neurological Diseases, Tokyo, Japan
| | - Mikihiro Fujiya
- Asahikawa Medical University, Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Hokkaido, Japan
| | - Mitsunori Fukuda
- Tohoku University, Department of Developmental Biology and Neurosciences, Graduate School of Life Sciences, Sendai, Miyagi, Japan
| | - Simone Fulda
- Goethe University, Institute for Experimental Cancer Research in Pediatrics, Frankfurt, Germany
| | - Carmela Fusco
- IRCCS Casa Sollievo della Sofferenza, Medical Genetics Unit, San Giovanni Rotondo (FG), Italy
| | - Bozena Gabryel
- Medical University of Silesia, Department of Pharmacology, Katowice, Poland
| | - Matthias Gaestel
- Hannover Medical School, Department of Biochemistry, Hannover, Germany
| | - Philippe Gailly
- Université Catholique de Louvain (UCL), Laboratory of Cell Physiology, Brussels, Belgium
| | - Malgorzata Gajewska
- Warsaw University of Life Sciences (SGGW), Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw, Poland
| | - Sehamuddin Galadari
- Al Jalila Foundation Research Centre, Dubai, UAE
- UAE University, Cell Signaling Laboratory, Department of Biochemistry, College of Medicine and Health Sciences, Al Ain, Abu Dhabi, UAE
| | - Gad Galili
- The Weizmann Institute of Science, Department of Plant Sciences, Rehovot, Israel
| | - Inmaculada Galindo
- Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Departamento de Biotecnología, Madrid, Spain
| | - Maria F Galindo
- Complejo Hospitalario Universitario de Albacete, Unidad de Neuropsicofarmacología, Albacete, Spain
| | - Giovanna Galliciotti
- University Medical Center Hamburg-Eppendorf, Institute of Neuropathology, Hamburg, Germany
| | - Lorenzo Galluzzi
- Centre de Recherche des Cordeliers, Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Gustave Roussy Cancer Campus, Villejuif, France
- INSERM, U1138, Paris, France
- Université Paris Descartes/Paris V, Paris, France
| | - Luca Galluzzi
- University of Urbino “Carlo Bo”, Department of Biomolecular Sciences, Urbino, Italy
| | - Vincent Galy
- Sorbonne Universités, CNRS, UPMC, Univ Paris 06, UMR 7622, IBPS, Paris, France
| | - Noor Gammoh
- University of Edinburgh, Edinburgh Cancer Research Centre, Edinburgh, UK
| | - Sam Gandy
- Icahn School of Medicine at Mount Sinai, Departments of Neurology and Psychiatry, Center for Cognitive Health, Mount Sinai Alzheimer's Disease Research Center, New York, NY, USA
- James J. Peters VA Medical Center, Bronx, NY, USA
| | | | - Swamynathan Ganesan
- University of Adelaide, Alzheimer's Disease Genetics Laboratory, Adelaide, Australia
| | - Ian G Ganley
- University of Dundee, MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, Dundee, UK
| | - Monique Gannagé
- University of Geneva, School of Medicine, Department of Pathology and Immunology, Geneva, Switzerland
| | - Fen-Biao Gao
- University of Massachusetts, Medical School, Department of Neurology, Worcester, MA, USA
| | - Feng Gao
- The Fourth Military Medical University, School of Basic Medical Sciences, Department of Physiology, Xi'an, China
| | - Jian-Xin Gao
- Shanghai Jiao Tong University, State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai, China
| | - Lorena García Nannig
- University of Chile, Advanced Center for Chronic Diseases (ACCDiS), Division of Cardiovascular Diseases, Faculty of Medicine, Santiago, Chile
| | | | - Marina Garcia-Macía
- Albert Einstein College of Medicine, Departments of Medicine (Endocrinology) and Molecular Pharmacology, Bronx, NY, USA
| | - Carmen Garcia-Ruiz
- Instituto de Investigaciones Biomédicas de Barcelona IIBB-CSIC, Liver Unit, Hospital Clinic de Barcelona-IDIBAPS and CIBEREHD, Barcelona, Spain
| | - Abhishek D Garg
- University of Leuven, Campus Gasthuisberg, Department of Cellular and Molecular Medicine, Laboratory for Cell Death Research and Therapy, Leuven, Belgium
| | - Pramod Kumar Garg
- All India Institute of Medical Sciences, Department of Gastroenterology, New Delhi, India
| | - Ricardo Gargini
- Universidad Autónoma de Madrid, Centro Nacional de Biotecnología (CNB-CSIC), Centro de Biología Molecular Severo Ochoa, Departamento de Biología Molecular, Madrid, Spain
| | - Nils Christian Gassen
- Max Planck Institute of Psychiatry, Translational Research in Psychiatry, Munich, Germany
| | - Damián Gatica
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Evelina Gatti
- Aix-Marseille Université, U2M, Centre d'Immunologie de Marseille-Luminy, Marseille, France
- CNRS, UMR 7280, Marseille, France
- INSERM, U1104, Marseille, France
| | - Julie Gavard
- Centre de Recherche en Cancérologie de Nantes-Angers, CNRS UMR6299, INSERM U892, Nantes, France
| | - Evripidis Gavathiotis
- Albert Einstein College of Medicine, Departments of Biochemistry and of Medicine, Bronx, NY, USA
| | - Liang Ge
- University of California Berkeley, Howard Hughes Medical Institute, Department of Molecular and Cell Biology, Berkeley, CA, USA
| | - Pengfei Ge
- First Hospital of Jilin University, Department of Neurosurgery, Changchun, China
| | - Shengfang Ge
- Shanghai Jiao Tong University, School of Medicine, Department of Biochemistry and Molecular Biology, Shanghai, China
| | - Po-Wu Gean
- National Cheng Kung University, Department of Pharmacology, Tainan, Taiwan
| | | | | | | | - Pascal Genschik
- Centre National de la Recherche Scientifique, Institut de Biologie Moléculaire des Plantes, Unité Propre de Recherche, Strasbourg, France
| | - Lisa Gerner
- University of Oslo, Oslo University Hospital, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, Oslo, Norway
| | - Jason E Gestwicki
- University of California San Francisco, Department of Pharmaceutical Chemistry, San Francisco, CA, USA
| | - David A Gewirtz
- Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA
| | - Saeid Ghavami
- University of Manitoba, Department of Human Anatomy and Cell Science, Winnipeg, Manitoba, Canada
| | - Eric Ghigo
- Aix-Marseille Université, CNRS UMR 7278, IRD198, INSERM U1095, Medicine Faculty, Marseille, France
| | - Debabrata Ghosh
- All India Institute of Medical Sciences, Department of Physiology, New Delhi, India
| | - Anna Maria Giammarioli
- Istituto Superiore di Sanità, Rome, Italy
- San Raffaele Institute, Dept. of Therapeutic Research and Medicine Evaluation, Sulmona, L'Aquila, Italy
| | - Francesca Giampieri
- Polytechnic University of Marche, Department of Clinical Science, Faculty of Medicine, Ancona, Italy
| | | | | | - Derrick J Gibbings
- University of Ottawa, Department of Cellular and Molecular Medicine, Ottawa, Ontario, Canada
| | - Lara Gibellini
- University of Modena and Reggio Emilia, Department of Surgery, Medicine, Dentistry and Morphological Sciences, Modena, Italy
| | - Spencer B Gibson
- University of Manitoba, CancerCare Manitoba, Manitoba Institute of Cell Biology, Departments of Biochemistry and Medical Genetics and Immunology, Winnipeg, Manitoba, Canada
| | - Vanessa Ginet
- University of Lausanne, Department of Fundamental Neurosciences, Faculty of Biology and Medicine, Lausanne, Switzerland
| | - Antonio Giordano
- Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Philadelphia, PA, USA
- University of Siena, Department of Medicine, Surgery & Neuroscience, Siena, Italy
| | | | - Elisa Giovannetti
- Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy
- VU University Medical Center, Department of Medical Oncology, Amsterdam, The Netherlands
| | - Stephen E Girardin
- University of Toronto, Department of Laboratory Medicine and Pathobiology, Toronto, Ontario, Canada
| | - Suzana Gispert
- Goethe University Medical School, Experimental Neurology, Frankfurt am Main, Germany
| | - Sandy Giuliano
- Centre Scientifique de Monaco, Biomedical Department, Monaco, Principality of Monaco
- University of Nice Sophia Antipolis, Institute of Research on Cancer and Ageing of Nice, CNRS UMR 7284/INSERM U1081, Nice, France
| | | | - Alvaro Glavic
- Universidad de Chile, Facultad de Ciencias, Departamento de Biología, Centro de Regulación del Genoma, Santiago, Chile
| | - Martin Gleave
- University of British Columbia, Department of Urological Sciences,Vancouver, BC, Canada
| | - Nelly Godefroy
- University of Montpellier, UMR 5554, Montpellier, France
| | - Robert M Gogal
- University of Georgia, College of Veterinary Medicine, Department of Biosciences and Diagnostic Imaging, Athens, GA, USA
| | - Kuppan Gokulan
- US Food and Drug Administration, National Center for Toxicology Research, Division of Microbiology, Jefferson, AR, USA
| | - Gustavo H Goldman
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP, USP), São Paulo, Brazil
| | - Delia Goletti
- National Institute for Infectious Diseases, Department of Epidemiology and Preclinical Research, Translational Research Unit, Rome, Italy
| | - Michael S Goligorsky
- New York Medical College, Department of Medicine, Pharmacology, and Physiology, Valhalla, NY, USA
| | - Aldrin V Gomes
- University of California Davis, Department of Neurobiology, Physiology, and Behavior, Davis, CA, USA
| | - Ligia C Gomes
- Danish Cancer Society Research Center, Unit of Cell Stress and Survival, Copenhagen, Denmark
| | - Hernando Gomez
- University of Pittsburgh, Department of Critical Care Medicine, Center for Critical Care Nephrology, Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, Pittsburgh, PA, USA
| | | | - Rubén Gómez-Sánchez
- Universidad de Extremadura, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Cáceres, Spain
| | - Dawit AP Gonçalves
- University of São Paulo, Ribeirão Preto Medical School, Department of Biochemistry and Immunology, Ribeirão Preto, São Paulo, Brazil
| | - Ebru Goncu
- Ege University, Faculty of Science, Department of Biology, Bornova, Izmir, Turkey
| | - Qingqiu Gong
- Nankai University, College of Life Sciences, Tianjin, China
| | - Céline Gongora
- IRCM, INSERM, U896, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
| | - Carlos B Gonzalez
- Universidad Austral de Chile, Department of Physiology, Valdivia, Chile
| | - Pedro Gonzalez-Alegre
- University of Pennsylvania, Center for Cell and Molecular Therapy, The Children Hospital of Philadelphia, Department of Neurology, Perelman School of Medicine, Philadelphia, PA, USA
| | - Pilar Gonzalez-Cabo
- CIBER de Enfermedades Raras (CIBERER), Valencia, Spain
- Program in Rare and Genetic Diseases, Centro de Investigación Príncipe Felipe (CIPF), IBV/CSIC Associated Unit at CIPF, Valencia, Spain
| | - Rosa Ana González-Polo
- Universidad de Extremadura, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Cáceres, Spain
| | - Ing Swie Goping
- University of Alberta, Department of Biochemistry, Edmonton, Alberta, Canada
| | - Carlos Gorbea
- University of Utah School of Medicine, Department of Biochemistry, Salt Lake City, UT, USA
| | - Nikolai V Gorbunov
- Uniformed Services University of the Health Sciences, Department of Anesthesiology, Bethesda, MD, USA
| | - Daphne R Goring
- University of Toronto, Department of Cell and Systems Biology, Toronto, Ontario, Canada
| | - Adrienne M Gorman
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Sharon M Gorski
- British Columbia Cancer Agency, Genome Sciences Centre, Vancouver, BC, Canada
- Simon Fraser University, Department of Molecular Biology and Biochemistry, Burnaby, BC, Canada
| | - Sandro Goruppi
- Massachusetts General Hospital and Harvard Medical School, Cutaneous Biology Research Center, Charlestown, MA
| | | | - Cecilia Gotor
- Consejo Superior de Investigaciones Científicas (CSIC), Instituto de Bioquímica Vegetal y Fotosíntesis, Sevilla, Spain
| | - Roberta A Gottlieb
- Cedars-Sinai Heart Institute, Barbra Streisand Women's Heart Center, Los Angeles, CA, USA
| | - Illana Gozes
- Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel
| | - Devrim Gozuacik
- Sabanci University, Molecular Biology, Genetics and Bioengineering Program, Istanbul, Turkey
| | - Yacine Graba
- Aix Marseille Université, CNRS, IBDM, UMR 7288, Campus de Luminy, Marseille, France
| | - Martin Graef
- Max Planck Institute for Biology of Ageing, Cologne, Germany
| | - Giovanna E Granato
- Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Philadelphia, PA, USA
| | - Gary Dean Grant
- Griffith University, Menzies Health Institute Queensland, Australia
| | - Steven Grant
- Virginia Commonwealth University, Department of Internal Medicine, Richmond, VA, USA
| | - Giovanni Luca Gravina
- University of L'Aquila, Department of Biotechnological and Applied Clinical Sciences, Division of Radiotherapy and Radiobiology, L'Aquila, Italy
| | | | | | - Michael T Greenwood
- Royal Military College, Chemistry and Chemical Engineering, Kingston, ON, Canada
| | - Benedetto Grimaldi
- Istituto Italiano di Tecnologia, Department of Drug Discovery and Development, Laboratory of Molecular Medicine, Genoa, Italy
| | - Frédéric Gros
- Université de Strasbourg/CNRS UPR3572, Immunopathologie et Chimie Thérapeutique, IBMC, Strasbourg, France
| | - Charles Grose
- University of Iowa, Children's Hospital, Iowa City, IA, USA
| | - Jean-Francois Groulx
- Sanford Burnham Medical Research Institute, Cell Death and Survival Networks Program, La Jolla, CA, USA
| | - Florian Gruber
- Medical University of Vienna, Department of Dermatology, CD Lab - Skin Aging, Vienna, Austria
| | - Paolo Grumati
- Goethe University School of Medicine, Institute of Biochemistry II and Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany
- University of Padova, Department of Molecular Medicine, Padova, Italy
| | - Tilman Grune
- German Institute of Human Nutrition, Department of Molecular Toxicology, Nuthetal, Germany
| | - Jun-Lin Guan
- University of Cincinnati College of Medicine, Department of Cancer Biology, Cincinnati, OH, USA
| | - Kun-Liang Guan
- University of California San Diego, Department of Pharmacology and Moores Cancer Center, La Jolla, CA, USA
| | - Barbara Guerra
- University of Southern Denmark, Villum Center for Bioanalytical Sciences, Department of Biochemistry and Molecular Biology, Odense, Denmark
| | - Carlos Guillen
- Universidad Complutense, School of Pharmacy, Madrid, Spain; and CIBER de Diabetes y Enfermedades Metab olicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Kailash Gulshan
- Cleveland Clinic, Department of Cellular and Molecular Medicine, Cleveland, OH, USA
| | - Jan Gunst
- KU Leuven, Clinical Division and Laboratory of Intensive Care Medicine, Department Cellular and Molecular Medicine, Leuven, Belgium
| | - Chuanyong Guo
- Tongji University School of Medicine, Department of Gastroenterology, Shanghai Tenth People's Hospital, Shanghai, China
| | - Lei Guo
- Food and Drug Administration (FDA), Division of Biochemical Toxicology, National Center for Toxicological Research (NCTR), Jefferson, AR, USA
| | - Ming Guo
- UCLA David Geffen School of Medicine, Brain Research Institute, Los Angeles, CA, USA
| | - Wenjie Guo
- Jiangsu University, School of Pharmacy, Zhenjiang, Jiangsu, China
| | - Xu-Guang Guo
- The Third Affiliated Hospital of Guangzhou Medical University, Department of Clinical Laboratory Medicine, Guangzhou, Guangdong, China
| | - Andrea A Gust
- University of Tübingen, Center for Plant Molecular Biology (ZMBP), Department of Plant Biochemistry, Tübingen, Germany
| | - Åsa B Gustafsson
- University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA
| | - Elaine Gutierrez
- University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
| | | | - Ho-Shin Gwak
- Graduate School of Cancer Science and Policy, Department of System Cancer Science, Goyang, Korea
| | - Albert Haas
- University of Bonn, Institute for Cell Biology, Bonn, Germany
| | - James E Haber
- Brandeis University, Department of Biology, Waltham, MA, USA
| | - Shinji Hadano
- Tokai University School of Medicine, Department of Molecular Life Sciences, Kanagawa, Japan
| | - Monica Hagedorn
- Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
| | - David R Hahn
- Cincinnati Children's Hospital Medical Center, Division of Clinical Pharmacology, Cincinnati, OH, USA
| | - Andrew J Halayko
- University of Manitoba, Department of Physiology and Pathophysiology, Winnipeg, Manitoba, Canada
| | - Anne Hamacher-Brady
- German Cancer Research Center (DKFZ), Lysosomal Systems Biology, Heidelberg, Germany
| | - Kozo Hamada
- RIKEN Brain Science Institute, Laboratory for Developmental Neurobiology, Saitama, Japan
| | - Ahmed Hamai
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | - Andrea Hamann
- Goethe University, Institute for Molecular Biosciences, Molecular Developmental Biology, Frankfurt, Hesse, Germany
| | - Maho Hamasaki
- Osaka University, Department of Genetics, Graduate School of Medicine, Osaka, Japan
| | - Isabelle Hamer
- University of Namur, Research Unit in Molecular Physiology (URPhyM), Namur, Belgium
| | - Qutayba Hamid
- University of Sharjah, College of Medicine, United Arab Emirates
| | - Ester M Hammond
- University of Oxford, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK
| | - Feng Han
- Zhejiang University, Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Hangzhou, China
| | - Weidong Han
- Zhejiang University, Sir Run Run Shaw Hospital, College of Medicine, Hangzhou, Zhejiang, China
| | - James T Handa
- Johns Hopkins, School of Medicine, Wilmer Eye Institute, Baltimore, MD, USA
| | - John A Hanover
- National Institutes of Health, NIDDK, LCMB, Bethesda, MD, USA
| | - Malene Hansen
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
| | - Masaru Harada
- University of Occupational and Environmental Health, Third Department of Internal Medicine, Kitakyushu, Japan
| | | | - J Wade Harper
- Harvard Medical School, Department of Cell Biology, Boston, MA, USA
| | - Abdel Halim Harrath
- King Saud University, College of Science, Department of Zoology, Riyadh, Saudi Arabia
| | - Adrian L Harris
- Oxford University, Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Molecular Oncology Laboratories, Oxford, UK
| | - James Harris
- Monash University, Centre for Inflammatory Diseases, Lupus Research Laboratory, Clayton, Victoria, Australia
| | - Udo Hasler
- University of Geneva, Department of Cellular Physiology and Metabolism, Geneva, Switzerland
| | - Peter Hasselblatt
- University Hospital Freiburg, Department of Medicine II, Freiburg, Germany
| | - Kazuhisa Hasui
- Kagoshima University, Graduate School of Medical and Dental Sciences, Division of Human Pathology, Department of Oncology, Course of Advanced Therapeutics, Kagoshima, Japan
| | - Robert G Hawley
- George Washington University, Department of Anatomy and Regenerative Biology, Washington, DC, USA
| | - Teresa S Hawley
- George Washington University, Flow Cytometry Core Facility, Washington, DC, USA
| | - Congcong He
- Northwestern University, Department of Cell and Molecular Biology, Feinberg School of Medicine, Chicago, IL, USA
| | - Cynthia Y He
- National University of Singapore, Department of Biological Sciences, Singapore
| | - Fengtian He
- Third Military Medical University, Department of Biochemistry and Molecular Biology, Chongqing, China
| | - Gu He
- Sichuan University, West China Hospital, State Key Labortary of Biotherapy, Sichuan, China
| | - Rong-Rong He
- Jinan University, Anti-stress and Health Center, College of Pharmacy, Guangzhou, China
| | - Xian-Hui He
- Jinan University, Department of Immunobiology, College of Life Science and Technology, Guangzhou, China
| | - You-Wen He
- Duke University, Medical Center, Department of Immunology, Durham, NC, USA
| | - Yu-Ying He
- University of Chicago, Department of Medicine, Section of Dermatology, Chicago, IL, USA
| | - Joan K Heath
- The Walter and Eliza Hall Institute of Medical Research, Development and Cancer Division, Parkville, VIC, Australia
| | - Marie-Josée Hébert
- Université de Montréal, Department of Medicine, Montréal, Quebec, Canada
| | - Robert A Heinzen
- National Institutes of Health, Rocky Mountain Laboratories, NIAID, Coxiella Pathogenesis Section, Hamilton, MT, USA
| | - Gudmundur Vignir Helgason
- University of Glasgow, Wolfson Wohl Cancer Research Centre, MVLS, Institute of Cancer Sciences, Glasgow, UK
| | - Michael Hensel
- University of Osnabrueck, Division of Microbiology, Osnabrueck, Germany
| | | | - Chengtao Her
- Washington State University, School of Molecular Biosciences, Pullman, WA, USA
| | - Paul K Herman
- Ohio State University, Department of Molecular Genetics, Columbus, OH, USA
| | - Agustín Hernández
- Universidade de São Paulo, Departamento de Parasitología, Instituto de Ciências Biomédicas, São Paulo, Brazil
| | | | - Sonia Hernández-Tiedra
- Complutense University, Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Department of Biochemistry and Molecular Biology I, School of Biology, Madrid, Spain
| | - Claudio Hetz
- FONDAP Center for Geroscience, Brain Health and Metabolism, Santiago, Chile
- University of Chile, Institute of Biomedical Sciences, Center for Molecular Studies of the Cell, Program of Cellular, Molecular Biology and Biomedical Neuroscience Institute, Faculty of Medicine, Santiago, Chile
| | | | - Katsumi Higaki
- Tottori University, Research Center for Bioscience and Technology, Yonago, Japan
| | - Sabine Hilfiker
- Consejo Superior de Investigaciones Científicas (CSIC), Institute of Parasitology and Biomedicine López-Neyra, Granada, Spain
| | - Bradford G Hill
- University of Louisville, Department of Medicine, Institute of Molecular Cardiology, Diabetes and Obesity Center, Louisville, KY, USA
| | - Joseph A Hill
- University of Texas, Southwestern Medical Center, Medicine and Molecular Biology, Dallas, TX
| | - William D Hill
- Georgia Regents University, Department of Neurology, Augusta, GA, USA
- Georgia Regents University, Department of Orthopaedic Surgery, Augusta, GA, USA
- Georgia Regents University, Institute for Regenerative and Reparative Medicine, Augusta, GA, USA
- Georgia Regents University, Medical College of Georgia, Department of Cellular Biology and Anatomy, Augusta, GA, USA
| | - Keisuke Hino
- Kawasaki Medical School, Department of Hepatology and Pancreatology, Kurashiki, Okayama, Japan
| | - Daniel Hofius
- Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, Department of Plant Biology, Uppsala BioCenter, Uppsala, Sweden
| | - Paul Hofman
- University of Nice-Sophia Antipolis, INSERM U1081, CNRS 7284, Faculty of Medicine, Nice, France
| | - Günter U Höglinger
- German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
- Technische Universität München, Department of Neurology, Munich, Germany
| | - Jörg Höhfeld
- University of Bonn, Institute for Cell Biology, Bonn, Germany
| | - Marina K Holz
- Albert Einstein Cancer Center, New York, NY, USA
- Yeshiva University, New York, NY, USA
| | - Yonggeun Hong
- Inje University, Department of Rehabilitation Science, College of Biomedical Science & Engineering, u-Healthcare & Anti-aging Research Center (u-HARC), Gimhae, Korea
| | - David A Hood
- York University, School of Kinesiology and Health Science, Toronto, Ontario, Canada
| | - Jeroen JM Hoozemans
- VU University Medical Center, Department of Pathology, Amsterdam, The Netherlands
| | - Thorsten Hoppe
- University of Cologne, Institute for Genetics, CECAD Research Center, Cologne, Germany
| | - Chin Hsu
- University of Kaohsiung Medical University, Department of Physiology, Faculty of Medicine, College of Medicine, Kaohsiung, Taiwan
| | - Chin-Yuan Hsu
- Chang Gung University, Department of Biomedical Sciences, College of Medicine, Taoyuan, Taiwan
| | - Li-Chung Hsu
- National Taiwan University, Institute of Molecular Medicine, College of Medicine, Taipei, Taiwan
| | - Dong Hu
- Anhui University of Science and Technology, Department of Immunology and Medical Inspection, Huainan, Anhui, China
| | - Guochang Hu
- University of Illinois at Chicago, Departments of Anesthesiology and Pharmacology, Chicago, IL, USA
| | - Hong-Ming Hu
- Providence Portland Medical Center, Earle A. Chiles Research Institute, Portland, OR, USA
| | - Hongbo Hu
- China Agricultural University, Department of Nutrition and Food Safety, Beijing, China
| | - Ming Chang Hu
- University of Texas, Southwestern Medical Center, Department of Internal Medicine, Center for Mineral Metabolism and Clinical Research, Dallas, TX, USA
| | - Yu-Chen Hu
- National Tsing Hua University, Department of Chemical Engineering, Hsinchu, Taiwan
| | - Zhuo-Wei Hu
- Chinese Academy of Medical Sciences and Peking Union Medical College, Molecular Immunology and Cancer Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Beijing, China
| | - Fang Hua
- Chinese Academy of Medical Sciences and Peking Union Medical College, Molecular Immunology and Cancer Pharmacology Group, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Beijing, China
| | - Ya Hua
- University of Michigan, Neurosurgery, Ann Arbor, MI, USA
| | - Canhua Huang
- Sichuan University, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy; West China Hospital, Chengdu, China
| | - Huey-Lan Huang
- Chang Jung Christian University, Department of Bioscience Technology, Tainan, Taiwan
| | - Kuo-How Huang
- National Taiwan University, Department of Urology, College of Medicine, Taipei, Taiwan
| | - Kuo-Yang Huang
- Chang Gung University, Molecular Regulation and Bioinformatics Laboratory, Department of Parasitology, Taoyuan, Taiwan
| | - Shile Huang
- Louisiana State University Health Sciences Center, Department of Biochemistry and Molecular Biology, Shreveport, LA, USA
| | - Shiqian Huang
- Shanghai Jiao Tong University, School of Medicine, Shanghai Institute of Immunology, Shanghai, China
| | - Wei-Pang Huang
- National Taiwan University, Department of Life Science, Taipei, Taiwan
| | - Yi-Ran Huang
- Shanghai Jiao Tong University, School of Medicine, Renji Hospital, Shanghai, China
| | - Yong Huang
- Icahn School of Medicine at Mount Sinai, Department of Neuroscience, New York, NY, USA
| | - Yunfei Huang
- Albany Medical College, Center for Neuropharmacology and Neuroscience, Albany, NY, USA
| | - Tobias B Huber
- Albert Ludwigs University, Renal Division, Freiburg, Germany
- BIOSS Centre for Biological Signalling Studies, Freiburg, Germany
- University Medical Center Freiburg, Freiburg, Germany
| | - Patricia Huebbe
- University of Kiel, Institute of Human Nutrition and Food Science, Kiel, Germany
| | - Won-Ki Huh
- Seoul National University, Department of Biological Sciences, Seoul, Korea
| | - Juha J Hulmi
- University of Helsinki, Department of Physiology, Faculty of Medicine, Helsinki, Finland
- University of Jyväskylä, Department of Biology of Physical Activity, Jyväskylä, Finland
| | - Gang Min Hur
- Chungnam National University, School of Medicine, Department of Pharmacology, Daejeon, Korea
| | - James H Hurley
- University of California Berkeley, Department of Molecular and Cell Biology, Berkeley, CA, USA
| | - Zvenyslava Husak
- St. Anna Kinderkrebsforschung, Children's Cancer Research Institute, Immunological Diagnostics, Vienna, Austria
| | - Sabah NA Hussain
- McGill University, Department of Critical Care, Montreal, Quebec, Canada
- McGill University, Health Centre, Department of Medicine, Montreal, Quebec, Canada
| | - Salik Hussain
- National Institutes of Health, National Institute of Environmental Health Sciences, Clinical Research Program, Research Triangle Park, NC, USA
| | - Jung Jin Hwang
- Asan Medical Center, Asan Institute for Life Sciences, Seoul, Korea
| | - Seungmin Hwang
- University of Chicago, Department of Pathology, Chicago, IL, USA
| | - Thomas IS Hwang
- Shin Kong Wu Ho-Su Memorial Hospital, Department of Urology, Taipei, Taiwan
| | - Atsuhiro Ichihara
- Tokyo Women's Medical University, Department of Endocrinology and Hypertension, Tokyo, Japan
| | - Yuzuru Imai
- Juntendo University, Department of Research for Parkinson's Disease, Tokyo, Japan
| | - Carol Imbriano
- University of Modena and Reggio Emilia, Department of Life Sciences, Modena, Italy
| | - Megumi Inomata
- Asahi University, School of Dentistry, Department of Oral Microbiology, Division of Oral Infections and Health Sciences, Mizuho, Gifu, Japan
| | - Takeshi Into
- Asahi University, School of Dentistry, Department of Oral Microbiology, Division of Oral Infections and Health Sciences, Mizuho, Gifu, Japan
| | - Valentina Iovane
- University of Salerno, Department of Pharmacy, Fisciano, Salerno, Italy
| | - Juan L Iovanna
- Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université, Institut Paoli-Calmette, Parc Scientifique et Technologique de Luminy, Marseille, France
| | - Renato V Iozzo
- Thomas Jefferson University, Department of Pathology, Anatomy and Cell Biology, Philadelphia, PA, USA
| | - Nancy Y Ip
- The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong
| | - Javier E Irazoqui
- Harvard Medical School, Laboratory of Comparative Immunology, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital Research Institute, Boston, MA, USA
| | - Pablo Iribarren
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Universidad Nacional de Córdoba, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina
| | - Yoshitaka Isaka
- Osaka University Graduate School of Medicine, Department of Nephrology, Osaka, Japan
| | | | - Harry Ischiropoulos
- Children's Hospital of Philadelphia, Research Institute, Philadelphia, PA, USA
- Perelman School of Medicine at the University of Pennsylvania, Departments of Pediatrics and Systems Pharmacology and Translational Therapeutics, Philadelphia, PA, USA
| | - Jeffrey S Isenberg
- University of Pittsburgh, Vascular Medicine Institute, Pittsburgh, PA, USA
| | - Mohammad Ishaq
- Institute of Microbial Technology (IMTECH), Cell Biology and Immunology Division, Chandigarh, India
| | - Hiroyuki Ishida
- Tohoku University, Graduate School of Agricultural Sciences, Sendai, Japan
| | - Isao Ishii
- Keio University, Graduate School of Pharmaceutical Sciences, Department of Biochemistry, Tokyo, Japan
| | - Jane E Ishmael
- Oregon State University, Department of Pharmaceutical Sciences, College of Pharmacy, Corvallis, OR, USA
| | - Ciro Isidoro
- Università del Piemonte Orientale “A. Avogadro”, Dipartimento di Scienze della Salute, Novara, Italy
| | | | - Erika Isono
- Technische Universität München, Plant Systems Biology, Freising, Germany
| | | | - Koji Itahana
- Duke-NUS Graduate Medical School, Cancer and Stem Cell Biology Program, Singapore
| | - Eisuke Itakura
- Chiba University, Department of Nanobiology, Chiba, Japan
| | - Andrei I Ivanov
- Virginia Commonwealth University, Department of Human and Molecular Genetics, Richmond, VA, USA
| | - Anand Krishnan V Iyer
- Hampton University, Department of Pharmaceutical Sciences, School of Pharmacy, Hampton, VA, USA
| | - José M Izquierdo
- Centro de Biologia Molecular “Severo Ochoa” (UAM/CSIC), Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Department of Cell Biology and Immunology, Madrid, Spain
| | - Yotaro Izumi
- Saitama Medical University, Saitama Medical Center, Department of General Thoracic Surgery, Saitama, Japan
| | - Valentina Izzo
- Centre de Recherche des Cordeliers, Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Gustave Roussy Cancer Campus, Villejuif, France
- INSERM, U1138, Paris, France
- Université Paris Descartes/Paris V, Paris, France
| | - Marja Jäättelä
- Danish Cancer Society Research Center, Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Copenhagen, Denmark
| | - Nadia Jaber
- Stony Brook University, Department of Molecular Genetics and Microbiology, Stony Brook, NY, USA
| | | | - William T Jackson
- University of Maryland, School of Medicine, Department of Microbiology and Immunology, Baltimore, MD, USA
| | - Tony George Jacob
- All India Institute of Medical Sciences, Department of Anatomy, New Delhi, India
| | - Thomas S Jacques
- UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
| | - Chinnaswamy Jagannath
- University of Texas, Health Science Center at Houston, Department of Pathology and Laboratory Medicine, Houston, TX, USA
| | - Ashish Jain
- Oslo University Hospital, Department of Molecular Cell Biology, Institute for Cancer Research, Oslo, Norway
- University of Oslo, Centre for Cancer Biomedicine, Oslo, Norway
| | | | - Byoung Kuk Jang
- Keimyung University, School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Daegu, Korea
| | - Alkesh Jani
- University of Colorado, Denver; and Denver VAMC, Denver, CO, USA
| | - Bassam Janji
- Luxembourg Institute of Health, Laboratory of Experimental Hemato-Oncology, Department of Oncology, Luxembourg City, Luxembourg
| | - Paulo Roberto Jannig
- University of São Paulo, School of Physical Education and Sport, Cellular and Molecular Exercise Physiology Laboratory, São Paulo, Brazil
| | - Patric J Jansson
- University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
| | - Steve Jean
- Université de Sherbrooke, Department of Anatomy and Cell Biology, Faculty of Medicine and Health Sciences, Sherbrooke, QC, Canada
| | - Marina Jendrach
- Charité - Universitätsmedizin Berlin, Department of Neuropathology, Campus Charité Mitte, Berlin, Germany
| | - Ju-Hong Jeon
- Seoul National University College of Medicine, Department of Physiology and Biomedical Sciences, Seoul, Korea
| | - Niels Jessen
- Aarhus University, Department of Clinical Medicine, Aarhus, Denmark
| | - Eui-Bae Jeung
- Chungbuk National University, College of Veterinary Medicine, Cheongju, Chungbuk, Korea
| | - Kailiang Jia
- Florida Atlantic University, Department of Biological Sciences, Jupiter, FL, USA
| | - Lijun Jia
- Cancer Institute, Fudan University Shanghai Cancer Center, Collaborative Innovation Center of Cancer Medicine, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
| | - Hong Jiang
- University of Texas, MD Anderson Cancer Center, Department of Neuro-Oncology, Houston, TX, USA
| | - Hongchi Jiang
- The First Affiliated Hospital of Harbin Medical University, Department of General Surgery, Harbin, Heilongjiang Province, China
| | - Liwen Jiang
- Chinese University of Hong Kong, School of Life Science, Centre for Cell and Developmental Biology and State Key Laboratory of Agrobiotechnology, Sha Tin, Hong Kong
| | - Teng Jiang
- Nanjing Medical University, Department of Neurology, Nanjing First Hospital, Nanjing, China
| | - Xiaoyan Jiang
- University of British Columbia, Medical Genetics, and BC Cancer Agency, Terry Fox Laboratory,Vancouver, BC, Canada
| | - Xuejun Jiang
- Chinese Academy of Sciences, State Key Laboratory of Mycology, Institute of Microbiology, Beijing, China
| | - Xuejun Jiang
- Mossakowski Medical Research Centre, Polish Academy of Sciences, Electron Microscopy Platform, Warsaw, Poland
| | - Ying Jiang
- Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
- New York University, Department of Psychiatry, New York, NY, USA
| | - Yongjun Jiang
- Freshwater Aquaculture Collaborative Innovation Center of Hubei Province, Wuhan, China
- Huazhong Agricultural University, Department of Aquatic Animal Medicine, College of Fisheries, Wuhan, China
| | - Alberto Jiménez
- Universidad de Salamanca, Campus Miguel de Unamuno, Departamento de Microbiología y Genética, Salamanca, Spain
| | - Cheng Jin
- Chinese Academy of Sciences, State Key Laboratory of Mycology, Institute of Microbiology, Beijing, China
| | | | - Lei Jin
- University of Newcastle, School of Medicine and Public Health, Callaghan, NSW, Australia
| | - Meiyan Jin
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Shengkan Jin
- Rutgers University-Robert Wood Johnson Medical School, Pharmacology Department, Piscataway, NJ, USA
| | - Umesh Kumar Jinwal
- University of South Florida, Department of Pharmaceutical Sciences, College of Pharmacy, Byrd Alzheimer's Institute, Tampa, FL, USA
| | - Eun-Kyeong Jo
- Chungnam National University, School of Medicine, Infection Signaling Network Research Center, Daejeon, Korea
| | - Terje Johansen
- University of Tromsø - The Arctic University of Norway, Molecular Cancer Research Group, Institute of Medical Biology, Tromsø, Norway
| | | | - Gail VW Johnson
- University of Rochester Medical Center, Department of Anesthesiology, Rochester, NY, USA
| | - James D Johnson
- University of British Columbia, Department of Cellular and Physiological Sciences, Vancouver, BC, Canada
| | - Eric Jonasch
- University of Texas, MD Anderson Cancer Center, Houston, TX, USA
| | - Chris Jones
- Institute of Cancer Research, Divisions of Molecular Pathology and Cancer Therapeutics, London, UK
| | - Leo AB Joosten
- Radboud University Nijmegen Medical Center, Department of Internal Medicine, Nijmegen, The Netherlands
| | - Joaquin Jordan
- Universidad de Castilla-La Mancha, Facultad de Medicina, Departamento Ciencias Medicas, Albacete, Spain
| | - Anna-Maria Joseph
- University of Florida, Department of Aging and Geriatric Research, Gainesville, FL, USA
| | - Bertrand Joseph
- Karolinska Institute, Cancer Center Karolinska, Department of Oncology-Pathology, Stockholm, Sweden
| | - Annie M Joubert
- University of Pretoria, Department of Physiology, Pretoria, Gauteng, South Africa
| | - Dianwen Ju
- Fudan University, Department of Biosynthesis, Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Shanghai, China
| | - Jingfang Ju
- Stony Brook University, Department of Pathology, Stony Brook, NY, USA
| | - Hsueh-Fen Juan
- National Taiwan University, Department of Life Science, Institute of Molecular and Cellular Biology, Taipei, Taiwan
| | - Katrin Juenemann
- University of Amsterdam, Department of Cellbiology and Histology, Academic Medical Center, Amsterdam, The Netherlands
| | - Gábor Juhász
- Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
| | - Hye Seung Jung
- Seoul National University Hospital, Department of Internal Medicine, Seoul, Korea
| | - Jae U Jung
- University of Southern California, Keck School of Medicine, Department of Molecular Microbiology and Immunology, Los Angeles, CA, USA
| | - Yong-Keun Jung
- Seoul National University, Department of Biological Sciences, Seoul, Korea
| | - Heinz Jungbluth
- Evelina's Children Hospital, Guy's and St. Thomas' Hospital NHS Foundation Trust, Department of Paediatric Neurology, Neuromuscular Service, London, UK
- King's College London, Department of Basic and Clinical Neuroscience, IoPPN, London, UK
- King's College, Randall Division of Cell and Molecular Biophysics, Muscle Signalling Section, London, UK
| | - Matthew J Justice
- Indiana University School of Medicine, Biochemistry and Molecular Biology, Denver, CO, USA
- National Jewish Health, Denver, CO, USA
| | - Barry Jutten
- Maastricht University, Maastricht Radiation Oncology (MaastRO) Lab, GROW – School for Oncology and Developmental Biology, Maastricht, The Netherlands
| | - Nadeem O Kaakoush
- University of New South Wales, School of Biotechnology and Biomolecular Sciences, Sydney, NSW, Australia
| | - Kai Kaarniranta
- University of Eastern Finland, Kuopio University Hospital, Department of Ophthalmology, Kuopio, Finland
| | - Allen Kaasik
- University of Tartu, Institute of Biomedicine and Translational Medicine, Tartu, Estonia
| | - Tomohiro Kabuta
- National Institute of Neuroscience, National Center of Neurology and Psychiatry, Department of Degenerative Neurological Diseases, Tokyo, Japan
| | | | - Katarina Kågedal
- Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden
| | - Alon Kahana
- University of Michigan, Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI, USA
| | - Shingo Kajimura
- University of California San Francisco, UCSF Diabetes Center, Department of Cell and Tissue Biology, San Francisco, CA, USA
| | - Or Kakhlon
- Hadassah Hebrew University Medical Center, Department of Neurology, Jerusalem, Israel
| | - Manjula Kalia
- Translational Health Science and Technology Institute, Vaccine and Infectious Disease Research Centre, Faridabad, India
| | - Dhan V Kalvakolanu
- University of Maryland, School of Medicine, Department of Microbiology and Immunology, Baltimore, MD, USA
| | - Yoshiaki Kamada
- National Institute for Basic Biology, Sokendai, Okazaki, Japan
| | - Konstantinos Kambas
- Democritus University of Thrace, Laboratory of Molecular Hematology, Alexandroupolis, Greece
| | - Vitaliy O Kaminskyy
- Karolinska Institute, Institute of Environmental Medicine, Stockholm, Sweden
| | - Harm H Kampinga
- University of Groningen, Department of Cell Biology, Groningen, The Netherlands
| | - Mustapha Kandouz
- Wayne State University, School of Medicine, Department of Pathology, Karmanos Cancer Institute, Detroit, MI, USA
| | - Chanhee Kang
- Harvard Medical School, Brigham and Women's Hospital, Department of Genetics, Division of Genetics, Boston, MA, USA
- Howard Hughes Medical Institute, Boston, MA, USA
| | - Rui Kang
- University of Pittsburgh, Department of Surgery, Hillman Cancer Center, Pittsburgh, PA, USA
| | - Tae-Cheon Kang
- Hallym University, Department of Anatomy and Neurobiology, College of Medicine, Kangwon-Do, Korea
| | - Tomotake Kanki
- Niigata University Graduate School of Medical and Dental Sciences, Laboratory of Biosignaling, Niigata, Japan
| | | | - Haruo Kanno
- Tohoku University School of Medicine, Department of Orthopaedic Surgery, Miyagi, Japan
| | - Anumantha G Kanthasamy
- Iowa State University, Department of Biomedical Science, Iowa Center for Advanced Neurotoxiclogy, Ames, IA, USA
| | - Marc Kantorow
- Florida Atlantic University, Schmidt College of Medicine, Department of Biomedical Sciences, Boca Raton, FL, USA
| | - Maria Kaparakis-Liaskos
- Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Diseases, Clayton, Melbourne, Victoria, Australia
| | - Orsolya Kapuy
- Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Budapest, Hungary
| | | | - Md Razaul Karim
- University of Minnesota, Department of Neuroscience, Minneapolis, MN, USA
| | - Parimal Karmakar
- Jadavpur University, Life Science and Biotechnology, Kolkata, West Bengal, India
| | - Arthur Kaser
- University of Cambridge, Addenbrooke's Hospital, Department of Medicine, Cambridge, UK
| | - Susmita Kaushik
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Bronx, NY, USA
| | - Thomas Kawula
- University of North Carolina, Microbiology and Immunology, Chapel Hill, NC, USA
| | - A Murat Kaynar
- University of Pittsburgh, School of Medicine, Department of Anesthesiology, Pittsburgh, PA, USA
- University of Pittsburgh, School of Medicine, Department of Critical Care Medicine, Pittsburgh, PA, USA
| | - Po-Yuan Ke
- Chang Gung University, Department of Biochemistry and Molecular Biology and Graduate Institute of Biomedical Sciences, College of Medicine, Taoyuan County, Taiwan
| | - Zun-Ji Ke
- Shanghai University of Traditional Chinese Medicine, Department of Biochemistry, Shanghai, China
| | - John H Kehrl
- National Institutes of Health, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - Kate E Keller
- Oregon Health and Science University, Casey Eye Institute, Portland, OR, USA
| | - Jongsook Kim Kemper
- University of Illinois at Urbana-Champaign, Department of Molecular and Integrative Physiology, Urbana, IL, USA
| | - Anne K Kenworthy
- Vanderbilt University, School of Medicine, Department of Molecular Physiology and Biophysics, Nashville, TN, USA
| | | | - Andreas Kern
- Medical Center of the Johannes Gutenberg University, Mainz, Germany
| | - Santosh Kesari
- John Wayne Cancer Institute, Department of Neurosciences, Santa Monica, CA, USA
| | - David Kessel
- Wayne State University, School of Medicine, Detroit, MI, USA
| | - Robin Ketteler
- University College London, MRC Laboratory for Molecular Cell Biology, London, UK
| | - Isis do Carmo Kettelhut
- University of São Paulo, Ribeirão Preto Medical School, Department of Biochemistry and Immunology, Ribeirão Preto, São Paulo, Brazil
| | - Bilon Khambu
- Indiana University School of Medicine, Department of Pathology and Laboratory Medicine, Indianapolis, IN, USA
| | - Muzamil Majid Khan
- Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Karlsruhe, Germany
| | | | - Sangeeta Khare
- US Food and Drug Administration, National Center for Toxicology Research, Division of Microbiology, Jefferson, AR, USA
| | - Juliann G Kiang
- Uniformed Services University of the Health Sciences, Radiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD, USA
| | - Amy A Kiger
- University of California San Diego, Division of Biological Sciences, La Jolla, CA, USA
| | - Akio Kihara
- Hokkaido University, Faculty of Pharmaceutical Sciences, Sapporo, Japan
| | - Arianna L Kim
- Columbia University Medical Center, New York, NY, USA
| | - Cheol Hyeon Kim
- Korea Cancer Center Hospital, Department of Internal Medicine, Seoul, Korea
| | - Deok Ryong Kim
- Gyeongsang National University School of Medicine, Department of Biochemistry and Convergence Medical Science and Institute of Health Sciences, JinJu, Korea
| | - Do-Hyung Kim
- University of Minnesota, Department of Biochemistry, Molecular Biology and Biophysics, Minneapolis, MN, USA
| | - Eung Kweon Kim
- Yonsei University, College of Medicine, Corneal Dystrophy Research Institute; and Department of Ophthalmology, Seoul, Korea
| | - Hye Young Kim
- Dong-A University, College of Medicine and Mitochondria Hub Regulation Center, Department of Anatomy and Cell Biology, Busan, Korea
| | - Hyung-Ryong Kim
- Wonkwang University, Department of Dental Pharmacology, School of Dentistry, Chonbuk, Korea
| | | | - Jeong Hun Kim
- Seoul National University College of Medicine, Department of Advanced Education for Clinician-Scientists (AECS), Seoul, Korea
- Seoul National University College of Medicine, Department of Ophthalmology, Seoul, Korea
| | - Jin Cheon Kim
- University of Ulsan College of Medicine, Asan Medical Center, Department of Surgery, Seoul, Korea
| | - Jin Hyoung Kim
- Seoul National University College of Medicine, Department of Advanced Education for Clinician-Scientists (AECS), Seoul, Korea
- Seoul National University College of Medicine, Department of Ophthalmology, Seoul, Korea
| | - Kwang Woon Kim
- Vanderbilt University Medical Center, Department of Pediatric Surgery, Nashville, TN, USA
| | - Michael D Kim
- University of Miami, Miller School of Medicine, Department of Molecular and Cellular Pharmacology, Miami, FL, USA
| | - Moon-Moo Kim
- Dong-Eui University, Department of Chemistry, Busan, Korea
| | - Peter K Kim
- University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Seong Who Kim
- University of Ulsan College of Medicine, Asan Medical Center, Department of Biochemistry and Molecular Biology, Seoul, Korea
| | - Soo-Youl Kim
- National Cancer Center, Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, Research Institute, Goyang, Korea
| | - Yong-Sun Kim
- Hallym University, Department of Microbiology, College of Medicine, Chuncheon, Gangwon, Korea
| | - Yonghyun Kim
- University of Alabama, Department of Chemical and Biological Engineering, Tuscaloosa, AL, USA
| | - Adi Kimchi
- Weizmann Institute of Science, Department of Molecular Genetics, Rehovot, Israel
| | - Alec C Kimmelman
- Harvard Medical School, Dana Farber Cancer Institute, Boston, MA, USA
| | - Tomonori Kimura
- University of New Mexico, Health Sciences Center, Department of Molecular Genetics and Microbiology, Albuquerque, NM, USA
| | - Jason S King
- University of Sheffield, Department of Biomedical Sciences, Sheffield, UK
| | - Karla Kirkegaard
- Stanford University, Department of Microbiology and Immunology, Stanford, CA, USA
| | | | - Lorrie A Kirshenbaum
- University of Manitoba, Institute of Cardiovascular Sciences, College of Medicine, Faculty of Health Sciences, Winnipeg, Manitoba, Canada
| | - Shuji Kishi
- The Scripps Research Institute, Department of Metabolism and Aging, Jupiter, FL, USA
| | - Yasuo Kitajima
- Tohoku University, Division of Biomedical Engineering for Health and Welfare, Sendai, Japan
| | | | - Yasushi Kitaoka
- St. Marianna University School of Medicine, Department of Ophthalmology, Kawasaki, Kanagawa, Japan
| | - Kaio Kitazato
- Nagasaki University, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki, Japan
| | - Rudolf A Kley
- Ruhr University Bochum, University Hospital Bergmannsheil, Department of Neurology, Heimer Institute for Muscle Research, Bochum, Germany
| | - Walter T Klimecki
- University of Arizona, Department of Pharmacology and Toxicology, College of Pharmacy, Tucson, AZ, USA
| | - Michael Klinkenberg
- Goethe University Medical School, Experimental Neurology, Frankfurt am Main, Germany
| | - Jochen Klucken
- University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
| | - Helene Knævelsrud
- Université de Montréal, Institute for Research in Immunology and Cancer, Montréal, Québec, Canada
| | - Erwin Knecht
- Centro de Investigación Príncipe Felipe, Valencia, Spain
| | - Laura Knuppertz
- Goethe University, Institute for Molecular Biosciences, Molecular Developmental Biology, Frankfurt, Hesse, Germany
| | - Jiunn-Liang Ko
- Chung-Shan Medical University, Institute of Medicine, Taichung, Taiwan
| | - Satoru Kobayashi
- New York Institute of Technology, Department of Biomedical Sciences, College of Osteopathic Medicine, Old Westbury, NY, USA
| | - Jan C Koch
- University Medicine Göttingen, Department of Neurology, Göttingen, Germany
| | | | - Ulrich Koenig
- Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Campus 1, Institute of Experimental Musculoskeletal Medicine, Münster, Germany
| | - Young Ho Koh
- Hallym University, Ilsong Institute of Life Science, Chuncheon, Korea
| | - Katja Köhler
- ETH Zurich, Institute of Molecular Systems Biology, Zurich, Switzerland
| | - Sepp D Kohlwein
- University of Graz, Institute of Molecular Biosciences, BioTechMed Graz, Graz, Austria
| | - Masato Koike
- Juntendo University, Graduate School of Medicine, Department of Cell Biology and Neuroscience, Tokyo, Japan
| | - Masaaki Komatsu
- Niigata University, School of Medicine, Department of Biochemistry, Niigata, Japan
| | | | - Dexin Kong
- Tianjin Medical University, School of Pharmaceutical Sciences, Tianjin, China
| | - Hee Jeong Kong
- National Fisheries Research and Development Institute (NFRDI), Busan, Korea
| | - Eumorphia G Konstantakou
- University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
| | - Benjamin T Kopp
- Nationwide Children's Hospital, Center for Microbial Pathogenesis, Columbus, OH, USA
| | - Tamas Korcsmaros
- The Genome Analysis Centre (TGAC), Institute of Food Research, Gut Health and Food Safety Programme, Norwich, UK
| | - Laura Korhonen
- Helsinki University, Central Hospital, Medical Faculty, Division of Child Psychiatry, Helsinki, Finland
| | - Viktor I Korolchuk
- Newcastle University, Campus for Ageing and Vitality, Institute for Cell and Molecular Biosciences and Institute for Ageing, Newcastle upon Tyne, UK
| | - Nadya V Koshkina
- University of Texas, MD Anderson Cancer Center, Houston, TX, USA
| | - Yanjun Kou
- Temasek Life Sciences Laboratory, Singapore
| | | | - Constantinos Koumenis
- University of Pennsylvania Perelman School of Medicine, Department of Radiation Oncology, Philadelphia, PA, USA
| | - Attila L Kovács
- Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
| | - Tibor Kovács
- Eötvös Loránd University, Department of Genetics, Budapest, Hungary
| | - Werner J Kovacs
- ETH Zurich, Department of Biology, Institute of Molecular Health Sciences, Zurich, Switzerland
| | - Daisuke Koya
- Kanazawa Medical University, Diabetology and Endocrinology, Ishikawa, Japan
| | - Claudine Kraft
- University of Vienna, Max F. Perutz Laboratories, Vienna, Austria
| | - Dimitri Krainc
- Northwestern University, Feinberg School of Medicine, Department of Neurology, Chicago, IL, USA
| | - Helmut Kramer
- University of Texas, Southwestern Medical Center, Department of Neuroscience, Dallas, TX
| | - Tamara Kravic-Stevovic
- University of Belgrade, Institute of Histology and Embryology, School of Medicine, Belgrade, Serbia
| | - Wilhelm Krek
- ETH Zurich, Institute of Molecular Health Sciences, Zurich, Switzerland
| | - Carole Kretz-Remy
- CNRS, UMR 5534, Villeurbanne, France
- Université de Lyon, Lyon France; and Centre de Génétique et de Physiologie Moléculaire et Cellulaire, Université Lyon 1, Villeurbanne, France
| | - Roswitha Krick
- Georg-August-University Göttingen, Institute of Cellular Biochemistry, Göttingen, Germany
| | | | - Janos Kriston-Vizi
- University College London, MRC Laboratory for Molecular Cell Biology, London, UK
| | - Guido Kroemer
- Gustave Roussy Comprehensive Cancer Center, Villejuif, France
- Hôpital Européen Georges Pompidou, AP-HP, Paris, France
- INSERM, Cordeliers Research Cancer, Paris, France
- Université Paris Descartes, Apoptosis, Cancer and Immunity Laboratory, Team 11, Equipe Labellisée Ligue contre le Cancer and Cell Biology and Metabolomics Platforms, Paris, France
| | - Michael C Kruer
- University of Arizona College of Medicine, Barrow Neurological Institute, Phoenix Children's Hospital, Department of Child Health, Phoenix, AZ, USA
| | - Rejko Kruger
- University of Luxembourg, Luxembourg Center for Systems Biomedicine, Luxembourg
| | | | - Kazuyuki Kuchitsu
- Tokyo University of Science, Department of Applied Biological Science and Imaging Frontier Center, Noda, Chiba, Japan
| | - Christian Kuhn
- University of Kiel, Department of Cardiology, Kiel, Germany
| | - Addanki Pratap Kumar
- University of Texas, Health Science Center at San Antonio, Department of Urology, San Antonio, TX, USA
| | - Anuj Kumar
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
| | - Ashok Kumar
- University of Louisville, School of Medicine, Department of Anatomical Sciences and Neurobiology, Louisville, KY, USA
| | - Deepak Kumar
- University of the District of Columbia, Cancer Research Laboratory, Washington, DC, USA
| | - Dhiraj Kumar
- International Center for Genetic Engineering and Biotechnology, Immunology Group, New Delhi, India
| | - Rakesh Kumar
- George Washington University, Department of Biochemistry and Molecular Medicine, Washington, DC, USA
| | - Sharad Kumar
- University of South Australia and SA Pathology, Centre for Cancer Biology, Adelaide, SA, Australia
| | - Mondira Kundu
- St. Jude Children's Research Hospital, Department of Pathology, Memphis, TN, USA
| | - Hsing-Jien Kung
- National Health Research Institutes, Institute of Molecular and Genomic Medicine, Miaoli, Taiwan
- University of California Davis, Cancer Center, Davis, CA, USA
| | - Atsushi Kuno
- Sapporo Medical University School of Medicine, Department of Pharmacology, Sapporo, Japan
| | - Sheng-Han Kuo
- Columbia University Medical Center, Department of Neurology, New York, NY, USA
| | - Jeff Kuret
- Ohio State University, Department of Molecular and Cellular Biochemistry, Columbus, OH, USA
| | - Tino Kurz
- Linköping University, Department of Medical and Health Sciences, Linköping, Sweden
| | - Terry Kwok
- Monash University, Department of Biochemistry and Molecular Biology, Victoria, Australia
- Monash University, Department of Microbiology, Victoria, Australia
| | | | - Yong Tae Kwon
- Seoul National University, Protein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul, Korea
| | - Irene Kyrmizi
- University of Crete, School of Medicine, Department of Infectious Diseases, Heraklion, Crete, Greece
| | - Albert R La Spada
- Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA
- University of California San Diego, Departments of Cellular and Molecular Medicine, Neurosciences, and Pediatrics, Division of Biological Sciences Institute for Genomic Medicine, La Jolla, CA, USA
| | - Frank Lafont
- Center for Infection and Immunity of Lille, Institut Pasteur de Lille, CNRS, INSERM, Lille Regional University Hospital Centre, Lille University, Lille, France
| | - Tim Lahm
- Indiana University School of Medicine, Richard L. Roudebush VA Medical Center, Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indianapolis, IN, USA
| | - Aparna Lakkaraju
- University of Wisconsin, Department of Ophthalmology and Visual Sciences, McPherson Eye Research Institute, Madison, WI, USA
| | - Truong Lam
- University of Texas, Medical School at Houston, Division of Cardiovascular Medicine, Department of Medicine, Houston, TX, USA
| | - Trond Lamark
- University of Tromsø - The Arctic University of Norway, Department of Medical Biology, Tromsø, Norway
| | - Steve Lancel
- University Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011, EGID, Lille, France
| | - Terry H Landowski
- University of Arizona Cancer Center, Department of Medicine, Tucson, AZ, USA
| | - Darius JR Lane
- University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
| | - Jon D Lane
- University of Bristol, School of Biochemistry, Bristol, UK
| | - Cinzia Lanzi
- Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Experimental Oncology and Molecular Medicine, Milan, Italy
| | - Pierre Lapaquette
- Université Bourgogne Franche-Comté, Agrosup Dijon, UMR PAM, Équipe Vin, Aliment, Microbiologie, Stress, Dijon, France
| | - Louis R Lapierre
- Brown University, Department of Molecular Biology, Cell Biology and Biochemistry, Providence, RI, USA
| | - Jocelyn Laporte
- INSERM U964, CNRS UMR7104, Université de Strasbourg, Department of Translational Medecine, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
| | - Johanna Laukkarinen
- Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland
| | - Gordon W Laurie
- University of Virginia, Department of Cell Biology, Charlottesville, VA, USA
| | - Sergio Lavandero
- Universidad de Chile, Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile
- University of Texas, Southwestern Medical Center, Department of Internal Medicine, Dallas, TX
| | - Lena Lavie
- Technion-Israel Institute of Technology, Unit of Anatomy and Cell Biology, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
| | - Matthew J LaVoie
- Brigham and Women's Hospital, Ann Romney Center for Neurologic Diseases, Department of Neurology, Harvard Medical School, Boston, MA, USA
| | - Betty Yuen Kwan Law
- Macau University of Science and Technology, State Key Laboratory of Quality Research in Chinese Medicine, Macau, China
| | - Helen Ka-wai Law
- Hong Kong Polytechnic University, Department of Health Technology and Informatics, Faculty of Health and Social Sciences, Kowloon, Hong Kong
| | - Kelsey B Law
- University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Robert Layfield
- University of Nottingham, School of Life Sciences, Nottingham, UK
| | - Pedro A Lazo
- Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, Salamanca, Spain
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain
| | - Laurent Le Cam
- ICM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
- INSERM U896, Montpellier, France
- Institut du Cancer de Montpellier, Montpellier, France
| | - Karine G Le Roch
- University of California Riverside, Department of Cell Biology and Neuroscience, Riverside, CA, USA
| | - Hervé Le Stunff
- Université Paris Diderot, Unité Biologie Fonctionnelle et Adaptative - CNRS UMR 8251, Paris, France
- Université Paris-Sud, CEA, CNRS, Institute for Integrative Biology of the Cell, Gif-sur-Yvette Cedex, France
| | | | - Marc Lecuit
- Institut Pasteur, INSERM, Biology of Infection Unit, Paris, France
| | - Byung-Hoon Lee
- Seoul National University, College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul, Korea
| | - Che-Hsin Lee
- China Medical University, Department of Microbiology, Taichung, Taiwan
| | - Erinna F Lee
- Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia
- La Trobe University, Department of Chemistry and Physics, Melbourne, Victoria, Australia
- La Trobe University, School of Cancer Medicine, Melbourne, Victoria, Australia
| | - Gyun Min Lee
- KAIST, Department of Biological Sciences, Daejon, Korea
| | - He-Jin Lee
- Konkuk University, School of Medicine, Department of Anatomy, Seoul, Korea
| | - Hsinyu Lee
- National Taiwan University, Department of Life Science and Center for Biotechnology, Taipei, Taiwan
| | - Jae Keun Lee
- Korea University, Department of Life Science and Biotechnology, Seoul, Korea
| | - Jongdae Lee
- University of California San Diego, Department of Medicine, La Jolla, CA, USA
| | - Ju-hyun Lee
- New York University, Department of Psychiatry, New York NY; and Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
| | - Jun Hee Lee
- University of Michigan, Department of Molecular and Integrative Physiology, Ann Arbor, MI, USA
| | - Michael Lee
- Incheon National University, Division of Life Siences, Incheon, Korea
| | - Myung-Shik Lee
- Yonsei University College of Medicine, Severans Biomedical Science Institute and Department of Internal Medicine, Seoul, Korea
| | - Patty J Lee
- Yale University School of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, New Haven, CT, USA
| | - Sam W Lee
- Massachusetts General Hospital and Harvard Medical School, Cutaneous Biology Research Center, Charlestown, MA
| | - Seung-Jae Lee
- Seoul National University College of Medicine, Neuroscience Research Institute, Department of Medicine, Seoul, Korea
| | - Shiow-Ju Lee
- National Health Research Institutes, Institute of Biotechnology and Pharmaceutical Research, Miaoli County, Taiwan
| | - Stella Y Lee
- Kansas State University, Division of Biology, Manhattan, KS, USA
| | | | - Sung Sik Lee
- ETH Zurich, Institute of Biochemistry, Zurich, Switzerland
- ETH Zurich, ScopeM (Scientific Center for Optical and Electron Microscopy), Zurich, Switzerland
| | - Sung-Joon Lee
- Korea University, Department of Biotechnology, BK21-PLUS Graduate School of Life Sciences and Biotechnology, Seoul, Korea
| | - Sunhee Lee
- Duke University, Department of Medicine, Human Vaccine Institute, Durham, NC, USA
| | - Ying-Ray Lee
- Ditmanson Medical Foundation Chia-Yi Christian Hospital, Center for Translational Medicine, Chiayi City, Taiwan
| | - Yong J Lee
- University of Pittsburgh, Department of Surgery, Pittsburgh, PA, USA
| | - Young H Lee
- National Institutes of Health, National Cancer Institute, Urologic Oncology Branch, Bethesda, MD, USA
| | | | - Sylvain Lefort
- British Columbia Cancer Agency, Terry Fox Laboratory, Vancouver, BC, Canada
| | - Renaud Legouis
- Université Paris-Sud, CEA, CNRS, Institute for Integrative Biology of the Cell, Gif-sur-Yvette Cedex, France
| | - Jinzhi Lei
- Tsinghua University, Zhou Pei-Yuan Center for Applied Mathematics, Beijing, China
| | - Qun-Ying Lei
- Fudan University Shanghai Medical College, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Institute of Biomedical Sciences, Shanghai, China
| | - David A Leib
- Geisel School of Medicine at Dartmouth, Department of Microbiology and Immunology, Lebanon, NH, USA
| | - Gil Leibowitz
- Hadassah Hebrew University Medical Center, Endocrinology and Metabolism Service, Department of Medicine, Jerusalem, Israel
| | - Istvan Lekli
- University of Debrecen, Faculty of Pharmacy, Department of Pharmacology, Debrecen, Hungary
| | - Stéphane D Lemaire
- Centre National de la Recherche Scientifique, Sorbonne Universités UPMC Univ Paris 06, UMR 8226, Laboratoire de Biologie Moléculaire et Cellulaire des Eucaryotes, Institut de Biologie Physico-Chimique, Paris, France
| | - John J Lemasters
- Medical University of South Carolina, Departments of Drug Discovery and Biomedical Sciences, and Biochemistry and Molecular Biology, Charleston, SC, USA
| | - Marius K Lemberg
- University of Heidelberg, Center for Molecular Biology, Heidelberg, Germany
| | - Antoinette Lemoine
- Hôpital Paul Brousse - Hôpitaux Universitaires Paris-Sud, Biochimie et Oncogénétique, Villejuif, France
| | - Shuilong Leng
- Guangzhou Medical University, Department of Human Anatomy, School of Basic Science, Guangzhou, Guangdong, China
| | - Guido Lenz
- Universidad Federal do Rio Grande do Sul (UFRGS), Department of Biophysics and Center of Biotechnology, Porto Alegre, Brazil
| | - Paola Lenzi
- University of Pisa, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy
| | - Lilach O Lerman
- Mayo Clinic, Division of Nephrology and Hypertension, Rochester, MN, USA
| | | | - Julia I-Ju Leu
- Perelman School of Medicine at the University of Pennsylvania, Department of Genetics, Philadelphia, PA, USA
| | - Hing Y Leung
- University of Glasgow, Cancer Research UK Beatson Institute, Glasgow, UK
- University of Glasgow, Institute of Cancer Sciences, Glasgow, UK
| | - Beth Levine
- Howard Hughes Medical Institute, Dallas, TX
- University of Texas, Southwestern Medical Center, Department of Internal Medicine, Center for Autophagy Research, Dallas, TX, USA
| | - Patrick A Lewis
- UCL Institute of Neurology, Department of Molecular Neuroscience, London, UK
- University of Reading, School of Pharmacy, Whiteknights, Reading, UK
| | | | - Chi Li
- University of Louisville, James Graham Brown Cancer Center, Department of Medicine, Department of Pharmacology and Toxicology, Louisville, KY, USA
| | - Faqiang Li
- Washington University in St Louis, Department of Biology, St. Louis, MO, USA
| | - Feng-Jun Li
- National University of Singapore, Department of Biological Sciences, Singapore
| | - Jun Li
- Vanderbilt University, Department of Neurology, Nashville, TN, USA
| | - Ke Li
- Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Medicinal Biotechnology, Beijing, China
| | - Lian Li
- Emory University, School of Medicine, Department of Pharmacology, Atlanta, GA, USA
| | - Min Li
- Hong Kong Baptist University, School of Chinese Medicine, Kowloon Tong, Hong Kong
| | - Min Li
- Sun Yat-Sen University, Department of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Guangzhou, China
| | - Qiang Li
- Chinese Academy of Sciences, Division of Medical Physics, Institute of Modern Physics, Lanzhou, Gansu Province, China
| | - Rui Li
- McGill University, Department of Neuroscience, Montreal Neurological Institute, Montreal, QC, Canada
| | - Sheng Li
- Chinese Academy of Sciences, Key Laboratory of Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Shanghai, China
| | - Wei Li
- Capital Medical University, Center for Medical Genetics, Beijing Children's Hospital, Beijing, China
| | - Wei Li
- Chinese Academy of Sciences, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Beijing, China
| | - Xiaotao Li
- East China Normal University, Shanghai, China
| | - Yumin Li
- Second Hospital of Lanzhou University, Key Laboratory of Digestive System Tumors, Gansu, China
| | - Jiqin Lian
- Third Military Medical University, Department of Biochemistry and Molecular Biology, Chongqing, China
| | - Chengyu Liang
- University of Southern California, Keck School of Medicine, Department of Molecular Microbiology and Immunology, Los Angeles, CA, USA
| | - Qiangrong Liang
- New York Institute of Technology, Department of Biomedical Sciences, College of Osteopathic Medicine, Old Westbury, NY, USA
| | - Yulin Liao
- Southern Medical University, Department of Cardiology, Nanfang Hospital, Guangzhou, China
| | - Joana Liberal
- University of Coimbra, Center for Neuroscience and Cell Biology and Faculty of Pharmacy, Coimbra, Portugal
| | - Pawel P Liberski
- Medical University of Lodz, Department of Molecular Pathology and Neuropathology, Lodz, Poland
| | - Pearl Lie
- Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
| | - Andrew P Lieberman
- University of Michigan Medical School, Department of Pathology, Ann Arbor, MI, USA
| | | | - Kah-Leong Lim
- National Neuroscience Institute, Singapore
- National University of Singapore, Department of Physiology, Yong Loo Lin School of Medicine, Singapore
| | - Kyu Lim
- Chungnam National University, School of Medicine, Department of Biochemistry, Infection Signaling Network Research Center, Cancer Research Institute, Daejeon, Korea
| | - Raquel T Lima
- University of Porto, Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology, Porto, Portugal
- University of Porto, Department of Pathology and Oncology, Faculty of Medicine, Porto, Portugal
- University of Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal
| | - Chang-Shen Lin
- Kaohsiung Medical University, Graduate Institute of Medicine, Kaohsiung, Taiwan
- National Sun Yat-Sen University, Department of Biological Sciences, Kaohsiung, Taiwan
| | - Chiou-Feng Lin
- Taipei Medical University, Department of Microbiology and Immunology, Institute of Medical Sciences, Taipei, Taiwan
| | - Fang Lin
- Soochow University, School of Pharmaceutical Science, Department of Pharmacology, Laboratory of Aging and Nervous Diseases, Su Zhou, Jiangsu Province, China
| | - Fangming Lin
- Columbia University, College of Physicians and Surgeons, Department of Pediatrics, New York, NY, USA
| | - Fu-Cheng Lin
- Zhejiang University, Institute of Agriculture and Biotechnology, Hangzhou, China
| | - Kui Lin
- Genentech Inc., Department of Translational Oncology, South San Francisco, CA, USA
| | - Kwang-Huei Lin
- Chang Gung University, Department of Biochemistry, College of Medicine, Taoyuan, Taiwan
| | - Pei-Hui Lin
- Ohio State University, Department of Surgery, Davis Heart and Lung Research Institute, Columbus, OH, USA
| | - Tianwei Lin
- Xiamen University, School of Life Sciences, Fujian, China
| | - Wan-Wan Lin
- National Taiwan University, Department of Pharmacology, College of Medicine, Taipei, Taiwan
| | - Yee-Shin Lin
- National Cheng Kung University, Department of Microbiology and Immunology, College of Medicine, Tainan, Taiwan
| | - Yong Lin
- Lovelace Respiratory Research Institute, Molecular Biology and Lung Cancer Program, Albuquerque, NM, USA
| | - Rafael Linden
- UFRJ, Instituto de Biofisica Carlos Chagas Filho, Rio de Janeiro, Brazil
| | - Dan Lindholm
- University of Helsinki, Biomedicum, Helsinki, Finland
| | - Lisa M Lindqvist
- Cell Signalling and Cell Death Division, and University of Melbourne, Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, Parkville, Victoria, Australia
| | - Paul Lingor
- University of Göttingen, Department of Neurology, Göttingen, Germany
| | - Andreas Linkermann
- Christian-Albrechts-University of Kiel, Department of Nephrology and Hypertension, Kiel, Germany
| | | | - Marta M Lipinski
- University of Maryland, School of Medicine, Department of Anesthesiology, Baltimore, MD, USA
| | - Vitor A Lira
- University of Iowa, Department of Health and Human Physiology, Iowa City, IA, USA
| | - Michael P Lisanti
- University of Manchester, Breakthrough Breast Cancer Research Unit, Manchester Centre for Cellular Metabolism, UK
| | - Paloma B Liton
- Duke University, Department of Ophthalmology, Durham, NC, USA
| | - Bo Liu
- Sichuan University, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, Chengdu, China
| | - Chong Liu
- Second Military Medical University, Department of Pharmacology, Shanghai, China
| | - Chun-Feng Liu
- Soochow University, Department of Neurology, Second Affiliated Hospital of Soochow University and Institute of Neuroscience, Suzhou, China
| | - Fei Liu
- University of Michigan, School of Dentistry, Department of Biologic and Materials Sciences, Ann Arbor, MI, USA
| | - Hung-Jen Liu
- National Chung Hsing University, Institute of Molecular Biology, Taichung, Taiwan
| | - Jianxun Liu
- China Academy of Chinese Medical Sciences, Institute of Basic Medical Sciences of Xiyuan Hospital, Beijing, China
| | - Jing-Jing Liu
- University of California San Diego, Division of Biological Sciences, Section of Molecular Biology, La Jolla, CA, USA
| | - Jing-Lan Liu
- Chang Gung Memorial Hospital, Department of Pathology, Chiayi, Taiwan
| | - Ke Liu
- Sichuan University, Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Science, Chengdu, Sichuan, China
| | - Leyuan Liu
- Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA
| | - Liang Liu
- Macau University of Science and Technology, State Key Laboratory of Quality Research in Chinese Medicine, Macau, China
| | - Quentin Liu
- Dalian Medical University, Institute of Cancer Stem Cell, Dalian, China
| | - Rong-Yu Liu
- The First Affiliated Hospital of Anhui Medical University, Department of Pulmonary, Anhui Geriatric Institute, Anhui, China
| | - Shiming Liu
- The Second Hospital Affiliated to Guangzhou Medical University, Guangzhou Institute of Cardiovascular Disease, Guangzhou, Guangdong Province, China
| | - Shuwen Liu
- Southern Medical University, School of Pharmaceutical Sciences, Guangzhou, Guangdong, China
| | - Wei Liu
- Zhejiang University, School of Medicine, Department of Biochemistry, Hangzhou, Zhejiang, China
| | - Xian-De Liu
- University of Texas, MD Anderson Cancer Center, Department of Genitourinary Medical Oncology, Houston, TX, USA
| | - Xiangguo Liu
- Shandong University, School of Life Sciences, Jinan, China
| | - Xiao-Hong Liu
- Zhejiang University, Institute of Agriculture and Biotechnology, Hangzhou, China
| | - Xinfeng Liu
- Nanjing University School of Medicine, Jinling Hospital, Department of Neurology, Nanjing, China
| | - Xu Liu
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Xueqin Liu
- Freshwater Aquaculture Collaborative Innovation Center of Hubei Province, Wuhan, China
- Huazhong Agricultural University, Department of Aquatic Animal Medicine, College of Fisheries, Wuhan, China
| | - Yang Liu
- University of Texas, Southwestern Medical Center, Department of Internal Medicine, Center for Autophagy Research, Dallas, TX, USA
| | - Yule Liu
- Tsinghua University, School of Life Sciences, Beijing, China
| | - Zexian Liu
- Huazhong University of Science and Technology, Department of Biomedical Engineering, College of Life Science and Technology, Wuhan, Hubei, China
| | - Zhe Liu
- Tianjin Medical University, Department of Immunology, Tianjin Key Laboratory of Medical Epigenetics, Tianjin, China
| | - Juan P Liuzzi
- Florida International University, Department of Dietetics and Nutrition, Miami, FL, USA
| | - Gérard Lizard
- University Bourgogne Franche Comté, EA 7270/INSERM, Dijon, France
| | - Mila Ljujic
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Irfan J Lodhi
- Washington University, School of Medicine, Division of Endocrinology, Metabolism and Lipid Research, Department of Medicine, St. Louis, MO, USA
| | - Susan E Logue
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Bal L Lokeshwar
- Georgia Regents University, Cancer Center, Department of Medicine, Augusta, GA, USA
| | - Yun Chau Long
- National University of Singapore, Yong Loo Lin School of Medicine, Department of Biochemistry, Singapore
| | - Sagar Lonial
- Emory University, Winship Cancer Institute, Department of Hematology and Medical Oncology, Atlanta, GA, USA
| | - Benjamin Loos
- Stellenbosch University, Department of Physiological Sciences, Stellenbosch, South Africa
| | - Carlos López-Otín
- Universidad de Oviedo, Instituto Universitario de Oncología, Departamento de Bioquímica y Biología Molecular, Oviedo, Spain
| | - Cristina López-Vicario
- University of Barcelona, Department of Biochemistry and Molecular Genetics, Hospital Clínic, IDIBAPS-CIBERehd, Barcelona, Spain
| | - Mar Lorente
- Complutense University, Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Department of Biochemistry and Molecular Biology I, School of Biology, Madrid, Spain
| | - Philip L Lorenzi
- University of Texas, MD Anderson Cancer Center, Department of Bioinformatics and Computational Biology, Houston, TX, USA
- University of Texas, MD Anderson Cancer Center, The Proteomics and Metabolomics Core Facility, Houston, TX, USA
| | - Péter Lõrincz
- Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
| | - Marek Los
- Medical University of Silesia, ENT Department, School of Medicine, Katowice, Poland
| | - Michael T Lotze
- University of Pittsburgh, Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
| | - Penny E Lovat
- Newcastle University, The Medical School, Institute of Cellular Medicine, Newcastle upon Tyne, UK
| | - Binfeng Lu
- University of Pittsburgh, School of Medicine, Department of Immunology, Pittsburgh, PA, USA
| | - Bo Lu
- Thomas Jefferson University Hospitals, Department of Radiation Oncology, Philadelphia, PA, USA
| | - Jiahong Lu
- University of Macau, State Key Lab of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, Macao, China
| | - Qing Lu
- Alpert Medical School of Brown University, Vascular Research Laboratory, Providence Veterans Affairs Medical Center, Department of Medicine, Providence, RI, USA
| | - She-Min Lu
- Xi'an Jiaotong University Health Science Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shaanxi, China
| | - Shuyan Lu
- Pfizer Inc., Drug Safety Research and Development, San Diego, CA, USA
| | - Yingying Lu
- City University of Hong Kong, Department of Biomedical Sciences, Kowloon Tong, Hong Kong, China
| | | | - Shirley Luckhart
- University of California Davis, Department of Medical Microbiology and Immunology, School of Medicine, Davis, CA, USA
| | | | - Paula Ludovico
- Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal
- ICVS/3B's – PT Government Associate Laboratory, Braga/Guimarães, Portugal
| | - Aurelia Lugea
- Cedars-Sinai Medical Center, VAGLAHS-UCLA, Pancreatic Research Group, Los Angeles, CA, USA
| | - Nicholas W Lukacs
- University of Michigan Medical School, Department of Pathology, Ann Arbor, MI, USA
| | - Julian J Lum
- Trev and Joyce Deeley Research Centre; and University of Victoria, BC Cancer Agency; and Department of Biochemistry and Microbiology, Victoria, BC, Canada
| | - Anders H Lund
- University of Copenhagen, Biotech Research and Innovative Center (BRIC), Copenhagen, Denmark
| | - Honglin Luo
- University of British Columbia, Department of Pathology and Laboratory Medicine, James Hogg Research Centre,Vancouver, BC, Canada
| | - Jia Luo
- University of Kentucky, College of Medicine, Department of Pharmacology and Nutritional Sciences, Lexington, KY, USA
| | - Shouqing Luo
- Plymouth University, Peninsula School of Medicine and Dentistry, Plymouth, UK
| | - Claudio Luparello
- University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Palermo, Italy
| | - Timothy Lyons
- Queen's University of Belfast, Centre for Experimental Medicine, Belfast, UK
| | - Jianjie Ma
- Ohio State University, Department of Surgery, Davis Heart and Lung Research Institute, Columbus, OH, USA
| | - Yi Ma
- Shanghai Jiao Tong University, School of Medicine, Center for Reproductive Medicine, Renji Hospital, Shanghai, China
| | - Yong Ma
- The First Affiliated Hospital of Harbin Medical University, Department of General Surgery, Harbin, Heilongjiang Province, China
| | - Zhenyi Ma
- Tianjin Medical University, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Key Laboratory of Medical Epigenetics, Tianjin, China
| | - Juliano Machado
- University of São Paulo, Ribeirão Preto Medical School, Department of Biochemistry and Immunology, Ribeirão Preto, São Paulo, Brazil
| | - Glaucia M Machado-Santelli
- University of São Paulo, Institute of Biomedical Science, Department of Cell and Developmental Biology, São Paulo, SP, Brazil
| | - Fernando Macian
- Albert Einstein College of Medicine, Department of Pathology, Bronx, NY, USA
| | - Gustavo C MacIntosh
- Iowa State University, Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology, Ames, IA, USA
| | - Jeffrey P MacKeigan
- Van Andel Research Institute, Laboratory of Systems Biology, Grand Rapids, MI, USA
| | - Kay F Macleod
- University of Chicago, The Ben May Department for Cancer Research, Chicago, IL, USA
| | - John D MacMicking
- Yale University School of Medicine, Department of Microbial Pathogenesis and Howard Hughes Medical Institute, New Haven, CT, USA
| | - Lee Ann MacMillan-Crow
- University of Arkansas for Medical Sciences, Department of Pharmacology/Toxicology, Little Rock, AR, USA
| | - Frank Madeo
- University of Graz, Institute of Molecular Biosciences, BioTechMed Graz, Graz, Austria
| | - Muniswamy Madesh
- Temple University, School of Medicine, Department of Biochemistry; and Center for Translational Medicine, Philadelphia, PA, USA
| | - Julio Madrigal-Matute
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Bronx, NY, USA
| | - Akiko Maeda
- Case Western Reserve University, Department of Ophthalmology and Visual Sciences, Cleveland, OH, USA
| | - Tatsuya Maeda
- University of Tokyo, Institute of Molecular and Cellular Biosciences, Tokyo, Japan
| | - Gustavo Maegawa
- University of Florida, Department of Pediatrics/Genetics and Metabolism, Gainesville, FL, USA
| | - Emilia Maellaro
- University of Siena, Department of Molecular and Developmental Medicine, Siena, Italy
| | - Hannelore Maes
- KU Leuven, Laboratory for Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, Campus Gasthuisberg, Leuven, Belgium
| | - Marta Magariños
- Universidad Autónoma de Madrid, Departamento de Biología, Madrid, Spain
| | - Kenneth Maiese
- University of Medicine and Dentistry of New Jersey, Cellular and Molecular Signaling, Newark, NJ, USA
| | - Tapas K Maiti
- Indian Institute of Technology Kharagpur, Department of Biotechnology, Kharagpur, India
| | - Luigi Maiuri
- San Raffaele Scientific Institute, European Institute for Research in Cystic Fibrosis, Milan, Italy
| | | | - Carl G Maki
- Rush University Medical Center, Department of Anatomy and Cell Biology, Chicago, IL, USA
| | - Roland Malli
- Medical University of Graz, Institute of Molecular Biology and Biochemistry, Centre of Molecular Medicine, Graz, Austria
| | - Walter Malorni
- Istituto Superiore di Sanità, Rome, Italy
- San Raffaele Institute, Dept. of Therapeutic Research and Medicine Evaluation, Sulmona, L'Aquila, Italy
| | - Alina Maloyan
- Oregon Health and Science University, Knight Cardiovascular Institute, Portland, OR, USA
| | | | - Na Man
- University of Miami, Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA
- University of Science and Technology of China, Anhui, China
| | - Joseph D Mancias
- Harvard Medical School, Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, Department of Radiation Oncology, Boston, MA, USA
| | - Eva-Maria Mandelkow
- DZNE, German Center for Neurodegenerative Diseases, and CAESAR Research Center, Bonn, Germany
| | - Michael A Mandell
- University of New Mexico, Health Sciences Center, Department of Molecular Genetics and Microbiology, Albuquerque, NM, USA
| | | | - Serge N Manié
- UMR CNRS 5286, INSERM 1052, Cancer Research Center of Lyon, Lyon, France
| | - Claudia Manzoni
- UCL Institute of Neurology, London, UK
- University of Reading, School of Pharmacy, Reading, UK
| | - Kai Mao
- Massachusetts General Hospital and Harvard Medical School, Department of Molecular Biology; Department of Genetics, Boston, MA, USA
| | - Zixu Mao
- Emory University, School of Medicine, Department of Pharmacology and Neurology, Atlanta, GA, USA
| | - Zong-Wan Mao
- Sun Yat-Sen University, School of Chemistry and Chemical Engineering, Guangzhou, China
| | - Philippe Marambaud
- The Feinstein Institute for Medical Research, North Shore LIJ Health System, Litwin-Zucker Research Center for the Study of Alzheimer's Disease, New York, NY, USA
| | | | - Zvonimir Marelja
- Paris Descartes University–Sorbonne Paris Cité, Imagine Institute, Paris, France
| | - Gabriella Marfe
- Second University of Naples, Department of Biochemistry and Biophysics, Naples, Italy
| | - Marta Margeta
- University of California San Francisco, School of Medicine, Department of Pathology, San Francisco, CA, USA
| | - Eva Margittai
- Semmelweis University, Institute of Human Physiology and Clinical Experimental Research, Budapest, Hungary
| | - Muriel Mari
- University Medical Center Utrecht, Department of Cell Biology, Groningen, The Netherlands
| | - Francesca V Mariani
- University of Southern California, Keck School of Medicine, Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, Department of Cell and Neurobiology, Los Angeles, CA, USA
| | - Concepcio Marin
- IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Sara Marinelli
- CNR, Institute of Cell Biology and Neurobiology and IRCCS Santa Lucia Foundation, Rome, Italy
| | - Guillermo Mariño
- University of Oviedo, Department of Animal Physiology, Faculty of Medicine, Campus del Cristo, Oviedo, Spain
| | - Ivanka Markovic
- University of Belgrade, Institute of Medical and Clinical Biochemistry, Faculty of Medicine, Belgrade, Serbia
| | - Rebecca Marquez
- University of Kansas and University of Kansas Cancer Center, Departments of Molecular Biosciences and Radiation Oncology, Lawrence, KS, USA
| | - Alberto M Martelli
- University of Bologna, Department of Biomedical and Neuromotor Sciences, Bologna, Italy
| | - Sascha Martens
- University of Vienna, Max F. Perutz Laboratories, Vienna, Austria
| | - Katie R Martin
- Van Andel Research Institute, Laboratory of Systems Biology, Grand Rapids, MI, USA
| | - Seamus J Martin
- Trinity College Dublin, Department of Genetics, The Smurfit Institute, Dublin, Ireland
| | - Shaun Martin
- KU Leuven, Department of Cellular and Molecular Medicine, Leuven, Belgium
| | - Miguel A Martin-Acebes
- Centro de Biologia Molecular “Severo Ochoa” (UAM/CSIC), Department of Virology and Microbiology, Madrid, Spain
| | - Paloma Martín-Sanz
- Instituto de Investigaciones Biomédicas Alberto Sols, CSIC/UAM, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
| | | | - Wim Martinet
- University of Antwerp, Laboratory of Physiopharmacology, Wilrijk, Antwerp, Belgium
| | - Jennifer Martinez
- National Institute of Environmental Health Sciences, Immunity, Inflammation, and Disease Laboratory, Research Triangle Park, NC, USA
| | - Nuria Martinez-Lopez
- Albert Einstein College of Medicine, Departments of Medicine and Molecular Pharmacology, Bronx, NY, USA
| | | | - Moisés Martínez-Velázquez
- Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, AC, Unidad de Biotecnología Médica y Farmacéutica, Guadalajara, Jalisco, México
| | - Marta Martinez-Vicente
- Vall d'Hebron Research Institute-CIBERNED, Neurodegenerative Diseases Research Group, Barcelona, Spain
| | - Waleska Kerllen Martins
- São Paulo University, Biochemistry Department; and Santo Amaro University, Life Sciences, São Paulo, Brazil
| | | | - James A Mastrianni
- University of Chicago, Pritzker School of Medicine, Department of Neurology, Chicago, IL, USA
| | - Giuseppe Matarese
- IRCCS-MultiMedica, Milan, Italy
- Università di Salerno, Dipartimento di Medicina e Chirurgia, Baronissi, Salerno, Italy
| | - Paola Matarrese
- Istituto Superiore di Sanità, Department of Therapeutic Research and Medicine, Evaluation Section of Cell Aging, Degeneration and Gender Medicine, Rome, Italy
| | - Roberto Mateo
- Stanford University, Department of Microbiology and Immunology, Stanford, CA, USA
| | - Satoaki Matoba
- Kyoto Prefectural University of Medicine, Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto, Japan
| | - Naomichi Matsumoto
- Yokohama City University Graduate School of Medicine, Department of Human Genetics, Yokohama, Japan
| | - Takehiko Matsushita
- Kobe University, Graduate School of Medicine, Department of Orthopaedic Surgery, Hyogo, Japan
| | - Akira Matsuura
- Chiba University, Department of Nanobiology, Chiba, Japan
| | - Takeshi Matsuzawa
- Osaka Prefecture University, Graduate School of Life and Environmental Science, Osaka, Japan
| | - Mark P Mattson
- National Institute on Aging, Intramural Research Program, Laboratory of Neurosciences, Baltimore, MD, USA
| | - Soledad Matus
- Neurounion Biomedical Foundation, Santiago, Chile
- FONDAP Center for Geroscience, Brain Health and Metabolism, Santiago, Chile
- University of Chile, Biomedical Neuroscience Institute, Santiago, Chile
| | - Norma Maugeri
- Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Autoimmunity and Vascular Inflammation Unit, Milan, Italy
| | - Caroline Mauvezin
- University of Minnesota, Department of Genetics, Cell Biology and Development, Minneapolis, MN, USA
| | - Andreas Mayer
- University of Lausanne, Department of Biochemistry, Epalinges, Switzerland
| | - Dusica Maysinger
- McGill University, Department of Pharmacology and Therapeutics, Montreal, Quebec, Canada
| | - Guillermo D Mazzolini
- Austral University-CONICET, Gene and Cell Therapy Laboratory, Pilar, Buenos Aires, Argentina
| | - Mary Kate McBrayer
- Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
| | | | - Craig McCormick
- Dalhousie University, Department of Microbiology and Immunology, Halifax, Nova Scotia, Canada
| | - Gerald M McInerney
- Karolinska Institute, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden
| | - Skye C McIver
- University of Wisconsin, School of Medicine and Public Health, Department of Cell and Regenerative Biology, Carbone Cancer Center, Madison, WI, USA
| | - Sharon McKenna
- University College Cork, Cork Cancer Research Centre, BioSciences Institute, Co. Cork, Ireland
| | - John J McMahon
- Duke University, Department of Molecular Genetics and Microbiology, Durham, NC, USA
| | - Iain A McNeish
- University of Glasgow, Institute of Cancer Sciences, Glasgow, UK
| | | | - Jan Paul Medema
- University of Amsterdam, Academic Medical Center, Laboratory of Experimental Oncology and Radiobiology, Amsterdam, North Holland, The Netherlands
| | - Diego L Medina
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy
| | - Klara Megyeri
- University of Szeged, Department of Medical Microbiology and Immunobiology, Szeged, Csongrád, Hungary
| | - Maryam Mehrpour
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | - Jawahar L Mehta
- University of Arkansas for Medical Sciences, Department of Cardiology, Little Rock, AR, USA
| | - Yide Mei
- University of Science and Technology of China, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Lifesciences, Hefei, Anhui, China
| | - Ute-Christiane Meier
- Queen Mary University of London, Blizard Institute, Department of Neuroscience and Trauma, London, UK
| | - Alfred J Meijer
- University of Amsterdam, Department of Medical Biochemistry, Academic Medical Center, Amsterdam, The Netherlands
| | - Alicia Meléndez
- City University of New York, Department of Biology, Queens College and The Graduate Center, Flushing, NY, USA
| | - Gerry Melino
- MRC Toxicology Unit, Leicester, UK
- University of Rome “Tor Vergata”, Department of Surgery and Experimental Medicine, Rome, Italy
| | - Sonia Melino
- University of Rome “Tor Vergata”, Department of Chemistry, Rome, Italy
| | - Edesio Jose Tenorio de Melo
- Universidade Estadual do Norte Fluminense Darcy Ribeiro, Centro de Biociencias e Biotecnologia, Lab Biologia Celular e Tecidual, Setor de Toxicologia Celular, Campos dos Goytacazes, Rio de Janeiro, Brazil
| | - Maria A Mena
- Hospital Universitario Ramón y Cajal, CIBERNED, Neurobiology Department, Madrid, Spain
| | - Marc D Meneghini
- University of Toronto, Department of Molecular Genetics, Toronto, Ontario, Canada
| | - Javier A Menendez
- Girona Biomedical Research Institute (IDIBGI), Catalan Institute of Oncology (ICO), Catalonia, Spain
| | - Regina Menezes
- iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal
| | - Liesu Meng
- Xi'an Jiaotong University Health Science Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shaanxi, China
| | - Ling-hua Meng
- Shanghai Institute of Materia Medica, Division of Antitumor Pharmacology, Shanghai, China
| | - Songshu Meng
- Dalian Medical University, Cancer Center, Institute of Cancer Stem Cell, Dalian, Liaoning Province, China
| | - Rossella Menghini
- University of Rome “Tor Vergata”, Department of Systems Medicine, Rome, Italy
| | - A Sue Menko
- Thomas Jefferson University, Department of Pathology, Anatomy, and Cell Biology, Sydney Kimmel Medical College, Philadelphia, PA, USA
| | - Rubem FS Menna-Barreto
- Instituto Oswaldo Cruz, FIOCRUZ, Laboratório de Biologia Celular, Rio de Janeiro, Brazil
| | - Manoj B Menon
- Hannover Medical School, Department of Biochemistry, Hannover, Germany
| | - Marco A Meraz-Ríos
- Center of Investigation and Advanced Studies, Cinvestav-IPN, Mexico City, Mexico
| | - Giuseppe Merla
- IRCCS Casa Sollievo della Sofferenza, Medical Genetics Unit, San Giovanni Rotondo (FG), Italy
| | - Luciano Merlini
- Istituto Ortopedico Rizzoli IOR-IRCCS, Laboratory of Musculoskeletal Cell Biology, Bologna, Italy
| | - Angelica M Merlot
- University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
| | - Andreas Meryk
- University of Innsbruck, Institute for Biomedical Aging Research, Innsbruck, Austria
| | - Stefania Meschini
- Italian National Institute of Health, Department of Technology and Health, Rome, Italy
| | - Joel N Meyer
- Duke University, Nicholas School of the Environment, Durham, NC, USA
| | - Man-tian Mi
- Third Military Medical University, Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Chongqing, China
| | - Chao-Yu Miao
- Second Military Medical University, Department of Pharmacology, Shanghai, China
| | - Lucia Micale
- IRCCS Casa Sollievo della Sofferenza, Medical Genetics Unit, San Giovanni Rotondo (FG), Italy
| | - Simon Michaeli
- Biochimie et Physiologie Moléculaire des Plantes, UMR5004 CNRS/INRA/UM2/SupAgro, Institut de Biologie Intégrative des Plantes, Montpellier, France
| | - Carine Michiels
- University of Namur, Laboratory of Biochemistry and Cell Biology (URBC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium
| | - Anna Rita Migliaccio
- Icahn School of Medicine at Mount Sinai, Department of Medicine, New York, NY, USA
| | - Anastasia Susie Mihailidou
- Royal North Shore Hospital, Cardiovascular and Hormonal Research Laboratory, Royal North Shore Hospital and Kolling Institute, Sydney, NSW, Australia
- University of Sydney, Department of Cardiology, Sydney, NSW, Australia
| | - Dalibor Mijaljica
- Monash University, Clayton Campus, Department of Biochemistry and Molecular Biology, Melbourne, Victoria, Australia
| | - Katsuhiko Mikoshiba
- RIKEN Brain Science Institute, Laboratory for Developmental Neurobiology, Saitama, Japan
| | - Enrico Milan
- Università Vita-Salute San Raffaele, Milan, Italy
- San Raffaele Scientific Institute, Milan, Italy
| | | | - Gordon B Mills
- University of Texas, MD Anderson Cancer Center, Department of Systems Biology, Houston, TX, USA
| | - Ian G Mills
- University of Oslo and Oslo University Hospital, Prostate Cancer Research Group, Centre for Molecular Medicine (Norway), Oslo, Norway
- University of Oslo, Department of Molecular Oncology, Department of Urology, Oslo, Norway
- Centre for Cancer Research and Cell Biology, Queen's University Belfast, Lisburn Road, Belfast, UK
| | - Georgia Minakaki
- University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
| | - Berge A Minassian
- The Hospital for Sick Children, Department of Paediatrics, Toronto, Ontario, Canada
| | - Xiu-Fen Ming
- University of Fribourg, Department of Medicine, Division of Physiology, Fribourg, Switzerland
| | - Farida Minibayeva
- Russian Academy of Sciences, Kazan Institute of Biochemistry and Biophysics, Kazan, Tatarstan, Russia
| | - Elena A Minina
- Swedish University of Agricultural Sciences and Linnean Center for Plant Biology, Department of Chemistry and Biotechnology, Uppsala BioCenter, Uppsala, Sweden
| | - Justine D Mintern
- Bio21 Molecular Science and Biotechnology Institute, Department of Biochemistry and Molecular Biology, Parkville, Victoria, Australia
| | - Saverio Minucci
- University of Milan, Department of Experimental Oncology, European Institute of Oncology and Department of Biosciences, Milan, Italy
| | - Antonio Miranda-Vizuete
- Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Sevilla, Spain
| | - Claire H Mitchell
- University of Pennsylvania, Department of Anatomy and Cell Biology, Philadelphia, PA, USA
| | - Shigeki Miyamoto
- University of California San Diego, Department of Pharmacology, La Jolla, CA, USA
| | - Keisuke Miyazawa
- Tokyo Medical University, Department of Biochemistry, Tokyo, Japan
| | - Noboru Mizushima
- University of Tokyo, Department of Biochemistry and Molecular Biology, Graduate School and Faculty of Medicine, Tokyo, Japan
| | - Katarzyna Mnich
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Baharia Mograbi
- INSERM U1081, CNRS UMR7284, Institute of Research on Cancer and Ageing of Nice (IRCAN), Nice, France
| | - Simin Mohseni
- Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden
| | | | | | - Maurizio Molinari
- Institute for Research in Biomedicine, Bellinzona, Switzerland, Università Svizzera italiana, Lugano, Switzerland
- Ecole Polytechnique Federale de Lausanne, Global Health Institute, School of Life Sciences, Lausanne, Switzerland
| | - Andreas Buch Møller
- Aarhus University, Medical Research Laboratory, Institute for Clinical Medicine, Aarhus, Denmark
| | - Bertrand Mollereau
- Université de Lyon, UMR 5239 CNRS, Laboratory of Molecular Biology of the Cell, Ecole Normale Supérieure de Lyon, Lyon, France
| | - Faustino Mollinedo
- Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca, Campus Miguel de Unamuno, Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Salamanca, Spain
| | - Marco Mongillo
- University of Padova, Venetian Institute of Molecular Medicine, Department of Biomedical Science, Padova, Italy
| | - Martha M Monick
- University of Iowa, Department of Medicine, Iowa City, IA, USA
| | - Serena Montagnaro
- University of Naples Federico II, Department of Veterinary Medicine and Animal Production, Naples, Italy
| | - Craig Montell
- Neuroscience Research Institute, Santa Barbara, CA, USA
- University of California Santa Barbara, Department of Molecular, Cellular, and Developmental Biology, Santa Barbara, CA, USA
| | - Darren J Moore
- Van Andel Institute, Center for Neurodegenerative Science, Grand Rapids, MI, USA
| | - Michael N Moore
- University of Exeter Medical School, European Centre for Environment and Human Health (ECEHH), Truro, Cornwall, UK
| | | | - Paula I Moreira
- University of Coimbra, CNC – Center for Neuroscience and Cell Biology and Faculty of Medicine, Coimbra, Portugal
| | - Etienne Morel
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | | | - Sandra Moreno
- University Roma Tre, Department of Science, LIME, Rome, Italy
| | - Michael J Morgan
- University of Colorado, School of Medicine, Department of Pharmacology, Aurora, CO, USA
| | - Arnaud Moris
- Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL 8255, Center for Immunology and Microbial Infections – CIMI-Paris, Paris, France
| | - Yuji Moriyasu
- Saitama University, Graduate School of Science and Engineering, Saitama, Japan
| | - Janna L Morrison
- University of South Australia, Early Origins of Adult Health Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, Adelaide, SA, Australia
| | - Lynda A Morrison
- Saint Louis University School of Medicine, Department of Molecular Microbiology and Immunology, St. Louis, MO, USA
| | - Eugenia Morselli
- Pontificia Universidad Católica de Chile, Physiology Department, Santiago, Chile
| | - Jorge Moscat
- Sanford Burnham Prebys NCI-Cancer Center, Cell Death and Survival Networks Program, La Jolla, CA, USA
| | - Pope L Moseley
- University of New Mexico, Department of Internal Medicine, Albuquerque, NM, USA
| | - Serge Mostowy
- Imperial College London, Section of Microbiology, MRC Centre for Molecular Bacteriology and Infection, London, UK
| | - Elisa Motori
- Max Planck Institute for Biology of Ageing, Cologne, Germany
| | - Denis Mottet
- University of Liege, GIGA-Signal Transduction Department, Protein Signalisation and Interaction Laboratory, Liège, Belgium
| | - Jeremy C Mottram
- University of York, Centre for Immunology and Infection, Department of Biology, Hull York Medical School, York, UK
| | - Charbel E-H Moussa
- Georgetown University Medical Center, Department of Neuroscience, Washington, DC, USA
| | - Vassiliki E Mpakou
- University of Athens, Medical School, Second Department of Internal Medicine and Research Institute, Attikon University General Hospital, Athens, Greece
| | - Hasan Mukhtar
- University of Wisconsin, Department of Dermatology, Madison, WI, USA
| | - Jean M Mulcahy Levy
- University of Colorado, Department of Pediatrics, Center for Cancer and Blood Disorders, Aurora, CO, USA
| | - Sylviane Muller
- CNRS, Immunopathology and Therapeutic Chemistry, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France
| | - Raquel Muñoz-Moreno
- Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Departamento de Biotecnología, Madrid, Spain
| | - Cristina Muñoz-Pinedo
- Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Cell Death Regulation Group, Barcelona, Spain
| | - Christian Münz
- University of Zurich, Institute of Experimental Immunology, Zurich, Switzerland
| | - Maureen E Murphy
- The Wistar Institute, Program in Molecular and Cellular Oncogenesis, Philadelphia, PA, USA
| | - James T Murray
- Trinity College Dublin, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Dublin, Ireland
| | - Aditya Murthy
- Genentech Inc., Department of Cancer Immunology, South San Francisco, CA, USA
| | - Indira U Mysorekar
- Washington University, School of Medicine, Departments of Obstetrics and Gynecology, and Pathology and Immunology, St. Louis, MO, USA
| | - Ivan R Nabi
- University of British Columbia, Department of Cellular and Physiological Sciences, Vancouver, BC, Canada
| | | | - Gustavo A Nader
- Karolinska Institute, Department of Physiology and Pharmacology, Stockholm, Sweden
| | - Yukitoshi Nagahara
- Tokyo Denki University, Division of Life Science and Engineering, Hatoyama, Hiki-gun, Saitama, Japan
| | - Yoshitaka Nagai
- National Center of Neurology and Psychiatry, Department of Degenerative Neurological Diseases, Kodaira, Tokyo, Japan
| | - Kazuhiro Nagata
- Kyoto Sangyo University, Department of Life Sciences, Kyoto, Japan
| | - Anika Nagelkerke
- Radboud University, Institute for Molecules and Materials, Department of Molecular Materials, Nijmegen, The Netherlands
| | - Péter Nagy
- Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
| | - Samisubbu R Naidu
- Indiana University School of Medicine, Department of Dermatology, Indianapolis, IN, USA
| | - Sreejayan Nair
- University of Wyoming, School of Pharmacy, College of Health Sciences, Laramie, WY, USA
| | - Hiroyasu Nakano
- Toho University, School of Medicine, Department of Biochemistry, Tokyo, Japan
| | - Hitoshi Nakatogawa
- Tokyo Institute of Technology, Graduate School of Bioscience and Biotechnology, Tokyo, Japan
| | - Meera Nanjundan
- University of South Florida, Department of Cell Biology, Microbiology, and Molecular Biology, Tampa, FL, USA
| | - Gennaro Napolitano
- Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy
| | | | - Roberta Nardacci
- National Institute for Infectious Diseases “L. Spallanzani” IRCCS, Rome, Italy
| | - Derek P Narendra
- Harvard Medical School, Neurology Residency Program, Brigham and Women's Hospital and Massachusetts General Hospital, Boston, MA, USA
| | - Masashi Narita
- University of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK
| | - Anna Chiara Nascimbeni
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | - Ramesh Natarajan
- Virginia Commonwealth University, Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Richmond, VA, USA
| | - Luiz C Navegantes
- University of São Paulo, Ribeirão Preto Medical School, Department of Physiology, Ribeirão Preto, São Paulo, Brazil
| | - Steffan T Nawrocki
- University of Texas, Health Science Center at San Antonio, CTRC Institute for Drug Development, San Antonio, TX, USA
| | - Taras Y Nazarko
- University of California San Diego, Division of Biological Sciences, Section of Molecular Biology, La Jolla, CA, USA
| | - Volodymyr Y Nazarko
- University of Illinois at Chicago, Deprtment of Biochemistry and Molecular Genetics, Chicago, IL, USA
| | - Thomas Neill
- Thomas Jefferson University, Department of Pathology, Anatomy and Cell Biology, Philadelphia, PA, USA
| | - Luca M Neri
- University of Ferrara, Department of Morphology, Surgery and Experimental Medicine, Ferrara, Italy
| | - Mihai G Netea
- Radboud University Nijmegen Medical Center, Department of Internal Medicine, Nijmegen, The Netherlands
| | - Romana T Netea-Maier
- Radboud University Nijmegen Medical Center, Department of Internal Medicine, Division of Endocrinology, Nijmegen, The Netherlands
| | - Bruno M Neves
- University of Aveiro/QOPNA, Department of Chemistry, Aveiro, Portugal
| | - Paul A Ney
- New York Blood Center, Lindsley F. Kimball Research Institute, New York, NY, USA
| | | | - Hang TT Nguyen
- Université d'Auvergne, M2iSH “Microbes, Intestine, Inflammation, Susceptibility of the Host”, UMR 1071 INSERM, Centre Biomédical de Recherche et Valorisation, Faculté de Médecine, Clermont-Ferrand, France
| | - Huu Phuc Nguyen
- University of Tübingen, Institute of Medical Genetics and Applied Genomics, Tübingen, Germany
| | - Anne-Sophie Nicot
- INSERM U964, CNRS UMR7104, Université de Strasbourg, Department of Translational Medecine, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
| | - Hilde Nilsen
- Akershus University Hospital, Oslo, Norway
- University of Oslo, Department of Clinical Molecular Biology, Oslo, Norway
| | - Per Nilsson
- Karolinska Institute, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Division for Neurogeriatrics, Huddinge, Sweden
- Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan
| | - Mikio Nishimura
- National Institute for Basic Biology, Department of Cell Biology, Okazaki, Japan
| | - Ichizo Nishino
- National Center of Neurology and Psychiatry, Department of Neuromuscular Research, National Institute of Neuroscience, Tokyo, Japan
| | - Mireia Niso-Santano
- Universidad de Extremadura, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Cáceres, Spain
| | - Hua Niu
- Soochow University, Department of Pathogenic Biology, Suzhou, Jiangsu, China
| | - Ralph A Nixon
- New York University, Nathan Kline Institute, Orangeburg, NY, USA
| | - Vincent CO Njar
- University of Maryland, School of Medicine, Department of Chemistry, Baltimore, MD, USA
| | - Takeshi Noda
- Osaka University, Graduate School of Dentistry, Osaka, Japan
| | - Angelika A Noegel
- University of Cologne, Institute of Biochemistry I, Medical Faculty, Koeln, Germany
| | | | - Erik Norberg
- Karolinska Institute, Department of Physiology and Pharmacology, Stockholm, Sweden
| | - Koenraad K Norga
- University of Antwerp, Department of Paediatric Oncology, Antwerp, Belgium
| | - Sakineh Kazemi Noureini
- Hakim Sabzevari University, Department of Biology, Faculty of Basic Sciences, Sabzevar, Iran
| | - Shoji Notomi
- Harvard Medical School, Ophthalmology, Boston, MA, USA
| | - Lucia Notterpek
- University of Florida, College of Medicine, Department of Neuroscience, Gainesville, FL, USA
| | - Karin Nowikovsky
- Medical University of Vienna, Internal Medicine I, Vienna, Austria
| | - Nobuyuki Nukina
- Juntendo University, Graduate School of Medicine, Department of Neuroscience for Neurodegenerative Disorders, Tokyo, Japan
| | - Thorsten Nürnberger
- University of Tübingen, Center for Plant Molecular Biology (ZMBP), Department of Plant Biochemistry, Tübingen, Germany
| | | | - Tracey O'Donovan
- University College Cork, Cork Cancer Research Centre, BioSciences Institute, Co. Cork, Ireland
| | - Peter J O'Dwyer
- University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, USA
| | - Ina Oehme
- German Cancer Research Center (DKFZ), Clinical Cooperation Unit (CCU) Pediatric Oncology, Heidelberg, Germany
| | - Clara L Oeste
- Consejo Superior de Investigaciones Científicas (CSIC), Centro de Investigaciones Biológicas, Madrid, Spain
| | - Michinaga Ogawa
- National Institute of Infectious Diseases, Department of Bacteriology I, Tokyo, Japan
| | - Besim Ogretmen
- Medical University of South Carolina, Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Charleston, SC, USA
| | - Yuji Ogura
- St. Marianna University School of Medicine, Department of Physiology, Kanagawa, Japan
| | - Young J Oh
- Yonsei University, College of Life Science and Biotechnology, Department of Systems Biology, Seoul, Korea
| | - Masaki Ohmuraya
- Kumamoto University, Institute of Resource Development and Analysis, Kumamoto, Japan
| | - Takayuki Ohshima
- Tokushima Bunri University, Faculty of Pharmaceutical Sciences at Kagawa Campus, Sanuki City, Kagawa, Japan
| | - Rani Ojha
- Post Graduate Institute of Medical Education and Research (PGIMER), Department of Urology, Chandigarh, India
| | - Koji Okamoto
- Osaka University, Graduate School of Frontier Biosciences, Osaka, Japan
| | - Toshiro Okazaki
- Kanazawa Medical University, Department of Medicine, Ishikawa, Japan
| | - F Javier Oliver
- Instituto de Parasitología y Biomedicina López Neyra (IPBLN), CSIC, Granada, Spain
| | - Karin Ollinger
- Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden
| | - Stefan Olsson
- University of Copenhagen, Department of Plant and Environmental Sciences, Section for Genetics and Microbiology, Copenhagen, Denmark
| | - Daniel P Orban
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Paulina Ordonez
- University of California San Diego, Department of Pediatrics, La Jolla, CA, USA
| | - Idil Orhon
- Université Paris Descartes-Sorbonne Paris Cité, Institut Necker Enfants-Malades (INEM), INSERM U1151-CNRS UMR 8253, Paris, France
| | - Laszlo Orosz
- University of Szeged, Department of Medical Microbiology and Immunobiology, Szeged, Csongrád, Hungary
| | - Eyleen J O'Rourke
- University of Virginia, Departments of Biology and Cell Biology, Charlottesville, VA, USA
| | - Helena Orozco
- University of Valencia, Departamento de Bioquimica y Biologia Molecular, IATA-CSIC, Valencia, Spain
- University of Valencia, Departamento de Biotecnología, IATA-CSIC, Valencia, Spain
| | - Angel L Ortega
- University of Valencia, Department of Physiology, Burjassot, Valencia, Spain
| | - Elena Ortona
- Istituto Superiore di Sanità, Department of Cell Biology and Neurosciences, Rome, Italy
| | - Laura D Osellame
- Monash University, Clayton Campus, Department of Biochemistry and Molecular Biology, Melbourne, Victoria, Australia
| | - Junko Oshima
- University of Washington, Department of Pathology, Seattle, WA
| | - Shigeru Oshima
- Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan
| | - Heinz D Osiewacz
- Goethe University, Institute for Molecular Biosciences, Molecular Developmental Biology, Frankfurt, Hesse, Germany
| | - Takanobu Otomo
- Osaka University Graduate School of Medicine, Department of Pediatrics, Osaka, Japan
| | - Kinya Otsu
- King's College London, Cardiovascular Division, London, UK
| | - Jing-hsiung James Ou
- University of Southern California, Keck School of Medicine, Department of Molecular Microbiology and Immunology, Los Angeles, CA, USA
| | - Tiago F Outeiro
- University Medical Centre Göttingen, Department of Neurodegeneration and Restorative Research, Göttingen, Germany
| | - Dong-yun Ouyang
- Jinan University, Department of Immunobiology, College of Life Science and Technology, Guangzhou, China
| | - Hongjiao Ouyang
- University of Pittsburgh, School of Dental Medicine, Department of Endodontics, Pittsburgh, PA, USA
| | | | - Michelle A Ozbun
- University of New Mexico, Comprehensive Cancer Center, Department of Molecular Genetics and Microbiology, Albuquerque, NM, USA
| | - P Hande Ozdinler
- Northwestern University, Department of Neurology, Feinberg School of Medicine, Chicago, IL, USA
| | - Bulent Ozpolat
- University of Texas, MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA
| | - Consiglia Pacelli
- Université de Montréal, Department of Pharmacology, Faculty of Medicine, Montreal, QC, Canada
| | - Paolo Paganetti
- Laboratory for Biomedical Neurosciences NSI/EOC, Neurodegeneration Group, Torricella-Taverne, Switzerland
| | - Guylène Page
- University of Poitiers, EA3808 Molecular Targets and Therapeutics in Alzheimer's Disease, Poitiers, France
| | - Gilles Pages
- University of Nice Sophia Antipolis, Institute of Research on Cancer and Ageing of Nice, CNRS UMR 7284/INSERM U1081, Nice, France
| | - Ugo Pagnini
- University of Naples Federico II, Department of Veterinary Medicine and Animal Production, Naples, Italy
| | - Beata Pajak
- Mossakowski Medical Research Centre, Polish Academy of Sciences, Electron Microscopy Platform, Warsaw, Poland
- Warsaw University of Life Sciences - SGGW, Faculty of Veterinary Medicine, Department of Physiological Sciences, Warsaw, Poland
| | - Stephen C Pak
- University of Pittsburgh, School of Medicine, Department of Pediatrics, Pittsburgh, PA, USA
| | | | - Nazzy Pakpour
- University of California Davis, Department of Medical Microbiology and Immunology, School of Medicine, Davis, CA, USA
| | - Zdena Palková
- Charles University in Prague, Faculty of Science, Department of Genetics and Microbiology, Prague, Czech Republic
| | | | - Kathrin Pallauf
- University of Kiel, Institute of Human Nutrition and Food Science, Kiel, Germany
| | | | - Marta Palmieri
- University of Verona, Department of Neurological, Biomedical and Movement Sciences, Verona, Italy
| | - Søren R Paludan
- Aarhus University, Department of Biomedicine, Aarhus, Denmark
| | - Camilla Palumbo
- University of Rome “Tor Vergata”, Department of Clinical Sciences and Translational Medicine, Rome, Italy
| | - Silvia Palumbo
- University of Pavia, Department of Biology and Biotechnology, Pavia, Italy
| | - Olatz Pampliega
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
| | - Hongming Pan
- Zhejiang University, Sir Run Run Shaw Hospital, Department of Medical Oncology, Hangzhou, Zhejiang, China
| | - Wei Pan
- Department of Cardiology, Nanhai Hospital Affiliated to Southern Medical University, Foshan, Guangdong Province, China
| | - Theocharis Panaretakis
- Karolinska Institute, Cancer Center Karolinska, Department of Oncology-Pathology, Stockholm, Sweden
| | - Aseem Pandey
- Texas A&M University, Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, TX, USA
- Texas A&M University, The Norman Borlaug Center, College Station, TX, USA
| | - Areti Pantazopoulou
- Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
| | - Zuzana Papackova
- Institute for Clinical and Experimental Medicine, Centre for Experimental Medicine, Department of Metabolism and Diabetes, Prague, Czech Republic
| | - Daniela L Papademetrio
- Universidad de Buenos Aires, Inmunología, Facultad de Farmacia y Bioquímica, Buenos Aires, Argentina
| | - Issidora Papassideri
- National and Kapodistrian University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
| | - Alessio Papini
- University of Florence, Department of Biology, Florence, Italy
| | - Nirmala Parajuli
- University of Arkansas for Medical Sciences, Department of Pharmacology/Toxicology, Little Rock, AR, USA
| | - Julian Pardo
- IIS Aragon, Universidad de Zaragoza/Araid, Centro de Investigación Biomédica de Aragón, Zaragoza, Spain
| | - Vrajesh V Parekh
- Vanderbilt University, School of Medicine, Pathology Microbiology and Immunology, Nashville, TN, USA
| | - Giancarlo Parenti
- Federico II University, Telethon Institute of Genetics and Medicine (TIGEM), Department of Medical and Translational Sciences, Naples, Italy
| | - Jong-In Park
- Medical College of Wisconsin, Department of Biochemistry, Milwaukee, WI, USA
| | - Junsoo Park
- Yonsei University, Division of Biological Science and Technology, Wonju, Korea
| | - Ohkmae K Park
- Korea University, Division of Life Sciences, Seoul, Korea
| | - Roy Parker
- University of Colorado, HHMI, Department of Chemistry and Biochemistry, Aurora, CO, USA
| | - Rosanna Parlato
- University of Heidelberg, Institute of Anatomy and Cell Biology, Heidelberg, Germany
- University of Ulm, Institute of Applied Physiology, Ulm, Germany
| | - Jan B Parys
- KU Leuven, Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular Medicine, Leuven, Belgium
| | - Katherine R Parzych
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Jean-Max Pasquet
- Université Bordeaux Segalen, U1035 INSERM, Hématopoïèse Leucémique et Cibles Thérapeutiques, Bordeaux, France
| | | | | | - Daniel Patschan
- University Hospital of Göttingen, Department of Nephrology and Rheumatology, Göttingen, Germany
| | - Cam Patterson
- New York-Presbyterian Hospital/Weill-Cornell Medical Center, New York, NY, USA
| | - Sophie Pattingre
- IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France
- Université de Montpellier, Institut régional du Cancer de Montpellier, INSERM, U 1194, Montpellier, France
| | - Scott Pattison
- University of South Dakota, Division of Basic Biomedical Sciences, Vermillion, SD, USA
| | - Arnim Pause
- McGill University, Goodman Cancer Research Centre and Department of Biochemistry, Montreal, Quebec, Canada
| | - Hermann Pavenstädt
- University Hospital Muenster Albert-Schweitzer-Campus, Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, Münster, Germany
| | - Flaminia Pavone
- CNR, Institute of Cell Biology and Neurobiology and IRCCS Santa Lucia Foundation, Rome, Italy
| | - Zully Pedrozo
- P Catholic University of Chile, Advanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, Santiago, Chile
| | - Fernando J Peña
- University of Extremadura, Department of Medicine, Faculty of Veterinary Medicine, Cáceres, Spain
| | - Miguel A Peñalva
- Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
| | - Mario Pende
- Université Paris Descartes, Institut Necker-Enfants Malades, INSERM, U1151, Paris, France
| | - Jianxin Peng
- College of Science, Central China Normal University, Wuhan, China
| | - Fabio Penna
- University of Turin, Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, Turin, Italy
| | - Josef M Penninger
- Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria
| | - Anna Pensalfini
- Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
| | - Salvatore Pepe
- Murdoch Childrens Research Institute, University of Melbourne, Department of Paediatrics, Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Gustavo JS Pereira
- Federal University of São Paulo, Department of Pharmacology, Paulista School of Medicine, São Paulo, Brazil
| | - Paulo C Pereira
- University of Coimbra, IBILI, Faculty of Medicine, Coimbra, Portugal
| | | | | | - Diego Pérez-Rodríguez
- Universidad de León, Área de Biología Celular, Instituto de Biomedicina, León, Spain
| | - Dolores Pérez-Sala
- Consejo Superior de Investigaciones Científicas (CSIC), Centro de Investigaciones Biológicas, Madrid, Spain
| | - Celine Perier
- Vall d'Hebron Research Institute, Neurodegenerative Diseases Lab, Barcelona, Spain
| | - Andras Perl
- State University of New York, College of Medicine, Departments of Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, Syracuse, NY, USA
| | | | - Ida Perrotta
- University of Calabria, Department of Biology, Ecology and Earth Science, Laboratory of Electron Microscopy, Cosenza, Italy
| | - Shazib Pervaiz
- Curtin University, School of Biomedical Sciences, Perth, Australia
- National University Cancer Institute, National University Health System, Singapore
- National University of Singapore, Department of Physiology, Yong Loo Lin School of Medicine, Singapore
| | - Maija Pesonen
- University of Eastern Finland, Faculty of Health Science, School of Pharmacy/Toxicology, Kuopio, Finland
| | - Jeffrey E Pessin
- Albert Einstein College of Medicine, Departments of Medicine and Molecular Pharmacology, Bronx, NY, USA
| | - Godefridus J Peters
- VU University Medical Center, Department of Medical Oncology, Amsterdam, The Netherlands
| | - Morten Petersen
- University of Copenhagen, Department of Biology, Copenhagen, Denmark
| | | | - Basil J Petrof
- McGill University, Health Centre Research Institute, Meakins Christie Laboratories, Montreal, Quebec, Canada
| | - Goran Petrovski
- Oslo University Hospital, Center for Eye Research, Oslo, Norway
- University of Oslo, Department of Ophthalmology, Oslo, Norway
- University of Szeged, Department of Ophthalmology, Faculty of Medicine, Szeged, Hungary
| | - James M Phang
- NCI/CCR, Basic Research Laboratory, Frederick, MD, USA
| | - Mauro Piacentini
- University of Rome “Tor Vergata”, Department of Biology, Rome, Italy
| | - Marina Pierdominici
- Istituto Superiore di Sanità, Department of Cell Biology and Neurosciences, Rome, Italy
| | - Philippe Pierre
- Aix-Marseille Université, U2M, Centre d'Immunologie de Marseille-Luminy, Marseille, France
- CNRS, UMR 7280, Marseille, France
- INSERM, U1104, Marseille, France
- University of Aveiro, Institute for Research in Biomedicine - iBiMED, Aveiro Health Sciences Program, Aveiro, Portugal
| | - Valérie Pierrefite-Carle
- Université Nice Sophia Antipolis, UMR E-4320TIRO-MATOs CEA/iBEB, Faculté de Médecine, Nice, France
| | - Federico Pietrocola
- Centre de Recherche des Cordeliers, Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Gustave Roussy Cancer Campus, Villejuif, France
- INSERM, U1138, Paris, France
- Université Paris Descartes/Paris V, Paris, France
| | - Felipe X Pimentel-Muiños
- Universidad de Salamanca, Campus Unamuno, Instituto de Biologia Molecular y Celular del Cancer (IBMCC), Centro de Investigacion del Cancer, Salamanca, Spain
| | - Mario Pinar
- Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
| | - Benjamin Pineda
- Instituto Nacional de Neurología y Neurocirugía, Neuroimmunology and Neuro-Oncology Unit, Mexico City, Mexico
| | | | - Marcello Pinti
- University of Modena and Reggio Emilia, Department of Life Sciences, Modena, Italy
| | - Paolo Pinton
- University of Ferrara, Department of Morphology, Surgery and Experimental Medicine, Ferrara, Italy
| | - Bilal Piperdi
- Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
| | - James M Piret
- University of British Columbia, Michael Smith Laboratories, Department of Chemical and Biological Engineering,Vancouver, BC, Canada
| | - Leonidas C Platanias
- Jesse Brown VA Medical Center, Department of Medicine, Chicago, IL, USA
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA
| | - Harald W Platta
- Ruhr University Bochum, Biochemie Intrazellulärer Transportprozesse, Bochum, Germany
| | - Edward D Plowey
- Stanford University, School of Medicine, Department of Pathology, Stanford, CA, USA
| | - Stefanie Pöggeler
- Georg-August-Universität Göttingen, Institute of Microbiology and Genetics, Department of Genetics of Eukaryotic Microorganisms, Göttingen, Germany
| | - Marc Poirot
- University of Toulouse, INSERM UMR 1037, Cancer Research Center of Toulouse, Toulouse, France
| | - Peter Polčic
- Comenius University in Bratislava, Department of Biochemistry, Faculty of Natural Sciences, Bratislava, Slovak Republic
| | - Angelo Poletti
- Universita' degli Studi di Milano, Dipartimento di Scienze Farmacologiche e Biomolecolari, Milan, Italy
| | - Audrey H Poon
- McGill University, Health Centre Research Institute, Meakins-Christie Laboratories, Montreal, Quebec, Canada
| | - Hana Popelka
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Blagovesta Popova
- Georg-August-Universität Göttingen, Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Göttingen, Germany
| | - Izabela Poprawa
- University of Silesia, Department of Animal Histology and Embryology, Katowice, Poland
| | - Shibu M Poulose
- USDA-Human Nutrition Research Center on Aging at Tufts University, Department of Neuroscience and Aging, Boston, MA, USA
| | - Joanna Poulton
- University of Oxford, Nuffield Department of Obstetrics and Gynaecology, Oxford, UK
| | - Scott K Powers
- University of Florida, Department of Applied Physiology and Kinesiology, Gainesville, FL, USA
| | - Ted Powers
- University of California Davis, Department of Molecular and Cellular Biology, Davis, CA, USA
| | - Mercedes Pozuelo-Rubio
- Centro Andaluz de Biología Molecular y Medicina Regenerativa, Consejo Superior de Investigaciones Científicas, Sevilla, Spain
| | - Krisna Prak
- University College London, MRC Laboratory for Molecular Cell Biology, London, UK
| | - Reinhild Prange
- Johannes Gutenberg University Mainz, University Medical Center, Department of Medical Microbiology and Hygiene, Mainz, Germany
| | - Mark Prescott
- Monash University, Clayton Campus, Department of Biochemistry and Molecular Biology, Melbourne, Victoria, Australia
| | - Muriel Priault
- Université Bordeaux Ségalen, Institut de Biochimie et de Génétique Cellulaires, CNRS, UMR 5095, Bordeaux, France
| | - Sharon Prince
- University of Cape Town, Department of Human Biology, Cape Town, Western Province, South Africa
| | - Richard L Proia
- National Institutes of Health, NIDDK, Genetics of Development and Disease Branch, Bethesda, MD, USA
| | - Tassula Proikas-Cezanne
- Eberhard Karls University Tübingen, Interfaculty Institute of Cell Biology, Tübingen, Germany
| | - Holger Prokisch
- Technical University Munich, Institute of Human Genetics, Munich, Bavaria, Germany
| | - Vasilis J Promponas
- University of Cyprus, Department of Biological Sciences, Bioinformatics Research Laboratory, Nicosia, Cyprus
| | - Karin Przyklenk
- Wayne State University, School of Medicine, Cardiovascular Research Institute, Detroit, MI, USA
| | - Rosa Puertollano
- National Institutes of Health, Cell Biology and Physiology Center, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | - Subbiah Pugazhenthi
- University of Colorado, School of Medicine, Anschutz Medical Campus, Aurora, CO, USA
| | - Luigi Puglielli
- University of Wisconsin, Department of Medicine, Madison, WI, USA
| | - Aurora Pujol
- Bellvitge Biomedical Research Institute (IDIBELL), Neurometabolic Diseases Laboratory, Barcelona, Spain
- CIBERER Spanish Network for Rare Diseases, Madrid, Spain
- ICREA Catalan Institution for Research and Advanced Studies, Catalonia, Spain
| | - Julien Puyal
- University Hospital Center, University of Lausanne, Clinic of Neonatology, Department of Pediatrics and Pediatric Surgery, Lausanne, Switzerland
- University of Lausanne, Department of Fundamental Neurosciences, Faculty of Biology and Medicine, Lausanne, Switzerland
| | - Dohun Pyeon
- University of Colorado, School of Medicine, Department of Immunology and Microbiology, Aurora, CO, USA
| | - Xin Qi
- Case Western Reserve University, School of Medicine, Department of Physiology and Biophysics, Cleveland, OH, USA
| | - Wen-bin Qian
- Zhejiang University, Institute of Hematology, First Affiliated Hospital, College of Medicine, Hangzhou, China
| | - Zheng-Hong Qin
- Soochow University, School of Pharmaceutical Science, Department of Pharmacology, Suzhou, China
| | - Yu Qiu
- St. Jude Children's Research Hospital, Department of Structural Biology, Memphis, TN, USA
| | - Ziwei Qu
- Temasek Life Sciences Laboratory, Singapore
| | - Joe Quadrilatero
- University of Waterloo, Department of Kinesiology, Waterloo, Ontario, Canada
| | - Frederick Quinn
- University of Georgia, Department of Infectious Diseases, Athens, GA, USA
| | - Nina Raben
- National Institutes of Health, NIAMS, Laboratory of Muscle Stem Cells and Gene Regulation, Bethesda, MD, USA
| | - Hannah Rabinowich
- University of Pittsburgh, Department of Pathology, Pittsburgh, PA, USA
| | - Flavia Radogna
- Hôpital Kirchberg, Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
| | | | - Mohamed Rahmani
- Virginia Commonwealth University, Massey Cancer Center, Department of Internal Medicine, Richmond, VA, USA
| | - Komal Raina
- University of Colorado Denver, Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Aurora, CO, USA
| | - Sasanka Ramanadham
- University of Alabama at Birmingham, Department of Cell, Developmental, and Integrative Biology (CDIB), Comprehensive Diabetes Center (UCDC), Birmingham, AL, USA
| | - Rajagopal Ramesh
- University of Oklahoma Health Sciences Center, Department of Pathology, Oklahoma City, OK, USA
| | - Abdelhaq Rami
- University Clinics, Institute of Cellular and Molecular Anatomy (Anatomie 3), Frankfurt, Germany
| | | | - Felix Randow
- MRC Laboratory of Molecular Biology, Cambridge, UK
- University of Cambridge, Department of Medicine, Addenbrooke's Hospital, Cambridge, UK
| | - Hai Rao
- University of Texas, Health Science Center at San Antonio, Department of Molecular Medicine, San Antonio, TX, USA
| | - V Ashutosh Rao
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA
| | - Blake B Rasmussen
- University of Texas, Medical Branch, Department of Nutrition and Metabolism, Galveston, TX, USA
| | - Tobias M Rasse
- Heidelberg University, Deutsches Krebsforschungszentrum, Proteostasis in Neurodegenerative Disease (B180), CHS Research Group at CellNetworks, Heidelberg, Germany
| | | | - Pierre-Emmanuel Rautou
- Hôpital Beaujon, Paris, France
- INSERM, U970, Paris, France
- Paris Cardiovascular Research Center - PARCC, Clichy, France
- Université Paris Descartes, Paris, France
| | - Swapan K Ray
- University of South Carolina School of Medicine, Department of Pathology, Microbiology, and Immunology, Columbia, SC, USA
| | - Babak Razani
- Washington University, School of Medicine, Cardiovascular Division, Department of Medicine, St. Louis, MO, USA
- Washington University, School of Medicine, Department of Pathology and Immunology, St. Louis, MO, USA
| | - Bruce H Reed
- University of Waterloo, Department of Biology, Waterloo, Ontario, Canada
| | - Fulvio Reggiori
- University Medical Center Utrecht, Department of Cell Biology, Groningen, The Netherlands
| | - Markus Rehm
- Royal College of Surgeons in Ireland, Department of Physiology and Medical Physics, Dublin, Ireland
| | - Andreas S Reichert
- Universitätsklinikum Düsseldorf, Institute for Biochemistry and Molecular Biology I, Düsseldorf, Germany
| | - Theo Rein
- Max Planck Institute of Psychiatry, Translational Research in Psychiatry, Munich, Germany
| | - David J Reiner
- Texas A&M University, Texas A&M Health Science Center, College of Medicine, Institute of Biosciences and Technology, Houston, TX, USA
| | - Eric Reits
- Academic Medical Center, University of Amsterdam, Department of Cell Biology and Histology, Amsterdam, The Netherlands
| | - Jun Ren
- University of Wyoming, School of Pharmacy, College of Health Sciences, Laramie, WY, USA
| | - Xingcong Ren
- Pennsylvania State University, College of Medicine, Department of Pharmacology, Hershey, PA, USA
| | - Maurizio Renna
- University of Cambridge, Department of Medical Genetics, Cambridge Institute for Medical Research, Cambridge, UK
| | - Jane EB Reusch
- Denver VAMC, Denver, CO, USA
- University of Colorado, School of Medicine, Aurora, CO, USA
| | - Jose L Revuelta
- Universidal de Salamanca, Campus Miguel de Unamuno, Departamento de Microbiologia y Genetica, Salamanca, Spain
| | - Leticia Reyes
- University of Wisconsin, School of Veterinary Medicine, Department of Pathobiological Sciences, Madison, WI, USA
| | - Alireza R Rezaie
- St. Louis University School of Medicine, Department of Biochemistry and Molecular Biology, St. Louis, MO, USA
| | - Robert I Richards
- University of Adelaide, Department of Genetics and Evolution, School of Biological Sciences, Adelaide, SA, Australia
| | - Des R Richardson
- University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
| | - Clémence Richetta
- Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL 8255, Center for Immunology and Microbial Infections – CIMI-Paris, Paris, France
| | - Michael A Riehle
- University of Arizona, Department of Entomology, Tucson, AZ, USA
| | - Bertrand H Rihn
- Lorraine University, CITHéFOR EA3452, Faculté de Pharmacie, Nancy, France
| | - Yasuko Rikihisa
- Ohio State University, Department of Veterinary Biosciences, College of Veterinary Medicine, Columbus, OH, USA
| | | | - Gerald Rimbach
- University of Kiel, Institute of Human Nutrition and Food Science, Kiel, Germany
| | - Maria Rita Rippo
- Università Politecnica delle Marche, Department of Clinical and Molecular Sciences, Ancona, Italy
| | - Konstantinos Ritis
- Democritus University of Thrace, Laboratory of Molecular Hematology, Alexandroupolis, Greece
| | - Federica Rizzi
- University of Parma, Department of Biomedical, Biotechnological and Translational Sciences, Parma, Italy
| | - Elizete Rizzo
- Universidade Federal de Minas Gerais, UFMG, Departamento de Morfologia, Instituto de Ciências Biológicas, Belo Horizonte, Minas Gerais, Brazil
| | - Peter J Roach
- Indiana University School of Medicine, Department of Biochemistry and Molecular Biology, Indianapolis, IN, USA
| | - Jeffrey Robbins
- University of Cincinnati, Cincinnati Children's Hospital, Cincinnati, OH, USA
| | - Michel Roberge
- University of British Columbia, Department of Biochemistry and Molecular Biology, Vancouver, BC Canada
| | - Gabriela Roca
- Technische Universität Braunschweig, Biozentrum, Braunschweig, Germany
| | - Maria Carmela Roccheri
- University of Palermo, Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Palermo, Italy
| | - Sonia Rocha
- University of Dundee, Centre for Gene Regulation and Expression, College of Life Sciences, UK
| | - Cecilia MP Rodrigues
- Universidade de Lisboa, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Lisboa, Portugal
| | - Clara I Rodríguez
- BioCruces Health Research Institute, Cruces University Hospital, Stem Cells and Cell Therapy Laboratory, Barakaldo, Spain
| | - Santiago Rodriguez de Cordoba
- Department of Cellular and Molecular Medicine, Center for Biological Research and Center for Biomedical Network Research on Rare Diseases, Madrid, Spain
| | - Natalia Rodriguez-Muela
- Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
| | - Jeroen Roelofs
- Kansas State University, Division of Biology, Manhattan, KS, USA
| | - Vladimir V Rogov
- Goethe University of Frankfurt, Institute of Biophysical Chemistry, Frankfurt am Main, Germany
| | - Troy T Rohn
- Boise State University, Department of Biological Sciences, Boise, ID, USA
| | - Bärbel Rohrer
- Medical University of South Carolina, Department of Ophthalmology, Charleston, SC, USA
| | - Davide Romanelli
- University of Insubria, Department of Biotechnology and Life Sciences, Varese, Italy
| | - Luigina Romani
- University of Perugia, Department of Experimental Medicine, Perugia, Italy
| | - Patricia Silvia Romano
- Universidad Nacional de Cuyo (FCM-UNCUYO), Instituto de Histologia y Embriologia (IHEM-CONICET), Facultad de Ciencias Medicas, Mendoza, Argentina
| | - M Isabel G Roncero
- Universidad de Córdoba, Campus de Excelencia Agroalimentario (ceiA3), Departamento de Genética, Córdoba, Spain
| | - Jose Luis Rosa
- Universitat de Barcelona, L'Hospitalet de Llobregat, Departament de Ciències Fisiol∫giques II, Campus de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
| | - Alicia Rosello
- Public Health England, Health Protection Services, Modelling and Economics Unit, Colindale, London, UK
| | - Kirill V Rosen
- Dalhousie University, Biochemistry and Molecular Biology, Halifax, NS, Canada
- Dalhousie University, Department of Pediatrics, Halifax, Nova Scotia, Canada
| | - Philip Rosenstiel
- University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany
| | | | - Kevin A Roth
- University of Alabama at Birmingham, Department of Pathology, Birmingham, AL, USA
| | - Gael Roué
- Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hemato-oncology Department, Barcelona, Spain
| | - Mustapha Rouis
- University Pierre et Marie Curie, UMR8256/INSERM U-1164, Biological Adaptation and Ageing (B2A), Paris, France
| | - Kasper M Rouschop
- Maastricht University, Maastricht Radiation Oncology (MaastRO) Lab, GROW – School for Oncology and Developmental Biology, Maastricht, The Netherlands
| | - Daniel T Ruan
- Beth Israel Deaconess Medical Center, Medical Genetics, Boston, MA, USA
| | - Diego Ruano
- Universidad de Sevilla, Instituto de Biomedicina de Sevilla, Sevilla, Spain
| | - David C Rubinsztein
- University of Cambridge, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Department of Medical Genetics, Cambridge, UK
| | - Edmund B Rucker
- University of Kentucky, Department of Biology, Lexington, KY, USA
| | - Assaf Rudich
- Ben-Gurion University, Department of Clinical Biochemistry and the National Institute of Biotechnology in the Negev, Beer-Sheva, Israel
| | - Emil Rudolf
- Charles University in Prague, Faculty of Medicine in Hradec Kralove, Department of Medical Biology and Genetics, Hradec Kralove, Czech Republic
| | - Ruediger Rudolf
- Mannheim University of Applied Sciences, Institute of Molecular and Cell Biology, Mannheim, Germany
| | | | - Carmen Ruiz-Roldan
- Universidad de Córdoba, Campus de Excelencia Agroalimentario (ceiA3), Departamento de Genética, Córdoba, Spain
| | | | - Paola Rusmini
- Universita' degli Studi di Milano, Dipartimento di Scienze Farmacologiche e Biomolecolari, Milan, Italy
| | - David W Russ
- Ohio University, Division of Physical Therapy, Athens, OH, USA
| | - Gian Luigi Russo
- National Research Council, Institute of Food Sciences, Avellino, Italy
| | - Giuseppe Russo
- Temple University, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Philadelphia, PA, USA
| | - Rossella Russo
- University of Calabria, Department of Pharmacy, Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, Rende (Cosenza), Italy
| | - Tor Erik Rusten
- Oslo University Hospital, Department of Molecular Cell Biology, Institute for Cancer Research, Oslo, Norway
- University of Oslo, Centre for Cancer Biomedicine, Oslo, Norway
| | | | - Kevin M Ryan
- University of Glasgow, Cancer Research UK Beatson Institute, Glasgow, UK
| | - Stefan W Ryter
- Weill Cornell Medical College, Joan and Sanford I. Weill Department of Medicine, New York, NY, USA
| | - David M Sabatini
- Whitehead Institute, HHMI and Massachusetts Institute of Technology, Cambridge, MA, USA
| | - Michael Sacher
- Concordia University, Department of Biology, Montreal, Canada
- McGill University, Department of Anatomy and Cell Biology, Montreal, Canada
| | - Carsten Sachse
- European Molecular Biology Laboratory (EMBL), Structural and Computational Biology Unit, Heidelberg, Germany
| | - Michael N Sack
- National Institutes of Health, Cardiovascular Branch, NHLB, Bethesda, MD, USA
| | - Junichi Sadoshima
- Rutgers New Jersey Medical School, Department of Cell Biology and Molecular Medicine, Newark, NJ, USA
| | - Paul Saftig
- Christian Albrechts University, Institut für Biochemie, Kiel, Germany
| | - Ronit Sagi-Eisenberg
- Tel Aviv University, Sackler Faculty of Medicine, Department of Cell and Developmental Biology, Tel Aviv, Israel
| | - Sumit Sahni
- University of Sydney, Department of Pathology and Bosch Institute, Sydney, New South Wales, Australia
| | - Pothana Saikumar
- University of Texas, Health Science Center at San Antonio, Department of Pathology, San Antonio, TX, USA
| | - Tsunenori Saito
- Nippon Medical School, Department of Cardiovascular Medicine, Tokyo, Japan
| | - Tatsuya Saitoh
- Tokushima University, Division of Molecular Genetics, Institute for Enzyme Research, Tokushima, Japan
| | - Koichi Sakakura
- Gunma University Graduate School of Medicine, Department of Otolaryngology-Head and Neck Surgery, Gunma, Japan
| | | | - Yasuhito Sakuraba
- Seoul National University, Department of Plant Science, Seoul, Korea
| | - María Salazar-Roa
- Spanish National Cancer Research Centre (CNIO), Cell Division and Cancer Group, Madrid, Spain
| | - Paolo Salomoni
- UCL Cancer Institute, Samantha Dickson Brain Cancer Unit, London, UK
| | - Ashok K Saluja
- University of Minnesota, Department of Surgery, Minneapolis, MN, USA
| | - Paul M Salvaterra
- Beckman Research Institute, City of Hope, Department of Neuroscience, Irell and Manella Graduate School of Biological Science, Duarte, CA, USA
| | - Rosa Salvioli
- Istituto Superiore di Sanità, Department of Haematology, Oncology and Molecular Medicine, Rome, Italy
| | - Afshin Samali
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Anthony MJ Sanchez
- Laboratoire Européen Performance Santé Altitude, EA 4604, University of Perpignan Via Domitia, Font-Romeu, France
| | - José A Sánchez-Alcázar
- Universidad Pablo de Olavide, Centro Andaluz de Biología del Desarrollo (CABD), Consejo Superior de Investigaciones Científicas-Junta de Andalucía, Sevilla, Spain
| | - Ricardo Sanchez-Prieto
- Universidad de Castilla-La Mancha, Laboratorio de Oncología Molecular, Centro Regional de Investigaciones Biomédicas, Albacete, Spain
| | - Marco Sandri
- University of Padova, Venetian Institute of Molecular Medicine, Department of Biomedical Science, Padova, Italy
| | - Miguel A Sanjuan
- MedImmune, Respiratory, Inflammation and Autoimmunity Research Department, Gaithersburg, MD, USA
| | - Stefano Santaguida
- Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
| | - Laura Santambrogio
- Albert Einstein College of Medicine, Departments of Pathology, Microbiology and Immunology, New York, NY, USA
| | - Giorgio Santoni
- University of Camerino, School of Pharmacy, Section of Experimental Medicine, Camerino, MC, Italy
| | - Claudia Nunes dos Santos
- iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal
| | - Shweta Saran
- Jawaharlal Nehru University, School of Life Sciences, New Delhi, India
| | - Marco Sardiello
- Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX, USA
| | - Graeme Sargent
- University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Pallabi Sarkar
- Center for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA
| | - Sovan Sarkar
- University of Birmingham, Institute of Biomedical Research, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Edgbaston, Birmingham, UK
| | | | - Minnie M Sarwal
- University of California San Francisco, Department of Surgery, San Francisco, CA, USA
| | - Chihiro Sasakawa
- Chiba University, Medical Mycology Research Center, Chiba, Japan
| | - Motoko Sasaki
- Kanazawa University Graduate School of Medical Sciences, Department of Human Pathology, Kanazawa, Japan
| | - Miklos Sass
- Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
| | - Ken Sato
- Gunma University, Laboratory of Molecular Traffic, Institute for Moleclualr and Cellular Regulation, Gunma, Japan
| | - Miyuki Sato
- Gunma University, Laboratory of Molecular Membrane Biology, Institute for Moleclualr and Cellular Regulation, Gunma, Japan
| | - Joseph Satriano
- University of California San Diego, Department of Medicine, San Diego, CA, USA
| | - Niramol Savaraj
- Miami VA Healthcare System and University of Miami Miller School of Medicine, Oncology/Hematology, Miami, FL, USA
| | | | - Liliana Schaefer
- Goethe University, Institue of Pharmacology and Toxicology, Frankfurt am Main, Germany
| | | | - Michael Scharl
- University Hospital Zürich, Division of Gastroenterology and Hepatolog, Zürich, Switzerland
| | - Hermann M Schatzl
- University of Calgary, Faculty of Veterinary Medicine, Calgary, AB, Canada
| | - Randy Schekman
- University of California Berkeley, Howard Hughes Medical Institute, Department of Molecular and Cell Biology, Berkeley, CA, USA
| | - Wiep Scheper
- VU University, Medical Center, Academic Medical Center, Department of Clinical Genetics and Alzheimer Center, Amsterdam, Netherlands
- Department of Genome Analysis, Amsterdam, Netherlands
- VU University, Departments of Functional Genomics and Molecular and Cellular Neuroscience, Center for Neurogenomics and Cognitive Research, Amsterdam, Netherlands
| | - Alfonso Schiavi
- IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany
- University of Rome “Tor Vergata”, Department of Biomedicine and Prevention, Rome, Italy
| | - Hyman M Schipper
- Jewish General Hospital, Department of Neurology and Neurosurgery, Department of Medicine, Montreal, Quebec, Canada
- McGill University, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
| | - Hana Schmeisser
- National Institutes of Health, National Institute of Allergy and Infectious Disease, Cytokine Biology Section, Bethesda, MD, USA
| | - Jens Schmidt
- University Medical Centre Göttingen, Clinic for Neurology and Department of Neuroimmunology, Göttingen, Germany
| | - Ingo Schmitz
- Systems-oriented Immunology and Inflammation Research, Helmholtz Centre for Infection Research, Braunschweig, Germany
- Otto-von-Guericke-University Magdeburg, Institute of Molecular and Clinical Immunology, Magdeburg, Germany
| | | | - E Marion Schneider
- University Hospital Ulm, Sektion Experimentelle Anaestesiologie, Ulm, Germany
| | - Jaime L Schneider
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
| | - Eric A Schon
- Columbia University Medical Center, New York, NY, USA
| | | | - Axel H Schönthal
- University of Southern California, Department of Molecular Microbiology and Immunology, Keck School of Medicine, Los Angeles, CA, USA
| | - Daniel F Schorderet
- IRO, Institute for Research in Ophthalmology, Sion, Switzerland
- University of Lausanne, Department of Ophthalmology, Lausanne, Switzerland
| | - Bernd Schröder
- Christian Albrechts University, Institut für Biochemie, Kiel, Germany
| | - Sebastian Schuck
- Heidelberg University, Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), Heidelberg, Germany
| | - Ryan J Schulze
- Mayo Clinic, Department of Biochemistry, Rochester, MN, USA
| | - Melanie Schwarten
- Forschungszentrum Juelich, ICS-6/Structural Biochemistry, Juelich, Germany
| | - Thomas L Schwarz
- Boston Children's Hospital, F.M. Kirby Neuroscience Center, Boston, MA, USA
| | - Sebastiano Sciarretta
- IRCCS Neuromed, Pozzilli, IS, Italy
- Rutgers New Jersey Medical School, Department of Cell Biology and Molecular Medicine, Newark, NJ, USA
- University of Rome “Sapienza”, Department of Medical-Surgical Sciences and Biotechnologies, Latina, Italy
| | - Kathleen Scotto
- Rutgers University-Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, Piscataway, NJ, USA
| | - A Ivana Scovassi
- Institute of Molecular Genetics, National Research Council, Pavia, Italy
| | - Robert A Screaton
- Sunnybrook Research Institute; and University of Toronto, Department of Biochemistry, Toronto, Ontario, Canada
| | - Mark Screen
- Helsinki University, Department of Medical Genetics, Helsinki, Finland
| | - Hugo Seca
- University of Porto, Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology, Porto, Portugal
- University of Porto, Department of Biological Sciences, Faculty of Pharmacy, Porto, Portugal
- University of Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal
| | - Simon Sedej
- Medical University of Graz, Division of Cardiology, Graz, Austria
| | - Laura Segatori
- Rice University, Chemical and Biomolecular Engineering, Houston, TX, USA
- Rice University, Department of BioSciences, Houston, TX, USA
| | - Nava Segev
- University of Illinois at Chicago, Deprtment of Biochemistry and Molecular Genetics, Chicago, IL, USA
| | - Per O Seglen
- University of Oslo, Centre for Molecular Medicine Norway (NCMM), Oslo, Norway
| | | | - Juan Segura-Aguilar
- University of Chile, Faculty of Medicine, ICBM, Molecular and Clinical Pharmacology, Santiago, Chile
| | - Ekihiro Seki
- Cedars-Sinai Medical Center, Department of Medicine, Los Angeles, CA, USA
| | - Iban Seiliez
- INRA, UR1067, Nutrion Métabolisme Aquaculture, St-Pée-sur-Nivelle, France
| | - Christian Sell
- Drexel University, College of Medicine, Department of Pathology, Philadelphia, PA, USA
| | | | - Gregg L Semenza
- Johns Hopkins University, School of Medicine, Institute for Cell Engineering and McKusick-Nathans Institute of Genetic Medicine, Baltimore, MD, USA
| | - Utpal Sen
- University of Louisville, Department of Physiology, Louisville, KY, USA
| | - Andreas L Serra
- University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Zurich, Switzerland
| | - Ana Serrano-Puebla
- Centro de Investigaciones Biológicas (CSIC), Department of Cellular and Molecular Biology, Madrid, Spain
| | - Hiromi Sesaki
- Johns Hopkins University, School of Medicine, Baltimore, MD, USA
| | - Takao Setoguchi
- Kagoshima University, The Near-Future Locomoter Organ Medicine Creation Course, Graduate School of Medical and Dental Sciences, Kagoshima, Japan
| | - Carmine Settembre
- Dulbecco Telethon Institute and Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
| | - John J Shacka
- University of Alabama at Birmingham, Department of Pathology, Birmingham, AL, USA
| | - Ayesha N Shajahan-Haq
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Department of Oncology, Washington, DC, USA
| | - Irving M Shapiro
- Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, PA, USA
| | - Shweta Sharma
- University of Maryland, Department of Nutrition and Food Science, College Park, MD, USA
| | - Hua She
- Emory University, School of Medicine, Department of Pharmacology, Atlanta, GA, USA
| | - C-K James Shen
- Academia Sinica, Institute of Molecular Biology, Taipei, Taiwan
| | - Chiung-Chyi Shen
- Hungkuang University, Department of Physical Therapy, Taichung, Taiwan
| | - Han-Ming Shen
- National University of Singapore, Department of Physiology, Yong Loo Lin School of Medicine, Singapore
| | - Sanbing Shen
- National University of Ireland, Regenerative Medicine Institute, Galway, Ireland
| | - Weili Shen
- Shanghai Jiao Tong University, School of Medicine, Shanghai Institute of Hypertension, Shanghai, China
| | - Rui Sheng
- Soochow University, School of Pharmaceutical Science, Department of Pharmacology and Laboratory of Aging and Nervous Diseases, Suzhou, China
| | | | - Zu-Hang Sheng
- NINDS, National Institutes of Health, Synaptic Function Section, Bethesda, MD, USA
| | - Trevor G Shepherd
- Western University, Department of Obstetrics and Gynaecology, London, ON, Canada
| | - Junyan Shi
- St. Paul's Hospital, Centre for Heart Lung Innovation, Vancouver, BC, Canada
- University of British Columbia, Department of Pathology and Laboratory Medicine,Vancouver, BC, Canada
| | - Qiang Shi
- US Food and Drug Administration, National Center for Toxicological Research, Division of Systems Biology, Jefferson, AR, USA
| | - Qinghua Shi
- University of Science and Technology of China, School of Life Sciences, and Hefei National Laboratory for Physical Sciences at Microscale, Hefei, Anhui, China
| | - Yuguang Shi
- Pennsylvania State University, College of Medicine, Department of Cellular and Molecular Physiology, Hershey, PA, USA
| | - Shusaku Shibutani
- Yamaguchi University, Joint Faculty of Veterinary Medicine, Laboratory of Veterinary Hygiene, Yamaguchi, Japan
| | | | - Yoshihiro Shidoji
- University of Nagasaki, Molecular and Cellular Biology, Graduate School of Human Health Science, Nagasaki, Japan
| | - Jeng-Jer Shieh
- National Chung-Hsing University, Institute of Biomedical Sciences, College of Life Sciences, Taichung, Taiwan
| | - Chwen-Ming Shih
- Taipei Medical University, Department of Biochemistry, College of Medicine, Taipei City, Taiwan
| | - Yohta Shimada
- Jikei University School of Medicine, Research Center for Medical Sciences, Division of Gene Therapy, Tokyo, Japan
| | - Shigeomi Shimizu
- Tokyo Medical and Dental University, Medical Research Institute, Pathological Cell Biology, Tokyo, Japan
| | - Dong Wook Shin
- Amorepacific Corporation RandD Center, Bioscience Research Institute, Gyeonggi, Korea
| | - Mari L Shinohara
- Duke University, Medical Center, Department of Immunology, Durham, NC, USA
| | - Michiko Shintani
- Kobe University, Graduate School of Health Sciences, Laboratory of Pathology, Division of Medical Biophysics, Hyogo, Japan
| | - Takahiro Shintani
- Tohoku University, Laboratory of Bioindustrial Genomics, Graduate School of Agricultural Science, Miyagi, Japan
| | - Tetsuo Shioi
- Kyoto University, Department of Cardiovascular Medicine, Kyoto, Japan
| | - Ken Shirabe
- Kyushu University, Department of Surgery and Science, Fukuoka, Japan
| | - Ronit Shiri-Sverdlov
- Maastricht University, Medical Centre, NUTRIM, Department of Molecular Genetics, Maastricht, The Netherlands
| | - Orian Shirihai
- Boston University, Department of Medicine, Boston, MA, USA
| | - Gordon C Shore
- McGill University, Department of Biochemistry, Montreal, Quebec, Canada
| | - Chih-Wen Shu
- Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung, Taiwan
| | - Deepak Shukla
- University of Illinois at Chicago, Departments of Ophthalmology and Microbiology and Immunology, Chicago, IL, USA
| | - Andriy A Sibirny
- National Academy of Sciences of Ukraine, Department of Biotechnology and Microbiology, Lviv, Ukraine
- University of Rzeszow, Institute of Cell Biology, Rzeszow, Poland
| | - Valentina Sica
- Centre de Recherche des Cordeliers, Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Paris, France
- Gustave Roussy Cancer Campus, Villejuif, France
- INSERM, U1138, Paris, France
- Université Paris Descartes/Paris V, Paris, France
| | | | - Einar M Sigurdsson
- New York University School of Medicine, Departments of Neuroscience and Physiology, and Psychiatry, New York, NY, USA
| | | | - Beata Sikorska
- Medical University of Lodz, Department of Molecular Pathology and Neuropathology, Lodz, Poland
| | - Wilian A Silveira
- University of São Paulo, Ribeirão Preto Medical School, Department of Physiology, Ribeirão Preto, São Paulo, Brazil
| | | | - Gary A Silverman
- University of Pittsburgh, School of Medicine, Department of Pediatrics, Pittsburgh, PA, USA
| | - Jan Simak
- U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA
| | - Thomas Simmet
- Ulm University, Institute of Pharmacology of Natural Compounds and Clinical Pharmacology, Ulm, Germany
| | - Anna Katharina Simon
- MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine and BRC Translational Immunology Lab, NDM, Oxford, UK
| | - Hans-Uwe Simon
- University of Bern, Institute of Pharmacology, Bern, Switzerland
| | - Cristiano Simone
- University of Bari ‘Aldo Moro’, Division of Medical Genetics, DIMO, School of Medicine, Bari, Italy
| | - Matias Simons
- Paris Descartes University–Sorbonne Paris Cité, Imagine Institute, Paris, France
| | - Anne Simonsen
- University of Oslo, Institute of Basic Medical Sciences, Oslo, Norway
| | - Rajat Singh
- Albert Einstein College of Medicine, Bronx, NY, USA
| | - Shivendra V Singh
- University of Pittsburgh Cancer Institute, Hillman Cancer Center Research Pavilion, Pittsburgh, PA, USA
| | - Shrawan K Singh
- Post Graduate Institute of Medical Education and Research (PGIMER), Department of Urology, Chandigarh, India
| | - Debasish Sinha
- Johns Hopkins University, School of Medicine, Wilmer Eye Institute, Baltimore, MD, USA
| | - Sangita Sinha
- North Dakota State University, Department of Chemistry and Biochemistry, Fargo, ND, USA
| | | | - Agnieszka Sirko
- Polish Academy of Sciences, Institute of Biochemistry and Biophysics, Warsaw, Poland
| | - Kapil Sirohi
- Centre for Cellular and Molecular Biology, Council of Scientific and Industrial Research, Hyderabad, India
| | - Balindiwe JN Sishi
- Stellenbosch University, Department of Physiological Sciences, Stellenbosch, South Africa
| | - Annie Sittler
- Sorbonne Universités, University Pierre and Marie Curie, Paris 6, Brain and Spine Institute, INSERM U1127, CNRS UMR722, Paris, France
| | - Parco M Siu
- Hong Kong Polytechnic University, Department of Health Technology and Informatics, Faculty of Health and Social Sciences, Kowloon, Hong Kong
| | - Efthimios Sivridis
- Democritus University of Thrace, Medical School, Department of Pathology, Alexandroupolis, Greece
| | - Anna Skwarska
- Gdansk University of Technology, Department of Pharmaceutical Technology and Biochemistry, Gdansk, Poland
| | - Ruth Slack
- University of Ottawa, Department of Cellular and Molecular Medicine, Faculty of Medicine, Ottawa, Ontario, Canada
| | - Iva Slaninová
- Masaryk University, Department of Biology, Faculty of Medicine, Brno, Czech Republic
| | - Nikolai Slavov
- Northeastern University, Department of Bioengineering, Boston, MA, USA
| | - Soraya S Smaili
- Federal University of São Paulo, Department of Pharmacology, Paulista School of Medicine, São Paulo, Brazil
| | | | - Duncan R Smith
- Mahidol University, Salaya Campus, Institute of Molecular Biosciences, Nakorn Pathom, Thailand
| | | | - Scott A Soleimanpour
- University of Michigan Medical School, Department of Internal Medicine, Ann Arbor, MI, USA
| | | | | | - Jin H Son
- Ewha W. University, Brain and Cognitive Sciences/Pharmacy, Seoul, Korea
| | | | - Chunjuan Song
- Applied Genetic Technologies Corporation, Alachua, FL, USA
| | - Fuyong Song
- Shandong University, Department of Toxicology, Jinan, Shandong, China
| | - Hyun Kyu Song
- Korea University, Division of Life Sciences, Seoul, Korea
| | - Ju-Xian Song
- Hong Kong Baptist University, School of Chinese Medicine, Kowloon Tong, Hong Kong
| | - Wei Song
- Jewish General Hospital, Bloomfield Centre for Research in Aging, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
| | - Kai Y Soo
- La Trobe University, Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Victoria, Australia
| | - Anil K Sood
- MD Anderson Cancer Center, Department of Cancer Biology, Houston, TX, USA
- MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA
| | - Tuck Wah Soong
- National University of Singapore, Department of Physiology, Singapore
| | | | - Maurizio Sorice
- Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy
| | - Federica Sotgia
- University of Manchester, Institute of Cancer Sciences, Faculty of Medical and Human Sciences, Manchester, UK
| | - David R Soto-Pantoja
- Wake Forest University, Department of Surgery and Cancer Biology, Winston-Salem, NC, USA
| | - Areechun Sotthibundhu
- Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand
| | - Maria João Sousa
- University of Minho, Molecular and Environmental Biology Centre (CBMA)/Department of Biology, Braga, Portugal
| | - Herman P Spaink
- Leiden University, Institute of Biology, Leiden, The Netherlands
| | - Paul N Span
- Radboud University Nijmegen Medical Center, Department of Radiation Oncology, Nijmegen, The Netherlands
| | - Anne Spang
- University of Basel, Biozentrum, Basel, Switzerland
| | - Janet D Sparks
- University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY, USA
| | - Peter G Speck
- Flinders University, School of Biological Sciences, Bedford Park, South Australia, Australia
| | - Stephen A Spector
- University of California San Diego, Department of Pediatrics, Division of Infectious Diseases, La Jolla, CA, USA
| | - Claudia D Spies
- Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Berlin, Germany
| | | | - Daret St Clair
- University of Kentucky, Department of Toxicology and Cancer Biology, Lexington, KY, USA
| | | | - Bart Staels
- University of Lille, INSERM UMR1011, Institut Pasteur de Lille, EGID, Lille, France
| | - Michael T Stang
- University of Pittsburgh, School of Medicine, Department of Surgery, Division of Endocrine Surgery, Pittsburgh, PA, USA
| | - Daniel T Starczynowski
- Cincinnati Children's Hospital Medical Center, Division of Experimental Hematology and Cancer Biology, Cincinnati, OH, USA
| | - Petro Starokadomskyy
- University of Texas, Southwestern Medical Center, Department of Internal Medicine, Dallas, TX
| | - Clemens Steegborn
- University of Bayreuth, Department of Biochemistry, Bayreuth, Germany
| | - John W Steele
- University of California San Diego, Department of Cellular and Molecular Medicine, La Jolla, CA, USA
| | - Leonidas Stefanis
- Biomedical Research Foundation of the Academy of Athens, Laboratory of Neurodegenerative Diseases, Athens, Attiki, Greece
| | - Joan Steffan
- University of California Irvine, Department of Psychiatry and Human Behavior, Irvine, CA, USA
| | - Christine M Stellrecht
- University of Texas, MD Anderson Cancer Center, Department of Experimental Therapeutics, Houston, TX, USA
| | - Harald Stenmark
- Oslo University Hospital, Department of Biochemistry, Institute for Cancer Research, Oslo, Norway
| | - Tomasz M Stepkowski
- Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Dorodna, Poland
| | - Stęphan T Stern
- Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Nanotechnology Characterization Lab, Cancer Research Technology Program, Frederick, MD, USA
| | - Craig Stevens
- Edinburgh Napier University, School of Life, Sport and Social Sciences, Edinburgh, UK
| | - Brent R Stockwell
- Columbia University, Department of Biological Sciences, New York, NY, USA
- Columbia University, Department of Chemistry, New York, NY, USA
| | - Veronika Stoka
- J. Stefan Institute, Department of Biochemistry and Molecular and Structural Biology, Ljubljana, Slovenia
| | - Zuzana Storchova
- Max Planck Institute of Biochemistry, Group Maintenance of Genome Stability, Martinsried, Germany
| | - Björn Stork
- Heinrich-Heine-University, Institute of Molecular Medicine, Düsseldorf, Germany
| | | | - Dimitrios J Stravopodis
- National and Kapodistrian University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
- University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
| | - Pavel Strnad
- University Hospital Aachen, IZKF and Department of Internal Medicine III, Aachen, Germany
| | - Anne Marie Strohecker
- Ohio State University, The James Comprehensive Cancer Center. Department of Molecular Virology, Immunology and Medical Genetics and Department of Surgery, Division of Surgical Oncology, Columbus, OH, USA
| | - Anna-Lena Ström
- Stockholm University, Department of Neurochemistry, Stockholm, Sweden
| | - Per Stromhaug
- Binghamton University, State University of New York, Binghamton, NY, USA
| | - Jiri Stulik
- Institute of Molecular Pathology and Biology, FMHS UO, Hradec Kralove, Czech Republic
| | - Yu-Xiong Su
- University of Hong Kong, Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hong Kong
| | - Zhaoliang Su
- Jiangsu University, Department of Immunology, Zhenjiang, Jiangsu, China
| | - Carlos S Subauste
- Case Western Reserve University, School of Medicine, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Cleveland, OH, USA
| | | | - Carolyn M Sue
- University of Sydney, Department of Neurogenetics, Kolling Institute, St Leonards, NSW, Australia
| | - Sang Won Suh
- Hallym University, School of Medicine, Department of Physiology, Chuncheon, Korea
| | - Xinbing Sui
- Zhejiang University, Sir Run Run Shaw Hospital, Department of Medical Oncology, Hangzhou, Zhejiang, China
| | - Supawadee Sukseree
- Medical University of Vienna, Department of Dermatology, Vienna, Austria
| | - David Sulzer
- Columbia University Medical Center, Department of Neurology, New York, NY, USA
| | - Fang-Lin Sun
- Tongji University, School of Life Science and Technology, Shanghai, China
| | - Jiaren Sun
- University of Texas, Medical Branch, Department of Microbiology and Immunology, Galveston, TX, USA
| | - Jun Sun
- University of Illinois at Chicago, Division of Gastroenterology and Hepatology, Department of Medicine, Chicago, IL, USA
| | - Shi-Yong Sun
- Emory University, School of Medicine, Winship Cancer Institute, Atlanta, GA, USA
| | - Yang Sun
- Nanjing University, School of Life Sciences, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing, Jiangsu, China
| | - Yi Sun
- University of Michigan, Department of Radiation Oncology, Division of Radiation and Cancer Biology, Ann Arbor, MI, USA
| | - Yingjie Sun
- Shanghai Veterinary Research Institute, Shanghai, China
| | - Vinod Sundaramoorthy
- Macquarie University, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Sydney, NSW, Australia
| | - Joseph Sung
- Chinese University of Hong Kong, Institute of Digestive Diseases, Shatin, Hong Kong
| | - Hidekazu Suzuki
- Keio University, School of Medicine, Medical Education Center, Tokyo, Japan
| | - Kuninori Suzuki
- University of Tokyo, Bioimaging Center, Graduate School of Frontier Sciences, Chiba, Japan
| | - Naoki Suzuki
- Tohoku University, Department of Neurology, Sendai, Japan
| | - Tadashi Suzuki
- RIKEN Global Research Cluster, Glycometabolome Team, Systems Glycobiology Research Group, Saitama, Japan
| | - Yuichiro J Suzuki
- Georgetown University, Department of Pharmacology and Physiology, Washington, DC, USA
| | - Michele S Swanson
- University of Michigan, Department of Microbiology and Immunology, Ann Arbor, MI, USA
| | | | - Karl Swärd
- Lund University, Biomedical Centre, Department of Experimental Medical Science, Lund, Sweden
| | - Ghanshyam Swarup
- Centre for Cellular and Molecular Biology, Council of Scientific and Industrial Research, Hyderabad, India
| | - Sean T Sweeney
- University of York, Department of Biology, Heslington, York, UK
| | - Paul W Sylvester
- University of Louisiana at Monroe, School of Pharmacy, Monroe, LA, USA
| | - Zsuzsanna Szatmari
- Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
| | - Eva Szegezdi
- National University of Ireland, Apoptosis Research Centre, Galway, Ireland
| | - Peter W Szlosarek
- Queen Mary University of London, Barts Cancer Institute, Center for Molecular Oncology, London, UK
| | - Heinrich Taegtmeyer
- University of Texas, Medical School at Houston, Division of Cardiovascular Medicine, Department of Medicine, Houston, TX, USA
| | - Marco Tafani
- Sapienza University of Rome, Department of Experimental Medicine, Rome, Italy
| | - Emmanuel Taillebourg
- Université Grenoble-Alpes, CEA-DSV-iRTSV-BGE-GenandChem, INSERM, U1038, Grenoble, France
| | - Stephen WG Tait
- University of Glasgow, Cancer Research UK Beatson Institute, Glasgow, UK
| | | | - Yoshinori Takahashi
- Pennsylvania State University, College of Medicine, Hershey Cancer Institute and Department of Pediatrics, Hershey, PA, USA
| | - Szabolcs Takáts
- Eötvös Loránd University, Department of Anatomy, Cell and Developmental Biology, Budapest, Hungary
| | - Genzou Takemura
- Asahi University, Department of Internal Medicine, Gifu, Japan
| | - Nagio Takigawa
- Kawasaki Medical School, Department of General Internal Medicine 4, Okayama, Japan
| | | | - Elena Tamagno
- University of Turin, Neuroscience Institute Cavalieri Ottolenghi, Turin, Italy
| | - Jerome Tamburini
- Université Paris Descartes, Institut Cochin, Faculté de Médecine Sorbonne Paris Cité, Paris, France
| | - Cai-Ping Tan
- Sun Yat-Sen University, School of Chemistry and Chemical Engineering, Guangzhou, China
| | - Lan Tan
- Qingdao University, Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao, Shandong Province, China
| | - Mei Lan Tan
- Malaysian Institute of Pharmaceuticals and Nutraceuticals, Pulau Pinang, Malaysia
- Universiti Sains Malaysia, Advanced Medical and Dental Institute, Ministry of Science, Technology and Innovation, Pulau Pinang, Malaysia
| | - Ming Tan
- University of South Alabama, Mitchell Cancer Institute, Mobile, AL, USA
| | - Yee-Joo Tan
- A*STAR (Agency for Science, Technology and Research), Institute of Molecular and Cell Biology, Singapore
- National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System (NUHS), Singapore
| | - Keiji Tanaka
- Tokyo Metropolitan Institute of Medical Science, Laboratory of Protein Metabolism, Tokyo, Japan
| | - Masaki Tanaka
- Kyoto Prefectural University of Medicine, Department of Basic Geriatrics, Kyoto, Japan
| | - Daolin Tang
- University of Pittsburgh, Department of Surgery, Hillman Cancer Center, Pittsburgh, PA, USA
| | - Dingzhong Tang
- Chinese Academy of Sciences, State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of Genetics and Developmental Biology, Beijing, China
| | - Guomei Tang
- Columbia University Medical Center, Department of Neurology, New York, NY, USA
| | - Isei Tanida
- Juntendo University, School of Medicine, Department of Cell Biology and Neuroscience, Tokyo, Japan
| | - Kunikazu Tanji
- Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Bakhos A Tannous
- Massachusetts General Hospital and Harvard Medical School, Experimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Charlestown, MA, USA
| | - Jose A Tapia
- University of Extremadura, Department of Medicine, Faculty of Veterinary Medicine, Cáceres, Spain
| | - Inmaculada Tasset-Cuevas
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
| | - Marc Tatar
- Brown University, Department of Ecology and Evolutionary Biology, Providence, RI, USA
| | - Iman Tavassoly
- Icahn School of Medicine at Mount Sinai, Department of Pharmacology and Systems Therapeutics, New York, NY, USA
| | - Nektarios Tavernarakis
- Foundation for Research and Technology - Hellas, Heraklion, Crete, Greece
- University of Crete, Department of Basic Sciences, Faculty of Medicine, Heraklion, Crete, Greece
- University of Crete, Institute of Molecular Biology and Biotechnology, Heraklion, Crete, Greece
| | - Allen Taylor
- Tufts University, USDA Human Nutrition Research Center on Aging, Boston, MA, USA
| | - Graham S Taylor
- University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, West Midlands, UK
| | - Gregory A Taylor
- Duke University, Medical Center, Department of Immunology, Durham, NC, USA
- Duke University, Medical Center, Department of Medicine, Durham, NC, USA
- Duke University, Medical Center, Department of Molecular Genetics and Microbiology, Durham, NC, USA
- Durham VA Medical Center, GRECC, Durham, NC, USA
| | - J Paul Taylor
- Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Cell and Molecular Biology, Memphis, TN, USA
| | - Mark J Taylor
- Liverpool School of Tropical Medicine, Department of Parasitology, Liverpool, Merseyside, UK
| | - Elena V Tchetina
- Nasonova Research Institute of Rheumatology, Immunology and Molecular Biology Laboratory, Moscow, Russia
| | - Andrew R Tee
- Cardiff University, Heath Park, Institute of Cancer and Genetics, Cardiff, Wales, UK
| | - Fatima Teixeira-Clerc
- INSERM U955, Faculté de Médecine de Créteil, UMR-S955, Créteil, France
- Université Paris-Est, Institut Mondor de Recherche Biomédicale, Paris, France
| | - Sucheta Telang
- University of Louisville, Department of Medicine (Hem-Onc), Louisville, KY, USA
| | - Tewin Tencomnao
- Chulalongkorn University, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Bangkok, Thailand
| | - Ba-Bie Teng
- University of Texas, Health Science Center at Houston, Center for Human Genetics, Institute of Molecular Medicine, Houston, TX, USA
| | - Ru-Jeng Teng
- Medical College of Wisconsin, Department of Pediatrics, Milwaukee, WI, USA
| | - Faraj Terro
- University of Limoges, Department of Histology and Cell Biology, Limoges, France
| | - Gianluca Tettamanti
- University of Insubria, Department of Biotechnology and Life Sciences, Varese, Italy
| | - Arianne L Theiss
- Baylor University Medical Center, Department of Internal Medicine, Division of Gastroenterology, Baylor Research Institute, Dallas, TX
| | - Anne E Theron
- University of Pretoria, Department of Physiology, Pretoria, Gauteng, South Africa
| | - Kelly Jean Thomas
- Colorado Mesa University, Department of Biological Sciences, Grand Junction, CO, USA
| | - Marcos P Thomé
- Universidad Federal do Rio Grande do Sul (UFRGS), Department of Biophysics and Center of Biotechnology, Porto Alegre, Brazil
| | - Paul G Thomes
- University of Nebraska Medical Center, Department of Internal Medicine, Omaha, NE, USA
| | - Andrew Thorburn
- University of Colorado, School of Medicine, Department of Pharmacology, Aurora, CO, USA
| | - Jeremy Thorner
- University of California Berkeley, Department of Molecular and Cell Biology, Berkeley, CA, USA
| | - Thomas Thum
- Hannover Medical School, Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover, Germany
| | - Michael Thumm
- Georg-August-University Göttingen, Institute of Cellular Biochemistry, Göttingen, Germany
| | - Teresa LM Thurston
- Imperial College London, MRC Centre for Molecular Bacteriology and Infection, London, UK
| | - Ling Tian
- Chinese Academy of Sciences, Key Laboratory of Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Shanghai, China
| | - Andreas Till
- University of Bonn, Institute of Reconstructive Neurobiology, Bonn, Germany
- University of California San Diego, San Diego Center for Systems Biology, La Jolla, CA, USA
| | - Jenny Pan-yun Ting
- University of North Carolina, Department of Microbiology-Immunology, Chapel Hill, NC, USA
- University of North Carolina, Lineberger Comprehensive Cancer Center, Institute of Inflammatory Diseases, Center for Translational Immunology, Chapel Hill, NC, USA
| | | | - Lilach Toker
- University of British Columbia, Department of Psychiatry,Vancouver, BC, Canada
| | - Stefano Toldo
- Virginia Commonwealth University, Internal Medicine, VCU Pauley Heart Center, Richmond, VA, USA
| | - Sharon A Tooze
- London Research Institute, Cancer Research UK, London, UK
| | - Ivan Topisirovic
- Jewish General Hospital, Department of Oncology, Montreal, Quebec, Canada
- McGill University, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
| | - Maria Lyngaas Torgersen
- Oslo University Hospital, Centre for Cancer Biomedicine, Oslo, Norway
- The Norwegian Radium Hospital, Faculty of Medicine, Oslo, Norway
- University of Oslo, Department of Biochemistry, Institute for Cancer Research, Oslo, Norway
| | | | | | - Maria Rosaria Torrisi
- Sapienza University of Rome, Department of Clinical and Molecular Medicine, Rome, Italy
| | - Cathy Tournier
- University of Manchester, Faculty of Life Sciences, Manchester, UK
| | | | | | - Leonardo H Travassos
- Federal University of Rio de Janeiro, Institute of Biophysics Carlos Chagas Filho, Laboratory of Immunoreceptors and Signaling, Rio de Janeiro, Brazil
| | - Gemma Triola
- Institute of Advanced Chemistry of Catalonia, Spanish Research Council (IQAC-CSIC), Department of Biomedicinal Chemistry, Barcelona, Spain
| | - Durga Nand Tripathi
- Texas A&M University Health Science Center, Center for Translational Cancer Research, Institute of Bioscience and Technology, Houston, TX, USA
| | - Daniela Trisciuoglio
- Regina Elena National Cancer Institute, Experimental Chemotherapy Laboratory, Rome, Italy
| | - Rodrigo Troncoso
- Universidad de Chile, Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas, Santiago, Chile
- Universidad de Chile, Instituto de Nutrición y Tecnología de los Alimentos (INTA), Santiago, Chile
| | - Ioannis P Trougakos
- University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
| | - Anita C Truttmann
- University Hospital Center, University of Lausanne, Clinic of Neonatology, Department of Pediatrics and Pediatric Surgery, Lausanne, Switzerland
| | - Kuen-Jer Tsai
- National Cheng Kung University, Institute of Clinical Medicine, Tainan, Taiwan
| | - Mario P Tschan
- University of Bern, Division of Experimental Pathology, Institute of Pathology, Bern, Switzerland
| | - Yi-Hsin Tseng
- Chang Gung University, Department of Biochemistry, College of Medicine, Taoyuan, Taiwan
| | - Takayuki Tsukuba
- Nagasaki University, Division of Dental Pharmacology, Graduate School of Biomedical Sciences, Nagasaki, Japan
| | - Allan Tsung
- University of Pittsburgh Medical Center, Department of Surgery, Pittsburgh, PA, USA
| | - Andrey S Tsvetkov
- University of Texas, Medical School at Houston, Department of Neurobiology and Anatomy, Houston, TX, USA
| | - Shuiping Tu
- Shanghai Jiao Tong University, School of Medicine, Renji Hospital, Shanghai, China
| | - Hsing-Yu Tuan
- National Tsing Hua University, Department of Chemical Engineering, Hsinchu, Taiwan
| | - Marco Tucci
- University of Bari ‘Aldo Moro', Department of Biomedical Sciences and Clinical Oncology, Bari, Italy
| | - David A Tumbarello
- University of Southampton, Centre for Biological Sciences, Highfield Campus, Southampton, UK
| | - Boris Turk
- J. Stefan Institute, Department of Biochemistry and Molecular and Structural Biology, Ljubljana, Slovenia
| | - Vito Turk
- J. Stefan Institute, Department of Biochemistry and Molecular and Structural Biology, Ljubljana, Slovenia
| | - Robin FB Turner
- University of British Columbia, Michael Smith Laboratories, Vancouver, British Columbia, Canada
| | - Anders A Tveita
- Oslo University Hospital, Centre for Immune Regulation, Oslo, Norway
| | - Suresh C Tyagi
- University of Louisville, School of Medicine, Department of Physiology and Biophysics, Louisville, KY, USA
| | - Makoto Ubukata
- Hokkaido University, Research Faculty of Agriculture, Sapporo, Japan
| | - Yasuo Uchiyama
- Juntendo University, School of Medicine, Department of Cell Biology and Neuroscience, Tokyo, Japan
| | - Andrej Udelnow
- Otto-von-Guericke-University Magdeburg, Department of General, Visceral and Vascular Surgery, Magdeburg, Germany
| | - Takashi Ueno
- Juntendo University, Graduate School of Medicine, Laboratory of Proteomics and Biomolecular Science, Tokyo, Japan
| | - Midori Umekawa
- Ritsumeikan University, Department of Biotechnology, Shiga, Japan
| | - Rika Umemiya-Shirafuji
- Obihiro University of Agriculture and Veterinary Medicine, National Research Center for Protozoan Diseases, Obihiro, Hokkaido, Japan
| | | | | | - Rodrigo P. Ureshino
- Federal University of São Paulo, Department of Pharmacology, Paulista School of Medicine, São Paulo, Brazil
| | - Ryo Ushioda
- Kyoto Sangyo University, Department of Molecular Biosciences, Faculty of Life Sciences, Kyoto, Japan
| | - Vladimir N Uversky
- University of South Florida, Department of Molecular Medicine, Tampa, FL, USA
| | - Néstor L Uzcátegui
- Central University of Venezuela, Institute for Anatomy, Caracas, Venezuela
| | - Thomas Vaccari
- IFOM - The FIRC Institute of Molecular Oncology, Milan, Italy
| | - Maria I Vaccaro
- University of Buenos Aires, National Council for Scientific and Technical Research (CONICET), Institute for Biochemistry and Molecular Medicine, Department of Pathophysiology, School of Pharmacy and Biochemistry, Buenos Aires, Argentina
| | - Libuše Váchová
- Institute of Microbiology ASCR, v.v.i., Prague, Czech Republic
| | | | - Rut Valdor
- University of Murcia-IMIB Virgen de la Arrixaca Hospital, Human Anatomy and Psycobiology Department, Cell Therapy and Hematopoietic Transplantation Unit, Murcia, Spain
| | - Enza Maria Valente
- University of Salerno, Section of Neurosciences, Department of Medicine and Surgery, Salerno, Italy
| | - Francois Vallette
- Université de Nantes, CRCNA, UMRINSERM 892/CNRS 6299, Nantes, France
| | - Angela M Valverde
- Instituto de Investigaciones Biomédicas Alberto Sols, CSIC/UAM, Madrid, Spain
| | - Greet Van den Berghe
- KU Leuven, Clinical Division and Laboratory of Intensive Care Medicine, Department Cellular and Molecular Medicine, Leuven, Belgium
| | - Ludo Van Den Bosch
- KU Leuven and VIB, Vesalius Research Center, Laboratory of Neurobiology, Leuven, Belgium
| | - Gijs R van den Brink
- Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands
| | - F Gisou van der Goot
- Ecole Polytechnique Federale de Lausanne, Global Health Institute, School of Life Sciences, Lausanne, Switzerland
| | - Ida J van der Klei
- University of Groningen, Molecular Cell Biology, Groningen, The Netherlands
| | - Luc JW van der Laan
- Erasmus MC-University Medical Center Rotterdam, Department of Surgery, Rotterdam, The Netherlands
| | - Wouter G van Doorn
- University of California Davis, Mann Laboratory, Department of Plant Sciences, Davis, CA, USA
| | - Marjolein van Egmond
- VU University Medical Center, Department of Molecular Cell Biology and Immunology, Amsterdam, The Netherlands
| | - Kenneth L van Golen
- The Helen F. Graham Cancer Center, Newark, DE, USA
- University of Delaware, Department of Biological Sciences, Newark, DE, USA
- University of Delaware, The Center for Translational Cancer Research, Newark, DE, USA
| | - Luc Van Kaer
- Vanderbilt University, School of Medicine, Department of Pathology, Microbiology and Immunology, Nashville, TN, USA
| | | | - Peter Vandenabeele
- Ghent University, Department of Biomedical Molecular Biology, Inflammation Research Center, VIB, Methusalem Program, Gent, Belgium
| | - Wim Vandenberghe
- University Hospitals Leuven, Department of Neurology, Leuven, Belgium
- University of Leuven, Department of Neurosciences, Leuven, Belgium
| | - Ilse Vanhorebeek
- KU Leuven, Clinical Division and Laboratory of Intensive Care Medicine, Department Cellular and Molecular Medicine, Leuven, Belgium
| | - Isabel Varela-Nieto
- CSIC-UAM and CIBERER, Institute for Biomedical Research “Alberto Sols”, Madrid, Spain
| | - M Helena Vasconcelos
- University of Porto, Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology, Porto, Portugal
- University of Porto, Department of Biological Sciences, Faculty of Pharmacy, Porto, Portugal
- University of Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal
| | - Radovan Vasko
- Georg-August-University Göttingen, Department of Nephrology and Rheumatology, Göttingen, Germany
| | | | - Ignacio Vega-Naredo
- University of Coimbra, CNC-Center for Neuroscience and Cell Biology, Cantanhede, Portugal
| | - Guillermo Velasco
- Complutense University, Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Department of Biochemistry and Molecular Biology I, School of Biology, Madrid, Spain
| | - Athanassios D Velentzas
- University of Athens, Department of Cell Biology and Biophysics, Faculty of Biology, Athens, Greece
| | - Panagiotis D Velentzas
- University of Massachusetts, Medical School, Department of Molecular, Cell and Cancer Biology, Worcester, MA, USA
| | - Tibor Vellai
- Eötvös Loránd University, Department of Genetics, Budapest, Hungary
| | - Edo Vellenga
- University Medical Center Groningen, University of Groningen, Department of Hematology, Groningen, The Netherlands
| | - Mikkel Holm Vendelbo
- Aarhus University Hospital, Department of Nuclear Medicine and PET Center, Aarhus, Denmark
| | - Kartik Venkatachalam
- University of Texas, Health Sciences Center-Houston (UTHSC), Department of Integrative Biology and Pharmacology, Houston, TX, USA
| | - Natascia Ventura
- Heinrich Heine University, Institute of Clinical Chemistry and Laboratory Diagnostic, Medical Faculty, Duesseldorf, Germany
- IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany
| | - Salvador Ventura
- Universitat Autònoma de Barcelona, Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Bellaterra (Barcelona), Spain
| | - Patrícia ST Veras
- Gonçalo Moniz Research Center, Oswaldo Cruz Foundation, FIOCRUZ-BA, Laboratory of Pathology and Biointervention, Salvador, BA, Brazil
| | - Mireille Verdier
- Université de Limoges, EA 3842, LHCP, Faculté de Médecine, Limoges, France
| | - Beata G Vertessy
- Budapest University of Technology and Economics, Institute of Enzymology, RCNC, HAS and Department of Applied Biotechnology, Budapest, Hungary
| | - Andrea Viale
- MD Anderson Cancer Center, Department of Genomic Medicine, Houston, TX, USA
| | - Michel Vidal
- University Montpellier, UMR5235, Montpellier, France
| | - Helena LA Vieira
- Universidade Nova de Lisboa, CEDOC, NOVA Medical School, Lisboa, Portugal
| | - Richard D Vierstra
- Washington University in St Louis, Department of Biology, St. Louis, MO, USA
| | - Nadarajah Vigneswaran
- University of Texas, Health Science Center at Houston, School of Dentistry, Houston, TX, USA
| | - Neeraj Vij
- Central Michigan University, College of Medicine, Mt. Pleasant, MI, USA
| | - Miquel Vila
- Autonomous University of Barcelona (UAB), Department of Biochemistry and Molecular Biology, Barcelona, Spain
- Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
- Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-CIBERNED, Barcelona, Spain
| | - Margarita Villar
- SaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ciudad Real, Spain
| | - Victor H Villar
- INSERM U916, Université de Bordeaux, Institut Européen de Chimie et Biologie, Pessac, France
| | - Joan Villarroya
- Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Institute for Aging Studies, Bronx, NY, USA
| | - Cécile Vindis
- University of Toulouse, INSERM UMR 1048, Toulouse, France
| | - Giampietro Viola
- University of Padova, Department of Woman's and Child's Health, Laboratory of Oncohematology, Padova, Italy
| | | | - Giovanni Vitale
- University of Milan, Istituto Auxologico Italiano, Department of Clinical Sciences and Community Health, Milan, Italy
| | - Dan T Vogl
- University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, USA
| | - Olga V Voitsekhovskaja
- Komarov Botanical Institute RAS, Plant Ecological Physiology Laboratory, Saint Petersburg, Russian Federation
| | - Clarissa von Haefen
- Charité - Universitätsmedizin Berlin, Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Berlin, Germany
| | | | - Daniel E Voth
- University of Arkansas for Medical Sciences, Department of Microbiology and Immunology, Little Rock, AR, USA
| | | | - Kristina Vuori
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
| | - Jatin M Vyas
- Massachusetts General Hospital, Division of Infectious Disease, Boston, MA, USA
| | - Christian Waeber
- University College Cork, School of Pharmacy, Department of Pharmacology and Therapeutics, Cork, Ireland
| | - Cheryl Lyn Walker
- Texas A&M Health Science Center, Institute of Biosciences and Technology, Houston, TX, USA
| | - Mark J Walker
- University of Queensland, Australian Infectious Diseases Research Centre and School of Chemistry and Molecular Biosciences, Brisbane, Queensland, Australia
| | - Jochen Walter
- University of Bonn, Department of Neurology, Bonn, Germany
| | - Lei Wan
- Asia University, Department of Biotechnology, Taichung, Taiwan
- China Medical University, School of Chinese Medicine, Taichung, Taiwan
| | - Xiangbo Wan
- Sixth Affiliated Hospital of Sun Yat-Sen University, Gastrointestinal Institute, Department of Radiation Oncology, Guangzhou, Guangdong, China
| | - Bo Wang
- Qilu Hospital of Shandong University, Department of Traditional Chinese Medicine, Jinan, China
| | - Caihong Wang
- Washington University, School of Medicine, Departments of Obstetrics and Gynecology, and Pathology and Immunology, St. Louis, MO, USA
| | - Chao-Yung Wang
- Chang Gung University, Chang Gung Memorial Hospital, Department of Cardiology, Internal Medicine, Taoyuan, Taiwan
| | - Chengshu Wang
- Chinese Academy of Sciences, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Shanghai, China
| | - Chenran Wang
- University of Cincinnati College of Medicine, Department of Cancer Biology, Cincinnati, OH, USA
| | - Chuangui Wang
- East China Normal University, School of Life Science, Shanghai, China
| | - Dong Wang
- Harbin Medical University, College of Bioinformatics Science and Technology, Harbin, Heilongjiang, China
| | - Fen Wang
- Texas A&M Health Science Center, Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Houston, TX, USA
| | - Fuxin Wang
- Chinese Academy of Sciences, Institute of Microbiology, Beijing, China
| | - Guanghui Wang
- Soochow University, College of Pharmaceutical Sciences, Jiangsu, China
| | - Hai-jie Wang
- Shanghai Medical School of Fudan University, Department of Anatomy, Histology and Embryology, Shanghai, China
| | - Haichao Wang
- North Shore University Hospital, Department of Emergency Medicine, Manhasset, NY, USA
| | - Hong-Gang Wang
- Pennsylvania State University, College of Medicine, Department of Pediatrics, Hershey, PA, USA
| | - Hongmin Wang
- University of South Dakota, Sanford School of Medicine, Division of Basic Biomedical Sciences, Vermillion, SD, USA
| | - Horng-Dar Wang
- National Tsing Hua University, Institute of Biotechnology, Institute of Systems Neuroscience, and Department of Life Science, HsinChu City, Taiwan
| | - Jing Wang
- University Montpellier 1, INSERM U1051, Montpellier, France
| | - Junjun Wang
- China Agricultural University, College of Animal Science and Technology, State Key Laboratory of Animal Nutrition, Beijing, China
| | - Mei Wang
- Duke-NUS Graduate Medical School, Cancer and Stem Cell Biology Program, Singapore
| | - Mei-Qing Wang
- Fourth Military Medical University, Department of Oral Anatomy and Physiology and TMD, College of Stomatology, Xi'an, China
| | - Pei-Yu Wang
- National Taiwan University, Graduate Institute of Brain and Mind Sciences, College of Medicine, Taipei, Taiwan
| | - Peng Wang
- Fudan University, Cancer Center, Department of Integrative Oncology, Shanghai, China
| | - Richard C Wang
- University of Texas, Southwestern Medical Center at Dallas, Department of Dermatology, Dallas, TX
| | - Shuo Wang
- Chinese Academy of Sciences, CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Beijing, China
| | - Ting-Fang Wang
- Academia Sinica, Institute of Molecular Biology, Taipei, Taiwan
| | - Xian Wang
- Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Department of Medical Oncology, Hangzhou, China
| | - Xiao-jia Wang
- Zhejiang Cancer Hospital, Department of Medical Oncology, Hangzhou, China
| | - Xiao-Wei Wang
- Zhejiang University, Institute of Insect Science, Hangzhou, China
| | - Xin Wang
- Brigham and Women's Hospital, Harvard Medical School, Department of Neurosurgery, Boston MA
| | - Xuejun Wang
- University of South Dakota, Vermillion, SD, USA
| | - Yan Wang
- Tsinghua University, School of Life Sciences, Beijing, China
| | - Yanming Wang
- Pennsylvania State University, Department of Biochemistry and Molecular Biology, Center for Eukaryotic Gene Regulation, University Park, PA, USA
| | - Ying Wang
- Beijing Jishuitan Hospital, Department of Molecular Orthopedics, Beijing Institute of Traumatology and Orthopedics, Beijing, China
| | - Ying-Jan Wang
- National Cheng Kung University, Medical College, Department of Environmental and Occupational Health, Tainan, Taiwan
| | - Yipeng Wang
- DZNE, German Center for Neurodegenerative Diseases, and CAESAR Research Center, Bonn, Germany
| | - Yu Wang
- University of Hong Kong, Department of Pharmacology and Pharmacy, Hong Kong, China
| | - Yu Tian Wang
- University of British Columbia, Department of Medicine and Brain Research Center,Vancouver, BC, Canada
| | - Yuqing Wang
- University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Zhi-Nong Wang
- Changzheng Hospital, The Second Military Medical University, Department of Cardiothoracic Surgery, Shanghai, China
| | | | - Carl Ward
- University of Birmingham, Institute of Biomedical Research, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Edgbaston, Birmingham, UK
| | - Diane McVey Ward
- University of Utah, School of Medicine, Department of Pathology, Salt Lake City, UT, USA
| | - Gary Warnes
- Queen Mary University of London, Blizard Institute, Flow Cytometry Core Facility, London, UK
| | - Hirotaka Watada
- Juntendo University, Graduate School of Medicine, Department of Metabolism and Endocrinology, Tokyo, Japan
| | - Yoshihisa Watanabe
- Kyoto Prefectural University of Medicine, Department of Basic Geriatrics, Kyoto, Japan
| | - Kei Watase
- Tokyo Medical and Dental University, Center for Brain Integration Research, Bunkyo, Tokyo, Japan
| | - Timothy E Weaver
- University of Cincinnati College of Medicine, Cincinnati Children's Research Foundation and Department of Pediatrics, Cincinnati, OH, USA
| | - Colin D Weekes
- University of Colorado Denver, Division of Medical Oncology, Department of Medicine, Aurora, CO, USA
| | - Jiwu Wei
- Nanjing University, Jiangsu Key Laboratory of Molecular Medicine, Medical School and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing, Jiangsu Province, China
| | - Thomas Weide
- University Hospital of Muenster, Department of Internal Medicine D, Molecular Nephrology, Muenster, Germany
| | - Conrad C Weihl
- Washington University, School of Medicine, Department of Neurology, St. Louis, MO, USA
| | - Günther Weindl
- Freie Universität Berlin, Institute of Pharmacy (Pharmacology and Toxicology), Berlin, Germany
| | - Simone Nardin Weis
- Universidade de Brasília, Departamento de Biologia Celular, Brasília, DF, Brazil
| | - Longping Wen
- University of Science and Technology of China, Anhui, China
| | - Xin Wen
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Yunfei Wen
- MD Anderson Cancer Center, Department of Cancer Biology, Houston, TX, USA
- MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA
| | | | | | - Anthony R White
- University of Melbourne, Department of Pathology, Parkville, Victoria, Australia
| | - Eileen White
- Rutgers University, The State University of New Jersey, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
| | - J Lindsay Whitton
- The Scripps Research Institute, Department of Immunology and Microbial Science, La Jolla, CA, USA
| | | | - Joëlle Wiels
- Université Paris-Sud, Université Paris-Saclay, UMR 8126CNRS, Institut Gustave Roussy, Villejuif, France
| | - Franziska Wild
- Mannheim University of Applied Sciences, Institute of Molecular and Cell Biology, Mannheim, Germany
| | - Manon E Wildenberg
- Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands
| | - Tom Wileman
- University of East Anglia, Norwich Medical School, Norfolk, UK
| | | | - Simon Wilkinson
- University of Edinburgh, Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK
| | - Dieter Willbold
- Forschungszentrum Juelich, ICS-6/Structural Biochemistry, Juelich, Germany
- Heinrich-Heine-University, Institut für Physikalische Biologie, Duesseldorf, Germany
| | - Chris Williams
- Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, The Netherlands
- University of Groningen, Molecular Cell Biology, Groningen, The Netherlands
| | - Katherine Williams
- US Food and Drug Administration, National Center for Toxicology Research, Division of Microbiology, Jefferson, AR, USA
| | - Peter R Williamson
- National Institutes of Health, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
| | - Konstanze F Winklhofer
- Ruhr University Bochum, Department of Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Bochum, Germany
| | - Steven S Witkin
- Weill Cornell Medical College, Department of Obstetrics and Gynecology, New York, NY, USA
| | - Stephanie E Wohlgemuth
- University of Florida, Department of Animal Sciences, IFAS/College of Agriculture and Life Science, Gainesville, FL, USA
| | - Thomas Wollert
- Max Planck Institute of Biochemistry, Molecular Membrane and Organelle Biology, Martinsried, Germany
| | - Ernst J Wolvetang
- University of Queensland, Australian Institute for Bioengineering and Nanotechnology (AIBN), Brisbane, Australia
| | - Esther Wong
- Nanyang Technological University, School of Biological Sciences, Singapore
| | - G William Wong
- Johns Hopkins University, School of Medicine, Department of Physiology and Center for Metabolism and Obesity Research, Baltimore, MD, USA
| | - Richard W Wong
- Kanazawa University, Cell-bionomics Unit and Laboratory of Molecular and Cellular Biology, Department of Biology, Faculty of Natural Systems, Institute of Science and Engineering, Ishikawa, Japan
| | - Vincent Kam Wai Wong
- Macau University of Science and Technology, State Key Laboratory of Quality Research in Chinese Medicine, Macau, China
| | - Elizabeth A Woodcock
- Baker IDI Heart and Diabetes Institute, Molecular Cardiology Laboratory, Melbourne, Australia
| | - Karen L Wright
- Lancaster University, Faculty of Health and Medicine, Division of Biomedical and Life Sciences, Lancaster, UK
| | - Chunlai Wu
- Louisiana State University Health Sciences Center, Neuroscience Center of Excellence, New Orleans, LA, USA
| | - Defeng Wu
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Gen Sheng Wu
- Wayne State University, School of Medicine, Departments of Oncology and Pathology, Detroit, MI, USA
| | - Jian Wu
- Fudan University Shanghai Medical College, Key Laboratory of Molecular Virology, Shanghai, China
| | - Junfang Wu
- University of Maryland, School of Medicine, Department of Anesthesiology and Center for Shock, Trauma and Anesthesiology Research (STAR), National Study Center for Trauma and EMS, Baltimore, MD, USA
| | - Mian Wu
- University of Science and Technology of China, School of Life Sciences, Hefei, Anhui, China
| | - Min Wu
- University of North Dakota, Department of Biomedical Sciences, School of Medicine and Health Sciences, Grand Forks, ND, USA
| | - Shengzhou Wu
- Wenzhou Medical University, School of Optometry and Ophthalmology and Eye Hospital, Wenzhou, Zhejiang, China
| | - William KK Wu
- Chinese University of Hong Kong, Department of Anaesthesia and Intensive Care, Hong Kong
| | - Yaohua Wu
- The First Affiliated Hospital of Harbin Medical University, Key Laboratory of Hepatosplenic Surgery, Department of General Surgery, Harbin, China
| | - Zhenlong Wu
- China Agricultural University, Department of Animal Nutrition and Feed Science, Beijing, China
| | - Cristina PR Xavier
- University of Porto, Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology, Porto, Portugal
- University of Porto, i3S-Instituto de Investigação e Inovação em Saúde, Porto, Portugal
| | | | - Gui-Xian Xia
- Chinese Academy of Sciences, Institute of Microbiology, Beijing, China
| | - Tian Xia
- University of California Los Angeles, Department of Medicine, Los Angeles, CA, USA
| | - Weiliang Xia
- Shanghai Jiao Tong University, School of Biomedical Engineering and Med-X Research Institute, Shanghai, China
- Shanghai Jiao Tong University, State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai, China
| | - Yong Xia
- The Third Affiliated Hospital of Guangzhou Medical University, Department of Clinical Laboratory Medicine, Guangzhou, Guangdong, China
| | - Hengyi Xiao
- Sichuan University, Aging Research Group, State Key Lab for Biotherapy, West China Hospital, Chengdu, China
| | - Jian Xiao
- Second Military Medical University, Department of Cardiothoracic Surgery, Changzheng Hospital, Shanghai, China
| | - Shi Xiao
- Sun Yat-Sen University, State Key Laboratory of Biocontrol, School of Life Sciences, Guangzhou, China
| | - Wuhan Xiao
- Chinese Academy of Sciences, Institute of Hydrobiology, Wuhan, Hubei, China
| | - Chuan-Ming Xie
- University of Michigan, Department of Radiation Oncology, Ann Arbor, MI, USA
| | - Zhiping Xie
- Shanghai Jiao Tong University, School of Life Sciences and Biotechnology, Shanghai, China
| | - Zhonglin Xie
- University of Oklahoma, Health Sciences Center, Section of Molecular Medicine, Department of Medicine, Oklahoma City, OK, USA
| | - Maria Xilouri
- Biomedical Research Foundation of the Academy of Athens, Center of Clinical, Experimental Surgery and Translational Research, Athens, Greece
| | - Yuyan Xiong
- University of Fribourg, Department of Medicine, Division of Physiology, Fribourg, Switzerland
| | - Chuanshan Xu
- Chinese University of Hong Kong, School of Chinese Medicine, Faculty of Medicine, Shatin, NT, Hong Kong
| | - Congfeng Xu
- Shanghai Jiao Tong University, School of Medicine, Shanghai Institute of Immunology, Shanghai, China
| | - Feng Xu
- Fudan University, Department of Neurosugery, Shanghai, China
| | - Haoxing Xu
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
| | - Hongwei Xu
- Harbin Medical University, Department of Immunology, Heilongjiang Provincial Key Laboratory for Infection and Immunity, Harbin, China
| | - Jian Xu
- University of Oklahoma Health Sciences Center, Department of Medicine, Oklahoma City, OK, USA
| | - Jianzhen Xu
- Shantou University Medical College, Department of Biochemistry and Molecular Biology, Shantou, China
| | - Jinxian Xu
- Georgia Regents University, Medical College of Georgia, Department of Cellular Biology and Anatomy, Augusta, GA, USA
- Georgia Regents University, Medical College of Georgia, Department of Medicine, Augusta, GA, USA
| | - Liang Xu
- University of Kansas and University of Kansas Cancer Center, Departments of Molecular Biosciences and Radiation Oncology, Lawrence, KS, USA
| | | | - Yangqing Xu
- Harvard Medical School, Department of Cell Biology, Boston, MA, USA
| | - Ye Xu
- Jilin Medical University, Medical Research Laboratory, Jilin City, Jilin Province, China
| | - Zhi-Xiang Xu
- University of Alabama at Birmingham, Department of Medicine, Division of Hematology and Oncology, Comprehensive Cancer Center, Birmingham, AL, USA
| | - Ziheng Xu
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Yu Xue
- Huazhong University of Science and Technology, Department of Biomedical Engineering, College of Life Science and Technology, Wuhan, Hubei, China
| | - Takahiro Yamada
- Hokkaido University Graduate School of Medicine, Department of Obstetrics and Gynecology, Sapporo, Hokkaido, Japan
| | - Ai Yamamoto
- Columbia University, Department of Neurology, New York, NY, USA
| | - Koji Yamanaka
- Nagoya University, Research Institute of Environmental Medicine, Nagoya, Aichi, Japan
| | - Shunhei Yamashina
- Juntendo University, School of Medicine, Department of Gastroenterology, Tokyo, Japan
| | - Shigeko Yamashiro
- Rutgers University, Molecular Biology and Biochemistry, Piscataway, NJ, USA
| | - Bing Yan
- Shandong University, School of Chemistry and Chemical Engineering, Jinan, Shandong, China
| | - Bo Yan
- Jining Medical University, Shandong Provincial Sino-US Cooperation Research Center for Translational Medicine, Shandong, China
| | - Xianghua Yan
- Huazhong Agricultural University, College of Animal Sciences and Technology, Wuhan, Hubei, China
| | - Zhen Yan
- University of Virginia, Charlottesville, VA, USA
| | - Yasuo Yanagi
- Singapore Eye Research Institute, Singapore National Eye Center, Singapore
| | - Dun-Sheng Yang
- New York University Langone Medical Center, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA
| | - Jin-Ming Yang
- Pennsylvania State University, College of Medicine, Department of Pharmacology, Pennsylvania State University Hershey Cancer Institute, Hershey, PA, USA
| | - Liu Yang
- The Fourth Military Medical University, Institute of Orthopaedics, Xijing Hospital, Xi'an, Shanxi, China
| | - Minghua Yang
- Central South University, Department of Pediatrics, Xiangya Hospital, Changsha, Hunan, China
| | - Pei-Ming Yang
- Taipei Medical University, Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei, Taiwan
| | - Peixin Yang
- University of Maryland, School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Baltimore, MD, USA
| | - Qian Yang
- The Fourth Military Medical University, Xi'an, China
| | - Wannian Yang
- Geisinger Clinic, Weis Center for Research, Danville, PA, USA
| | - Wei Yuan Yang
- Academia Sinica, Institute of Biological Chemistry, Taipei, Taiwan
| | - Xuesong Yang
- Jinan University, Medical College, Division of Histology and Embryology, Guangzhou, Guangdong, China
| | - Yi Yang
- Hangzhou Normal University, Department of Pharmacology, School of Medicine, Hangzhou, China
| | - Ying Yang
- Shanghai Jiao Tong University, Department of Endocrinology and Metabolism, Affiliated Sixth People's Hospital, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai, China
| | - Zhifen Yang
- Stanford University, Department of Radiation Oncology, Stanford, CA, USA
| | - Zhihong Yang
- University of Fribourg, Department of Medicine, Division of Physiology, Faculty of Science, Fribourg, Switzerland
| | - Meng-Chao Yao
- Academia Sinica, Institute of Molecular Biology, Taipei, Taiwan
| | - Pamela J Yao
- National Institutes of Health, National Institute on Aging, Biomedical Research Center, Laboratory of Neurosciences, Baltimore, MD, USA
| | - Xiaofeng Yao
- Dalian Medical University, Department of Environmental and Occupational Hygiene, Dalian, China
| | - Zhenyu Yao
- Chinese Academy of Sciences, Shenzhen Institutes of Advanced Technology, Guangdong, China
| | - Zhiyuan Yao
- University of Michigan, Department of Molecular, Cellular, and Developmental Biology, Ann Arbor, MI, USA
- University of Michigan, Life Sciences Institute, Ann Arbor, MI, USA
| | - Linda S Yasui
- Northern Illinois University, Department of Biological Sciences, DeKalb, IL, USA
| | - Mingxiang Ye
- Fourth Military Medical University, Department of Biochemistry and Molecular Biology, Xi'an, China
| | | | - Behzad Yeganeh
- University of Toronto, Hospital for Sick Children Research Institute, Department of Physiology and Experimental Medicine, Toronto, Canada
| | - Elizabeth S Yeh
- Medical University of South Carolina, Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Charleston, SC, USA
| | | | - Fan Yi
- Shandong University, School of Medicine, Department of Pharmacology, Jinan, Shandong Province, China
| | - Long Yi
- Third Military Medical University, Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Chongqing, China
| | - Xiao-Ming Yin
- Indiana University School of Medicine, Department of Pathology and Laboratory Medicine, Indianapolis, IN, USA
| | - Calvin K Yip
- University of British Columbia, Department of Biochemistry and Molecular Biology, Vancouver, British Columbia, Canada
| | - Yeong-Min Yoo
- Yonsei University, Department of Biomedical Engineering, College of Health Science, Seoul, Korea
| | - Young Hyun Yoo
- Dong-A University, College of Medicine and Mitochondria Hub Regulation Center, Department of Anatomy and Cell Biology, Busan, Korea
| | - Seung-Yong Yoon
- University of Ulsan College of Medicine, Department of Brain Science, Seoul, Korea
| | | | - Tamotsu Yoshimori
- Osaka University, Department of Genetics, Graduate School of Medicine, Laboratory of Intracellular Membrane Dynamics, Graduate School of Frontier Biosciences, Osaka, Japan
| | - Ken H Young
- University of Texas, MD Anderson Cancer Center, Department of Hematopathology, Houston, TX, USA
| | - Huixin Yu
- Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, China
| | - Jane J Yu
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Jin-Tai Yu
- Qingdao University, Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao, Shandong Province, China
| | - Jun Yu
- Chinese University of Hong Kong, Institute of Digestive Diseases, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Hong Kong
| | - Li Yu
- Tsinghua University, State Key Laboratory of Biomembrane and Membrane Biotechnology, Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Science, Beijing, China
| | - W Haung Yu
- Columbia University, Taub Institute for Alzheimer's Disease Research, Department of Pathology and Cell Biology, New York, NY, USA
| | - Xiao-Fang Yu
- First Hospital of Jilin University, Changchun, Jilin, China
| | - Zhengping Yu
- Third Military Medical University, Department of Occupational Health, Chongqing, China
| | - Junying Yuan
- Harvard Medical School, Department of Cell Biology, Boston, MA, USA
| | - Zhi-Min Yuan
- Harvard University, School of Public Health, Department of Genetics and Complex Diseases, Boston, MA, USA
| | - Beatrice YJT Yue
- University of Illinois at Chicago, College of Medicine, Department of Ophthalmology and Visual Sciences, Chicago, IL, USA
| | - Jianbo Yue
- City University of Hong Kong, Department of Biomedical Sciences, Kowloon Tong, Hong Kong, China
| | - Zhenyu Yue
- Icahn School of Medicine at Mount Sinai, Friedman Brain Institute, New York, NY, USA
| | - David N Zacks
- University of Michigan, Department of Ophthalmology and Visual Sciences, Ann Arbor, MI, USA
| | - Eldad Zacksenhaus
- Toronto General Research Institute - University Health Network, Division of Advanced Diagnostics, Toronto, Ontario, Canada
| | - Nadia Zaffaroni
- Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Experimental Oncology and Molecular Medicine, Milan, Italy
| | - Tania Zaglia
- University of Padova, Venetian Institute of Molecular Medicine, Department of Biomedical Science, Padova, Italy
| | - Zahra Zakeri
- Queens College of the City University of New York, Department of Biology, Flushing, NY, USA
| | - Vincent Zecchini
- MRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK
| | - Jinsheng Zeng
- Sun Yat-Sen University, Department of Neurology and Stroke Center, The First Affiliated Hospital, Guangzhou, China
| | - Min Zeng
- The People's Hospital of Hainan Province, Medical Care Center, Haikou, Hainan, China
| | - Qi Zeng
- A*STAR (Agency for Science, Technology and Research), Institute of Molecular and Cell Biology, Singapore
| | - Antonis S Zervos
- University of Central Florida College of Medicine, Burnett School of Biomedical Sciences, Orlando, FL, USA
| | - Donna D Zhang
- University of Arizona, Department of Pharmacology and Toxicology, College of Pharmacy, Tucson, AZ, USA
| | - Fan Zhang
- Vancouver Prostate Centre,Vancouver, BC, Canada
| | - Guo Zhang
- The People's Hospital of Guangxi Zhuang Autonomous Region, Department of Gastroenterology, Nanning, Guangxi, China
| | - Guo-Chang Zhang
- University of Illinois at Urbana-Champaign, Institute for Genomic Biology, Urbana, IL, USA
| | - Hao Zhang
- Shantou University Medical College, Cancer Research Center, Shantou, Guangdong, China
| | - Hong Zhang
- Chinese Academy of Sciences, Institute of Biophysics, State Key Laboratory of Biomacromolecules, Beijing, China
| | - Hong Zhang
- Peking University First Hospital, Renal Division, Beijing, China
| | - Hongbing Zhang
- Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Physiology, Institute of Basic Medical Sciences, Beijing, China
- Peking University First Hospital, Department of Internal Medicine, Beijing, China
| | - Jian Zhang
- Fourth Military Medical University, Department of Biochemistry and Molecular Biology, Xi'an, China
| | - Jian Zhang
- Fourth Military Medical University, Department of Pulmonary Medicine, Xijing Hospital, Xi'an, Shaanxi Province, China
| | - Jiangwei Zhang
- Texas A&M University Health Science Center, Center for Translational Cancer Research, Institute of Biosciences and Technology, Houston, TX, USA
| | - Jianhua Zhang
- University of Alabama at Birmingham, Department of Pathology, Birmingham, AL, USA
| | - Jing-pu Zhang
- Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Medicinal Biotechnology, Beijing, China
| | - Li Zhang
- Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, China
| | - Lin Zhang
- University of Pennsylvania, Department of Obstetrics and Gynecology; Perelman School of Medicine, Philadelphia, PA, USA
| | - Lin Zhang
- University of Pittsburgh, School of Medicine, Department of Pharmacology and Chemical Biology, Pittsburgh, PA, USA
| | - Long Zhang
- Zhejiang University, Life Sciences Institute, Zhejiang, China
| | - Ming-Yong Zhang
- Chinese Academy of Sciences, South China Botanical Garden, Guangzhou, China
| | - Xiangnan Zhang
- Fudan University, Cancer Center, Department of Integrative Oncology, Shanghai, China
| | - Xu Dong Zhang
- University of Newcastle, School of Biomedical Sciences and Pharmacy, Newcastle, NSW, Australia
| | - Yan Zhang
- Shandong Agricultural University, State Key Laboratory of Crop Science, Tai'an, China
| | - Yang Zhang
- University of Houston, College of Pharmacy, Pharmacological and Pharmaceutical Sciences, Houston, TX, USA
| | - Yanjin Zhang
- University of Maryland, Department of Veterinary Medicine, College Park, MD, USA
| | - Yingmei Zhang
- University of Wyoming, School of Pharmacy, College of Health Sciences, Laramie, WY, USA
- Xijing Hospital, The Fourth Military Medical University, Xi'an, China
| | - Yunjiao Zhang
- University of Science and Technology of China, Anhui, China
| | - Mei Zhao
- Xi'an Jiaotong University Health Center, Department of Pharmacology, Xi'an, Shaanxi, China
| | - Wei-Li Zhao
- Shanghai Jiao Tong University, School of Medicine, State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Shanghai Rui Jin Hospital, Shanghai, China
| | - Xiaonan Zhao
- Shanghai Jiao Tong University, School of Medicine, Shanghai Institute of Immunology, Shanghai, China
| | - Yan G Zhao
- Chinese Academy of Sciences, State Key Laboratory of Biomacromolecules, Institute of Biophysics, Beijing, China
| | - Ying Zhao
- Peking University, Health Science Center, Department of Biochemistry and Molecular Biology, Beijing, China
| | - Yongchao Zhao
- University of Michigan, Department of Radiation Oncology, Division of Radiation and Cancer Biology, Ann Arbor, MI, USA
| | - Yu-xia Zhao
- Qilu Hospital of Shandong University, Department of Traditional Chinese Medicine, Jinan, China
| | - Zhendong Zhao
- Chinese Academy of Medical Sciences and Peking Union Medical College, MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Beijing, China
| | - Zhizhuang J Zhao
- University of Oklahoma Health Sciences Center, Department of Pathology, Oklahoma City, OK, USA
| | - Dexian Zheng
- Chinese Academy of Medical Sciences and Peking Union Medical College, National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Beijing, China
| | - Xi-Long Zheng
- University of Calgary, Department of Biochemistry and Molecular Biology, Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada
| | - Xiaoxiang Zheng
- Zhejiang University, Department of Biomedical Engineering, Qiushi Academy for Advanced Studies, Hangzhou, China
| | - Boris Zhivotovsky
- Institute of Environmental Medicine, Division of Toxicology, Karolinska Institute, Stockholm, Sweden
- Lomonosov Moscow State University, Faculty of Basic Medicine, Moscow, Russia
| | - Qing Zhong
- University of Texas, Department of Biochemistry, Dallas, TX, USA
- University of Texas, Southwestern Medical Center, Department of Internal Medicine, Center for Autophagy Research, Dallas, TX, USA
| | - Guang-Zhou Zhou
- Henan University of Technology, College of Bioengineering, Zhengzhou, Henan Province, China
| | - Guofei Zhou
- University of Illinois at Chicago, College of Medicine, Department of Pediatrics, Chicago, IL, USA
| | - Huiping Zhou
- Virginia Commonwealth University, Department of Microbiology and Immunology, Richmond, VA, USA
| | - Shu-Feng Zhou
- University of South Florida, Department of Pharmaceutical Science, Tampa, FL, USA
| | - Xu-jie Zhou
- Peking University First Hospital, Renal Division, Beijing, China
- Peking University, Department of Medicine, Beijing, China
- Peking University, Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education, Beijing, China
| | - Hongxin Zhu
- Shanghai Jiao Tong University, Bio-X Institutes, Shanghai, China
| | - Hua Zhu
- Ohio State University, Department of Surgery, Davis Heart and Lung Research Institute, Columbus, OH, USA
| | - Wei-Guo Zhu
- Peking University, Health Science Center, Department of Biochemistry and Molecular Biology, Beijing, China
| | - Wenhua Zhu
- Xi'an Jiaotong University Health Science Center, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shaanxi, China
| | - Xiao-Feng Zhu
- Sun Yat-Sen University, State Key Laboratory of Oncology in South China, Cancer Center, Guangzhou, China
| | - Yuhua Zhu
- China Agricultural University, College of Animal Science and Technology, State Key Laboratory of Animal Nutrition, Beijing, China
| | - Shi-Mei Zhuang
- Sun Yat-Sen University, School of Life Sciences, Guangzhou, China
| | - Xiaohong Zhuang
- Chinese University of Hong Kong, School of Life Science, Centre for Cell and Developmental Biology and State Key Laboratory of Agrobiotechnology, Sha Tin, Hong Kong
| | - Elio Ziparo
- Sapienza University of Rome, DAHFMO-Section of Histology, Rome, Italy
| | - Christos E Zois
- Oxford University, Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Molecular Oncology Laboratories, Oxford, UK
| | - Teresa Zoladek
- Polish Academy of Sciences, Institute of Biochemistry and Biophysics, Warsaw, Poland
| | - Wei-Xing Zong
- Stony Brook University, Department of Molecular Genetics and Microbiology, Stony Brook, NY, USA
| | - Antonio Zorzano
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain
- Universitat de Barcelona, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Barcelona, Spain
| | - Susu M Zughaier
- Emory University, School of Medicine, Department of Microbiology and Immunology, Atlanta, GA, USA
| |
Collapse
|
47
|
Ramachandran IR, Condamine T, Lin C, Herlihy SE, Garfall A, Vogl DT, Gabrilovich DI, Nefedova Y. Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy. Cancer Lett 2015; 371:117-24. [PMID: 26639197 DOI: 10.1016/j.canlet.2015.10.040] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Revised: 10/05/2015] [Accepted: 10/07/2015] [Indexed: 10/22/2022]
Abstract
Multiple myeloma (MM) is an incurable cancer of plasma cells localized preferentially in the bone marrow (BM). Resistance to chemotherapy represents one of the main challenges in MM management. BM microenvironment is known to play a critical role in protection of MM cells from chemotherapeutics; however, mechanisms responsible for this effect are largely unknown. Development of MM is associated with accumulation of myeloid-derived suppressor cells (MDSCs) mostly represented by pathologically activated relatively immature polymorphonuclear neutrophils (PMN-MDSCs). Here, we investigated whether PMN-MDSCs are responsible for BM microenvironment-mediated MM chemoresistance. Using in vivo mouse models allowing manipulation of myeloid cell number, we demonstrated a critical role for myeloid cells in MM growth and chemoresistance. PMN-MDSCs isolated from MM-bearing host are immunosuppressive and thus, functionally distinct from their counterpart in tumor-free host neutrophils. We found, however, that both PMN-MDSCs and neutrophils equally promote MM survival from doxorubicin and melphalan and that this effect is mediated by soluble factors rather than direct cell-cell contact. Our data indicate that targeting PMN-MDSCs would enhance chemotherapy efficacy in MM.
Collapse
Affiliation(s)
- Indu R Ramachandran
- Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - Thomas Condamine
- Translational Tumor Immunology Program, The Wistar Institute, Philadelphia, PA, USA; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - Cindy Lin
- Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA
| | - Sarah E Herlihy
- Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA
| | - Alfred Garfall
- Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| | - Dan T Vogl
- Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| | - Dmitry I Gabrilovich
- Translational Tumor Immunology Program, The Wistar Institute, Philadelphia, PA, USA; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - Yulia Nefedova
- Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA, USA; Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
| |
Collapse
|
48
|
Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol 2015; 2:e408-16. [PMID: 26686042 DOI: 10.1016/s2352-3026(15)00151-9] [Citation(s) in RCA: 140] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2015] [Revised: 08/05/2015] [Accepted: 08/06/2015] [Indexed: 10/23/2022]
Abstract
BACKGROUND Financial toxicity is increasingly recognised as adversely affecting the quality of life and medication adherence in patients with cancer in the USA. Patients with multiple myeloma might be particularly vulnerable because of high use of novel treatments and extended treatment duration. METHODS Between Aug 18, 2014, and Jan 7, 2015, we did a cross-sectional survey of individuals receiving at least 3 months of ongoing treatment for multiple myeloma at a tertiary academic medical centre in the USA. The survey was derived from previous reported studies and included the 11-item COST measure (financial toxicity score range 0-44). A paper survey was offered to eligible patients on arrival for routine follow-up visits, and participants were asked to complete the survey before or after their visit to the clinic. Insurance and treatment data were obtained from patients' electronic health records. FINDINGS Of 111 patients approached for the study, 100 individuals completed the survey. 59 (59%) of 100 patients reported that treatment costs were higher than expected, 70 (71%) of 99 had at least minor financial burden, and 36 (36%) of 100 reported applying for financial assistance. Use of savings to pay for myeloma treatment was common (43 [46%] of 94 patients) and 21 (21%) of 98 individuals borrowed money to pay for medications. COST scores were highly correlated with patient-reported use of strategies to cope with myeloma treatment expenses. On multivariable analysis, younger age (correlation coefficient β 0·36, 95% CI 0·15 to 0·56, p=0·00092), non-married status (5·6, 1·5 to 9·6, p=0·0074), longer duration since diagnosis (-4·8, -9·3 to -0·2, p=0·042), and lower household income (US$40 000-79 999: 7·8, 2·7 to 12·9, p=0·0031; ≥$80 000: 11·8, 7·1 to 16·4, p<0·0001) were associated with higher financial burden as measured with the COST score. INTERPRETATION Patient-reported financial toxicity and use of coping mechanisms were common in our insured population with multiple myeloma. Additional attention to rising treatment costs and cost sharing is needed to address the increasing evidence of financial toxicity affecting patients with cancer. FUNDING University of Pennsylvania Perelman School of Medicine.
Collapse
Affiliation(s)
- Scott F Huntington
- Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
| | - Brendan M Weiss
- Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| | - Dan T Vogl
- Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| | - Adam D Cohen
- Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| | - Alfred L Garfall
- Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| | - Patricia A Mangan
- Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| | - Jalpa A Doshi
- Division of General Internal Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Edward A Stadtmauer
- Division of Hematology-Oncology, Division of Internal Medicine and the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
49
|
D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol 2015; 33:3741-9. [PMID: 26371138 DOI: 10.1200/jco.2015.62.4015] [Citation(s) in RCA: 134] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
PURPOSE Autologous hematopoietic cell transplantation, or autotransplantation, is effective in light-chain amyloidosis (AL), but it is associated with a high risk of early mortality (EM). In a multicenter randomized comparison against oral chemotherapy, autotransplantation was associated with 24% EM. We analyzed trends in outcomes after autologous hematopoietic cell transplantation for AL in North America. PATIENTS AND METHODS Between 1995 and 2012, 1,536 patients with AL who underwent autotransplantation at 134 centers were identified in the Center for International Blood and Marrow Transplant Research database. EM and overall survival (OS) were analyzed in three time cohorts: 1995 to 2000 (n = 140), 2001 to 2006 (n = 596), and 2007 to 2012 (n = 800). Hematologic and renal responses and factors associated with EM, relapse and/or progression, progression-free survival and OS were analyzed in more recent subgroups from 2001 to 2006 (n = 197) and from 2007 to 2012 (n = 157). RESULTS Mortality at 30 and 100 days progressively declined over successive time periods from 11% and 20%, respectively, in 1995 to 2000 to 5% and 11%, respectively, in 2001 to 2006, and to 3% and 5%, respectively, in 2007 to 2012. Correspondingly, 5-year OS improved from 55% in 1995 to 2000 to 61% in 2001 to 2006 and to 77% in 2007 to 2012. Hematologic response to transplantation improved in the latest cohort. Renal response rate was 32%. Centers performing more than four AL transplantations per year had superior survival outcomes. In the multivariable analysis, cardiac AL was associated with high EM and inferior progression-free survival and OS. Autotransplantation in 2007 to 2012 and use of higher dosages of melphalan were associated with a lowered relapse risk. A Karnofsky score less than 80 and creatinine levels 2 mg/m(2) or greater were associated with worsened OS. CONCLUSION Post-transplantation survival in AL has improved, with a dramatic reduction in early post-transplantation mortality and excellent 5-year survival. The risk-benefit ratio for autotransplantation has changed, and randomized comparison with nontransplantation approaches is again warranted.
Collapse
Affiliation(s)
- Anita D'Souza
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Angela Dispenzieri
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Baldeep Wirk
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Mei-Jie Zhang
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Jiaxing Huang
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Morie A Gertz
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Robert A Kyle
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Shaji Kumar
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Raymond L Comenzo
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Robert Peter Gale
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Hillard M Lazarus
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Bipin N Savani
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Robert F Cornell
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Brendan M Weiss
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Dan T Vogl
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - César O Freytes
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Emma C Scott
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Heather J Landau
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Jan S Moreb
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Luciano J Costa
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Muthalagu Ramanathan
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Natalie S Callander
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Rammurti T Kamble
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Richard F Olsson
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Siddhartha Ganguly
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Taiga Nishihori
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Tamila L Kindwall-Keller
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - William A Wood
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Tomer M Mark
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| | - Parameswaran Hari
- Anita D'Souza, Mei-Jie Zhang, Jiaxing Huang, and Parameswaran Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin; Mei-Jie Zhang, Institute for Health and Society, Medical College of Wisconsin, Milwaukee; Natalie S. Callander, University of Wisconsin Carbone Cancer Center, Madison, WI; Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle, and Shaji Kumar, Mayo Clinic, Rochester, MN; Baldeep Wirk, Seattle Cancer Care Alliance, Seattle, WA; Raymond L. Comenzo, Tufts Medical Center, Boston; Muthalagu Ramanathan, University of Massachusetts Memorial Medical Center, Worcester, MA; Robert Peter Gale, Hematology Research Centre, Imperial College London, London, United Kingdom; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Bipin N. Savani and Robert F. Cornell, Vanderbilt University Medical Center, Nashville, TN; Brendan M. Weiss and Dan T. Vogl, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center San Antonio, San Antonio; Rammurti T. Kamble, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX; Emma C. Scott, Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Heather J. Landau, Memorial Sloan Kettering Cancer Center; Tomer M. Mark, Weill Cornell Medical College, New York, NY; Jan S. Moreb, Shands HealthCare and University of Florida, Gainesville; Taiga Nishihori, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Richard F. Olsson, Karolinska Institutet, Stockholm; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Tamila L. Kindwall-Keller, University of Virginia Health Sys
| |
Collapse
|
50
|
Garfall AL, Maus MV, Hwang WT, Lacey SF, Mahnke YD, Melenhorst JJ, Zheng Z, Vogl DT, Cohen AD, Weiss BM, Dengel K, Kerr NDS, Bagg A, Levine BL, June CH, Stadtmauer EA. Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma. N Engl J Med 2015; 373:1040-7. [PMID: 26352815 PMCID: PMC4646711 DOI: 10.1056/nejmoa1504542] [Citation(s) in RCA: 435] [Impact Index Per Article: 48.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
A patient with refractory multiple myeloma received an infusion of CTL019 cells, a cellular therapy consisting of autologous T cells transduced with an anti-CD19 chimeric antigen receptor, after myeloablative chemotherapy (melphalan, 140 mg per square meter of body-surface area) and autologous stem-cell transplantation. Four years earlier, autologous transplantation with a higher melphalan dose (200 mg per square meter) had induced only a partial, transient response. Autologous transplantation followed by treatment with CTL019 cells led to a complete response with no evidence of progression and no measurable serum or urine monoclonal protein at the most recent evaluation, 12 months after treatment. This response was achieved despite the absence of CD19 expression in 99.95% of the patient's neoplastic plasma cells. (Funded by Novartis and others; ClinicalTrials.gov number, NCT02135406.).
Collapse
Affiliation(s)
- Alfred L Garfall
- From the Division of Hematology-Oncology, Department of Medicine (A.L.G., M.V.M., D.T.V., A.D.C., B.M.W., E.A.S.), Department of Biostatistics and Epidemiology (W.-T.H.), Department of Pathology and Laboratory Medicine (S.F.L., Y.D.M., J.J.M., Z.Z., A.B., B.L.L., C.H.J.), and Abramson Cancer Center (A.L.G., M.V.M., W.-T.H., S.F.L., Y.D.M., J.J.M., Z.Z., D.T.V., A.D.C., B.M.W., K.D., N.D.S.K., A.B., B.L.L., C.H.J., E.A.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|